PCDC Data Model `2.0`

Schema IDhttps://models.d4cg.org/pcdc

LicenseCC BY-NC 4.0

Concepts38 classes · 700 slots · 351 enums

Community ·

View

Scope Matrix

Class Inclusion by View

Domain	Class	ALL	AML	CNS	EWS	FA	FPRH	GCT	HL	LS	LT	NBL	NPC	NRSTS	OS	PRE	RB	RMS
Demographics	ClinicalEpisode
Demographics	Consult
Demographics	ExternalReference
Demographics	FamilyMedicalHistory
Demographics	MedicalHistory
Demographics	OffProtocolTherapyOrStudy
Demographics	SocialAndBehavioralDeterminantsOfHealth
Demographics	StudyMetadata
Demographics	StudySubgroupAssignment
Demographics	Subject
Demographics	SurvivalCharacteristics
Disease Attributes	Diagnosis
Disease Attributes	DiseaseCharacteristics
Disease Attributes	DiseaseSiteAssessment
Disease Attributes	Staging
Intervention	CellularImmunotherapy
Intervention	FertilityProcedures
Intervention	LocoregionalTherapy
Intervention	Medication
Intervention	ProtocolTreatmentModifications
Intervention	RadiationTherapy
Intervention	StemCellTransplant
Intervention	SurgicalProcedures
Intervention	TransfusionMedicineProcedure
Monitoring	AdverseEvents
Monitoring	LateEffects
Monitoring	MinimalResidualDisease
Monitoring	PatientReportedOutcomesMetadata
Monitoring	ReproductiveOutcomes
Monitoring	SubjectResponse
Monitoring	SubsequentMalignantNeoplasm
Testing	Biospecimen
Testing	FunctionTest
Testing	GeneticAnalysis
Testing	Immunohistochemistry
Testing	LaboratoryTest
Testing	VitalsAndAnthropometrics

Rendered Raw

Demographics

Demographics contains subject identity, enrollment, study participation, longitudinal episode structure, survival status, family and medical history, and other contextual information needed to interpret records across the model.

Subject

Subject represents an enrolled or contributed study participant and captures core identifiers, contributor context, disease group membership, demographic attributes, ancestry-related fields, and selected follow-up status fields.

Diagram

Slot	Description	Range
person	This is an example description that needs to be long in order to determine if the content is being properly clipped and extended in a dropdown when selected by the user.	`Person`
honest_broker_subject_id		`string`
data_contributor_id
consortium
disease_group
sex
race
race_identification_source
race_other		`string`
race_specified
ethnicity
ethnicity_other		`string`
ethnicity_specified
country		`string`
ashkenazi_jewish_ancestry
efs_censor_status
age_at_censor_status		`integer`
proband_status

ExternalReference

ExternalReference captures links between a PCDC subject and identifiers or URLs in external resources, enabling cross-resource navigation and provenance for linked data assets.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
external_links		`string`
external_resource_icon_path		`string`
external_resource_id		`string`
external_resource_name		`string`
external_subject_id		`string`
external_subject_submitter_id		`string`
external_subject_url		`string`

StudyMetadata

StudyMetadata describes the study, registry, trial, institutional database, or other data source context in which a subject or cohort was enrolled or represented.

Slot	Description	Range
study_id
enrolled_status
age_at_enrollment		`integer`
year_at_enrollment		`integer`
study_age_precision
data_source
study_phase
study_type
urls		`string`

StudySubgroupAssignment

StudySubgroupAssignment captures a subject's assignment to study strata, treatment arms, risk groups, or other protocol-defined subgroups, including ordering and randomization context where applicable.

Diagram

Slot	Description	Range
subject		`Subject`
honest_broker_subject_id		`string`
study		`StudyMetadata`
study_id
subgroup_type
subgroup_name
subgroup_assignment_order		`integer`
age_at_subgroup_assignment		`integer`
randomized

ClinicalEpisode

ClinicalEpisode represents a longitudinal time period such as a disease phase, treatment course, exam, or related episode used to organize observations across diagnosis, treatment, monitoring, and follow-up.

Diagram

Slot	Description	Range
episode_submitter_id
subject		`Subject`
honest_broker_subject_id		`string`
episode_type
disease_phase
course
exam_type
episode_number		`integer`
episode_sequence		`integer`
age_at_start		`integer`
year_at_start		`integer`
age_at_end		`integer`
age_at_course_anc_500		`integer`
age_precision
parent_episode		`ClinicalEpisode`
parent_episode_id		`string`

Consult

Consult captures fertility preservation consultation details, including eligibility, reasons for declining consultation or preservation, participants in the consult, interpreter use, insurance type, and consult outcome.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_fertility_consult		`integer`
fertility_consult_eligibility
fertility_consult_ineligible_reason
reason_declined_fertility_consult		`string`
reason_declined_fertility_preservation
fertility_consult_who_present
fertility_consult_outcome
interpreter_used
insurance_type

OffProtocolTherapyOrStudy

OffProtocolTherapyOrStudy records when and why a subject went off protocol therapy, off study, or transitioned to another study, preserving study participation and treatment-discontinuation context.

Diagram

Slot	Description	Range
subject		`Subject`
honest_broker_subject_id		`string`
episode		`ClinicalEpisode`
episode_submitter_id
age_off		`integer`
off_type
reason_off
reason_off_other		`string`
another_study

SurvivalCharacteristics

SurvivalCharacteristics captures last-known survival status, follow-up timing, disease status at last contact, cause of death, and treatment-related mortality details.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_lkss		`integer`
age_lost_to_follow_up		`integer`
age_at_last_follow_up		`integer`
lkss
lkss_with_disease
cause_of_death
cause_of_death_other		`string`
trm_type
trm_type_other		`string`
cause_of_death_detail
cause_of_death_detail_other		`string`
cause_of_death_ranking

FamilyMedicalHistory

FamilyMedicalHistory captures relevant conditions, procedures, reproductive history, lineage, relationship, and survival information for family members or relatives when family history informs disease risk or interpretation.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
condition_state
family_medical_history_condition		`string`
relation
relation_lineage
lkss_of_relative
age_at_lkss_of_relative		`integer`
relative_sct_status
number_of_pregnancies		`integer`
number_of_live_births		`integer`
number_of_abortions		`integer`
laterality
family_medical_history_procedure
proband_generation
age_at_condition		`integer`
sex_at_birth
age_at_time_of_pedigree_creation		`integer`
year_at_pedigree_creation		`integer`

MedicalHistory

MedicalHistory records prior or concurrent conditions and selected background health factors for the subject, supporting interpretation of diagnosis, risk, treatment, and outcomes.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
age_at_condition		`integer`
condition_state
medical_history_condition
condition_other		`string`
assisted_conception

SocialAndBehavioralDeterminantsOfHealth

SocialAndBehavioralDeterminantsOfHealth captures selected social, behavioral, exposure, gender identity, occupation, marital, and religious-context variables that may influence care, risk, or outcomes.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_status		`integer`
gender_identity
exposure
exposure_status
sunscreen_use
occupation		`string`
marital_status
religion_type
religion_type_other		`string`

Testing

Testing contains laboratory, pathology, genomic, functional, anthropometric, and specimen-related observations used to characterize subjects, disease biology, eligibility, monitoring, and research sample availability.

VitalsAndAnthropometrics

VitalsAndAnthropometrics records physical measurements such as anthropometrics, vital measurements, measurement units, values, and gestational age at birth where relevant.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_measurement		`integer`
vital_measurement_type
anthropometric_measurement_type
result_text		`string`
result_numeric		`decimal`
vital_measurement_result_unit
anthropometric_measurement_result_unit
gestational_age_at_birth		`integer`

LaboratoryTest

LaboratoryTest captures laboratory assessments and results, including test status, method, specimen, text or numeric result values, units, thresholds, and disease-specific laboratory modifiers.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_lab		`integer`
laboratory_test_status
laboratory_test
laboratory_test_method
laboratory_test_specimen
laboratory_test_specimen_other		`string`
laboratory_result
result_text		`string`
result_numeric		`decimal`
laboratory_test_result_unit
traumatic_tap
quantification_type
threshold_level
threshold_high		`decimal`
threshold_low		`decimal`
pmid_ref		`decimal`
breakage_source_lab
bm_morphology
result_hormone_status

GeneticAnalysis

GeneticAnalysis captures germline and somatic genomic findings, testing context, specimens, methods, genes, variants, copy number, cytogenetic findings, HGVS expressions, significance, inheritance, and related genomic interpretation fields.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_genetic_analysis		`integer`
year_at_genetic_analysis		`integer`
review_source
determination_source
source_lab
test_name		`string`
test_version		`string`
gene_panel_size
cascade_testing
genetic_analysis_method
genetic_analysis_specimen
biological_analyte
source_pct
source_pct_numeric		`decimal`
genomic_source_class
mosaicism
mosaicism_percent		`decimal`
alteration_presence
alteration
alteration_type
alteration_effect
alteration_region
chromosome
chromosomal_translocation_partner
cytoband		`string`
iscn		`string`
gene		`string`
gene_fusion_partner		`string`
exon_number		`decimal`
hgvs_genomic_transcript		`string`
hgvs_genomic		`string`
hgvs_coding_transcript		`string`
hgvs_coding		`string`
hgvs_protein_transcript		`string`
hgvs_protein		`string`
reference_genome		`string`
reference_genome_accession		`string`
parental_status
inheritance_pattern
reported_significance
reported_significance_numeric		`integer`
reported_significance_other		`string`
external_ref_id_system
external_ref_id		`string`
copy_number		`decimal`
maf
maf_numeric		`decimal`
vaf_numeric		`decimal`
dna_index
dna_index_numeric		`decimal`
allelic_state
allele_count		`decimal`
allelic_ratio		`decimal`
clonal_status
cytodifferentiation
mitotic_rate
alt_status
founder_population
acmg_based_significance
karyotype_status
total_chromosomes		`decimal`
independent_aberrations		`decimal`
cells_in_metaphase		`decimal`
associated_condition

Biospecimen

Biospecimen describes collected or stored biospecimens, including specimen type, container, media, and available quantity, supporting specimen tracking and downstream research use.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
biospecimen_container_type		`string`
biospecimen_media		`string`
biospecimen_type		`string`
current_qty_unit		`string`
current_qty_value		`string`

FunctionTest

FunctionTest captures functional assessments such as audiology, pulmonary, cardiac, neurologic, or other function-related tests, including result values, units, laterality, grade, and frequency-specific measurements.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_function_test		`integer`
function_test
functional_measurement_type
result_text		`string`
result_numeric		`decimal`
functional_measurement_result_unit
function_test_laterality
hz_frequency
average_loss_low		`decimal`
average_loss_high		`decimal`
function_test_grade

Immunohistochemistry

Immunohistochemistry captures marker-level IHC testing, review source, age at assessment, and text or numeric results for pathology-based disease characterization.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_ihc		`integer`
review_source
markers
result_text		`string`
result_numeric		`decimal`
ihc_result_unit

Disease Attributes

Disease Attributes contains diagnostic, staging, anatomic, histologic, biologic, risk, extent-of-disease, and disease-site concepts used to characterize the subject's cancer or cancer-related condition.

Diagnosis

Diagnosis captures disease diagnosis and diagnostic assessment details, including timing, review source, diagnosis basis, diagnosis category, morphology, histology, disease-specific diagnostic flags, and transformation information.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_diag_assessment		`integer`
year_at_diagnosis		`integer`
age_at_diag_resolved		`integer`
review_source
determination_source
evaluator
diagnosis_site
laterality
diagnosis_category
diagnosis_basis
suspected_referring_diagnosis
diagnosis
mpal
mlds
tam
secondary_aml
result_text		`string`
result_numeric		`decimal`
path_morph_reporting		`string`
morph_code_text		`string`
morph_code		`string`
morph_code_system
morph_code_system_version		`string`
diagnosis_conf_source
transformation
transformation_conf_source
mature_glial_implants
somatic_malignancy_type
histology_grade
revised_inpc
histologic_features

Staging

Staging captures stage, group, TNM, disease extent, and staging-system details used to summarize disease burden and classification at a defined time point.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_staging		`integer`
review_source
staging_site
laterality
stage_category
tnm_finding
tnm_tumor_t
tnm_node_n
tnm_metastasis_m
tnm_overall
h_stage
group_system
group
stage_system
stage_system_version		`string`
stage
stage_text		`string`
disease_extent
ann_arbor_mod_ab
ann_arbor_mod_e
ann_arbor_mod_s
pretext_mod_v
pretext_mod_p
pretext_mod_e
pretext_mod_m
pretext_mod_f
pretext_mod_r
kaposi_sarcoma_t
kaposi_sarcoma_i
kaposi_sarcoma_s
skip_lesion

DiseaseSiteAssessment

DiseaseSiteAssessment captures assessment of tumors, lesions, nodes, sites of disease, measurements, laterality, detection methods, anatomic coding, and disease-specific site findings.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_disease_site_assessment		`integer`
review_source
tumor_state
detection_method
sedation_type
mri_sequence
site_classification
disease_presence
assessment_reason
disease_site
site_other		`string`
laterality
measurement1		`decimal`
measurement1_axis
measurement2		`decimal`
measurement2_axis
measurement3		`decimal`
measurement3_axis
measurement_unit
nodes_assessed_number		`integer`
myeloid_sarcoma_involvement
bulky_disease
bulk_med_mass
pleural_effusion
pericardial_effusion
bulk_nodal_aggregate
med_ratio		`decimal`
nodular_splenic
tumor_size
tumor_number		`decimal`
invasiveness
depth
nodal_pathology
nodal_clinical
parameningeal_extension
top_code		`string`
top_code_text		`string`
top_code_system
top_code_system_version		`string`
tumor_presentation
tissue_type
multiplicity
tumor_volume
estimated_volume		`decimal`
fracture
ipsilateral_nodules
joint_involvement
site_within_bone
dysplasia
hpv_status
extension_tumor_type
visual_discrete_tumors
number_of_tumors_numeric		`decimal`
tumor_from_fovea
optic_nerve_obscuration
optic_nerve_obscuration_degree
tumor_from_optic_nerve
fluid_from_tumor
seeds_present
seeds_pattern
seeds_type
seeds_classification
finding
colon_polyp_max_size
colon_polyp_min_size
barretts_esophagus
bowel_preparation
bbps_score
bbps_score_total		`decimal`
tumor_budding
number_nodes_numeric		`decimal`
colon_polyps_total		`decimal`
gastric_polyps_total		`decimal`
small_bowel_polyps_total		`decimal`
site_finding
volume		`decimal`
volume_unit
endometrial_stripe_thickness		`decimal`
endometrial_stripe_thickness_unit

DiseaseCharacteristics

DiseaseCharacteristics captures additional disease-level attributes such as risk group, imaging response scores, performance status, clinical findings, presentation symptoms, and disease-specific biologic or clinical characteristics.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_disease_characteristic		`integer`
disease_characteristics_site
laterality
detection_method
risk_group
gts_treatment
imaging_result
deauville_score
qpet_score		`decimal`
performance_score
initial_treatment_category
mki
vacterlh
phenos
vacterlh_phenos_status
clinical_finding
clinical_finding_other		`string`
modified_rankin_scale		`integer`
fans_symptom_acuity
skip_met_involvement
trilateral_retinoblastoma
presentation_symptoms
presentation_symptoms_status
anterior_segment_exam
retinal_detachment
prior_steroids_week
prior_steroids_month
gonadotoxic_risk
gonadotoxic_risk_system		`string`
gonadotoxic_risk_system_version		`string`

Intervention

Intervention contains treatment and procedure records, including surgery, medications, radiation therapy, transplantation, transfusion, cellular therapy, locoregional therapy, fertility preservation procedures, and protocol treatment modifications.

SurgicalProcedures

SurgicalProcedures records biopsy, resection, procedural, and surgery-related interventions, including site, laterality, extent, margins, complications, outcome, and disease-specific surgical details.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_procedure		`integer`
protocol_procedure
non_protocol_timing
procedure_performed
site_classification
procedure
procedure_other		`string`
procedure_site
site_other		`string`
laterality
extent
mass_present
viable_tumor_specimen
viable_tumor_margin
margins
number_nodes
number_nodes_numeric		`decimal`
purpose
nephron_sparing_partial_nephrectomy
tumor_rupture
surgical_complications
surgical_complications_other		`string`
outcome
hydrocephalus
posterior_fossa_syndrome
csf_diversion
procedure_extent
distance_from_margin		`decimal`
laser_type
laser_power
laser_duration
laser_duration_numeric		`decimal`
cryotherapy_freezes		`integer`
freeze_thaw_cycle_number		`integer`
remaining_colon

Medication

Medication captures medication exposure and administration details, including chemotherapy or supportive care agents, regimen, route, dose, frequency, cumulative exposure, timing, and protocol or non-protocol context.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_medication_start		`integer`
age_at_medication_end		`integer`
year_at_medication_start		`integer`
administration_status
cycles_planned		`decimal`
cycle_number		`decimal`
session_number		`integer`
protocol_medication
non_protocol_timing
non_protocol_reason
medication_category
supportive_care_detail
route
medication
medication_other		`string`
regimen
administration_site
laterality
number_doses		`decimal`
medication_dose_administered		`decimal`
medication_dose_intended		`decimal`
medication_dose_unit
frequency
frequency_other		`string`
total_dose_given
delivery_status
lifetime_cumulative_dose		`decimal`
lifetime_cumulative_dose_unit

LocoregionalTherapy

LocoregionalTherapy captures localized treatment approaches such as embolization or ablation, including technique, dose, administration status, and timing.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_locoregional_therapy		`integer`
administration_status
locoregional_therapy_technique
locoregional_therapy_dose		`decimal`
locoregional_therapy_dose_unit

ProtocolTreatmentModifications

ProtocolTreatmentModifications captures changes to planned protocol therapy, including modification type, basis, reason, toxicity details, and agent substitutions.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_modification		`integer`
modification
modification_other		`string`
modification_basis
reason
reason_other		`string`
toxicity_detail
toxicity_detail_other		`string`
toxicity_immune
toxicity_infusion
original_agent
original_agent_other		`string`
sub_agent
sub_agent_other		`string`

RadiationTherapy

RadiationTherapy captures radiation treatment timing, site, technique, energy type, dose, fractions, boosts, treatment volume, brachytherapy or plaque details, shielding, and protocol context.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_rt_start		`integer`
year_at_rt_start		`integer`
age_at_rt_end		`integer`
administration_status
indication
protocol_radiation_therapy
non_protocol_timing
rt_data_source
site_classification
rt_site
laterality
energy_type
technique
rt_dose		`decimal`
rt_dose_unit
boost_type
boost_dose		`decimal`
num_fraction		`integer`
fraction_dose		`decimal`
fraction_dose_unit
apex_dose		`decimal`
dose_rate_at_apex		`decimal`
treatment_volume
rt_margins
transposition_organ
rt_completed
plaque_size
rad_seeds_type
rad_seeds_num		`decimal`
plaque_source
plaque_model		`string`
reporting_level
brach_calc_type
implant_duration		`decimal`
suture_coordinates		`string`
shielding

StemCellTransplant

StemCellTransplant records hematopoietic stem cell transplant details, including timing, transplant type, donor relationship, HLA matching, conditioning, cell source, CD34 collection or infusion, chimerism, and recovery status.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_sct		`integer`
year_at_sct		`integer`
age_at_sct_harvest		`integer`
age_at_recovery		`integer`
sct_status
non_protocol_timing
protocol_sct
sct_type
stem_cell_source
donor_relationship
hla_match
number_hla		`decimal`
number_matches		`decimal`
hla_a_result
hla_b_result
hla_c_result
hla_drb1_result
hla_dq_result
conditioning_type
prior_tbi
total_cycles		`decimal`
recovery_type
recovery_status
cd34_collected		`decimal`
cd34_transplant		`decimal`
chimerism		`decimal`
chimerism_unit
sct_success
stem_cell_processing
stem_cell_processing_other		`string`

TransfusionMedicineProcedure

TransfusionMedicineProcedure captures transfusion or transfusion-medicine procedures, including product type, procedure type, number of units, and timing.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_tmp_start		`integer`
tmp_type
tmp_product
product_type
number_units		`decimal`

CellularImmunotherapy

CellularImmunotherapy captures cellular immunotherapy infusions or related immune effector cell interventions and their timing and therapy type.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
cimt_type

FertilityProcedures

FertilityProcedures captures fertility preservation procedures and reproductive tissue handling, including collection, cryopreservation, oocyte, embryo, semen, testicular, ovarian, and surgical procedure details.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_fertility_procedure		`integer`
fertility_procedure
procedure_class
tissue_type
laterality
transport_media
transport_media_other		`string`
cryopreservation_media
cryopreservation_media_other		`string`
freezing_method
freezing_method_other		`string`
monitor_method
retrieval_method
collection_status
cryopreservation_status
oocyte_collection_attempts		`integer`
oocyte_retrieved_numeric		`integer`
mature_oocytes_numeric		`integer`
oocytes_fertilized_numeric		`decimal`
fertilization_rate		`decimal`
maturity_rate		`decimal`
cryopreserved_embryo_numeric		`decimal`
cryopreserved_oocyte_numeric		`decimal`
embryo_cryopreserved_day		`integer`
embryo_vitrification_stage
menstrual_phase
preimplantation_genetic_testing
preimplantation_genetic_testing_type
semen_volume		`decimal`
semen_concentration		`decimal`
semen_motility		`decimal`
semen_morphology		`decimal`
semen_count		`decimal`
semen_motility_count		`decimal`
semen_abnormality
cryopreserved_semen_vials_numeric		`decimal`
semen_cryopreservation_attempts		`decimal`
testicular_tissue_weight_processed		`integer`
testicular_tissue_weight_unit
testicular_tissue_pieces_cryopreserved		`integer`
testicular_tissue_vials_cryopreserved		`integer`
sperm_present
surgeon_type
otc_resection_type
otc_surgical_technique
otc_conversion_reason
otc_surgical_energy_source
germ_cells_present_spermatogonia
spermatogonia_density		`decimal`
spermatogonia_density_unit
germ_cells_present_follicles
follicle_density		`decimal`
follicle_density_unit
ovary_resect_percent		`decimal`
otc_vials_number		`integer`
otc_strips_number		`integer`
otc_strips_weight		`decimal`
otc_strips_weight_unit
menarchal_status
sexual_maturity_index

Monitoring

Monitoring contains response, residual disease, toxicity, late effects, subsequent neoplasms, reproductive outcomes, patient-reported outcomes, and other follow-up concepts used to evaluate disease course and treatment impact over time.

SubjectResponse

SubjectResponse captures response assessments across disease sites and treatment time points, including response methods, categories, systems, scores, marrow findings, imaging findings, necrosis, symptoms, and disease-specific response details.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_response		`integer`
response_site
laterality
cycle_number		`decimal`
tx_prior_response
response_method
response_category
response_system
response_system_version		`string`
response
mibg_score_type
mibg_score		`decimal`
bm_pct_blasts_at_response		`decimal`
bm_analysis_method_at_response
anc_at_response		`decimal`
anc_threshold_at_response
platelet_count_at_response		`decimal`
platelet_threshold_at_response
interim_response
pct_change		`decimal`
symptoms_at_response
palpable_nodes
nodular_splenic
necrosis
necrosis_pct		`decimal`
mri_sequence
neurological_status
anaplasia
anaplasia_type
anaplasia_pct_numeric		`decimal`

MinimalResidualDisease

MinimalResidualDisease captures MRD assessments, including method, specimen, result text or numeric value, unit, assay sensitivity, and molecular markers.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_mrd_assessment		`integer`
mrd_method
result_text		`string`
result_numeric		`decimal`
mrd_result_unit
sensitivity		`decimal`
mrd_specimen
molecular_markers

AdverseEvents

AdverseEvents captures toxicities, complications, infections, GVHD, adverse-event grading, attribution, interventions, hospitalization, outcomes, and other treatment-related safety events.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_ae		`integer`
age_at_ae_resolved		`integer`
ae_treatment
ae_detection_method
adverse_event
ae_site
laterality
ae_code		`string`
ae_code_system
ae_system_version		`string`
ae_grade
ae_grade_system
outcome
icu
supportive_medication
ae_pathogen
ae_pathogen_confirmation
infection_classification
gvhd_acuity
gvhd_organ
grade_system
grade_system_version		`string`
ae_immune
ae_infusion
ae_reported
ae_attribution
ae_expected
ae_tx_mod
ae_hospitalization
ae_medication
ae_intervention_status
ae_intervention
ae_pathogen_status
ae_outcome
hospitalization
hospitalization_reason
hospitalization_reason_other		`string`
avn_joint
avn_joint_laterality
modification_required
tox_delay
tox_high_grade_events		`integer`
tox_dose_reductions		`integer`

SubsequentMalignantNeoplasm

SubsequentMalignantNeoplasm records subsequent malignant neoplasms, including site, type, morphology, topography, coding systems, timing, and radiation-field context where available.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_smn		`integer`
smn_site
smn_type
morph_code		`string`
morph_code_text		`string`
morph_code_system
morph_code_system_version		`string`
top_code		`string`
top_code_text		`string`
top_code_system
top_code_system_version		`string`
smn_field

LateEffects

LateEffects captures late effects and survivorship-related outcomes, including evaluation timing, effect type, detail, severity grade, and CTCAE version.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
age_at_le_eval		`integer`
le
le_detail
le_sub_detail
le_severity_grade
le_ctcae_version		`string`

PatientReportedOutcomesMetadata

PatientReportedOutcomesMetadata describes patient-reported outcome study instruments, measurement types, raters, time points, and eligible age ranges.

Diagram

Slot	Description	Range
pro_study_id		`string`
honest_broker_subject_id		`string`
subject		`Subject`
time_point
pro_measures
pro_measurement_type
raters
eligible_age_lower		`integer`
eligible_age_upper		`integer`

ReproductiveOutcomes

ReproductiveOutcomes captures pregnancy, conception, tissue utilization, fertility treatment, delivery, birth, and menstrual-status outcomes following cancer therapy or fertility preservation.

Diagram

Slot	Description	Range
honest_broker_subject_id		`string`
subject		`Subject`
episode_id		`string`
episode		`ClinicalEpisode`
age_at_pregnancy		`integer`
gestational_age_end_of_pregnancy_days		`integer`
age_at_pregnancy_method
age_precision
menstrual_status
pregnancy_attempted
pregnancy_achieved
pregnancy_person
fertility_tissue_utilized
tissue_type_utilized
conception_type
oocyte_or_embryo_source
sperm_source
oocyte_or_embryo_state
sperm_state
ectopic_status
plurality		`integer`
pregnancy_outcome
delivery_route
birth_order		`integer`
birth_weight		`decimal`
birth_weight_unit

Permissible Value	Description	Meaning
Eye		C12401
Femoral Artery
Unknown		ncit:C17998
Not Reported		ncit:C43234

AdministrationStatusEnum

Permissible Value	Description	Meaning
Medication Administered		ncit:C173298
Medication Not Administered		ncit:C173299
Radiation Administered
Radiation Not Administered
Unknown		ncit:C17998
Not Reported		ncit:C43234

AdverseEventEnum

Permissible Value	Description	Meaning
Allergic Reaction		ncit:C114476
Anemia		ncit:C2869
Aortic Valve Disease		ncit:C143290
Asystole		ncit:C146731
Atrial Fibrillation		ncit:C54767
Atrial Flutter		ncit:C54768
Atrioventricular Block Complete		ncit:C143308
Atrioventricular Block First Degree		ncit:C143309
Avascular Necrosis		ncit:C118385
Bleeding
Blood and Lymphatic System Disorders - Other, specify
Bone Marrow Hypocellular		ncit:C3516
Cardiac Arrest		ncit:c143351
Cardiac Disorders - Other, Specify		ncit:c143352
Chest Pain - Cardiac		ncit:c143364
Conduction Disorder		ncit:c143380
CNS Necrosis		ncit:C55367
Cardiac Toxicity		ncit:C27994
Cataract		ncit:C26713
Chorioretinal Toxicity
Cranial Nerve Palsy		ncit:C26941
Heart Failure		ncit:c143529
Mitral Valve Disease		ncit:c143674
Mobitz (Type) Ii Atrioventricular Block		ncit:c54772
Mobitz Type I		ncit:c54771
Myocardial Infarction		ncit:c143691
Myocarditis		ncit:c146695
Palpitations		ncit:c54935
Paroxysmal Atrial Tachycardia		ncit:c143738
Pericardial Effusion		ncit:c143743
Pericardial Tamponade		ncit:c143744
Pericarditis		ncit:c55067
Pulmonary Valve Disease		ncit:c143793
Restrictive Cardiomyopathy		ncit:c55069
Right Ventricular Dysfunction		ncit:c55070
Sick Sinus Syndrome		ncit:c54938
Sinus Bradycardia		ncit:c54940
Sinus Tachycardia		ncit:c26889
Supraventricular Tachycardia		ncit:c54945
Tricuspid Valve Disease		ncit:c143889
Ventricular Arrhythmia		ncit:c146629
Ventricular Fibrillation		ncit:c146732
Ventricular Tachycardia		ncit:c146733
Congenital, Familial And Genetic Disorders - Other, Specify		ncit:c143382
Ear And Labyrinth Disorders - Other, Specify		ncit:c143429
Ear Pain		ncit:c143430
External Ear Pain		ncit:c146745
Precocious Puberty		ncit:c146645
Testosterone Deficiency		ncit:c143195
Virilization		ncit:c143937
Blurred Vision		ncit:c55906
Corneal Ulcer		ncit:c143387
Dry Eye		ncit:c143410
Extraocular Muscle Paresis		ncit:c143466
Eye Disorders - Other, Specify		ncit:c143468
Eye Pain		ncit:c146751
Eyelid Function Disorder		ncit:c143471
Flashing Lights		ncit:c143489
Floaters		ncit:c143491
Glaucoma		ncit:c55842
Keratitis		ncit:c55847
Night Blindness		ncit:c143705
Papilledema		ncit:c143734
Periorbital Edema		ncit:c143747
Photophobia		ncit:c146770
Retinal Detachment		ncit:c146729
Retinal Tear		ncit:c143814
Retinal Vascular Disorder		ncit:c143815
Scleral Disorder		ncit:c143823
Uveitis		ncit:c55901
Vitreous Hemorrhage		ncit:c146677
Watering Eyes		ncit:c143944
Abdominal Distension		ncit:c143253
Abdominal Pain		ncit:c143255
Anal Fissure		ncit:c143197
Anal Fistula		ncit:c143275
Anal Hemorrhage		ncit:c143276
Anal Mucositis		ncit:c143277
Anal Necrosis		ncit:c143278
Anal Pain		ncit:c143279
Anal Stenosis		ncit:c143280
Anal Ulcer		ncit:c143281
Ascites		ncit:c143300
Belching		ncit:c143198
Bloating		ncit:c143322
Cecal Hemorrhage		ncit:c143358
Cheilitis		ncit:c57901
Chylous Ascites		ncit:c143199
Colitis		ncit:c57134
Colonic Fistula		ncit:c143373
Colonic Hemorrhage		ncit:c143374
Colonic Obstruction		ncit:c143375
Colonic Perforation		ncit:c143376
Colonic Stenosis		ncit:c143377
Colonic Ulcer		ncit:c143378
Constipation		ncit:c57141
Dental Caries		ncit:c143402
Diarrhea		ncit:c57788
Dry Mouth		ncit:c143411
Duodenal Fistula		ncit:c57789
Duodenal Hemorrhage		ncit:c143414
Duodenal Obstruction		ncit:c143416
Duodenal Perforation		ncit:c143417
Duodenal Stenosis		ncit:c143418
Duodenal Ulcer		ncit:c143419
Dyspepsia		ncit:c143425
Enterocolitis		ncit:c143445
Enterovesical Fistula		ncit:c143446
Esophageal Fistula		ncit:c57798
Esophageal Hemorrhage		ncit:c143453
Esophageal Necrosis		ncit:c143455
Esophageal Obstruction		ncit:c143456
Esophageal Pain		ncit:c143457
Esophageal Perforation		ncit:c143458
Esophageal Stenosis		ncit:c143459
Esophageal Ulcer		ncit:c143460
Esophageal Varices Hemorrhage		ncit:c146710
Esophagitis		ncit:c57797
Fecal Incontinence		ncit:c143482
Flatulence		ncit:c57807
Gastric Fistula		ncit:c143499
Gastric Hemorrhage		ncit:c143500
Gastric Necrosis		ncit:c143501
Gastric Perforation		ncit:c143502
Gastric Stenosis		ncit:c143503
Gastric Ulcer		ncit:c143504
Gastritis		ncit:c57812
Gastroesophageal Reflux Disease		ncit:c143506
Gastrointestinal Disorders - Other, Specify		ncit:c143508
Gastrointestinal Fistula		ncit:c146637
Gastrointestinal Pain		ncit:c143510
Gastroparesis		ncit:c143512
Gingival Pain		ncit:c146626
Hemorrhoidal Hemorrhage		ncit:c143537
Hemorrhoids		ncit:c146738
Ileal Fistula		ncit:c57821
Ileal Hemorrhage		ncit:c56542
Ileal Obstruction		ncit:c57823
Ileal Perforation		ncit:c146633
Ileal Stenosis		ncit:c143578
Ileal Ulcer		ncit:c57826
Ileus		ncit:c57814
Intra-Abdominal Hemorrhage		ncit:c143595
Jejunal Fistula		ncit:c57827
Jejunal Hemorrhage		ncit:c56543
Jejunal Obstruction		ncit:c57829
Jejunal Perforation		ncit:c143622
Jejunal Stenosis		ncit:c143623
Jejunal Ulcer		ncit:c57832
Lip Pain		ncit:c146761
Lower Gastrointestinal Hemorrhage		ncit:c143656
Malabsorption		ncit:c57838
Mucositis Oral		ncit:c143679
Nausea		ncit:c146764
Obstruction Gastric		ncit:c143710
Oral Cavity Fistula		ncit:c143715
Oral Dysesthesia		ncit:c143716
Oral Hemorrhage		ncit:c56551
Oral Pain		ncit:c146627
Pancreatic Duct Stenosis		ncit:c143730
Pancreatic Fistula		ncit:c57845
Pancreatic Hemorrhage		ncit:c56554
Pancreatic Necrosis		ncit:c143732
Pancreatitis		ncit:c146789
Periodontal Disease		ncit:c57849
Peritoneal Necrosis		ncit:c57850
Proctitis		ncit:c57857
Rectal Fissure		ncit:c143200
Rectal Fistula		ncit:c57859
Rectal Hemorrhage		ncit:c56560
Rectal Mucositis		ncit:c143802
Rectal Necrosis		ncit:c57863
Rectal Obstruction		ncit:c57864
Rectal Pain		ncit:c146631
Rectal Perforation		ncit:c146634
Rectal Stenosis		ncit:c143803
Rectal Ulcer		ncit:c57867
Retroperitoneal Hemorrhage		ncit:c146632
Salivary Duct Inflammation		ncit:c143821
Salivary Gland Fistula		ncit:c57868
Small Intestinal Mucositis		ncit:c143842
Small Intestinal Obstruction		ncit:c143843
Small Intestinal Perforation		ncit:c146635
Small Intestinal Stenosis		ncit:c143844
Small Intestine Ulcer		ncit:c143846
Stomach Pain		ncit:c146774
Middle Ear Inflammation		ncit:c143673
Vestibular Disorder		ncit:c143936
Adrenal Insufficiency		ncit:c55748
Cushingoid		ncit:c143392
Delayed Puberty		ncit:c55742
Endocrine Disorders - Other, Specify		ncit:c143442
Growth Accelerated		ncit:c143520
Hyperparathyroidism		ncit:c143557
Hyperthyroidism		ncit:c143560
Hypoparathyroidism		ncit:c143572
Tooth development disorder
Tooth discoloration
Toothache
Pelvic floor muscle weakness
Pelvic pain
Penile pain
Perineal pain
Premature menopause
Prostatic hemorrhage
Prostatic obstruction
Prostatic pain
Reproductive system and breast disorders - Other, specify
Scrotal pain
Spermatic cord hemorrhage
Spermatic cord obstruction
Testicular disorder
Testicular hemorrhage
Testicular pain
Treatment, NOS
Uterine fistula
Uterine hemorrhage
Uterine obstruction
Uterine pain
Vaginal discharge
Vaginal dryness
Vaginal fistula
Vaginal hemorrhage
Vaginal inflammation
Vaginal obstruction
Vaginal pain
Vaginal perforation
Vaginal stricture
Adult respiratory distress syndrome
Allergic rhinitis
Apnea
Aspiration
Atelectasis
Bronchial fistula
Bronchial obstruction
Bronchial stricture
Bronchopleural fistula
Bronchopulmonary hemorrhage
Bronchospasm
Chylothorax
Cough
Dyspnea
Epistaxis
Hiccups
Hypoxia
Laryngeal edema
Laryngeal fistula
Laryngeal hemorrhage
Laryngeal inflammation
Laryngeal mucositis
Laryngeal obstruction
Laryngeal stenosis
Laryngopharyngeal dysesthesia
Laryngospasm
Mediastinal hemorrhage
Nasal congestion
Oropharyngeal pain
Pharyngeal fistula
Pharyngeal hemorrhage
Pharyngeal mucositis
Pharyngeal necrosis
Pharyngeal stenosis
Pharyngolaryngeal pain
Pleural effusion
Pleural hemorrhage
Pleuritic pain
Pneumonitis
Pneumothorax
Postnasal drip
Productive cough
Pulmonary edema
Pulmonary fibrosis
Pulmonary fistula
Pulmonary hypertension
Respiratory failure
Respiratory, thoracic and mediastinal disorders - Other, specify
Retinoic acid syndrome
Rhinorrhea
Sinus disorder
Sinus pain
Sleep apnea
Sneezing
Sore throat
Stridor
Tracheal fistula
Tracheal mucositis
Tracheal stenosis
Voice alteration
Wheezing
Alopecia
Body odor
Bullous dermatitis
Dry skin
Eczema
Erythema multiforme
Erythroderma
Fat atrophy
Hair color changes
Hair texture abnormal
Hirsutism
Hyperhidrosis
Hyperkeratosis
Hypertrichosis
Hypohidrosis
Lipohypertrophy
Nail changes
Nail discoloration
Nail loss
Nail ridging
Pain of skin
Palmar-plantar erythrodysesthesia syndrome
Photosensitivity
Pruritus
Purpura
Rash acneiform
Rash maculo-papular
Scalp pain
Skin and subcutaneous tissue disorders - Other, specify
Skin atrophy
Skin hyperpigmentation
Skin hypopigmentation
Skin induration
Skin ulceration
Stevens-Johnson syndrome
Subcutaneous emphysema
Telangiectasia
Toxic epidermal necrolysis
Urticaria
Social circumstances - Other, specify
Surgical and medical procedures - Other, specify
Arterial thromboembolism
Capillary leak syndrome
Flushing
Hematoma
Hot flashes
Hypertension
Hypotension
Lymph leakage
Lymphedema
Lymphocele
Peripheral ischemia
Phlebitis
Superficial thrombophlebitis
Superior vena cava syndrome
Thromboembolic event
Vascular disorders - Other, specify
Vasculitis
Superficial soft tissue fibrosis
Unequal limb length
Leukemia secondary to oncology chemotherapy
Myelodysplastic syndrome
Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
Skin papilloma
Treatment related secondary malignancy
Tumor hemorrhage
Tumor pain
Abducens nerve disorder
Accessory nerve disorder
Acoustic nerve disorder NOS
Akathisia
Amnesia
Anosmia
Aphonia
Arachnoiditis
Ataxia
Brachial plexopathy
Central nervous system necrosis
Cerebrospinal fluid leakage
Cognitive disturbance
Concentration impairment
Depressed level of consciousness
Dizziness
Dysarthria
Dysesthesia
Dysgeusia
Dysphasia
Edema cerebral
Encephalopathy
Extrapyramidal disorder
Facial muscle weakness
Facial nerve disorder
Glossopharyngeal nerve disorder
Guillain-Barre syndrome
Headache
Hydrocephalus
Hypersomnia
Hypoglossal nerve disorder
Intracranial hemorrhage
Ischemia cerebrovascular
Lethargy
Leukoencephalopathy
Memory impairment
Meningismus
Movements involuntary
Muscle weakness left-sided
Muscle weakness right-sided
Myasthenia gravis
Nervous system disorders - Other, specify
Neuralgia
Nystagmus
Oculomotor nerve disorder
Olfactory nerve disorder
Paresthesia		ncit:C143736
Peripheral motor neuropathy
Peripheral sensory neuropathy
Phantom pain
Presyncope
Pyramidal tract syndrome
Radiculitis
Recurrent laryngeal nerve palsy
Reversible posterior leukoencephalopathy syndrome
Seizure
Somnolence
Spasticity
Spinal cord compression
Syncope
Tendon reflex decreased
Transient ischemic attacks
Tremor
Trigeminal nerve disorder
Trochlear nerve disorder
Vagus nerve disorder
Vasovagal reaction
Fetal growth retardation
Pregnancy loss
Pregnancy, puerperium and perinatal conditions - Other, specify
Premature delivery
Agitation
Anorgasmia
Anxiety
Confusion
Delayed orgasm
Delirium
Delusions
Depression
Euphoria
Hallucinations
Insomnia
Irritability
Libido decreased
Libido increased
Mania
Personality change
Psychiatric disorders - Other, specify
Psychosis
Restlessness
Suicidal ideation
Suicide attempt
Acute kidney injury
Bladder perforation
Bladder spasm
Chronic kidney disease
Cystitis noninfective
Dysuria
Glucosuria
Hemoglobinuria
Nephrotic syndrome
Renal and urinary disorders - Other, specify
Renal calculi
Renal colic
Renal hemorrhage
Urinary fistula
Urinary frequency
Urinary incontinence
Urinary retention
Urinary tract obstruction
Urinary tract pain
Urinary urgency
Urine discoloration
Amenorrhea
Azoospermia
Breast atrophy
Breast pain
Dysmenorrhea
Dyspareunia
Ejaculation disorder
Erectile dysfunction
Fallopian tube obstruction
Feminization acquired
Genital edema
Gynecomastia
Hematosalpinx
Irregular menstruation
Lactation disorder
Menorrhagia
Nipple deformity
Oligospermia
Ovarian hemorrhage
Ovarian rupture
Ovulation pain
Intraoperative respiratory injury
Intraoperative splenic injury
Intraoperative urinary injury
Intraoperative venous injury
Kidney anastomotic leak
Large intestinal anastomotic leak
Pancreatic anastomotic leak
Pharyngeal anastomotic leak
Postoperative hemorrhage
Postoperative thoracic procedure complication
Prolapse of intestinal stoma
Prolapse of urostomy
Radiation recall reaction (dermatologic)
Rectal anastomotic leak
Seroma
Small intestinal anastomotic leak
Spermatic cord anastomotic leak
Spinal fracture
Stenosis of gastrointestinal stoma
Stomal ulcer
Tracheal hemorrhage
Tracheal obstruction
Tracheostomy site bleeding
Ureteric anastomotic leak
Urethral anastomotic leak
Urostomy leak
Urostomy obstruction
Urostomy site bleeding
Urostomy stenosis
Uterine anastomotic leak
Uterine perforation
Vaccination complication
Vaginal anastomotic leak
Vas deferens anastomotic leak
Vascular access complication
Venous injury
Wound complication
Wound dehiscence
Wrist fracture
Activated partial thromboplastin time prolonged
Alanine aminotransferase increased
Alkaline phosphatase increased
Aspartate aminotransferase increased
Blood antidiuretic hormone abnormal
Blood bicarbonate decreased
Blood bilirubin increased
Blood corticotrophin decreased
Blood gonadotrophin abnormal
Blood lactate dehydrogenase increased
Blood prolactin abnormal
Carbon monoxide diffusing capacity decreased
Cardiac troponin I increased
Cardiac troponin T increased
CD4 lymphocytes decreased
Cholesterol high
CPK increased
Creatinine increased
Ejection fraction decreased
Electrocardiogram QT corrected interval prolonged
Electrocardiogram T wave abnormal
Fibrinogen decreased
Forced expiratory volume decreased
GGT increased
Growth hormone abnormal
Haptoglobin decreased
Hemoglobin increased
INR increased
Investigations - Other, specify
Lipase increased
Lymphocyte count decreased
Lymphocyte count increased
Neutrophil count decreased
Pancreatic enzymes decreased
Platelet count decreased
Serum amylase increased
Thyroid stimulating hormone increased
Urine output decreased
Vital capacity abnormal
Weight gain
Weight loss
White blood cell decreased
Acidosis
Alcohol intolerance
Alkalosis
Anorexia
Dehydration
Glucose intolerance
Hypercalcemia
Hyperglycemia
Hyperkalemia
Hyperlipidemia
Hypermagnesemia
Hypernatremia
Hyperphosphatemia
Hypertriglyceridemia
Hyperuricemia
Hypoalbuminemia
Hypocalcemia
Hypoglycemia
Hypokalemia
Hypomagnesemia
Hyponatremia
Hypophosphatemia
Iron overload
Metabolism and nutrition disorders - Other, specify
Obesity
Tumor lysis syndrome
Abdominal soft tissue necrosis
Arthralgia
Arthritis
Avascular necrosis
Back pain
Bone pain
Buttock pain
Chest wall necrosis
Chest wall pain
Exostosis
Fibrosis deep connective tissue
Flank pain
Generalized muscle weakness
Growth suppression
Head soft tissue necrosis
Joint effusion
Joint range of motion decreased
Joint range of motion decreased cervical spine
Joint range of motion decreased lumbar spine
Kyphosis
Lordosis
Muscle cramp
Muscle weakness lower limb
Muscle weakness trunk
Muscle weakness upper limb
Musculoskeletal and connective tissue disorder - Other, specify
Musculoskeletal deformity
Myalgia
Myositis
Neck pain
Neck soft tissue necrosis
Osteonecrosis
Osteonecrosis of jaw
Osteoporosis
Pain in extremity
Pelvic soft tissue necrosis
Rhabdomyolysis
Rotator cuff injury
Scoliosis
Soft tissue necrosis lower limb
Soft tissue necrosis upper limb
Gallbladder fistula
Gallbladder necrosis
Gallbladder obstruction
Gallbladder pain
Gallbladder perforation
Hepatic failure
Hepatic hemorrhage
Hepatic necrosis
Hepatic pain
Hepatobiliary disorders - Other, specify
Perforation bile duct
Portal hypertension
Portal vein thrombosis
Anaphylaxis
Autoimmune disorder
Cytokine release syndrome
Immune system disorders - Other, specify
Serum sickness
Abdominal infection
Anorectal infection
Appendicitis
Appendicitis perforated
Arteritis infective
Bacteremia
Biliary tract infection
Bladder infection
Bone infection
Breast infection
Bronchial infection
Catheter related infection
Cecal infection
Cervicitis infection
Conjunctivitis
Conjunctivitis infective
Corneal infection
Cranial nerve infection
Cytomegalovirus infection reactivation
Device related infection
Duodenal infection
Encephalitis infection
Encephalomyelitis infection
Endocarditis infective
Endophthalmitis
Enterocolitis infectious
Epstein-Barr virus infection reactivation
Esophageal infection
Eye infection
Folliculitis
Fungemia
Gallbladder infection
Gum infection
Hepatic infection
Hepatitis B reactivation
Hepatitis viral
Herpes simplex reactivation
Infections and infestations - Other, specify
Infective myositis
Joint infection
Kidney infection
Laryngitis
Lip infection
Lung infection
Lymph gland infection
Mediastinal infection
Meningitis
Mucosal infection
Myelitis
Nail infection
Otitis externa
Otitis media
Ovarian infection
Pancreas infection
Papulopustular rash
Paronychia
Pelvic infection
Penile infection
Periorbital infection
Peripheral nerve infection
Peritoneal infection
Pharyngitis
Phlebitis infective
Pleural infection
Prostate infection
Rash pustular
Rhinitis infective
Salivary gland infection
Scrotal infection
Sepsis
Shingles
Sinusitis
Skin infection
Small intestine infection
Soft tissue infection
Splenic infection
Stoma site infection
Thrush
Tooth infection
Tracheitis
Upper respiratory infection
Urethral infection
Urinary tract infection
Uterine infection
Vaginal infection
Viremia
Vulval infection
Wound infection
Ankle fracture
Aortic injury
Arterial injury
Biliary anastomotic leak
Bladder anastomotic leak
Bruising
Burn
Dermatitis radiation
Esophageal anastomotic leak
Fall
Fallopian tube anastomotic leak
Fallopian tube perforation
Fracture
Gastric anastomotic leak
Gastrointestinal anastomotic leak
Gastrointestinal stoma necrosis
Hip fracture
Infusion related reaction
Injury to carotid artery
Injury to inferior vena cava
Injury to jugular vein
Injury to superior vena cava
Injury, poisoning and procedural complications - Other, specify
Intestinal stoma leak
Intestinal stoma obstruction
Intestinal stoma site bleeding
Intraoperative arterial injury
Intraoperative breast injury
Intraoperative cardiac injury
Intraoperative ear injury
Intraoperative endocrine injury
Intraoperative gastrointestinal injury
Intraoperative head and neck injury
Intraoperative hemorrhage
Intraoperative hepatobiliary injury
Intraoperative musculoskeletal injury
Intraoperative neurological injury
Intraoperative ocular injury
Intraoperative renal injury
Intraoperative reproductive tract injury
Upper gastrointestinal hemorrhage
Visceral arterial ischemia
Vomiting
Chills
Death neonatal
Death NOS
Disease progression
Edema face
Edema limbs
Edema trunk
Facial pain
Fever
Flu like symptoms
Gait disturbance
General disorders and administration site conditions - Other, specify
Generalized edema
Hypothermia
Infusion site extravasation
Injection site reaction
Localized edema
Malaise
Multi-organ failure
Neck edema
Non-cardiac chest pain
Pain
Sudden death NOS
Vaccination site lymphadenopathy
Bile duct stenosis
Biliary fistula
Budd-Chiari syndrome
Cholecystitis
Dental Developmental Abnormality		ncit:C35596
Dermatitis		ncit:C2983
Disseminated Intravascular Coagulation		ncit:C2992
Dysphagia		ncit:C57795
Embolic CVA
Endocrine Toxicity		ncit:C138163
Eosinophilia		ncit:C143190
Fatigue		ncit:C3036
Febrile Neutropenia		ncit:C35665
GI Toxicity		ncit:C185646
Graft Versus Host Disease		ncit:C3063
Growth Hormone Deficiency		ncit:C112835
Hearing Impaired		ncit:C143528
Hematuria		ncit:C3090
Hemolysis		ncit:C37965
Hemolytic Uremic Syndrome		ncit:C75545
Hemorrhage		ncit:C26791
Hepatic Toxicity		ncit:C185645
Hoarseness		ncit:C47813
Hyperbilirubinemia		ncit:C27088
Hypopituitarism		ncit:C143194
Hypothyroidism		ncit:C143576
Infection		ncit:C128320
Left Ventricular Systolic Dysfunction		ncit:C64251
Leukocytosis		ncit:C35524
Lymph Node Pain		ncit:C78440
Methemoglobinemia		ncit:C143191
Mucositis		ncit:C115965
Multi Organ Failure		ncit:C75568
Musculoskeletal Toxicity		ncit:C185647
Neck Fibrosis		ncit:C55368
Neuropathy		ncit:C4731
Neurotoxicity Syndrome		ncit:C27961
Neutropenia		ncit:C80520
Optic Nerve Disorder		ncit:C143714
Osteoradionecrosis		ncit:C115459
Ototoxicity		ncit:C66929
Proteinuria		ncit:C38012
Psychiatric Toxicity		ncit:C185648
Pulmonary Toxicity		ncit:C177374
Radiation Caries
Rashes		ncit:C39594
Renal Toxicity		ncit:C115459
Retinopathy		ncit:C55891
Sinusoidal Obstruction Syndrome		ncit:C26793
Spinal Cord Toxicity		ncit:C55369
Spleen Disorder		ncit:C35823
Stroke		ncit:C143862
Surgical Complications, NOS
Surgical Death within 30 days
Thrombocytopenia		ncit:C3408
Thrombosis of Femoral Artery
Thrombosis of Ophthalmic Artery
Thrombotic Thrombocytopenic Purpura		ncit:C78797
Tinnitus		ncit:C146690
Trismus		ncit:C58404
Typhlitis		ncit:C38043
Vertigo		ncit:C143935
Vision Decreased		ncit:C143196
Weight Loss		ncit:C55339
Xerostomia		ncit:C26917
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

AeAttributionEnum

Permissible Value	Description	Meaning
Definite		ncit:C53260
Possible		ncit:C53258
Probable		ncit:C41357
Unlikely		ncit:C53257
Unrelated		ncit:C53256
Unknown		ncit:C17998
Not Reported		ncit:C43234

AeCodeSystemEnum

Permissible Value	Description	Meaning
Balis Neuropathy Scale		ncit:C178081
CTCAE		ncit:C49704
European Society for Blood and Marrow Transplantation (EBMT)		ncit:C168842
ICD
Other		ncit:C17649
RTOG		ncit:C19778
SNOMED
Unknown		ncit:C17998
Not Reported		ncit:C43234

Permissible Value	Description	Meaning
Expected		ncit:C41333
Unexpected		ncit:C41334

AeGradeEnum

Permissible Value	Description	Meaning
CTCAE >> Grade 1
CTCAE >> Grade 2
CTCAE >> Grade 3
CTCAE >> Grade 4
CTCAE >> Grade 5
RTOG >> Grade 3/Grade 4
RTOG >> Grade1/Grade2
System NOS >> Grade 1		ncit:C41338
System NOS >> Grade 2		ncit:C41339
System NOS >> Grade 3		ncit:C41340
System NOS >> Grade 4		ncit:C41337
System NOS >> Grade 5		ncit:C48275
Clavien-Dindo, Grade I		ncit:C121447
Clavien-Dindo, Grade II		ncit:C121447
Clavien-Dindo, Grade III		ncit:C121449
Clavien-Dindo, Grade IIIa		ncit:C121450
Clavien-Dindo, Grade IIIb		ncit:C121451
Clavien-Dindo, Grade IV		ncit:C121452
Clavien-Dindo, Grade IVa		ncit:C121453
Clavien-Dindo, Grade IVb		ncit:C121454
Clavien-Dindo, Grade V		ncit:C121455
Unknown		ncit:C17998
Not Reported		ncit:C43234

Permissible Value	Description	Meaning
Clavien-Dindo Classification

AeInterventionEnum

Permissible Value	Description	Meaning
ACE-Inhibitor		ncit:C247
Arthroplasty, Hemi/Resurfacing		ncit:C178086
Arthroplasty, Total		ncit:C178087
Bone Graft, Free Vascularized		ncit:C178088
Bone Graft, Nonvascularized		ncit:C178089
Chondroplasty		ncit:C178090
Core Decompression		ncit:C157826
Heart Transplant		ncit:C15246
Inotropic Support		ncit:C168966
Osteotomy		ncit:C51903
Unknown		ncit:C17998
Not Reported		ncit:C43234

AeOutcomeEnum

Permissible Value	Description	Meaning
Death, Contributory		ncit:C168948
Death, Noncontributory		ncit:C173315
Not Recovered		ncit:C49494
Recovered		ncit:C85257
Recovered With Sequelae		ncit:C49495

AePathogenEnum

Permissible Value	Description	Meaning
Bacteria	(hl) ConsortiumNote: If multiple pathogens involved, include one observation per pathogen.	ncit:C14187
Fungus		ncit:C14209
Virus		ncit:C14283
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

AlterationEffectEnum

Permissible Value	Description	Meaning
Amplification		ncit:C16605
Chromothripsis		ncit:C129355
Copy Neutral Loss of Heterozygosity		ncit:C18016
Frameshift		ncit:C17354
Gain		ncit:C189957
Gene Fusion		ncit:C20195
Inframe		ncit:C62199
Isochromosome		ncit:C3897
Loss		ncit:C189958
Missense		ncit:C18133
Monosomy		ncit:C3239
No Gain/Loss/Amplification
Nonsense		ncit:C62198
Nullisomy		ncit:C198674
Splice Acceptor		ncit:C45389
Splice Donor		ncit:C45390
Start Lost		ncit:C148649
Stop Gained		ncit:C62198
Stop Lost		ncit:C148650
Synonymous		ncit:C20629
Trisomy		ncit:C3421
Unknown		ncit:C17998
Not Reported		ncit:C43234

AlterationEnum

Permissible Value	Description	Meaning
12q Gain		ncit:C36441
16q Loss		ncit:C36515
17q Gain		ncit:C36484
1q Gain		ncit:C36482
22q11.23 alterations
45XO		ncit:C26900
45XO w/ Y chromosomal material		ncit:C176781
46XX		ncit:C120197
46XY		ncit:C120198
47XXX		ncit:C129718
47XXY		ncit:C34752
47XYY		ncit:C85237
48XXXX		ncit:C176787
48XXXY		ncit:C89799
5q21 loss; trisomies 8,20
8q Gain		ncit:C36488
ACD Variant		ncit:C152088
AKT Variant		ncit:C98303
ALK Alteration, NOS
ALK Amplification		ncit:C131136
ALK Copy Number Gain
ALK Copy Number Loss
ALK Rearrangement		ncit:C129574
ALK Variant		ncit:C81945
ANKRD26 Variant		ncit:C151909
APC Variant		ncit:C164173
ARID1A Variant
ASPSCR1-TFE3		ncit:C99705
ASXL1 Variant
ATM Variant		ncit:C178532
ATP7B Variant
BAP1 Variant
BCOR Deletion		ncit:C101091
BCOR ITT Rearranged
BCOR Rearranged		ncit:C174461
BCOR Variant
BCOR-CCNB3
BCOR-MAML3		ncit:C174487
BLM Variant
BMPR1A
BRAF Gene		ncit:C18363
BRAF Variant		ncit:C98307
BRCA1 Variant		ncit:C131467
BRCA2 Variant		ncit:C131468
BRIP1 Variant
BUB1B Variant
C19MC Amplification		ncit:C129498
CBL Variant
CCNB3-BCOR		ncit:C139666
CCND1 Variant
CCND2 Amplification		ncit:C131785
CCND2 Variant
CDC73 Variant		ncit:C164265
CDH1 Variant		ncit:C165503
CDK4 Variant		ncit:C146926
CDKN1B Variant
CDKN1C Variant
CDKN2A		ncit:C128817
CDKN2A Variant		ncit:C146926
CEBPA Mutation - Biallelic		ncit:C157569
CEBPA Mutation - Monoallelic		ncit:C168774
CEBPA Variant
CHEK2 Variant		ncit:C173450
CIC Rearranged		ncit:C165668
CIC-DUX4		ncit:C139663
CIC-DUX4L10		ncit:C174463
CKIT Mutation - Ex17		ncit:C116396
CKIT Mutation - Ex8		ncit:C128660
CKIT Mutation - Unspecified		ncit:C39712
CREBBP Variant
CTNNB1 Variant		ncit:C36659
CTR9 Variant
Chromosome 11 Loss		ncit:C36549
Chromosome 13q Loss		ncit:C36497
Chromosome 14q Loss		ncit:C39795
Chromosome 16q Loss		ncit:C36515
Chromosome 1q Gain		ncit:C36482
Chromosome 2p Gain		ncit:C36439
Chromosome 6p Gain		ncit:C36633
Complex Karyotype		ncit:C97138
DDB2 Variant
DDX3X Variant		ncit:C199674
DDX41 Variant
DICER1 Variant		ncit:C164287
DIS3L2 Variant
DKC1 Variant
Deletion of 1p.8p
E2A/PBX1 t(1;19)		ncit:C128654
EP300 Variant
EPCAM Variant		ncit:C178537
ERCC2 Variant		ncit:C165564
ERCC3 Variant
ERCC4 Variant
ERCC5 Variant
ETV6 Rearranged		ncit:C155992
ETV6 Variant
ETV6-MN1 Fusion		ncit:C99678
ETV6-RUNX1 t(12;21)(p13;q22)(formerly TEL-AML1)		ncit:C13727
EWSR1 Rearranged		ncit:C165667
EWSR1-ATF1		ncit:C99216
EWSR1-CREB1		ncit:C99249
EWSR1-DDIT3		ncit:C99200
EWSR1-ERG		ncit:C99211
EWSR1-ETV1		ncit:C99259
EWSR1-ETV4		ncit:C99262
EWSR1-FEV		ncit:C99226
EWSR1-FLI1		ncit:C99202
EWSR1-KLF17		ncit:C174474
EWSR1-NR4A3		ncit:C99252
EWSR1-PBX1		ncit:C139668
EWSR1-POU5F1		ncit:C99256
EWSR1-WT1		ncit:C99213
EWSR1-ZNF444		ncit:C139731
EZH2 Variant		ncit:C188740
FAH Variant
FANCA Variant
FANCB Variant
FANCC Variant
FANCD2 Variant
FANCE Variant
FANCF Variant
FANCG Variant
FANCI Variant
FANCL Variant
FANCM Variant
FBXW7 Variant		ncit:C165603
FGFR4 Variant		ncit:C165755
FH Variant
FLCN Variant
FLT3 D835N Pathogenic Variant
FLT3 Internal Tandem Duplication (ITD)		ncit:C67494
FLT3 Tyrosine Kinase Domain (TKD)		ncit:C67495
FOXO1 Rearranged		ncit:C175960
FUS Rearranged		ncit:C174462
FUS Translocation Present		ncit:C25626
FUS-CREB3L2		ncit:C99283
FUS-DDIT3		ncit:C99279
FUS-ERG		ncit:C99281
FUS-FEV		ncit:C174466
FUS-KLF17		ncit:C174473
GAB1 Variant
GATA1 Mutation		ncit:C82340
GATA2 Variant
GLI2 Amplification		ncit:C199588
GPC3 Variant
GPC4 Variant
Gain of Chromosome 12q		ncit:C36441
Gain of Chromosome 15q		ncit:C36481
Gain of Chromosome 17q		ncit:C36484
Gain of Chromosome 1q		ncit:C36482
Gain of Chromosome 20q		ncit:C36480
Gain of Chromosome 9q		ncit:C36483
H19 Variant
HRAS Variant		ncit:C140251
IGF1R Variant
IGF2 Variant
ITK Variant
Inv(X)(p11.4 p11.22)
Isochromosome 17q		ncit:C36477
K-RAS Mutation		ncit:C41361
KBTBD4 Variant		ncit:C186573
KCNQ1OT1 Variant
KDM3B Variant
KIT Variant		ncit:C126819
KRAS Variant		ncit:C98362
LZTR1 Variant
Loss of Chromosome 11q		ncit:C37312
Loss of Chromosome 13q		ncit:C36497
Loss of Chromosome 14		ncit:C36490
Loss of Chromosome 1p		ncit:C36501
Loss of Chromosome 22		ncit:C36491
Loss of Chromosome 3p		ncit:C36502
Loss of Chromosome Y		ncit:C36599
MAP2K1 Variant
MAPK1 Variant		ncit:C187408
MAX Variant
MDM2 Amplification		ncit:C36681
MDM2 Variant
MEN1 Variant
MET Variant		ncit:C136286
MLH1 Variant		ncit:C178530
MLL Other Partner		ncit:C36517
MLL Rearrangement (Translocation)		ncit:C167144
MPL Variant		ncit:C126823
MRAS Variant
MSH2 Variant		ncit:C131462
MSH6 Variant		ncit:C178531
MTOR Variant		ncit:C166384
MUTYH Variant		ncit:C169096
MYC Amplification		ncit:C36641
MYCL Amplification		ncit:C36675
MYCN Amplification		ncit:C36673
MYCN Variant		ncit:C188676
MYOD1 Variant		ncit:C178252
Monosomy 5		ncit:C36523
Monosomy 7		ncit:c36411
Mutated
N-RAS Mutation		ncit:C41381
NBN Variant
NF1 Variant		ncit:C167058
NF2 Variant
NHP2 Variant
NOP10 Variant
NOTCH3 Variant
NPM1 Mutation		ncit:C168774
NRAS Variant		ncit:C98439
NSD1 Variant
NTRK Rearranged		ncit:C171043
NTRK1 Variant		ncit:C169007
NYNRIN Variant
Non-KMT2A MLLT10		ncit:C168771
OCA2 Variant
OCA5 Variant
OFD1 Variant
Other-FOXO1 Gene Fusion
PALB2 Variant		ncit:C178538
PARN Variant
PAX3-FOXO1 Gene Fusion		ncit:C99712
PAX3-Other Gene Fusion
PAX5 Variant		ncit:C158140
PAX7-FOXO1 Gene Fusion		ncit:C99363
PDGFRA Variant		ncit:C107569
PDGFRB Variant		ncit:C128173
PHOX2B Variant
PIK3CA Variant		ncit:C98460
PKN1 Variant
PMS2 Variant		ncit:C178529
POLH Variant
PPM1D Amplification		ncit:C156762
PPP1CB Variant
PRKAR1A Variant
PTCH1 Variant		ncit:C133669
PTEN Variant		ncit:C165569
PTPN11 Mutation		ncit:C82612
PTPN11 Variant		ncit:C169022
RAD51C Variant
RAF1 Variant
RASA2 Variant
RB Mutation		ncit:C133696
RB1 Allele		ncit:C52102
RB1 Variant		ncit:C169031
RBM8A Variant
RECQL2 mutation		ncit:C43292
RECQL3 mutation		ncit:C43292
RECQL4 Variant
RECQL4 mutation		ncit:C53977
REST Variant
RET Variant
RIT1 Variant
ROBO1 Variant
ROS1 Rearranged		ncit:C130236
RPL11 Variant
RPL19 Variant
RPL26 Variant
RPL35A Variant
RPL5 Variant
RPS10 Variant
RPS17 Variant
RPS19 Variant
RPS24 Variant
RPS26 Variant
RPS7 Variant
RRAS Variant
RRAS2 Variant
RTEL1 Variant
RUNX1 Mutation		ncit:C38362
RUNX1 Variant
RUNX1-RUNX1T1 Fusion		ncit:C99294
SAMD9 Variant
SAMD9L Variant
SBDS Variant
SDHA Variant		ncit:C126832
SDHAF2 Variant
SDHB Variant		ncit:C169033
SDHC Variant
SDHD Variant		ncit:C169036
SETBP1 Variant
SH2D1A Variant
SHOC2 Variant
SLC24A5 Variant
SLC45A2 Variant
SMAD4 Variant
SMARCA4 Variant		ncit:C142126
SMARCB1 Deleted/Mutated
SMARCB1 Variant		ncit:C18394
SMARCE1 Variant
SMO Variant		ncit:C124793
SOS1 Variant		ncit:C180788
SOS2 Variant		ncit:C199592
SPRED1 Variant
SSX-SS18
STAG2		ncit:C153513
STK11 Variant		ncit:C178533
SUFU Variant		ncit:C189843
Somatic Gene Mutation		ncit:C18060
TAF15-NR4A3		ncit:C99501
TCF3-PBX1 Fusion		ncit:C99291
TERC Variant
TERT Variant
TGFBR3-MGEA5		ncit:C175987
TINF2 Variant
TMEM127 Variant
TP53		ncit:C118396
TP53 Variant		ncit:C118396
TRIM28 Variant
TRIM37 Variant
TSC1 Variant
TSC2 Variant
TYR Variant
TYRP1 Variant
Translocations involving 2p23 and other chromosomes
Trisomies 8,11,17,20
Trisomy 10		ncit:C81729
Trisomy 17		ncit:C37865
Trisomy 21		ncit:43224
Trisomy 3		ncit:C36425
Trisomy 4		ncit:C36530
Trisomy 7		ncit:C36476
Trisomy 8		ncit:C36396
VGLL2 Rearranged
VHL Variant
WRAP53 Variant
WT1 Mutation		ncit:C146726
WT1 Variant
Wild Type		ncit:C62195
X Chromosome Inversion		ncit:C199586
XIAP Variant
XPA Variant
XPC Variant		ncit:C169090
ZC3H7B-BCOR		ncit:C174491
del(11p15.5)		ncit:C177306
del(13q)		ncit:C36497
del(13q)(13q 14 - 21)		ncit:C168770
del(17p)		ncit:C36499
del(5q)(5q31-q32)		ncit:C168769
del(9p21)		ncit:C177307
der.12p		ncit:C173542
iAMP21		ncit:C124874
inv(16)(p13.3q24.3) / CBFA2T3-GLIS2		ncit:C167195
inv(16)(p13q22)		ncit:C36373
inv(3)(q21.3;q26.2)		ncit:C36407
inv(X)(p11.4;p11.22)		ncit:C174489
p53 mutation		ncit:C118396
t(10;11)(p11.2;q23)		ncit:C168758
t(10;11)(p12;q23) / MLL-MLLT10(AF10)		ncit:C132102
t(10;19)(q26;q13)		ncit:C120223
t(11;15)(p15;q35) / NUP98/JARID1A		ncit:C131505
t(11;16)(q13;p11)
t(11;17)(AF17)		ncit:C168760
t(11;19)(q13;q13.4)		ncit:C199595
t(11;19)(q23;p13) / (MLL-ENL)/(MLL-ELL)		ncit:C168764
t(11;19)(q23;p13.1)(MLL-ELL)		ncit:C36371
t(11;19)(q23;p13.3)(MLL-ENL)		ncit:C36372
t(11;22)		ncit:C128642
t(11;22)(p13;q12)		ncit:C36375
t(11;22)(q24;q12)		ncit:C27214
t(12;15)(p13;q25)
t(12;16)(q13;p11)		ncit:C36317
t(12;22)(q13.12;q12)		ncit:C174478
t(12;22)(q13.3;q12)		ncit:C174479
t(12;22)(q13;q12)		ncit:C36374
t(12;22;20)(q13;q12;q11)
t(15;17)(q24;q21)		ncit:C27758
t(16;16)(p13.1;q22)		ncit:C27759
t(16;21)(p11;q22)		ncit:C36616
t(16;21)(p11;q22) / FUS/ERG		ncit:C36616
t(16;21)(q24;q22) / RUNX1-CBFA2T3		ncit:C168773
t(17;22)(q21;q12)		ncit:C36369
t(17;22)(q22;q13)		ncit:C36520
t(19;22)(q13;q12)		ncit:C174480
t(1;10)(p22-31; q24-25)
t(1;11)(q21;q23) / MLL-MLLT11(AF1Q)		ncit:C168759
t(1;16)(p34;p11)		ncit:C174475
t(1;22)(RBM15-MKL1)		ncit:C36417
t(1;22)(p34;q12)		ncit:C174476
t(1;22)(q23;q12)		ncit:C174477
t(21;22)(q22;q12)		ncit:C36367
t(2;12)		ncit:C173543
t(2;16)(q35;p11)		ncit:C174465
t(2;22)(q33.3;q12)		ncit:C199598
t(2;22)(q33;q12)		ncit:C37249
t(2;22)(q34;q12)		ncit:C174481
t(3;12)(q23;p12.3)(ETV6/EVI1)		ncit:C168766
t(3;3)(q21;q26.2)		ncit:C36406
t(3;3)(q21;q26.2), RPN1-EVI1		ncit:C36406
t(3;5)(q25;q34) / NPM1/MLF1		ncit:C36415
t(4;11)(q21;q23) / MLL-MLLT2(AF4)		ncit:C36365
t(4;19)(q25;q13)		ncit:C174482
t(4;19)(q35;q13)		ncit:C120222
t(5;11)(q35;p15) / NSD1/NUP98		ncit:C131503
t(5;18)(q35;q11)		ncit:C199600
t(6;11)(q27;q23) / MLL-MLLT4(AF6)		ncit:C36610
t(6;22)(p21;q12)		ncit:C174483
t(6;9)(p23;q34) DEK/NUP214		ncit:C36532
t(7;12)(q36;p13) / HLXB9(MNX1)/ETV6(TEL)		ncit:C122689
t(7;16)(q33;p11)
t(7;22)(p22;q12)		ncit:C36368
t(8;14)(q24;q32) or other variant of B-ALL		ncit:C36319
t(8;16)MOZ/CBP		ncit:C167194
t(8;21)(q22;q22) RUNX1/ETO
t(8;8)(q21;q13)
t(9;11)(p22;q23) / MLL-MLLT3(AF9)		ncit:C36370
t(9;15)(q22;q21)
t(9;17)(q22;q11)		ncit:C36393
t(9;17)(q22;q11.2)		ncit:C199602
t(9;22)(q22-23;q11-12)		ncit:C199603
t(9;22)(q22;q12)		ncit:C174484
t(9;22)(q34;q11.2) / ABL/BCR		ncit:C13271
t(9;22)(q34;q11.2) ABL/BCR		ncit:C13271
t(X;17)(p11.2;q25)		ncit:C36392
t(X;18)(p11.21;q11)		ncit:C199604
t(X;18)(p11.23;q11)
t(X;20)(p11.2;q13.3)		ncit:C199606
t(X;22)(p11;q13)		ncit:C174495
t(X;4)(p11;q31)		ncit:C174490
t(v;q23.3); KMT2A
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

AlterationTypeEnum

Permissible Value	Description	Meaning
Deletion		ncit:C16606
Duplication
Indel
Insertion		SO:0000667
Inversion
Rearrangement, NOS
Substitution		SO:1000002
Translocation
Unknown
Not Reported		ncit:C43234

AnthropometricMeasurementTypeEnum

Permissible Value	Description	Meaning
BMI		ncit:C138901
BSA		ncit:C25157
Head Circumference	(fa) ConsortiumNote: Prioritize Head Circumference at birth and at other evaluations.	ncit:C81255
Height		ncit:C164634
Weight		ncit:C81328

AssistedConceptionEnum

Permissible Value	Description	Meaning
In Vitro Fertilization		ncit:C16580
Intracytoplasmic Sperm Injection		ncit:C185482
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

AssociatedConditionEnum

Permissible Value	Description	Meaning
ANKRD26-Related Thrombocytopenia and Leukemia Predisposition		ncit:C178387
Acute Lymphoblastic Leukemia Susceptibility - PAX5		ncit:C176907
Ataxia Telangiectasia Syndrome		ncit:C2887
Ataxia-Pancytopenia Syndrome		ncit:C176909
Attenuated Familial Adenomatous Polyposis		ncit:C6729
BAP1 Tumor Predisposition Syndrome		ncit:C172639
Beckwith-Wiedemann Syndrome/Isolated Hemihyperplasia		ncit:C34415
Birt-Hogg-Dube Syndrome		ncit:C28244
Bloom Syndrome		ncit:C2903
Bohring-Opitz Syndrome		ncit:C131533
CBL Syndrome		ncit:C176942
CDC73-Related Neoplastic Syndrome		ncit:C178382
CDH1-Associated Breast Carcinoma Syndrome		ncit:C176628
CEBPA-Related Leukemia Predisposition		ncit:C178379
CHEK2-Associated Cancer Predisposition		ncit:C176588
Carney Complex		ncit:C4705
Congenital Amegakaryocytic Thrombocytopenia		ncit:C115207
Constitutional Mismatch Repair Deficiency		ncit:C130202
Costello Syndrome		ncit:C84652
Cowden Syndrome		ncit:C3076
DDX41-Related Leukemia Predisposition		ncit:C178380
DICER1 Syndrome		ncit:C123317
Diamond-Blackfan Anemia		ncit:C176913
Dyskeratosis Congenita		ncit:C111802
ETV6-Related Thrombocytopenia and Leukemia Predisposition		ncit:C178386
Familial Adenomatous Polyposis		ncit:C3339
Familial Gastrointestinal Stromal Tumor		ncit:C176906
Familial Paraganglioma-Pheochromocytoma Syndrome		ncit:C48300
Familial Platelet Disorder and AML Syndrome		ncit:C41527
Fanconi Anemia		ncit:C62505
GATA2 Deficiency		ncit:C126349
Genetic Predisposition to Melanoma		ncit:C179472
Genetic Predisposition to Meningioma		ncit:C179471
Genetic Predisposition to Myofibromatosis		ncit:C179470
Genetic Predisposition to Neuroblastoma		ncit:C179469
Genetic Predisposition to Non-Syndromic Wilms Tumor		ncit:C178392
Genetic Predisposition to Papillary Renal Cell Carcinoma		ncit:C179473
Hepatolenticular Degeneration		ncit:C84756
Hereditary Breast and Ovarian Cancer Syndrome		ncit:C41527
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome		ncit:C41527
Hereditary Retinoblastoma		ncit:C8495
Juvenile Polyposis Syndrome		ncit:C7754
LEOPARD Syndrome		ncit:C84820
Legius Syndrome		ncit:C176941
Li-Fraumeni Syndrome		ncit:C3476
Lymphoproliferative Syndrome 1/ITK Deficiency		ncit:C126344
Lynch Syndrome		ncit:C8494
MIRAGE Syndrome		ncit:C147530
MUTYH-Associated Polyposis		ncit:C96520
Mosaic Variegated Aneuploidy Syndrome 1		ncit:C128192
Mulibrey Nanism		ncit:C84906
Multiple Endocrine Neoplasia Type 1		ncit:C3225
Multiple Endocrine Neoplasia Type 2		ncit:C123329
Multiple Endocrine Neoplasia Type 4		ncit:C157449
Neurofibromatosis Type 1		ncit:C3273
Neurofibromatosis Type 2		ncit:C3274
Nevoid Basal Cell Carcinoma Syndrome		ncit:C2892
Nijmegen Breakage Syndrome		ncit:C4692
Noonan Syndrome		ncit:C34854
Noonan Syndrome-Like Disorder with Loose Anagen Hair		ncit:C178129
Oculocutaneous Albinism		ncit:C84941
PIK3CA-Related Overgrowth Spectrum		ncit:C178285
Perlman Syndrome		ncit:C103144
Peutz-Jeghers Syndrome		ncit:C3324
Radial Aplasia-Thrombocytopenia Syndrome		ncit:C99038
Rhabdoid Tumor Predisposition Syndrome 1		ncit:C178393
Rhabdoid Tumor Predisposition Syndrome 2		ncit:C178394
Rothmund-Thompson Syndrome		ncit:C3335
Rubinstein-Taybi Syndrome		ncit:C75466
SAMD9L-Related Myelodysplastic Syndrome Predisposition		ncit:C178390
Schinzel-Giedion Syndrome		ncit:C129308
Schwannomatosis		ncit:C6557
Shwachman-Diamond Syndrome		ncit:C61235
Simpson-Golabi-Behmel Syndrome		ncit:C131002
Sotos Syndrome		ncit:C75019
Tuberous Sclerosis		ncit:C3424
Tyrosinemia Type I		ncit:C98641
Von Hippel-Lindau Syndrome		ncit:C3105
WT1 Syndromes		ncit:C131006
Weaver Syndrome		ncit:C125599
X-linked Lymphoproliferative Syndrome		ncit:C61246
Xeroderma Pigmentosum		ncit:C3452

AttributionEnum

Permissible Value	Description	Meaning
Definite		ncit:C53260
Possible		ncit:C53258
Probable		ncit:C41357
Unlikely		ncit:C53257
Unrelated		ncit:C53256
Unknown		ncit:C17998
Not Reported		ncit:C43234

AvnJointEnum

Permissible Value	Description	Meaning
Ankle (distal tibia, instrinsic ankle bones)		ncit:C32078
Elbow (distal humerus, proximal radius, proximal ulna)		ncit:C32497
Heel (calcaneus)		ncit:C161381
Hip (proximal femur)		ncit:C32742
Knee (distal femur, proximal tibia)		ncit:C32898
Shoulder (proximal humerus)		ncit:C25203
Wrist (distal radius, distal ulna, instrinsic wrist bones)		ncit:C33894
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

BbpsScoreEnum

Permissible Value	Description	Meaning
Segment Score 0		ncit:C138207
Segment Score 1		ncit:C138208
Segment Score 2		ncit:C138209
Segment Score 3		ncit:C138210
Surgically Absent
Unknown		ncit:C17998

BreakageSourceLabEnum

Permissible Value	Description	Meaning
ARUP
Cincinnati Children's Hospital Medical Center
Dana-Farber Cancer Institute		ncit:C177330
Julius-Maximilians-Universität of Würzburg
Laboratorio de Citogenética, Instituto Nacional de Pediatría, México
OHSU
Quest Diagnostics
Stanford University
The Rockefeller University
University of Chicago
University of Minnesota
Other

CauseOfDeathDetailEnum

Permissible Value	Description	Meaning
Acute Respiratory Distress Syndrome		ncit:C3353
Bacterial Infection		ncit:C2890
Bone Marrow Failure Complications
Cancer Progression, NOS		ncit:C19987
Cardiac Disease		ncit:C3079
Cardiac Failure		ncit:C50577
Fungal Infection		ncit:C3245
Graft Versus Host Disease		ncit:C3063
Hemorrhage	(hl) ConsortiumNote: If multiple cause of death details, include one observation per cause of death detail.	ncit:C26791
Immunotherapy-Related		ncit:C168874
Infection, NOS		ncit:C128320
Infection, Not Otherwise Specified		ncit:C128320
Kidney Failure		ncit:C4376
Liver Failure		ncit:C26922
Multi-Organ Failure		ncit:C75568
Organ Failure, NOS		ncit:C185320
Pulmonary Disease		ncit:C3198
Sinusoidal Obstruction Syndrome		ncit:C26793
Surgical Complication		ncit:C164157
Unacceptable Toxicity		ncit:C199267
Viral Infection		ncit:C3439
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

CauseOfDeathEnum

Permissible Value	Description	Meaning
Disease Progression	(cns) ConsortiumNote: Deceased-due to disease. (fa) ConsortiumNote: Cancer-related disease progression. Deceased-due to disease. (gct) ConsortiumNote: If multiple causes of death, include one observation per cause of death. (hl) ConsortiumNote: If multiple causes of death, include one observation per cause of death. (nrsts) ConsortiumNote: If multiple causes of death, include one observation per cause of death. There can only be one record where CAUSE_OF_DEATH_RANKING=Primary. (os) ConsortiumNote: If multiple causes of death, include one observation per cause of death. However, only one cause of death can have the varaiable CAUSE_OF_DEATH_RANKING=Primary. Note: Only fill in this variable if LKSS is 'Dead'. (rms) ConsortiumNote: If multiple causes of death, include one observation per cause of death. However, only one cause of death can have the varaiable CAUSE_OF_DEATH_RANKING=Primary.	ncit:C168970
Post-Treatment Disease Complications		ncit:C168877
Pre-Treatment Disease Complications		ncit:C168876
Secondary Malignancy	D4CGNote: Use the Subsequent Malignant Neoplasm table for any additional details. Do not use CAUSE_OF_DEATH_DETAIL.	ncit:C4968
Treatment-Related Mortality	D4CGNote: Use the Adverse Events table for any additional details. Do not use CAUSE_OF_DEATH_DETAIL.	ncit:C166165
Unrelated to Disease or Treatment	(cns) ConsortiumNote: Deceased-due to other causes. (fa) ConsortiumNote: Deceased-due to other causes.	ncit:C17649
Other		ncit:C17649
Unknown	(cns) ConsortiumNote: Deceased-due to unknown causes. (fa) ConsortiumNote: Deceased-due to unknown causes.	ncit:C17998
Not Reported	(cns) ConsortiumNote: Deceased-causes unavailable. (fa) ConsortiumNote: Deceased-causes unavailable.	ncit:C43234

CauseOfDeathRankingEnum

Permissible Value	Description	Meaning
Contributory		ncit:C168948
Primary	(os) ConsortiumNote: There may be multiple contributory causes of death, but only one primary cause of death. Note: Only fill in this variable if LKSS is 'Dead'.	ncit:C99531
Unknown		ncit:C17998
Not Reported		ncit:C43234

ChromosomalTranslocationPartnerEnum

Permissible Value	Description	Meaning
1		ncit:C13204
10		ncit:C13205
11		ncit:C13206
12		ncit:C13207
13		ncit:C13208
14		ncit:C13209
15		ncit:C13210
16		ncit:C13211
17		ncit:C13212
18		ncit:C13213
19		ncit:C13214
2		ncit:C13215
20		ncit:C13216
21		ncit:C13217
22		ncit:C13218
3		ncit:C13219
4		ncit:C13220
5		ncit:C13221
6		ncit:C13222
7		ncit:C13223
8		ncit:C13224
9		ncit:C13225
X		ncit:C13285
Y		ncit:C13286

ChromosomeEnum

Permissible Value	Description	Meaning
1		ncit:C13204
10		ncit:C13205
11		ncit:C13206
12		ncit:C13207
13		ncit:C13208
14		ncit:C13209
15		ncit:C13210
16		ncit:C13211
17		ncit:C13212
18		ncit:C13213
19		ncit:C13214
2		ncit:C13215
20		ncit:C13216
21		ncit:C13217
22		ncit:C13218
3		ncit:C13219
4		ncit:C13220
5		ncit:C13221
6		ncit:C13222
7		ncit:C13223
8		ncit:C13224
9		ncit:C13225
X		ncit:C13285
Y		ncit:C13286

CimtTypeEnum

Permissible Value	Description	Meaning
Chimeric Antigen Receptor T-cell Therapy		ncit:C126102
Donor Lymphocyte Infusion		ncit:C16145
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

ClinicalFindingEnum

Permissible Value	Description	Meaning
Abdominal pain
Abnormal Anus Morphology NOS	(fa) ConsortiumNote: Anal Anomaly
Abnormal Duodenal Morphology NOS	(fa) ConsortiumNote: Esophageal Duodenal Atresia
Abnormal Esophagus Morphology NOS	(fa) ConsortiumNote: Esophageal Duodenal Atresia
Abnormal Heart Morphology NOS	(fa) ConsortiumNote: Cardiac Anomaly
Abnormal Heart Valve Morphology NOS	(fa) ConsortiumNote: Cardiac Anomaly
Abnormal Morphology of the Thumb	(fa) ConsortiumNote: Upper Limb Anomaly
Abnormal Renal Morphology NOS	(fa) ConsortiumNote: Renal Anomaly
Abnormal Speech	(fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C5041
Abnormal Thumb Morphology	(fa) ConsortiumNote: Upper Limb Anomaly
Abnormal Uterine Bleeding
Abnormal corpus callosum morphology
Abnormal fallopian tube morphology NOS
Abnormal female external genitalia morphology
Abnormal malleus morphology
Abnormal nervous system morphology NOS
Abnormal oral mucosa morphology NOS
Abnormal pinna morhology (Microtia, poliotia, abnormal helix, etc)
Abnormal size of the palpebral fissures
Abnormal tympanic membrane morphology (no hay HP para "small")
Abnormality of skin pigmentation
Abnormality of the Upper Limb NOS	(fa) ConsortiumNote: Upper Limb Anomaly
Abnormality of the Ureter NOS	(fa) ConsortiumNote: Renal Anomaly
Abnormality of the Vertebral Column NOS	(fa) ConsortiumNote: Vertebral Anomaly
Abnormality of the dentition NOS
Abnormality of the ear NOS
Abnormality of the eye NOS
Abnormality of the female genitalia NOS
Abnormality of the male genitalia NOS
Absent Radius	(fa) ConsortiumNote: Upper Limb Anomaly
Absent Thumb	(fa) ConsortiumNote: Upper Limb Anomaly
Absent testes
Acute Lymphoblastic Leukemia Susceptibility - PAX5		ncit:C176907
Anal Atresia	(fa) ConsortiumNote: Anal Anomaly
Anal Fistula	(fa) ConsortiumNote: Anal Anomaly
Anal Stenosis	(fa) ConsortiumNote: Anal Anomaly
Aplasia of the ovary
Aplasia uterus
Aspiration
Ataxia	(fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C26702
Atresia of the external auditory canal
Atrial Septal Defect	(fa) ConsortiumNote: Cardiac Anomaly	ncit:C84473
Attentions Deficit Hyperactivity Disorder
Back Pain	(fa) ConsortiumNote: FANS Diagnosis
Behavioral/Cognitive Changes	(fa) ConsortiumNote: FANS Diagnosis
Birth length less than 3rd percentile
Bleeding, NOS
Blurry Vision/Loss of Vision	(fa) ConsortiumNote: FANS Diagnosis	ncit:C50602
Bruising
Cataracts
Central nervous system cysts
Cerebellar hypoplasia (vermis, olivo-ponto and hemisphere cerebellar hypoplasia)
Cerebral hypoplasia
Chest pain
Choking
Cleft Palate
Coarctation of Aorta	(fa) ConsortiumNote: Cardiac Anomaly	ncit:C84567
Complex Migraine	(fa) ConsortiumNote: Neurological Symptoms History
Cortical Signs	(fa) ConsortiumNote: Neurological Exam/Phenotype
Coughing
Cranial Mono-neuropathy	(fa) ConsortiumNote: Neurological Exam/Phenotype
Craniosynostosis	(fa) ConsortiumNote: PHENOS Feature	ncit:C84655
Crossed Fused Renal Ectopia	(fa) ConsortiumNote: Renal Anomaly
Cryptorchidism
Decreased testicular size
Difficulty Breathing
Difficulty Swallowing
Double Vision	(fa) ConsortiumNote: FANS Diagnosis	ncit:C37941
Duodenal Atresia	(fa) ConsortiumNote: Esophageal Duodenal Atresia
Duodenal Stenosis	(fa) ConsortiumNote: Esophageal Duodenal Atresia
Duodenal Web	(fa) ConsortiumNote: Esophageal Duodenal Atresia
Dysdiadochokinesia	(fa) ConsortiumNote: Neurological Exam/Phenotype
Dysphagia
Dysplastic Kidney	(fa) ConsortiumNote: Renal Anomaly	ncit:C123031
Earache
Ectopic Anus	(fa) ConsortiumNote: Anal Anomaly
Ectopic Kidney	(fa) ConsortiumNote: Renal Anomaly
Encephalopathy	(fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C26920
Encephalopathy, Focal Numbness	(fa) ConsortiumNote: Neurological Exam/Phenotype
Encephalopathy, Focal Weakness	(fa) ConsortiumNote: Neurological Exam/Phenotype
Epicanthal folds (epicanthus)
Erectile Dysfunction		ncit:C3133
Erythroplakia		ncit:C3025
Esophageal Atresia	(fa) ConsortiumNote: Esophageal Duodenal Atresia
Esophageal Stenosis	(fa) ConsortiumNote: Esophageal Duodenal Atresia
Esophageal Web	(fa) ConsortiumNote: Esophageal Duodenal Atresia
Eye Movement Abnormalities	(fa) ConsortiumNote: Neurological Exam/Phenotype
Fatigue		ncit:C3036
Feeling of lump in throat
Fevers
Focal Weakness, NOS	(fa) ConsortiumNote: Neurological Symptoms History
Gagging
Generalized hyperpigmentation
Glaucoma
Halitosis
Headache	(fa) ConsortiumNote: FANS Diagnosis (fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C34661
Hearing impairment
Hematemesis		ncit:C37964
Hepatomegaly
Hoarseness
Horseshoe Kidney	(fa) ConsortiumNote: Renal Anomaly	ncit:C98947
Human Papillomavirus Infection		ncit:C27851
Human immunodeficiency virus [HIV] disease		icd10:B20
Hydrocephalus	(fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C3111
Hydronephrosis	(fa) ConsortiumNote: Renal Anomaly	ncit:C26796
Hydroureter	(fa) ConsortiumNote: Renal Anomaly	ncit:C26927
Hyperpigmented freckle like macules/acanthomas in flexural areas
Hyperpigmented macules (hypermelanotic macule)
Hyperreflexia	(fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C43248
Hypertension	(fa) ConsortiumNote: Medical HIstory
Hypopigmented macules
Hypoplasia of penis
Hypoplasia of the Radius	(fa) ConsortiumNote: Upper Limb Anomaly
Hypoplasia of the ovary
Hypoplasia of the uterus
Hypoplastic Thenar Eminence	(fa) ConsortiumNote: Upper Limb Anomaly
Hypospadias
Hypotelorism
Imbalance	(fa) ConsortiumNote: FANS Diagnosis	ncit:C200084
Impaired Consciousness	(fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C121627
Incontinence	(fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C3429
Increased Intracranial Pressure	(fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C187268
Intellectual disability
Intrauterine Growth Restriction	(fa) ConsortiumNote: Birth History	ncit:C87088
Itching
Jaw pain
Leukopenia		ncit:C26816
Leukoplakia		ncit:C3186
Lichen Planus
Limb Pain
Limbal neovascularization
Liver abnormalities
Liver adenomas
Loss of smell
Loss of taste
Low set ears
Melena/Black Stool		ncit:C86571
Meningismus	(fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C79694
Microcornea
Microdontia
Microphtalmia
Migraine	(fa) ConsortiumNote: Neurological Symptoms History
Multiple Cranial Neuropathies	(fa) ConsortiumNote: Neurological Exam/Phenotype
Myelopathy, Focal Numbness	(fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C34857
Myelopathy, Focal Weakness	(fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C182336
Narrow internal auditory canal
Nausea
Neck Pain	(fa) ConsortiumNote: FANS Diagnosis
Neural Tube Defects	(fa) ConsortiumNote: Vertebral Anomaly
Neurogenic Bladder/Bowel	(fa) ConsortiumNote: FANS Diagnosis	ncit:C79696
Neuropathy	(fa) ConsortiumNote: Neurological Symptoms History
Night sweats
Numbness, NOS	(fa) ConsortiumNote: Neurological Symptoms History
Optic nerve hypoplasia
Oral Bacterial Infection
Oral Fungal Infection
Oral Viral Infection
Pain, NOS
Paresthesia	(fa) ConsortiumNote: FANS Diagnosis (fa) ConsortiumNote: Neurological Symptoms History	ncit:C28177
Partial Duplication of Thumb Phalanx	(fa) ConsortiumNote: Upper Limb Anomaly
Patent Ductus Arteriosus	(fa) ConsortiumNote: Cardiac Anomaly	ncit:C84492
Patent Foramen Ovale	(fa) ConsortiumNote: Cardiac Anomaly
Pelvic Pain
Petechiae
Positive Visual Phenomenon	(fa) ConsortiumNote: Neurological Symptoms History
Postcoital Bleeding
Postmenopausal Bleeding
Preaxial Hand Polydactyly	(fa) ConsortiumNote: Upper Limb Anomaly
Premalignant lesion / dysplasia
Ptosis
Recurrent Mouth Sores
Reflux
Renal Agenesis	(fa) ConsortiumNote: Renal Anomaly	ncit:C101220
Renal Cysts	(fa) ConsortiumNote: Renal Anomaly
Renal Duplication	(fa) ConsortiumNote: Renal Anomaly
Renal Hypoplasia	(fa) ConsortiumNote: Renal Anomaly
Renal Malrotation	(fa) ConsortiumNote: Renal Anomaly
Retinopathy
Scoliosis	(fa) ConsortiumNote: Vertebral Anomaly
Seizure	(fa) ConsortiumNote: FANS Diagnosis (fa) ConsortiumNote: Neurological Exam/Phenotype	ncit:C2962
Sensorineural Hearing Loss	(fa) ConsortiumNote: Medical HIstory
Severe aplastic anemia
Severe isolated lineage cytopenia: platelet
Severe isolated lineage cytopenia: red cell
Severe isolated lineage cytopenia: white cell
Short Thumb	(fa) ConsortiumNote: Upper Limb Anomaly
Short stature NOS
Situs Inversus		ncit:C87121
Slurred Speech	(fa) ConsortiumNote: FANS Diagnosis
Small for Gestational Age	(fa) ConsortiumNote: Birth History	ncit:C114934
Small pituitary gland
Sore throat
Spinal Level Myelopathy	(fa) ConsortiumNote: Neurological Exam/Phenotype
Stenosis of the external auditory canal
Strabismus
Subluxed Thumb	(fa) ConsortiumNote: Upper Limb Anomaly
Supernumerary tooth
Swelling
Systemic Lupus Erythematosus	(fa) ConsortiumNote: Medical HIstory
Tetralogy of Fallot	(fa) ConsortiumNote: Cardiac Anomaly	ncit:C84505
Thrombocytopenia		ncit:C3408
Tightness in chest
Tooth agenesis
Transient cytopenia
Triphalangeal Thumb	(fa) ConsortiumNote: Upper Limb Anomaly
Truncus Arteriosus	(fa) ConsortiumNote: Cardiac Anomaly	ncit:C98880
Ureteral Agenesis	(fa) ConsortiumNote: Renal Anomaly
Ureteral Duplication	(fa) ConsortiumNote: Renal Anomaly	ncit:C98917
Ureteral Hypoplasia	(fa) ConsortiumNote: Renal Anomaly
Vaginal Discharge
Ventricular Septal Defect	(fa) ConsortiumNote: Cardiac Anomaly	ncit:C84506
Ventriculomegaly
Vertebral Fusion	(fa) ConsortiumNote: Vertebral Anomaly
Vertigo	(fa) ConsortiumNote: FANS Diagnosis	ncit:C38057
Vesicoureteral Reflux	(fa) ConsortiumNote: Renal Anomaly	ncit:C84467
Voice Alteration
Vomiting		ncit:C3442
Vulvar Pain
Weight Loss
Wheezing

ConceptionTypeEnum

Permissible Value	Description	Meaning
Artifical Insemination		ncit:C16739
In Vitro Fertilization, Conventional		ncit:C16580
In Vitro Fertilization, Intracytoplasmic Sperm Injection		ncit:C185482
Egg Donor
Ovulation Induction
Non-assisted
Other

ConditioningTypeEnum

Permissible Value	Description	Meaning
Antibody Conditioning
Myeloablative		ncit:C131679
Non-Myeloablative		ncit:C62714
Reduced Intensity Conditioning/Reduced Toxicity Conditioning		ncit:C116471
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

ConsortiumEnum

Permissible Value	Description	Meaning
ALLIES
C3P		ncit:C192767
CHIC
FRIENDS
Global REACH		ncit:C192766
HIBiSCus		ncit:C192763
INRG		ncit:C192762
INSPiRE		ncit:C192765
INSTRuCT		ncit:C192762
INTERACT		ncit:C192762
LINEAGE		ncit:C192767
MaGIC		ncit:C192759
NOBLE
NODAL		ncit:C192759
RHOPE

CourseEnum

Permissible Value	Description	Meaning
Chemoimmunotherapy		ncit:C94251
Chemoradiotherapy	(cns) ConsortiumNote: SIOPE groups should use this value in place of what they may have as 'concommitant'.	ncit:C94626
Chemotherapy Window
Chemotherapy, NOS	(npc) ConsortiumNote: Only when DISEASE_PHASE = 'Relapse'.	ncit:C15632
Concomitant Chemoradiation Therapy	(npc) ConsortiumNotes: Specifically for TROD data.
Consolidation		ncit:C15679
Continuation		ncit:C123452
Curative Intent, No Surgery Planned
Delayed Intensification		ncit:C178270
Fertility Preservation Therapy		ncit:C71326
Fertility Utilization
Immunotherapy	(npc) ConsortiumNote: Only when DISEASE_PHASE = 'Relapse'.	ncit:C15262
Induction		ncit:C158876
Intensification		ncit:C173105
Interim Maintenance		ncit:C178069
Investigational Agent	(cns) ConsortiumNote: This value should be used for data that may have 'concomitant' listed in the source.	ncit:C49135
Maintenance	(ews) ConsortiumNote: In EE99, we did not differenciate maintenance and consolidation courses. They will be all coded as consolidation courses.	ncit:C15688
Palliative Treatment		ncit:C15292
Postoperative Chemotherapy
Preoperative Chemotherapy
Prephase		ncit:C168826
Radiation Therapy	(npc) ConsortiumNote: Only when DISEASE_PHASE = 'Relapse'.	ncit:C15313
Stem Cell Transplant Conditioning		ncit:C168794
Other		ncit:C17649

DataContributorIdEnum

Permissible Value	Description	Meaning
AIEOP		ncit:C168887
BC Cancer
Corewell Health
BFM-SG		ncit:C168888
BOCG		ncit:C180373
CBTN		ncit:C192778
CCHE 57357	(aml) ConsortiumNote: Children's Cancer Hospital Egpyt 57357
CCLG	(gct) ConsortiumNote: Children’s Cancer and Leukaemia Group	ncit:C177327
CHLA		ncit:C192782
Children's Healthcare of Atlanta (CHOA)
Children's Hospital of Orange County
Children's National Hospital
Cincinnati Children's Hospital Medical Center
CIBER
CMC Vellore
COG		ncit:C39353
COSS-GPOH		ncit:C186743
CRCTU		ncit:C174966
CWS		ncit:C192777
Cedars Sinai
Christian Medical College and Hospital
City of Hope National Medical Center
Cleveland Clinic
Columbia University
DCOG		ncit:C168889
DEPICT		ncit:C192784
DFCI		ncit:C177330
Dana Farber Cancer Institute
Deutsche Fanconi Anämie-Hilfe e.V.
Duke University
EORTC		ncit:C19741
EURO-EWING		ncit:C174964
EXPeRT
Emory
Endeavor Health
EpSSG		ncit:C192774
EuRBG		ncit:C192785
FSG		ncit:C174962
Fanconi Cancer Foundation
FertiProtekt
GALOP		ncit:C192786
GEIS		ncit:C180341
GPOH		ncit:C174960
IDIPGR		ncit:C180886
ISG		ncit:C174965
ISPHO
Icahn School of Medicine Mount Sinai
Indiana University
Indraprastha Apollo Hospital
Instituto Nacional de Pediatria
JACLS		ncit:C168890
JCCG		ncit:C192770
JPLSG		ncit:C168891
Johns Hopkins University
Kaiser Foundation Research Institute
Loma Linda University
Lurie Children's University
MD Anderson Cancer Center
Meharry Medical College
MMT		ncit:C192775
MRC		ncit:C168892
Massachusetts General Hospital
Mazumdar Shaw Medical Centrem Bangalore
MedStar Health
Medanta Gurugram
Memorial Sloan Kettering
Michigan State University (Henry Ford)
NOPHO		ncit:C168893
NRG-Oncology		ncit:C177331
National Cancer Institute
Nationwide Children's Hospital
NIH/NICHD
Northwestern University
Ohio State University Medical Center
PHC
PNOC		ncit:C192779
PPLLSG		ncit:C168894
Penn State
Phoenix Children's Hospital
RBTR		ncit:C192780
SARC
Seattle Children's Hospital
SFCE	(gct) ConsortiumNote: Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent	ncit:C177328
SIOP MMT		ncit:C192775
SIOPE		ncit:C192781
SIOPEL
SIOPEN
SJCRH		ncit:C39510
SOPOBE	(gct) ConsortiumNote: Brazilian Society of Pediatric Oncology	ncit:C177329
SSG		ncit:C174961
STSC
Schneider Children's Medical Center
Shalby Sanar International Hospital
St. Vincent's Institute for Medical Research
Stanford University
TROD
Tata Memorial Centre
The Rockefeller University
UCL		ncit:C174967
UK		ncit:C174963
University Hospitals Cleveland Medical Center
University of Colorado Anschutz Medical Campus
University of Michigan (Michigan Medicine)
University of Pittsburgh
University of Utah
Washington University in St. Louis
UT Southwestern
Un Corazón por Fanconi
University of Alabama at Birmingham
University of Arizona
University of California San Diego
University of California San Francisco
University of Chicago
University of Colorado
University of Düsseldorf
University of Kansas Medical Center
University of Manchester
University of Manitoba
University of Miami School of Medicine
University of Michigan
University of Pennsylvania
University of Pittsburgh Medical Center
University of Rochester Medical Center
University of Wisconsin
Virginia Mason CommonSpirit Health

DataSourceEnum

Permissible Value	Description	Meaning
Institutional Study		ncit:C41206
Registry	(npc) ConsortiumNotes: For TROD, use Registry only.	ncit:C129000
Therapeutic Trial		ncit:C39536
Unknown		ncit:C17998
Not Reported		ncit:C43234

DepthEnum

Permissible Value	Description	Meaning
Cortical		ncit:C52714
Deep		ncit:C25240
Intra-Medullary		ncit:C96266
Superficial		ncit:C25239
Surface		ncit:C25245
Unknown		ncit:C17998
Not Reported		ncit:C43234

DetectionMethodEnum

Permissible Value	Description	Meaning
Angiogram		ncit:C16290
Attachment Device (Cap, Endocuff, etc.)
Audiogram
B-Scan Ultrasonography		ncit:C198675
Biopsy		ncit:C15189
Blood Work
Bone Marrow Aspirates
Bone Marrow Results		ncit:C190021
Bone Marrow Trephine Biopsy
Bone Scan		ncit:C17646
CT		ncit:C17204
CT Scan		ncit:C17204
CTA		ncit:C202408
Cerebrospinal Fluid Results		ncit:C168884
Clinical Signs or Symptoms		ncit:C100104
Colonoscopy
Colposcopy		ncit:C16451
Computer Aided Diagnosis
Cytology		ncit:C16491
Dye Chromoendoscopy
Echocardiogram
Endoscopy
Fine-Needle Aspiration		ncit:C15361
Flexible Fiberoptic Sigmoidoscopy
Flexible Sigmoidoscopy		ncit:C51588
Flexible sigmoidoscopy/colonoscopy
Fluorescein Angiography		ncit:C190541
Gallium Scan		ncit:C38087
High Definition Equipment
Histological Assessment
Imaging		ncit:C17369
Imaging, NOS		ncit:C17369
Incisional Biopsy		ncit:C15386
Liquid Biopsy		ncit:C135727
Lower Endoscopy (colonoscopy)		ncit:C16450
Lymphangiogram		ncit:C16805
MRA		ncit:C114867
MRI		ncit:C16809
Mammogram		ncit:C20178
Not Applicable		ncit:C48660
Optical Coherence Tomography (OCT)		ncit:C20828
Oral Brush Biopsy
PET Scan		ncit:C17007
PET-CT		ncit:C103512
PET-MRI		ncit:C103514
Palpation		ncit:C16950
Physical Examination		ncit:C20989
Rectal Retroflexion
Right Colon Retroflexion
Serum Antigen
Staging Laparotomy		ncit:C185327
Stool Antigen
Surgical Pathology		ncit:C16958
Technetium Bone Scan
Tumor Marker		ncit:C17220
Ultrasound		ncit:C64384
Ultrasound Biomicroscopy (UBM)		ncit:C94186
Upper Endoscopy (Colonscope)		ncit:C16604
Upper Endoscopy (Gastroscope)		ncit:C16604
Upper endoscopy
Urea Breath Test
Urine Test
Video Capsule Endoscopy		ncit:C16546
Virtual Chromoendoscopy
Wide Field Retinal Photography
X-Ray		ncit:C38101
cfDNA Analysis
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234
Lower Endoscopy, Attachment Device (Cap, Endocuff, etc.)
Lower Endoscopy, NOS
Lower Endoscopy, Computer Aided Diagnosis
Lower Endoscopy, Dye Chromoendoscopy
Lower Endoscopy, Flexible Sigmoidoscopy		ncit:C51588
Upper Endoscopy, High Definition Equipment
Lower Endoscopy, High Defnition Equipment
Lower Endoscopy, Rectal Retroflexion
Lower Endoscopy, Right Colon Retroflexion
Lower Endoscopy, Virtual Chromoendoscopy

DiagnosisBasisEnum

Permissible Value	Description	Meaning
Clinical		ncit:C15607
Clinical Exam		ncit:C38060
Histological		ncit:C25526
Integrated		ncit:C165682
Molecular		ncit:C20826
Not Reported		ncit:C43234

DiagnosisCategoryEnum

Permissible Value	Description	Meaning
Atypical Teratoid/Rhabdoid Tumor		ncit:C6906
CNS Germ Cell Tumors		ncit:C5461
Choroid Plexus Tumors		ncit:C3473
Craniopharyngioma		ncit:C2964
Carcinoma In Situ		icdo:8010/2
Duodenal/Jejunal Histology
Endometrial Histology
Ependymoma	(cns) ConsortiumNote: Includes ependymal tumors	icdo:9391/3
Esophageal Histology
Fibrolamellar carcinoma
Gastric Histology
Glioneuronal and Neuronal Tumors		ncit:C4747
Hepatic Tumor, Other
Hepatoblastoma (HB)		ncit:C3728
Hepatocelluar Carcinoma (HCC)		ncit:C3099
High-Grade Glioma	(cns) ConsortiumNote: Includes adult-type diffuse gliomas, pediatric type diffuse high-grade gliomas, some circumscribed astrocytic gliomas	ncit:C162993
Low-Grade Glioma	(cns) ConsortiumNote: Includes pediatric type diffuse low-grade gliomas, some circumscribed astrocytic gliomas.	ncit:C132067
Carcinoma		icdo:8010/3
Large Cell Carcinoma		icdo:8012/3
Carcinoma, Undifferentiated Type		icdo:8020/3
Carcinoma, Anaplastic Type		icdo:8021/3
Papillary carcinoma		icdo:8050/3
Verrucous carcinoma		icdo:8051/3
Squamous cell carcinoma in situ		icdo:8070/2
Squamous cell carcinoma		icdo:8070/3
Sq. cell carcinoma, keratinizing		icdo:8071/3
Adenocarcinoma		icdo:8140/3
Papillary adenocarcinoma		icdo:8260/3
Malignant melanoma		icdo:8720/3
Spindle cell melanoma		icdo:8772/3
Mixed tumor, malignant		icdo:8940/3
Marginal zone B-cell lymphoma		icdo:9699/3
Metaplastic carcinoma		icdo:8575/3
Rhabdomyosarcoma		icdo:8900/3
Malignant lymphoma		icdo:9590/3
Hodgkin lymphoma		icdo:9650/3
Hodgkin lymphoma, mixed cellularity		icdo:9652/3
Hodgkin lymphoma, lymphocytic deplet.		icdo:9653/3
Hodgkin lymphoma, nodular sclerosis		icdo:9663/3
ML, small B lymphocytic		icdo:9670/3
ML, large B-cell, diffuse, immunoblastic		icdo:9684/3
Burkitt lymphoma		icdo:9687/3
Follicular lymphoma		icdo:9690/3
Mature T-cell lymphoma		icdo:9702/3
Precursor cell lymphoblastic lymphoma		icdo:9727/3
Plasmacytoma		icdo:9731/3
Langerhans cell histiocytosis		icdo:9751/3
B lymphoblastic leukemia/lymphoma		icdo:9811/3
Clear cell adenocarcinoma		icdo:8310/3
Cystadenocarcinoma		icdo:8440/3
Fibrosarcoma		icdo:8810/3
Carcinosarcoma		icdo:8980/3
Solid carcinoma		icdo:8230/3
Sarcoma		icdo:8800/3
Liposarcoma		icdo:8850/3
Leiomyosarcoma		icdo:8890/3
Transitional Cell Carcinoma		icdo:8120/3
Small Cell Carcinoma		icdo:8041/3
Embryonal Carcinoma		icdo:9070/3
Chordoma		icdo:9370/3
Medullary Carcinoma		icdo:8510/3
Stromal Sarcoma		icdo:8935/3
Micropapillary Carcinoma		icdo:8265/3
Mucinous Cystadenocarcinoma		icdo:8470/3
Intraductal Carcinoma, Noninfiltrating		icdo:8500/2
Intracystic Carcinoma		icdo:8504/3
Hepatocellular Carcinoma		icdo:8170/3
Comedocarcinoma		icdo:8501/3
Papillary Cystadenocarcinoma		icdo:8450/3
Intraductal Oncocytic Papillary Neoplasm		icdo:8455/2
Synovial Sarcoma		icdo:9040/3
Clear Cell Sarcoma, NOS (Except of Kidney M-)		icdo:9044/3
Teratoma, Malignant		icdo:9080/3
Neuroblastoma		icdo:9500/3
Medulloepithelioma		icdo:9501/3
Neuroepithelioma		icdo:9503/3
Chondrosarcoma		icdo:9220/3
Thymoma, Malignant		icdo:8580/3
Thymic Carcinoma		icdo:8586/3
Cutaneous T-cell Lymphoma		icdo:9709/3
Seminoma		icdo:9061/3
Osteosarcoma		icdo:9180/3
Immunoproliferative Disease		icdo:9760/3
Heavy Chain Disease		icdo:9762/3
Leukemia		icdo:9800/3
Acute Leukemia		icdo:9801/3
Mixed Phenotype Acute Leukemia, B/Myeloid		icdo:9808/3
Mixed Phenotype Acute Leukemia, T/Myeloid		icdo:9809/3
Lymphoid Leukemia		icdo:9820/3
Acute Lymphoblastic Leukemia, L2 Type		icdo:9828/3
Prolymphocytic Leukemia		icdo:9832/3
Precursor Cell Lymphoblastic Leukemia		icdo:9835/3
Myeloid Leukemia		icdo:9860/3
Chronic Myeloid Leukemia		icdo:9863/3
Therapy-related Acute Myeloid Leukemia		icdo:9920/3
Chronic Myelomonocytic Leukemia		icdo:9945/3
Chronic Myeloproliferative Disease		icdo:9960/3
Therapy-related Myelodysplastic Syndrome		icdo:9987/3
Myelodysplastic Syndrome		icdo:9989/3
Precancerous Melanosis		icdo:8741/2
Dermatofibrosarcoma		icdo:8832/3
Lobular Carcinoma		icdo:8520/3
Sq. Cell Carcinoma, Keratinizing, in Situ		icdo:8071/2
Basal Cell Carcinoma		icdo:8090/3
Infiltrating Basal Cell Carcinoma		icdo:8092/3
Adenocarcinoma, HPV-independent		icdo:8484/3
Nephroblastoma		icdo:8960/3
Retinoblastoma		icdo:9510/3
Fibroma		icdo:8810/0
Lipoma		icdo:8850/0
Angiolipoma		icdo:8861/0
Teratoma		icdo:9080/1
Dermoid Cyst		icdo:9084/0
Hemangioma		icdo:9120/0
Hemangiopericytoma		icdo:9150/1
Meningioma		icdo:9530/0
Meningiomatosis		icdo:9530/1
Paraganglioma		icdo:8680/1
Astrocytoma		icdo:9400/3
Glioblastoma		icdo:9440/3
Oligodendroglioma		icdo:9450/3
Embryonal Tumor with Multilayered Rosettes		icdo:9478/3
Ganglioglioma		icdo:9505/1
Neurofibroma		icdo:9540/0
Neurofibromatosis		icdo:9540/1
Neurilemoma		icdo:9560/0
Neuroma		icdo:9570/0
Perineurioma		icdo:9571/0
Choroid Plexus Papilloma		icdo:9390/0
Medulloblastoma		icdo:9470/3
Cerebellar Sarcoma		icdo:9480/3
Leiomyoma		icdo:8890/0
Smooth Muscle Tumor		icdo:8897/1
Rhabdomyoma		icdo:8900/0
Hemangioendothelioma		icdo:9130/1
Follicular Adenocarcinoma		icdo:8330/3
Clear Cell Tumor		icdo:8005/0
Adenoma		icdo:8140/0
Papillary Adenoma		icdo:8260/0
Pituitary Adenoma		icdo:8272/0
Pituitary Carcinoma		icdo:8272/3
Granular Cell Tumor		icdo:9580/0
Pinealoma		icdo:9360/1
Other CNS Embryonal Tumors	(cns) ConsortiumNote: Includes pineoblastoma	ncit:C6990
Other		ncit:C17649

DiagnosisEnum

Permissible Value	Description	Meaning
ACTH-producing tumor		icdo:8158/3
ALK positive large B-cell lymphoma		icdo:9737/3
AML, NOS		ncit:C27753
Ac. myelomonocytic leuk. w abn. mar. eosinophils		icdo:9871/3
Acidophil adenoma		icdo:8280/0
Acidophil carcinoma		icdo:8280/3
Acinar cell carcinoma		icdo:8550/3
Acinar cell cystadenocarcinoma		icdo:8551/3
Acral lentiginous melanoma, malig.		icdo:8744/3
Acute Myeloid Leukemia, NOS
Acute basophilic leukemia		icdo:9870/3
Acute biphenotypic leukemia		icdo:9805/3
Acute Leukemia, ambiguous lineage (mixed or biphenotypic)		ncit:C7464
Acute leukemia, NOS		icdo:9801/3
Acute lymphoblastic leukemia		icdo:9828/3
Acute lymphoblastic leukemia, L2 type, NOS		icdo:9828/3
Acute megakaryoblastic leukemia		icdo:9910/3
Acute monocytic leukemia		icdo:9891/3
Acute myeloid leuk. with multilineage dysplasia		icdo:9895/3
Acute myeloid leukemia		icdo:9861/3
Acute myeloid leukemia (megakaryoblastic) with		icdo:9911/3
Acute myeloid leukemia with BCR-ABL1		icdo:9912/3
Acute myeloid leukemia with biallelic mutations of CEBPA		icdo:9878/3
Acute myeloid leukemia with inv(3)(q21q26.2) or		icdo:9869/3
Acute myeloid leukemia with maturation		icdo:9874/3
Acute myeloid leukemia with mutated NPM1		icdo:9877/3
Acute myeloid leukemia with mutated RUNX1		icdo:9879/3
Acute myeloid leukemia with t(6;9)(p23;q34) DEK-NUP214		icdo:9865/3
Acute myeloid leukemia without maturation		icdo:9873/3
Acute myeloid leukemia, 11q23 abnormalities		icdo:9897/3
Acute myeloid leukemia, M6 type		icdo:9840/3
Acute myeloid leukemia, minimal differentiation		icdo:9872/3
Acute myeloid leukemia, t(8;21)(q22;q22)		icdo:9896/3
Acute myelomonocytic leukemia		icdo:9867/3
Acute panmyelosis with myelofibrosis		icdo:9931/3
Acute promyelocytic leuk.,t(15;17)(q22;q11-12)		icdo:9866/3
Adamantinoma of long bones		icdo:9261/3
Adamantinomatous Craniopharyngioma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Craniopharyngioma'	ncit:C4726
Adenocarc. in situ in mult. adenomatous polyps		icdo:8221/2
Adenocarcinoid tumor		icdo:8245/3
Adenocarcinoma		icdo:8140/3
Adenocarcinoma in adenoma. polyposis coli		icdo:8220/3
Adenocarcinoma in adenomatous polyp		icdo:8210/3
Adenocarcinoma in mult. adenomatous polyps		icdo:8221/3
Adenocarcinoma in situ		icdo:8140/2
Adenocarcinoma in situ in adenomatous polyp		icdo:8210/2
Adenocarcinoma in situ in familial polyp. coli		icdo:8220/2
Adenocarcinoma in situ in tubulovillous adenoma		icdo:8263/2
Adenocarcinoma in situ in villous adenoma		icdo:8261/2
Adenocarcinoma in situ, mucinous		icdo:8253/2
Adenocarcinoma in situ, non-mucinous		icdo:8250/2
Adenocarcinoma in tubulovillous adenoma		icdo:8263/3
Adenocarcinoma in villous adenoma		icdo:8261/3
Adenocarcinoma of anal glands		icdo:8215/3
Adenocarcinoma w cartilag. & oss. metaplas.		icdo:8571/3
Adenocarcinoma with apocrine metaplasia		icdo:8573/3
Adenocarcinoma with mixed subtypes		icdo:8255/3
Adenocarcinoma with neuroendocrine differen.		icdo:8574/3
Adenocarcinoma with spindle cell mataplasia		icdo:8572/3
Adenocarcinoma with squamous metaplasia		icdo:8570/3
Adenocarcinoma, HPV-associated		icdo:8483/3
Adenocarcinoma, HPV-independent, NOS		icdo:8484/3
Adenocarcinoma, NOS		icdo:8140/3
Adenocarcinoma, endocervical type		icdo:8384/3
Adenocarcinoma, intestinal type		icdo:8144/3
Adenoid basal cell carcinoma		icdo:8098/3
Adenoid cystic carcinoma		icdo:8200/3
Adenoma, NOS		icdo:8140/0
Adenomyoepithelioma with carcinoma		icdo:8983/3
Adenosarcoma		icdo:8933/3
Adenosquamous carcinoma		icdo:8560/3
Adrenal cortical carcinoma		icdo:8370/3
Adult Fibrosarcoma		ncit:C7809
Adult T-cell leukemia/lymphoma (HTLV-1 pos.)		icdo:9827/3
Aggressive NK-cell leukemia		icdo:9948/3
Alveolar Soft-Part Sarcoma		ncit:C3750
Alveolar adenocarcinoma		icdo:8251/3
Alveolar rhabdomyosarcoma		icdo:8920/3
Alveolar rhabdomyosarcoma (ARMS)	(rms) ConsortiumNote: If multiple histological findings, include one observation per histological finding.
Alveolar soft part sarcoma		icdo:9581/3
Amelanotic melanoma		icdo:8730/3
Ameloblastic fibrosarcoma		icdo:9330/3
Ameloblastic odontosarcoma		icdo:9290/3
Ameloblastoma, malignant		icdo:9310/3
Anaplastic Ganglioglioma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C4717
Anaplastic Large Cell Lymphoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C3720
Anaplastic Oligoastrocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C6959
Anaplastic Oligodendroglioma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C4326
Anaplastic large cell lymphoma, ALK negative		icdo:9715/3
Anaplastic large cell lymphoma, T-cell and Null cell type		icdo:9714/3
Androblastoma, malignant		icdo:8630/3
Angiocentric Glioma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Low-Grade Glioma'	icdo:9431/1
Angioimmunoblastic T-cell lymphoma		icdo:9705/3
Angiolipoma, NOS		icdo:8861/0
Angiomatoid Fibrous Histiocytoma		ncit:C6494
Angiomatous meningioma		icdo:9534/0
Angiomyosarcoma		icdo:8894/3
Angiosarcoma Of Soft Tissue		ncit:C121671
Aortic body tumor, malignant		icdo:8691/3
Apocrine adenocarcinoma		icdo:8401/3
Askin tumor		icdo:9365/3
Astroblastoma		icdo:9430/3
Astroblastoma, MN1-Altered	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C4324
Astrocytoma		icdo:9400/3
Astrocytoma Tumors	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma' OR 'Low-Grade Glioma'	ncit:C60781
Astrocytoma With Piloid Features	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C185879
Astrocytoma, IDH-Mutant	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C185167
Astrocytoma, NOS		icdo:9400/3
Astrocytoma, anaplastic		icdo:9401/3
Atypical Choroid Plexus Papilloma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Choroid Plexus Tumors'	ncit:C53686
Atypical Fibroxanthoma		ncit:C4246
Atypical Lipomatous Tumor		ncit:C6505
Atypical Teratoid/Rhabdoid Tumor, MYC Gene (ATRT-MYC)	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Atypical Teratoid/Rhabdoid Tumor'	ncit:C200599
Atypical Teratoid/Rhabdoid Tumor, NOS or NEC	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Atypical Teratoid/Rhabdoid Tumor'	ncit:C6906
Atypical Teratoid/Rhabdoid Tumor, Sonic Hedgehog (ATRT-SHH)	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Atypical Teratoid/Rhabdoid Tumor'	ncit:C200598
Atypical Teratoid/Rhabdoid Tumor, Tyrosinase Gene (ATRT-TYR)	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Atypical Teratoid/Rhabdoid Tumor'	ncit:C200600
Atypical chronic myeloid leuk., BCR/ABL negative		icdo:9876/3
Atypical lipoma		icdo:8850/1
Atypical medullary carcinoma		icdo:8513/3
Atypical meningioma		icdo:9539/1
Atypical teratoid/rhabdoid tumor		icdo:9508/3
B-ALL		ncit:C8644
B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH		icdo:9817/3
B lymphoblastic leukemia/lymphoma with hyperdiploidy		icdo:9815/3
B lymphoblastic leukemia/lymphoma, NOS		icdo:9811/3
B-lymphocytic leukemia/lymphoma, BCR-ABL1-like		icdo:9819/3
Balloon cell melanoma		icdo:8722/3
Basal cell adenocarcinoma		icdo:8147/3
Basal cell carcinoma		icdo:8090/3
Basal cell carcinoma, NOS		icdo:8090/3
Basal cell carcinoma, fibroepithelial		icdo:8093/3
Basal cell carcinoma, nodular		icdo:8097/3
Basaloid carcinoma		icdo:8123/3
Basaloid squamous cell carcinoma		icdo:8083/3
Basophil adenoma		icdo:8300/0
Basophil carcinoma		icdo:8300/3
Basosquamous carcinoma		icdo:8094/3
Bile duct cystadenocarcinoma		icdo:8161/3
Biphenotypic sinonasal sarcoma		icdo:9045/3
Blue nevus, malignant		icdo:8780/3
Borderline tumor	(ls) ConsortiumNote: Use for Ovarian/Fallopian Tube/Primary Peritoneal Histology
Botryoid rhabdomyosarcoma (BRMS)
Bowen disease		icdo:8081/2
Brenner tumor, malignant		icdo:9000/3
Bronchiolo-alveolar carcinoma, non-mucinous		icdo:8252/3
Burkitt cell leukemia		icdo:9826/3
Burkitt lymphoma, NOS		icdo:9687/3
CIC-Rearranged Sarcoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C120224
CIC-rearranged sarcoma		icdo:9367/3
CNS Germinoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'CNS Germ Cell Tumors'	ncit:C7009
CNS Non-Germinomatous Germ Cell Tumor	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'CNS Germ Cell Tumors'	ncit:C100093
CNS1		ncit:C116833
CNS2		ncit:C116834
CNS2a		ncit:C116836
CNS2b		ncit:C116837
CNS2c		ncit:C116838
CNS3		ncit:C116835
CNS3a		ncit:C116840
CNS3b		ncit:C116841
CNS3c		ncit:C116843
Capillary hemangioma		icdo:9131/0
Carcinoid tumor, malignant		icdo:8240/3
Carcinoma in pleomorphic adenoma		icdo:8941/3
Carcinoma in situ, NOS		icdo:8010/2
Carcinoma showing thymus-like element		icdo:8589/3
Carcinoma simplex		icdo:8231/3
Carcinoma with osteoclast-like giant cells		icdo:8035/3
Carcinoma, NOS		icdo:8010/3
Carcinoma, anaplastic type, NOS		icdo:8021/3
Carcinoma, diffuse type		icdo:8145/3
Carcinoma, undifferentiated type, NOS		icdo:8020/3
Carcinosarcoma		icdo:8980/3
Carcinosarcoma, NOS		icdo:8980/3
Carcinosarcoma, embryonal type		icdo:8981/3
Carotid body tumor, malignant		icdo:8692/3
Cavernous hemangioma		icdo:9121/0
Central Nervous System B-Cell Non-Hodgkin Lymphoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C147948
Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C129600
Central Neurocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	ncit:C3791
Central osteosarcoma		icdo:9186/3
Centrol neurocytoma		icdo:9506/1
Cerebellar Liponeurocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	ncit:C6905
Cerebellar sarcoma, NOS		icdo:9480/3
Ceruminous adenocarcinoma		icdo:8420/3
Cholangiocarcinoma	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatic Tumor, Other'	icdo:8160/3
Chondroblastic osteosarcoma		icdo:9181/3
Chondroblastoma, malignant		icdo:9230/3
Chondroid chordoma		icdo:9371/3
Chondrosarcoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C2946
Chondrosarcoma, NOS		icdo:9220/3
Chordoid glioma		icdo:9444/1
Chordoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C2947
Chordoma, NOS		icdo:9370/3
Choriocarcinoma		ncit:C2948
Choriocarcinoma combined w/ other germ cell elements		icdo:9101/3
Choroid Plexus Carcinoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Choroid Plexus Tumors'	ncit:C4715
Choroid Plexus Papilloma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Choroid Plexus Tumors'	ncit:C3698
Choroid plexus papilloma, NOS		icdo:9390/0
Choroid plexus papilloma, malignant		icdo:9390/3
Chromophobe adenoma		icdo:8270/0
Chromophobe carcinoma		icdo:8270/3
Chronic lymphocytic leukemia		icdo:9823/3
Chronic lymphocytic leukemia/small lymphocytic lymphoma		icdo:9823/3
Chronic myelogenous leukemia, BCR/ABL positive		icdo:9875/3
Chronic myeloid leukemia		icdo:9863/3
Chronic myeloid leukemia, NOS		icdo:9863/3
Chronic myelomonocytic leukemia, NOS		icdo:9945/3
Chronic myeloproliferative disease, NOS		icdo:9960/3
Chronic neutrophilic leukemia		icdo:9963/3
Clear Cell Sarcoma Of Soft Tissue		ncit:C3745
Clear cell adenocarcinofibroma		icdo:8313/3
Clear cell adenocarcinoma, NOS		icdo:8310/3
Clear cell adenoma		icdo:8310/0
Clear cell carcinoma		icdo:9863/3
Clear cell chondrosarcoma		icdo:9242/3
Clear cell meningioma		icdo:9538/1
Clear cell odontogenic carcinoma		icdo:9341/3
Clear cell sarcoma of kidney		icdo:8964/3
Clear cell sarcoma, NOS		icdo:9044/3
Clear cell tumor, NOS		icdo:8005/0
Cloacogenic carcinoma		icdo:8124/3
Collecting duct carcinoma		icdo:8319/3
Comb. hepatocel. carcinoma & cholangiocarcinoma		icdo:8180/3
Combined hepatocellular-cholangiocarcinoma	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatic Tumor, Other'
Combined small cell carcinoma		icdo:8045/3
Comedocarcinoma, NOS		icdo:8501/3
Comedocarcinoma, non-infiltrating		icdo:8501/2
Composite Hemangioendothelioma		ncit:C45475
Composite Hodgkin and non-Hodgkin lymphoma		icdo:9596/3
Composite carcinoid		icdo:8244/3
Conventional Osteosarcoma		ncit:C35870
Craniopharyngioma		icdo:9350/1
Cribriform carcinoma		icdo:8201/3
Cribriform carcinoma in situ		icdo:8201/2
Cutaneous T-cell lymphoma		icdo:9709/3
Cutaneous T-cell lymphoma, NOS		icdo:9709/3
Cyst-associated renal cell carcinoma		icdo:8316/3
Cystadenocarcinoma, NOS		icdo:8440/3
Cystic hypersecretory carcinoma		icdo:8508/3
Dedifferentiated Liposarcoma		ncit:C3704
Dedifferentiated chondrosarcoma		icdo:9243/3
Dedifferentiated chordoma		icdo:9372/3
Dermatofibrosarcoma Protuberans		ncit:C4683
Dermatofibrosarcoma, NOS		icdo:8832/3
Dermoid cyst, NOS		icdo:9084/0
Desmoid-Type Fibromatosis		ncit:C9182
Desmoplastic Myxoid Tumor of the Pineal Region SMARCB1-Mutant	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C178507
Desmoplastic infantile astrocytoma		icdo:9412/1
Desmoplastic medulloblastoma		icdo:9471/3
Desmoplastic melanoma, malignant		icdo:8745/3
Desmoplastic Small Round Cell Tumor		icdo:8806/3
Diffuse Astrocytoma, MYB- Or MYBL1-Altered	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Low-Grade Glioma'	ncit:C129274
Diffuse Glioneuronal Tumor with Oligodendroglioma-Like Features and Nuclear Clusters	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	ncit:C185935
Diffuse Hemispheric Glioma, H3 G34-Mutant	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C185371
Diffuse Leptomeningeal Glioneuronal Tumor	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	icdo:9509/3
Diffuse Low-Grade Glioma, MAPK Pathway-Altered	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Low-Grade Glioma'	ncit:C185218
Diffuse Midline Glioma, H3 K27-Altered	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C185368
Diffuse Pediatric-Type High-Grade Glioma, H3-Wildtype And IDH-Wildtype	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C185467
Diffuse melanocytosis		icdo:8728/0
Diffuse midline glioma, H3 K27M-mutant		icdo:9385/3
Duct carcinoma in situ, solid type		icdo:8230/2
Duct carcinoma, desmoplastic type		icdo:8514/3
Ductal carcinoma in situ		icdo:9709/3
Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C95991
Dysembryoplastic Neuroepithelial Tumor	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	icdo:9413/0
Dysgerminoma		icdo:9060/3
Dysplastic Cerebellar Gangliocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	ncit:C8419
Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)		icdo:9493/0
Eccrine adenocarcinoma		icdo:8413/3
Eccrine papillary adenocarcinoma		icdo:8408/3
Eccrine poroma, malignant		icdo:8409/3
Ectomesenchymoma		ncit:C4716
Embryonal Carcinoma		ncit:C3752
Embryonal Tumor with Multilayered Rosettes, C19MC Amplified	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other CNS Embryonal tumors'	ncit:C186534
Embryonal Tumor with Multilayered Rosettes, C19MC Not Amplified	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other CNS Embryonal tumors'	ncit:C4915
Embryonal Tumor with Multilayered Rosettes, NOS or NEC	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other CNS Embryonal tumors'	ncit:C186534
Embryonal carcinoma, NOS		icdo:9070/3
Embryonal rhabdomyosarcoma		icdo:8910/3
Embryonal rhabdomyosarcoma (ERMS)
Embryonal sarcoma		icdo:8991/3
Embryonal tumor with multilayered rosettes, NOS		icdo:9478/3
Endometrial stromal sarcoma		icdo:8930/3
Endometrial stromal sarcoma, low grade		icdo:8931/3
Endometrioid adenocarcinoma		icdo:8380/3
Endometrioid adenocarcinoma, ciliated cell variant		icdo:8383/3
Endometrioid adenocarcinoma, secretory variant		icdo:8382/3
Endometrioid adenofibroma, malignant		icdo:8381/3
Endometrioid carcinoma		icdo:8380/3
Endometrioid intraepithelial neoplasia		icdo:8380/2
Enterochromaffin cell carcinoid		icdo:8241/3
Enterochromaffin-like cell tumor, malignant		icdo:8242/3
Enteroglucagonoma, malignant		icdo:8157/3
Ependymoma, RELA fusion-positive		icdo:9396/3
Ependymoma, anaplastic		icdo:9392/3
Epithel. mesothelioma, mal.		icdo:9052/3
Epithelial tumor, benign		icdo:8010/0
Epithelial, Cholangioblastic	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Epithelial, Embryonal	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Epithelial, Epithelial mixed	(lt) ConsortiumNote: Retrospective only
Epithelial, Fetal, crowded, mitotically active	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Epithelial, Fetal, well-differentiated, mitotically inactive	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Epithelial, Glandular	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Epithelial, Macrotrabecular	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Epithelial, Pleomorphic, poorly differentiated	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Epithelial, Primitive, small cell undifferentiated or blastemal	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Epithelial, Pure Fetal, well-differentiated, mitotically inactive	(lt) ConsortiumNote: Examination of whole tumor is required for this diagnosis. (lt) ConsortiumNote: Note: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Epithelial, Squamous	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Epithelial-myoepithelial carcinoma		icdo:8562/3
Epithelioid Haemangioendothelioma		ncit:C3800
Epithelioid Malignant Peripheral Nerve Sheath Tumor		ncit:C6561
Epithelioid cell melanoma		icdo:8771/3
Epithelioid hemangioendothelioma, malignant		icdo:9133/3
Epithelioid leiomyosarcoma		icdo:8891/3
Epithelioma, malignant		icdo:8011/3
Erdheim-Chester Disease	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	icdo:9749/3
Essential thrombocythemia		icdo:9962/3
Ewing Sarcoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	icdo:9260/3
Extra-Renal Rhabdoid Tumor		ncit:C6586
Extra-adrenal paraganglioma, malignant		icdo:8693/3
Extraskeletal Mesenchymal Chondrosarcoma		ncit:C27481
Extraskeletal Myxoid Chondrosarcoma		ncit:C27502
Extraskeletal Osteosarcoma		ncit:C8810
Extraventricular Neurocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	ncit:C92555
FAB >> Version NOS >> M0		ncit:C8460
FAB >> Version NOS >> M1		ncit:C3249
FAB >> Version NOS >> M2		ncit:C3250
FAB >> Version NOS >> M3		ncit:C3182
FAB >> Version NOS >> M3 Variant		ncit:C27757
FAB >> Version NOS >> M4		ncit:C7463
FAB >> Version NOS >> M4eo		ncit:C9020
FAB >> Version NOS >> M5		ncit:C4861
FAB >> Version NOS >> M6		ncit:C8923
FAB >> Version NOS >> M7		ncit:C3170
Fanconi Anemia		ncit:C62505
Fanconi Anemia Neurological Syndrome
Fascial fibrosarcoma		icdo:8813/3
Fetal adenocarcinoma		icdo:8333/3
Fibrillary astrocytoma		icdo:9420/3
Fibroblastic Osteosarcoma		ncit:C4020
Fibroblastic liposarcoma		icdo:8857/3
Fibroblastic reticular cell tumor		icdo:9759/3
Fibrolipoma		icdo:8851/0
Fibroma, NOS		icdo:8810/0
Fibromyxosarcoma		icdo:8811/3
Fibrosarcoma, NOS		icdo:8810/3
Fibrosarcomatous Dermatofibrosarcoma Protuberans		ncit:C27547
Fibrous histiocytoma, malignant		icdo:8830/3
Fibrous meningioma		icdo:9532/0
Fibrous mesothelioma, malignant		icdo:9051/3
Follicular adenocarcinoma trabecular		icdo:8332/3
Follicular adenocarcinoma well diff.		icdo:8331/3
Follicular adenocarcinoma, NOS		icdo:8330/3
Follicular carcinoma, minimally invasive		icdo:8335/3
Follicular dendritic cell sarcoma		icdo:9758/3
Follicular lymphoma, NOS		icdo:9690/3
Follicular lymphoma, grade 1		icdo:9695/3
Follicular lymphoma, grade 2		icdo:9691/3
Follicular lymphoma, grade 3		icdo:9698/3
Follicular thyroid carcinoma (FTC), encapsulated angioinvasive		icdo:8339/3
Gangliocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	icdo:9492/0
Ganglioglioma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	ncit:C3788
Ganglioglioma, NOS		icdo:9505/1
Ganglioglioma, anaplastic		icdo:9505/3
Ganglioneuroblastoma		icdo:9490/3
Ganglioneuroblastoma, Intermixed (Schwannian Stroma-Rich)		ncit:C42057
Ganglioneuroblastoma, Nodular (Composite)		ncit:C42058
Ganglioneuroma		icdo:9490/0
Ganglioneuroma (Schwannian Stroma-Dominant), Maturing Subtype		ncit:C42064
Gastrinoma, malignant		icdo:8153/3
Gastroblastoma		icdo:8976/3
Gastrointestinal Stromal Tumor, Malignant		ncit:C53999
Gastrointestinal Stromal Tumor, Uncertain Malignant Potential		ncit:C54000
Gastrointestinal stromal sarcoma		icdo:8936/3
Gastrointestinal stromal tumor		icdo:8936/3
Gemistocytic astrocytoma		icdo:9411/3
Germ cell tumor
Germ cell tumor, nonseminomatous		icdo:9065/3
Germ cell tumors with associated hematological malignancy		icdo:9086/3
Germinoma		ncit:C3753
Ghost cell odontogenic carcinoma		icdo:9302/3
Giant Cell Astrocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C3696
Giant Cell Fibroblastoma		ncit:C4700
Giant Cell Rich Osteosarcoma		ncit:C179410
Giant Cell Tumor of Soft Tissue		ncit:C49107
Giant cell and spindle cell carcinoma		icdo:8030/3
Giant cell carcinoma		icdo:8031/3
Giant cell glioblastoma		icdo:9441/3
Giant cell sarcoma		icdo:8802/3
Giant cell tumor of bone, malignant		icdo:9250/3
Glandular intraepithelial neoplasia, grade III		icdo:8148/2
Glassy cell carcinoma		icdo:8015/3
Glioblastoma, IDH-Wildtype	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C39750
Glioblastoma, IDH-mutant		icdo:9445/3
Glioblastoma, NOS		icdo:9440/3
Gliofibroma		icdo:9442/1
Glioma, NOS
Glioma, malignant		icdo:9380/3
Gliomatosis cerebri		icdo:9381/3
Glioneuronal and Neuronal Tumors	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	ncit:C4747
Gliosarcoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	icdo:9442/3
Glomangiomatosis		ncit:C27496
Glomangiosarcoma		icdo:8710/3
Glomus Tumor		ncit:C27496
Glucagonoma, malignant		icdo:8152/3
Glycogen-rich carcinoma		icdo:8315/3
Goblet cell carcinoid		icdo:8243/3
Granular cell carcinoma		icdo:8320/3
Granular cell tumor of the sellar region		icdo:9582/0
Granular cell tumor, NOS		icdo:9580/0
Granular cell tumor, malignant		icdo:9580/3
Granulosa cell tumor, malignant		icdo:8620/3
Granulosa cell-theca cell tumor, mal.		icdo:8621/3
Gynandroblastoma, malignant		icdo:8632/3
Hairy cell leukemia		icdo:9940/3
Heavy chain disease, NOS		icdo:9762/3
Hemangioblastoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	icdo:9161/1
Hemangioendothelioma, NOS		icdo:9130/1
Hemangioendothelioma, benign		icdo:9130/0
Hemangioendothelioma, malignant		icdo:9130/3
Hemangioma, NOS		icdo:9120/0
Hemangiomas and Vascular Malformations	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'
Hemangiopericytoma, NOS		icdo:9150/1
Hemangiopericytoma, benign		icdo:9150/0
Hemangiopericytoma, malignant		icdo:9150/3
Hemangiosarcoma		icdo:9120/3
Hemosiderotic Fibrolipomatous Tumor		ncit:C121752
Hepatoblastoma		icdo:8970/3
Hepatocellular adenoma (expand?)	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatic Tumor, Other'
Hepatocellular carcinoma		icdo:8170/3
Hepatocellular carcinoma, NOS		icdo:8170/3
Hepatocellular carcinoma, associated with hepatocellular adenoma	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatocellular Carcinoma'
Hepatocellular carcinoma, associated with hepatocellular adenoma, with underlying liver disease	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatocellular Carcinoma'
Hepatocellular carcinoma, classic	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatocellular Carcinoma'
Hepatocellular carcinoma, classic, with underlying liver disease	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatocellular Carcinoma'
Hepatocellular carcinoma, clear cell type		icdo:8174/3
Hepatocellular carcinoma, fibrolamellar		icdo:8171/3
Hepatocellular carcinoma, pleomorphic type		icdo:8175/3
Hepatocellular carcinoma, scirrhous		icdo:8172/3
Hepatocellular carcinoma, spindle cell variant		icdo:8173/3
Hepatocellular malignancy, NOS	(lt) ConsortiumNote: Includes transitional cell liver tumor. DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Hepatoid adenocarcinoma		icdo:8576/3
Hepatosplenic gamma-delta cell lymphoma		icdo:9716/3
Hereditary leiomyomatosis and RCC-associated renal cell carcinoma		icdo:8311/3
High grade appendiceal mucinous neoplasm		icdo:8480/2
High grade surface osteosarcoma		icdo:9194/3
High-Grade Glioma, NOS or NEC	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C4822
High-grade serous carcinoma		icdo:8461/3
Histiocytic Sarcoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C27349
Hodgkin Lymphoma, Classical, NOS		ncit:C9357
Hodgkin Lymphoma, Lymphocyte Depletion, NOS		ncit:C9283
Hodgkin Lymphoma, Nodular Lymphocyte Predominance		ncit:C7258
Hodgkin granuloma [obs]		icdo:9661/3
Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis		icdo:9654/3
Hodgkin lymph., nodular lymphocyte predom.		icdo:9659/3
Hodgkin lymphoma		icdo:9650/3
Hodgkin lymphoma, Mixed Cellularity, NOS		ncit:C3517
Hodgkin Lymphoma, NOS		icdo:9650/3
Hodgkin lymphoma, lymphocyt. deplet., reticular		icdo:9655/3
Hodgkin lymphoma, lymphocytic deplet., NOS		icdo:9653/3
Hodgkin lymphoma, mixed cellularity, NOS		icdo:9652/3
Hodgkin lymphoma, nod. scler., cellular phase		icdo:9664/3
Hodgkin lymphoma, nod. scler., grade 1		icdo:9665/3
Hodgkin lymphoma, nod. scler., grade 2		icdo:9667/3
Hodgkin Lymphoma, Nodular Sclerosis, NOS		icdo:9663/3
Hodgkin sarcoma [obs]		icdo:9662/3
Hybrid Nerve Sheath Tumor	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C121686
Hydroa vacciniforme-like lymphoma		icdo:9725/3
Hypereosinophilic syndrome		icdo:9964/3
Hyperplastic polyp
Immature Teratoma		ncit:C4286
Immunodeficiency-Related Central Nervous System Lymphoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C186658
Immunoproliferative disease, NOS		icdo:9760/3
Immunoproliferative small intestinal disease		icdo:9764/3
Infant-Type Hemispheric Glioma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C185471
Infantile Fibrosarcoma		icdo:8814/3
Infiltr. duct mixed with other types of carcinoma		icdo:8523/3
Infiltr. duct mixed with other types of carcinoma, in situ		icdo:8523/2
Infiltrating basal cell carcinoma, NOS		icdo:8092/3
Infiltrating duct and lobular carcinoma		icdo:8522/3
Infiltrating ductular carcinoma		icdo:8521/3
Infiltrating lobular mixed with other types of carc.		icdo:8524/3
Inflammatory Myofibroblastic Tumor		ncit:C6481
Inflammatory carcinoma		icdo:8530/3
Instrosseous well differentiated osteosarcoma		icdo:9187/3
Insular carcinoma		icdo:8337/3
Insulinoma, malignant		icdo:8151/3
Interdigitating dendritic cell sarcoma		icdo:9757/3
Intestinal T-cell lymphoma		icdo:9717/3
Intestinal-type adenoma, high grade		icdo:8144/2
Intimal Sarcoma		icdo:9137/3
Intracortical osteosarcoma		icdo:9195/3
Intracranial Mesenchymal Tumor FET-CREB Fusion-Positive	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C186614
Intracystic carcinoma, NOS		icdo:8504/3
Intraductal and lobular in situ carcinoma		icdo:8522/2
Intraductal carcinoma, noninfiltrating, NOS		icdo:8500/2
Intraductal micropapillary carcinoma		icdo:8507/2
Intraductal oncocytic papillary neoplasm, NOS		icdo:8455/2
Intraductal oncocytic papillary neoplasms with associated invasive		icdo:8455/3
Intraductal papillary adenocarcinoma with invasion		icdo:8503/3
Intraductal papillary-mucinous carcinoma, invasive		icdo:8453/3
Intraductal papillary-mucinous carcinoma, non-inv.		icdo:8453/2
Intratubular malignant germ cells		icdo:9064/2
Intravascular Large B-Cell Lymphoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	icdo:9712/3
Invasive carcinoma of no special type		icdo:8500/3
Invasive ductal carcinoma
Invasive lobular carcinoma		icdo:8520/3
Invasive micropapillary carcinoma		icdo:8507/3
Invasive mucinous adenocarcinoma		icdo:8253/3
Islet cell carcinoma		icdo:8150/3
Juvenile Xanthogranuloma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	icdo:9749/1
Juvenile myelomonocytic leukemia		icdo:9946/3
Juxtacortical chondrosarcoma		icdo:9221/3
Kaposi Sarcoma		icdo:9140/3
Kaposiform Hemangioendothelioma		ncit:C27510
Keratoacanthoma
Klatskin tumor		icdo:8162/3
Kupffer cell sarcoma		icdo:9124/3
Langerhans Cell Histiocytosis	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C3107
Langerhans cell histiocytosis, NOS		icdo:9751/3
Langerhans cell histiocytosis, disseminated		icdo:9754/3
Langerhans cell sarcoma		icdo:9756/3
Large Cell Ewing Tumor		ncit:C174456
Large cell carcinoma with rhabdoid phenotype		icdo:8014/3
Large cell carcinoma, NOS		icdo:8012/3
Large cell medulloblastoma		icdo:9474/3
Large cell neuroendocrine carcinoma		icdo:8013/3
Leiomyoma, NOS		icdo:8890/0
Leiomyomatosis, nOS		icdo:8890/1
Leiomyosarcoma		ncit:C3158
Leiomyosarcoma, NOS		icdo:8890/3
Lentigo maligna		icdo:8742/2
Lentigo maligna melanoma		icdo:8742/3
Lepidic adenocarcinoma		icdo:8250/3
Leukemia, NOS		icdo:9800/3
Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)		icdo:9816/3
Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)		icdo:9814/3
Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)		icdo:9818/3
Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1		icdo:9812/3
Leukemia/lymphoma with t(v;11q23);MLL rearranged		icdo:9813/3
Leydig cell tumor, malignant		icdo:8650/3
Linitis plastica		icdo:8142/3
Lipid-rich carcinoma		icdo:8314/3
Lipofibromatosis		ncit:C99180
Lipoma, NOS		icdo:8850/0
Liposarcoma, NOS		ncit:C3194
Liposarcoma, well differentiated		icdo:8851/3
Lobular carcinoma in situ		icdo:8520/2
Lobular carcinoma, NOS		icdo:8520/3
Low-Grade Fibromyxoid Sarcoma		ncit:C45202
Low-Grade Glioma, NOS or NEC	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Low-Grade Glioma'	ncit:C132067
Low-Grade Myofibroblastic Sarcoma		ncit:C49024
Low-grade dysplasia
Low-grade serous carcinoma		icdo:8460/3
Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ		icdo:9738/3
Lymphangioleiomyomatosis		icdo:9174/3
Lymphangiosarcoma		icdo:9170/3
Lymphoepithelial carcinoma		icdo:8082/3
Lymphoid leukemia, NOS		icdo:9820/3
Lymphoma, NOS		icdo:9590/3
Lymphomatoid Granulomatosis	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C7930
Lymphomatoid granulomatosis, grade 3		icdo:9766/3
MDS/MPN, NOS		icdo:9989/3
ML, large B-cell, diffuse		icdo:9680/3
ML, large B-cell, diffuse, immunoblastic, NOS		icdo:9684/3
ML, lymphoplasmacytic		icdo:9671/3
ML, mixed sm. and lg. cell, diffuse		icdo:9675/3
ML, small B lymphocytic, NOS		icdo:9670/3
MPNST with rhabdomyoblastic differentiation		icdo:9561/3
Mal. melanoma in giant pigmented nevus		icdo:8761/3
Mal. melanoma in junctional nevus		icdo:8740/3
Mal. melanoma in precan. melanosis		icdo:8741/3
Malignant Glomus Tumor		ncit:C4221
Malignant Granular Cell Tumor		ncit:C4336
Malignant Melanotic Nerve Sheath Tumor	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C4748
Malignant Peripheral Nerve Sheath Tumor	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	icdo:9540/3
Malignant Teratoma		ncit:C4287
Malignant Triton Tumor		ncit:C4335
Malignant cystic nephroma		icdo:8959/3
Malignant eccrine spiradenoma		icdo:8403/3
Malignant giant cell tumor of soft parts		icdo:9251/3
Malignant hepatocellular neoplasm, NOS, with carcinoma features	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Malignant histiocytosis		icdo:9750/3
Malignant lymphoma, NOS		icdo:9590/3
Malignant lymphoma, non-Hodgkin		icdo:9591/3
Malignant mastocytosis		icdo:9741/3
Malignant melanoma, NOS		icdo:8720/3
Malignant melanoma, regressing		icdo:8723/3
Malignant myoepithelioma		icdo:8982/3
Malignant placental site trophoblastic tumor		icdo:9104/3
Malignant rhabdoid tumor	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatic Tumor, Other'	icdo:8963/3
Malignant tenosynovial giant cell tumor		icdo:9252/3
Malignant teratoma, intermediate		icdo:9083/3
Malignant teratoma, trophoblastic		icdo:9102/3
Malignant teratoma, undiff.		icdo:9082/3
Malignant tumor, clear cell type		icdo:8005/3
Malignant tumor, giant cell type		icdo:8003/3
Malignant tumor, small cell type		icdo:8002/3
Malignant tumor, spindle cell type		icdo:8004/3
Mantle cell lymphoma		icdo:9673/3
Marginal zone B-cell lymphoma, NOS		icdo:9699/3
Mast cell leukemia		icdo:9742/3
Mast cell sarcoma		icdo:9740/3
Mature T-cell lymphoma, NOS		icdo:9702/3
Mature Teratoma		ncit:C9015
Mediastinal large B-cell lymphoma		icdo:9679/3
Medullary carcinoma		icdo:8510/3
Medullary carcinoma with amyloid stroma		icdo:8345/3
Medullary carcinoma with lymphoid stroma		icdo:8512/3
Medullary carcinoma, NOS		icdo:8510/3
Medulloblastoma		icdo:9473/3
Medulloblastoma, Classic	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Medulloblastoma'	ncit:C54039
Medulloblastoma, Group 3	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Medulloblastoma'	ncit:C129445
Medulloblastoma, Group 4	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Medulloblastoma'	ncit:C129446
Medulloblastoma, Large Cell/Anaplastic	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Medulloblastoma'	ncit:C129436
Medulloblastoma, NOS		icdo:9470/3
Medulloblastoma, NOS or NEC	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Medulloblastoma'	ncit:C3222
Medulloblastoma, Nodular Desmoplastic	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Medulloblastoma'	ncit:C4956
Medulloblastoma, Non-WNT/Non-SHH	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Medulloblastoma'	ncit:C129444
Medulloblastoma, SHH-Activated and TP53-Mutant	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Medulloblastoma'	ncit:C129442
Medulloblastoma, SHH-Activated and TP53-Wildtype	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Medulloblastoma'	ncit:C129443
Medulloblastoma, SHH-activated and TP53-mutant		icdo:9476/3
Medulloblastoma, WNT-Activated	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Medulloblastoma'	ncit:C129440
Medulloblastoma, WNT-activated		icdo:9475/3
Medulloblastoma, non-WNT/non-SHH		icdo:9477/3
Medulloepithelioma, NOS		icdo:9501/3
Medullomyoblastoma		icdo:9472/3
Melanoma		icdo:8720/3
Melanoma in situ		icdo:8720/2
Melanotic neurofibroma		icdo:9541/0
Melanotic schwannoma		icdo:9560/1
Meningeal melanocytoma		icdo:8728/1
Meningeal melanomatosis		icdo:8728/3
Meningeal sarcomatosis		icdo:9539/3
Meningioma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C3230
Meningioma, NOS		icdo:9530/0
Meningioma, malignant		icdo:9530/3
Meningothelial meningioma		icdo:9531/0
Merkel cell carcinoma		icdo:8247/3
Mesenchymal Chondrosarcoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	icdo:9240/3
Mesenchymal hamartoma	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatic Tumor, Other'
Mesenchymoma, malignant		icdo:8990/3
Mesodermal mixed tumor		icdo:8951/3
Mesonephric-like adenocarcinoma		icdo:9111/3
Mesonephroma, malignant		icdo:9110/3
Mesothelioma		icdo:9050/3
Mesothelioma, biphasic, malignant		icdo:9053/3
Mesothelioma, in situ		icdo:9050/2
Mesothelioma, malignant		icdo:9050/3
Metaplastic carcinoma		icdo:8575/3
Metaplastic carcinoma, NOS		icdo:8575/3
Metatypical carcinoma		icdo:8095/3
Micropapillary carcinoma, NOS		icdo:8265/3
Middle ear paraganglioma		icdo:8690/3
Minimally invasive adenocarcinoma, mucinous		icdo:8257/3
Minimally invasive adenocarcinoma, non-mucinous		icdo:8256/3
Mixed Germ Cell Tumor		ncit:C4290
Mixed Tumor NOS, Malignant		ncit:C3729
Mixed Tumour NOS		ncit:C121786
Mixed acidophil-basophil adenoma		icdo:8281/0
Mixed acidophil-basophil carcinoma		icdo:8281/3
Mixed acinar ductal carcinoma		icdo:8552/3
Mixed cell adenocarcinoma		icdo:8323/3
Mixed cell adenoma		icdo:8323/0
Mixed epithel. & spindle cell melanoma		icdo:8770/3
Mixed epithelial-mesenchymal, Cholangioblastic	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Mixed epithelial-mesenchymal, Embryonal	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Mixed epithelial-mesenchymal, Fetal, crowded, mitotically active	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Mixed epithelial-mesenchymal, Fetal, well-differentiated, mitotically inactive	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Mixed epithelial-mesenchymal, Glandular	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Mixed epithelial-mesenchymal, Macrotrabecular	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Mixed epithelial-mesenchymal, Mesenchymal, non-teratoid	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Mixed epithelial-mesenchymal, Pleomorphic, poorly differentiated	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Mixed epithelial-mesenchymal, Primitive (small cell undifferentiated or blastemal)	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Mixed epithelial-mesenchymal, Squamous	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Mixed epithelial-mesenchymal, with teratoid features	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatoblastoma'
Mixed epithelial-mesenchymal, without teratoid features	(lt) ConsortiumNote: Retrospective only
Mixed glioma		icdo:9382/3
Mixed invasive mucinous and non-mucinous adenocarcinoma		icdo:8254/3
Mixed medullary-follicular carcinoma		icdo:8346/3
Mixed medullary-papillary carcinoma		icdo:8347/3
Mixed neuroendocrine non-neuroendocrine neoplasm		icdo:8154/3
Mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR-ABL1		icdo:9806/3
Mixed phenotype acute leukemia with t(v;11q23);MLL rearranged		icdo:9807/3
Mixed phenotype acute leukemia, B/myeloid, NOS		icdo:9808/3
Mixed phenotype acute leukemia, T/myeloid, NOS		icdo:9809/3
Mixed tumor, malignant, NOS		icdo:8940/3
Mixed type liposarcoma		icdo:8855/3
Mixed type rhabdomyosarcoma		icdo:8902/3
Monomorphic adenoma		icdo:8146/0
MPAL		ncit:C82179
Mucin-producing adenocarcinoma		icdo:8481/3
Mucinous adenocarcinofibroma		icdo:9015/3
Mucinous adenocarcinoma		icdo:8480/3
Mucinous adenocarcinoma, endocervical type		icdo:8482/3
Mucinous cystadenocarcinoma, NOS		icdo:8470/3
Mucinous cystadenocarcinoma, non-invasive		icdo:8470/2
Mucinous cystic tumor of borderline malignancy (C56.9)		icdo:8472/1
Mucoepidermoid carcinoma		icdo:8430/3
Mucosal lentiginous melanoma		icdo:8746/3
Mullerian carcinoma		icdo:8950/3
Mullerian mixed tumor		icdo:8950/3
Multifocal superficial basal cell carcinoma		icdo:8091/3
Multinodular and Vacuolated Neuronal Tumor	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	ncit:C129427
Multinodular and vacuolating neuronal tumor		icdo:9509/0
Multinodular and vascolating neuronal tumor		icdo:9505/0
Multiple myeloma		icdo:9732/3
Mycosis fungoides		icdo:9700/3
Myelodysplastic syndr. with 5q deletion syndrome		icdo:9986/3
Myelodysplastic syndrome with ring sideroblasts and multilineage		icdo:9993/3
Myelodysplastic syndrome, NOS
Myelodysplastic/Myeloproliferative neoplasm, unclassifiable		icdo:9975/3
Myeloid and lymphoid neoplasm with FGFR1 abnormalities		icdo:9967/3
Myeloid and lymphoid neoplasms with PDGFRB re arrangement		icdo:9966/3
Myeloid and lymphoid neoplasms with PDGFRB rearrangement		icdo:9965/3
Myeloid leukemia associated with Down Syndrome		icdo:9898/3
Myeloid leukemia, NOS		icdo:9860/3
Myeloid sarcoma		icdo:9930/3
Myeloid/lymphoid neoplasm with PCM1-JAK2		icdo:9968/3
Myelosclerosis with myeloid metaplasia		icdo:9961/3
Myoepithelioma		ncit:C40392
Myoepithelioma Carcinoma		ncit:C7596
Myofibroblastic sarcoma		icdo:8825/3
Myosarcoma		icdo:8895/3
Myxofibrosarcoma		ncit:C6496
Myxoid Glioneuronal Tumor	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	ncit:C179229
Myxoid Liposarcoma		ncit:C27781
Myxoid chondrosarcoma		icdo:9231/3
Myxoid Leiomyosarcoma		icdo:8896/3
Myxoinflammatory Fibroblastic Sarcoma/Atypical Myxoinflammatory Fibroblastic Tumor		ncit:C49025
Myxopapillary Ependymoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Ependymoma'	ncit:C3697
Myxosarcoma		icdo:8840/3
NK/T-cell lymphoma, nasal and nasal-type		icdo:9719/3
NUT carcinoma		icdo:8023/3
Necrotic Tumor		ncit:C36029
Neoplasm, benign		icdo:8000/0
Neoplasm, malignant		icdo:8000/3
Neoplasm, uncertain whether benign or malignant		icdo:8000/1
Nephroblastoma, NOS		icdo:8960/3
Nested stromal-epithelial tumor	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatic Tumor, Other'
Neurilemmoma, malignant		icdo:9560/3
Neurilemoma, NOS		icdo:9560/0
Neuro-differentiated Ewing Tumor		ncit:C9341
Neuroblastoma		icdo:9500/3
Neuroblastoma (Schwannian Stroma Poor)
Neuroblastoma, NOS		icdo:9500/3
Neuroendocrine carcinoma		icdo:8246/3
Neuroendocrine tumor		icdo:8249/3
Neuroepithelioma, NOS		icdo:9503/3
Neurofibroma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C3272
Neurofibroma, NOS		icdo:9540/0
Neurofibromatosis, NOS		icdo:9540/1
Neuroma, NOS		icdo:9570/0
Neurothekeoma		icdo:9562/0
Nodular hidradenoma, malignant		icdo:8402/3
Nodular melanoma		icdo:8721/3
Non-Hodgkin lymphoma		icdo:9591/3
Non-invasive EFVPTC		icdo:8343/2
Non-invasive low grade serous carcinoma		icdo:8460/2
Non-small cell carcinoma		icdo:8046/3
Nonencapsulated sclerosing carcinoma		icdo:8350/3
Noninfiltrating intracystic carcinoma		icdo:8504/2
Noninfiltrating intraductal papillary adenocarcinoma		icdo:8503/2
Oat cell carcinoma		icdo:8042/3
Odontogenic carcinosarcoma		icdo:9342/3
Odontogenic tumor, malignant		icdo:9270/3
Olfactory neurcytoma		icdo:9521/3
Olfactory neuroblastoma		icdo:9522/3
Olfactory neuroepithelioma		icdo:9523/3
Olfactory neurogenic tumor		icdo:9520/3
Oligoastrocytic Tumors	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma' OR 'Low-Grade Glioma'	ncit:C186217
Oligoastrocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Low-Grade Glioma'	ncit:C4050
Oligodendroblastoma		icdo:9460/3
Oligodendroglial Tumors	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma' OR 'Low-Grade Glioma'	ncit:C103050
Oligodendroglioma, IDH-Mutant, And 1P/19Q-Codeleted	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C129318
Oligodendroglioma, NOS		icdo:9450/3
Oligodendroglioma, anaplastic		icdo:9451/3
Ossifying Fibromyxoid Tumor		ncit:C6582
Ossifying Fibromyxoid Tumor, Malignant		ncit:C121774
Osteoblastic Osteosarcoma		ncit:C53953
Osteosarcoma		icdo:9180/3
Osteosarcoma in Paget disease		icdo:9184/3
Osteosarcoma, NOS		icdo:9180/3
Ovarian stromal tumor, mal.		icdo:8590/3
Oxyphilic adenocarcinoma		icdo:8290/3
Oxyphilic adenoma		icdo:8290/0
PEComa, malignant		icdo:8714/3
Paget dis. & infil. duct carcinoma		icdo:8541/3
Paget disease and intraductal ca.		icdo:8543/3
Paget disease, extramammary		icdo:8542/3
Paget disease, mammary		icdo:8540/3
Palmar/Plantar Fibromatosis		ncit:C4680
Pancreatobiliary-type carcinoma		icdo:8163/3
Pancreatoblastoma		icdo:8971/3
Papillary Craniopharyngioma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Craniopharyngioma'	icdo:9352/1
Papillary Glioneuronal Tumor	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	icdo:9509/1
Papillary Intralymphatic Angioendothelioma		ncit:C7526
Papillary Tumor of the Pineal Region	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C92624
Papillary adenocarcinoma, NOS		icdo:8260/3
Papillary adenoma, NOS		icdo:8260/0
Papillary carcinoma		icdo:8050/3
Papillary carcinoma in situ		icdo:8050/2
Papillary carcinoma, NOS		icdo:8050/3
Papillary carcinoma, columnar cell		icdo:8344/3
Papillary carcinoma, encapsulated		icdo:8343/3
Papillary carcinoma, follicular variant		icdo:8340/3
Papillary carcinoma, oxyphilic cell		icdo:8342/3
Papillary cystadenocarcinoma, NOS		icdo:8450/3
Papillary cystadenoma, borderline malignancy (C56.9)		icdo:8451/1
Papillary ependymoma		icdo:9393/3
Papillary meningioma		icdo:9538/3
Papillary microcarcinoma		icdo:8341/3
Papillary mucinous cystadenocarcinoma		icdo:8471/3
Papillary mucinous cystadenoma, borderline malignancy (C56.9)		icdo:8473/1
Papillary squamous cell carcinoma		icdo:8052/3
Papillary squamous cell carcinoma, non-invasive		icdo:8052/2
Papillary trans. cell carcinoma		icdo:8130/3
Papillary trans. cell carcinoma, non-invasive		icdo:8130/2
Papillary tumor of pineal region		icdo:9395/3
Paraganglioma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C3308
Paraganglioma, NOS		icdo:8680/1
Paraganglioma, malignant		icdo:8680/3
Parasympathetic paraganglioma		icdo:8682/3
Parietal cell carcinoma		icdo:8214/3
Parosteal Osteosarcoma		icdo:9192/3
Pecoma NOS, Benign		ncit:C121791
Pecoma NOS, Malignant		ncit:C121792
Perineurioma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C4973
Perineurioma, NOS		icdo:9571/0
Perineurioma, malignant		icdo:9571/3
Periosteal fibrosarcoma		icdo:8812/3
Periosteal Osteosarcoma		icdo:9193/3
Peripheral neuroectodermal tumor		icdo:9364/3
Pheochromocytoma		icdo:8700/3
Phosphaturic Mesenchymal Tumor, Benign		ncit:C121788
Phosphaturic Mesenchymal Tumor, Malignant		ncit:C121789
Phyllodes tumor, malignant		icdo:9020/3
Pilocytic Astrocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Low-Grade Glioma'	icdo:9421/1
Pilomatrix carcinoma		icdo:8110/3
Pilomyxoid Astrocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Low-Grade Glioma'	icdo:9425/3
Pineal Parenchymal Tumor of Intermediate Differentiation	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C6967
Pineal Tumors	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other CNS Embryonal tumors'	ncit:C41834
Pineoblastoma, MYC/FOXR2	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other CNS Embryonal tumors'	ncit:C201973
Pineoblastoma, MiRNA1	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other CNS Embryonal tumors'	ncit:C201967
Pineoblastoma, MiRNA2	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other CNS Embryonal tumors'	ncit:C201968
Pineoblastoma, NOS or NEC	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other CNS Embryonal tumors'	ncit:C9344
Pineoblastoma, RB1	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other CNS Embryonal tumors'	ncit:C201969
Pineocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	icdo:9361/1
Pituicytoma		icdo:9432/1
Pituitary Gland Blastoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C155304
Pituitary Neuroendocrine Tumor	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C3329
Pituitary adenoma		icdo:8272/0
Pituitary adenoma, NOS		icdo:8272/0
Pituitary blastoma		icdo:8273/3
Pituitary carcinoma, NOS		icdo:8272/3
Plasma cell leukemia		icdo:9733/3
Plasmablastic lymphoma		icdo:9735/3
Plasmacytoma, NOS		icdo:9731/3
Plasmacytoma, extramedullary		icdo:9734/3
Pleomorphic Xanthoastrocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	icdo:9424/3
Pleomorphic carcinoma		icdo:8022/3
Pleomorphic Liposarcoma		icdo:8854/3
Pleomorphic lobular carcinoma in situ		icdo:8519/2
Pleomorphic rhabdomyosarcoma (PRMS)
Pleomorphic rhabdomyosarcoma, adult type		icdo:8901/3
Pleuropulmonary blastoma		icdo:8973/3
Plexiform Fibrohistiocytic Tumor		ncit:C6493
Plexiform neurofibroma		icdo:9550/0
Polar spongioblastoma		icdo:9423/3
Polycythemia vera		icdo:9950/3
Polygonal cell carcinoma		icdo:8034/3
Polymorphic PTLD		icdo:9971/3
Polymorphous Low-Grade Neuroepithelial Tumor Of The Young	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Low-Grade Glioma'	ncit:C180378
Polymorphous low grade adenocarcinoma		icdo:8525/3
Posterior Fossa Ependymoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Ependymoma'	ncit:C186443
Posterior Fossa Ependymoma, Group PFA	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Ependymoma'	ncit:C186450
Posterior Fossa Ependymoma, Group PFB	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Ependymoma'	ncit:C186451
Posterior Pituitary Gland Neoplasm	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C7157
Precancerous melanosis, NOS		icdo:8741/2
Precursor B-cell lymphoblastic leukemia		icdo:9836/3
Precursor B-cell lymphoblastic lymphoma		icdo:9728/3
Precursor T-cell lymphoblastic lymphoma		icdo:9729/3
Precursor cell lymphoblastic leukemia, NOS		icdo:9835/3
Precursor cell lymphoblastic lymphoma, NOS		icdo:9727/3
Primary Cutaneous follicle centre lymphoma		icdo:9597/3
Primary Cutaneous gamma-delta T-cell lymphoma		icdo:9726/3
Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C71720
Primary Intracranial Sarcoma DICER1-Mutant	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C186610
Primary Meningeal Melanocytic Neoplasm	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C4661
Primary cutan. CD30+ T-cell lymphoprolif. disorder		icdo:9718/3
Primary effusion lymphoma		icdo:9678/3
Primitive Neuroectodermal Tumor		icdo:9473/3
Prolactinoma		icdo:8271/0
Prolymphocytic leukemia, B-cell type		icdo:9833/3
Prolymphocytic leukemia, NOS		icdo:9832/3
Prolymphocytic leukemia, T-cell type		icdo:9834/3
Protoplasmic astrocytoma		icdo:9410/3
Psammomatous meningioma		icdo:9533/0
Pseudomyogenic Hemangioendothelioma		ncit:C121668
Pseudosarcomatous carcinoma		icdo:8033/3
Pulmonary blastoma		icdo:8972/3
Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation		icdo:8842/3
Queyrat erythroplasia		icdo:8080/2
Refract. anemia with excess blasts in transformation		icdo:9984/3
Refractory anemia		icdo:9980/3
Refractory anemia with excess blasts		icdo:9983/3
Refractory anemia with sideroblasts		icdo:9982/3
Refractory cytopenia with multilineage dysplasia		icdo:9985/3
Refractory neutropenia		icdo:9991/3
Refractory thrombocytopenia		icdo:9992/3
Renal cell carcinoma		icdo:8312/3
Renal cell carcinoma, chromophobe type		icdo:8317/3
Renal cell carcinoma, sarcomatoid		icdo:8318/3
Retiform Hemangioendothelioma		ncit:C27511
Retinoblastoma		icdo:9510/3
Retinoblastoma, NOS		icdo:9510/3
Retinoblastoma, differentiated		icdo:9511/3
Retinoblastoma, diffuse		icdo:9513/3
Retinoblastoma, undifferentiated		icdo:9512/3
Retinoma		ncit:C66812
Rhabdomyoma, NOS		icdo:8900/0
Rhabdomyosarcoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C3359
Rhabdomyosarcoma (RMS), inadequate tissue for classification
Rhabdomyosarcoma (RMS), not classifiable
Rhabdomyosarcoma (RMS), with Mixed Embryonal and Alveolar Features
Rhabdomyosarcoma with ganglionic differentiation		icdo:8921/3
Rhabdomyosarcoma, NOS		icdo:8900/3
Rosai-Dorfman Disease	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C36075
Rosette-Forming Glioneuronal Tumor	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Glioneuronal and Neuronal Tumors'	ncit:C129431
Round Blue Cell Tumor/Sarcoma
Round cell liposarcoma		icdo:8853/3
Round cell sarcoma with EWSR1-non-ETS fusions		icdo:9366/3
Sarcoma with BCOR genetic alterations		icdo:9368/3
Sarcoma, NOS		icdo:8800/3
Schneiderian carcinoma		icdo:8121/3
Schwannoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C3269
Scirrhous adenocarcinoma		icdo:8141/3
Sclerosing Epithelioid Fibrosarcoma		ncit:C49027
Sclerosing sweat duct carcinoma		icdo:8407/3
Sebaceous adenocarcinoma		icdo:8410/3
Secretory carcinoma of no special type		icdo:8502/3
Sellar ependymoma		icdo:9391/1
Seminoma		ncit:C9309
Seminoma, NOS		icdo:9061/3
Seminoma, anaplastic		icdo:9062/3
Seminoma/Dysgerminoma/Germinoma		ncit:C121618
Seromucinous carcinoma		icdo:8474/3
Serous adenocarcinofibroma		icdo:9014/3
Serous carcinoma
Serous cystadenocarcinoma		icdo:8441/3
Serous cystadenoma, borderline malignancy (C56.9)		icdo:8442/1
Serous papillary cystic tumor of borderline malignancy (C56.9)		icdo:8462/1
Serous tubal intraepithelial carcinoma		icdo:8441/2
Serrated adenocarcinoma		icdo:8213/3
Serrated dysplasia, high grade		icdo:8213/2
Sertoli cell carcinoma		icdo:8640/3
Sertoli-Leydig cell tumor, poorly differentiated		icdo:8631/3
Sertoli-Leydig cl tum., p.d. w heterologous elements		icdo:8634/3
Sessile serrated lesion
Sezary syndrome		icdo:9701/3
Signet ring cell carcinoma		icdo:8490/3
Skin appendage carcinoma		icdo:8390/3
Small cell carcinoma		icdo:8041/3
Small cell carcinoma, NOS		icdo:8041/3
Small cell carcinoma, fusiform cell		icdo:8043/3
Small cell carcinoma, intermediate cell		icdo:8044/3
Small cell sarcoma		icdo:8803/3
Smooth muscle tumor, NOS		icdo:8897/1
Soft Tissue Chondroma		ncit:C9482
Soft tissue tumor, benign		icdo:8800/0
Solid carcinoma, NOS		icdo:8230/3
Solid papillary carcinoma in situ		icdo:8509/2
Solid papillary carcinoma with invasion		icdo:8509/3
Solid pseudopapillary carcinoma		icdo:8452/3
Solitary Fibrous Tumor	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Other'	ncit:C7634
Solitary Fibrous Tumor, Malignant		icdo:8815/3
Solitary fibrous tumor/hemangiopericytoma Grade 2		icdo:8815/1
Somatic Malignancy		ncit:C18060
Somatostatinoma, malignant		icdo:8156/3
Spermatocytic seminoma		icdo:9063/3
Spinal Ependymoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Ependymoma'	ncit:C3875
Spinal Ependymoma, MYCN-Amplified	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Ependymoma'	ncit:C186494
Spindle cell
Spindle cell carcinoma		icdo:8032/3
Spindle cell melanoma, NOS		icdo:8772/3
Spindle cell melanoma, type A		icdo:8773/3
Spindle cell melanoma, type B		icdo:8774/3
Spindle cell rhabdomyosarcoma		icdo:8912/3
Spindle cell sarcoma		icdo:8801/3
Spindle epithelial tumor with thymus-like element		icdo:8588/3
Splenic marginal zone B-cell lymphoma		icdo:9689/3
Spongioneuroblastoma		icdo:9504/3
Sq. cell carc. in situ with question. stromal invas.		icdo:8076/2
Sq. cell carcinoma, keratinizing, NOS		icdo:8071/3
Sq. cell carcinoma, keratinizing, NOS, in situ		icdo:8071/2
Sq. cell carcinoma, lg. cell, non-ker.		icdo:8072/3
Sq. cell carcinoma, lg. cell, non-ker., in situ		icdo:8072/2
Sq. cell carcinoma, micro-invasive		icdo:8076/3
Sq. cell carcinoma, sm. cell, non-ker.		icdo:8073/3
Sq. cell carcinoma, spindle cell		icdo:8074/3
Squamous Cell Carcinoma, Keratinizing, NOS		icdo:8071/3
Squamous Cell Carcinoma, Large Cell, Nonkeratinizing, NOS		icdo:8072/3
Squamous Cell Carcinoma, NOS		icdo:8070/3
Squamous cell carcinoma in situ, NOS		icdo:8070/2
Squamous cell carcinoma with horn formation		icdo:8078/3
Squamous cell carcinoma, HPV-negative		icdo:8086/3
Squamous cell carcinoma, HPV-positive		icdo:8085/3
Squamous cell carcinoma, adenoid		icdo:8075/3
Squamous cell carcinoma, clear cell type		icdo:8084/3
Squamous intraepithelial neoplasia, grade III		icdo:8077/2
Steroid cell tumor, malignant		icdo:8670/3
Stromal sarcoma, NOS		icdo:8935/3
Struma ovarii, malignant		icdo:9090/3
Subcutaneous panniculitis-like T-cell lymphoma		icdo:9708/3
Subependymal Giant Cell Astrocytoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Low-Grade Glioma'	ncit:C3696
Subependymoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Ependymoma'	icdo:9383/1
Supependymal giant cell astrocytoma		icdo:9384/1
Superficial spreading adenocarcinoma		icdo:8143/3
Superficial spreading melanoma		icdo:8743/3
Superficial spreading melanoma, in situ		icdo:8743/2
Supratentorial Ependymoma	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Ependymoma'	ncit:C186343
Supratentorial Ependymoma, YAP1 fusion-positive	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Ependymoma'	ncit:C186351
Supratentorial Ependymoma, ZFTA fusion-positive	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Ependymoma'	ncit:C186350
Surface Osteosarcoma		ncit:C7134
Sweat gland adenocarcinoma		icdo:8400/3
Sympathetic Paraganglioma		icdo:8681/3
Synovial Sarcoma, NOS		ncit:C3400
Synovial sarcoma, NOS		icdo:9040/3
Synovial sarcoma, epithelioid cell		icdo:9042/3
SystemicEBV pos. T-cell lymphoproliferative disease of childhood		icdo:9724/3
T lymphoblastic leukemia/lymphoma		icdo:9837/3
T-ALL		ncit:C3183
T-cell histiocyte rich large B-cell lymphoma		icdo:9688/3
T-cell large granular lymphocytic leukemia		icdo:9831/3
Tenosynovial Giant Cell Tumor Diffuse Type		ncit:C3401
Tenosynovial Giant Cell Tumor Localized Type		ncit:C6532
Tenosynovial Giant Cell Tumor Malignant		ncit:C6535
Teratocarcinoma		icdo:9081/3
Teratoid medulloepithelioma		icdo:9502/3
Teratoma with malig. transformation		icdo:9084/3
Teratoma, benign		icdo:9080/0
Teratoma, malignant, NOS		icdo:9080/3
Thecoma, malignant		icdo:8600/3
Therapy-related acute myeloid leukemia, NOS		icdo:9920/3
Therapy-related myelodysplastic syndrome, NOS		icdo:9987/3
Thymic carcinoma, NOS		icdo:8586/3
Thymoma, malignant, NOS		icdo:8580/3
Thymoma, type A, malignant		icdo:8581/3
Thymoma, type AB, malignant		icdo:8582/3
Thymoma, type B1, malignant		icdo:8583/3
Thymoma, type B2, malignant		icdo:8584/3
Thymoma, type B3, malignant		icdo:8585/3
Trabecular adenocarcinoma		icdo:8190/3
Traditional serrated adenoma
Trans. cell carcinoma, spindle cell		icdo:8122/3
Transitional cell carcinoma in situ		icdo:8120/2
Transitional cell carcinoma, NOS		icdo:8120/3
Transitional cell carcinoma, micropapillary		icdo:8131/3
Transitional meningioma		icdo:9537/0
Trophoblastic tumor, epithelioid		icdo:9105/3
Tubular adenocarcinoma		icdo:8211/3
Tubular adenoma
Tubulovillous adenoma
Tumor cells, benign		icdo:8001/0
Tumor cells, malignant		icdo:8001/3
Tumor cells, uncertain whether benign or malignant		icdo:8001/1
Undifferentiated Epithelioid Sarcoma		ncit:C121802
Undifferentiated Ewing Tumor		ncit:C121799
Undifferentiated Pleomorphic Sarcoma		ncit:C4247
Undifferentiated Round Cell Sarcoma		ncit:C121799
Undifferentiated Sarcoma, NOS		ncit:C121804
Undifferentiated Spindle Cell Sarcoma		ncit:C121797
Undifferentiated embryonal sarcoma	(lt) ConsortiumNote: DIAGNOSIS_CATEGORY == 'Hepatic Tumor, Other'
Undifferentiated sarcoma		icdo:8805/3
Urothelial carcinoma		icdo:8120/3
Venous hemangioma		icdo:9122/0
Verrucous carcinoma, NOS		icdo:8051/3
Villous adenocarcinoma		icdo:8262/3
Villous adenoma
WHO, Version 4 >> AML (megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1		ncit:C82427
WHO, Version 4 >> AML with Biallelic Mutations of CEBPA		ncit:C129782
WHO, Version 4 >> AML with Maturation		ncit:C3250
WHO, Version 4 >> AML with Minimal Differentiation		ncit:C8460
WHO, Version 4 >> AML with Mutated NPM1		ncit:C82431
WHO, Version 4 >> AML with Myelodysplasia-related Changes		ncit:C7600
WHO, Version 4 >> AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11		ncit:C9287
WHO, Version 4 >> AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM		ncit:C82426
WHO, Version 4 >> AML with t(6;9)(p23;q34.1);DEK-NUP214		ncit:C82423
WHO, Version 4 >> AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1		ncit:C9288
WHO, Version 4 >> AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3		ncit:C82403
WHO, Version 4 >> AML without Maturation		ncit:C3249
WHO, Version 4 >> APL with PML-RARA		ncit:C7968
WHO, Version 4 >> Acute Basophilic Leukemia		ncit:C3164
WHO, Version 4 >> Acute Megakaryoblastic Leukemia		ncit:C3170
WHO, Version 4 >> Acute Monoblastic/Monocytic Leukemia		ncit:C7318
WHO, Version 4 >> Acute Myelomonocytic Leukemia		ncit:C7463
WHO, Version 4 >> Acute Panmyelosis with Myelofibrosis		ncit:C4344
WHO, Version 4 >> Myeloid Leukemia Associated with Down Syndrome		ncit:C43223
WHO, Version 4 >> Myeloid Proliferations Related to Down Syndrome		ncit:C82338
WHO, Version 4 >> Myeloid Sarcoma		ncit:C3520
WHO, Version 4 >> Provisional Entity: AML with BCR-ABL1		ncit:C129785
WHO, Version 4 >> Provisional Entity: AML with Mutated RUNX1		ncit:C129786
WHO, Version 4 >> Pure Erythroid Leukemia		ncit:C7467
WHO, Version 4 >> Therapy-Related Myeloid Neoplasms		ncit:C27912
WHO, Version 4 >> Transient Abnormal Myelopoiesis (TAM)		ncit:C82339
WHO, Version 5 >> AML with KMT2A Rearrangement
Waldenstrom macroglobulinemia		icdo:9761/3
Warthin tumor, malignant		icdo:8561/3
Warty carcinoma		icdo:8054/3
Water-clear cell adenocarcinoma		icdo:8322/3
Well Differentiated Liposarcoma		ncit:C6505
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234
Condyloma
Hamartoma
Inflammatory Polyp
Inflammation (neutrophils, lymphocytes, eosinophils)
Juvenile Polyp
Lipoma
Lymphoid Aggregate
Normal Colonic Mucosa
Oligodendroglial-astrocytic
Scar
Neoplasm, Malignant		icdo:8000/3
Tumor Cells, Malignant		icdo:8001/3
Malignant Tumor, Small Cell Type		icdo:8002/3
Malignant Tumor, Giant Cell Type		icdo:8003/3
Malignant Tumor, Spindle Cell Type		icdo:8004/3
Malignant Tumor, Clear Cell Type		icdo:8005/3
Carcinoma In Situ, NOS		icdo:8010/2
Epithelioma, Malignant		icdo:8011/3
Large Cell Carcinoma, NOS		icdo:8012/3
Large Cell Neuroendocrine Carcinoma		icdo:8013/3
Large Cell Carcinoma With Rhabdoid Phenotype		icdo:8014/3
Glassy Cell Carcinoma		icdo:8015/3
Carcinoma, Undifferentiated Type, NOS		icdo:8020/3
Carcinoma, Anaplastic Type, NOS		icdo:8021/3
Pleomorphic Carcinoma		icdo:8022/3
Giant Cell And Spindle Cell Carcinoma		icdo:8030/3
Giant Cell Carcinoma		icdo:8031/3
Spindle Cell Carcinoma		icdo:8032/3
Pseudosarcomatous Carcinoma		icdo:8033/3
Polygonal Cell Carcinoma		icdo:8034/3
Carcinoma With Osteoclast-Like Giant Cells		icdo:8035/3
Papillary Carcinoma In Situ		icdo:8050/2
Papillary Carcinoma, NOS		icdo:8050/3
Verrucous Carcinoma, NOS		icdo:8051/3
Papillary Squamous Cell Carcinoma, Non-Invasive		icdo:8052/2
Papillary Squamous Cell Carcinoma		icdo:8052/3
Squamous Cell Carcinoma In Situ, NOS		icdo:8070/2
Sq. Cell Carcinoma, Keratinizing, NOS		icdo:8071/3
Sq. Cell Carcinoma, Lg. Cell, Non-Ker.		icdo:8072/3
Sq. Cell Carcinoma, Sm. Cell, Non-Ker.		icdo:8073/3
Sq. Cell Carcinoma, Spindle Cell		icdo:8074/3
Squamous Cell Carcinoma, Adenoid		icdo:8075/3
Sq. Cell Carc. In Situ With Question. Stromal Invas.		icdo:8076/2
Sq. Cell Carcinoma, Micro-Invasive		icdo:8076/3
Squamous Cell Carcinoma With Horn Formation		icdo:8078/3
Bowen Disease		icdo:8081/2
Lymphoepithelial Carcinoma		icdo:8082/3
Basaloid Squamous Cell Carcinoma		icdo:8083/3
Squamous Cell Carcinoma, Clear Cell Type		icdo:8084/3
Adenocarcinoma In Situ		icdo:8140/2
Scirrhous Adenocarcinoma		icdo:8141/3
Superficial Spreading Adenocarcinoma		icdo:8143/3
Basal Cell Adenocarcinoma		icdo:8147/3
Adenoid Cystic Carcinoma		icdo:8200/3
Cribriform Carcinoma In Situ		icdo:8201/2
Cribriform Carcinoma		icdo:8201/3
Adenocarcinoma With Mixed Subtypes		icdo:8255/3
Papillary Adenocarcinoma, NOS		icdo:8260/3
Adenocarcinoma In Situ In Villous Adenoma		icdo:8261/2
Adenocarcinoma In Villous Adenoma		icdo:8261/3
Villous Adenocarcinoma		icdo:8262/3
Adenocarcinoma In Situ In Tubulovillous Adenoma		icdo:8263/2
Adenocarcinoma In Tubulovillous Adenoma		icdo:8263/3
Mucoepidermoid Carcinoma		icdo:8430/3
Mucinous Adenocarcinoma		icdo:8480/3
Mucin-Producing Adenocarcinoma		icdo:8481/3
Melanoma In Situ		icdo:8720/2
Malignant Melanoma, NOS		icdo:8720/3
Nodular Melanoma		icdo:8721/3
Balloon Cell Melanoma		icdo:8722/3
Malignant Melanoma, Regressing		icdo:8723/3
Amelanotic Melanoma		icdo:8730/3
Superficial Spreading Melanoma		icdo:8743/3
Desmoplastic Melanoma, Malignant		icdo:8745/3
Mucosal Lentiginous Melanoma		icdo:8746/3
Mixed Epithel. & Spindle Cell Melanoma		icdo:8770/3
Epithelioid Cell Melanoma		icdo:8771/3
Spindle Cell Melanoma, NOS		icdo:8772/3
Mixed Tumor, Malignant, NOS		icdo:8940/3
Carcinoma In Pleomorphic Adenoma		icdo:8941/3
Marginal Zone B-Cell Lymphoma, NOS		icdo:9699/3
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma		icdo:9823/3
Squamous Cell Carcinoma, HPV-Positive		icdo:8085/3
Squamous Cell Carcinoma, HPV-Negative		icdo:8086/3
Adenosquamous Carcinoma		icdo:8560/3
Epithelial-Myoepithelial Carcinoma		icdo:8562/3
Adenocarcinoma With Squamous Metaplasia		icdo:8570/3
Adenocarcinoma With Cartilaginous & Oss. Metaplasia		icdo:8571/3
Adenocarcinoma With Spindle Cell Metaplasia		icdo:8572/3
Adenocarcinoma With Apocrine Metaplasia		icdo:8573/3
Adenocarcinoma With Neuroendocrine Differentiation		icdo:8574/3
Metaplastic Carcinoma, NOS		icdo:8575/3
Myofibroblastic Sarcoma		icdo:8825/3
Pleomorphic Rhabdomyosarcoma, Adult Type		icdo:8901/3
Mixed Type Rhabdomyosarcoma		icdo:8902/3
Embryonal Rhabdomyosarcoma		icdo:8910/3
Spindle Cell Rhabdomyosarcoma		icdo:8912/3
Malignant Lymphoma, NOS		icdo:9590/3
Malignant Lymphoma, Non-Hodgkin		icdo:9591/3
Composite Hodgkin and Non-Hodgkin Lymphoma		icdo:9596/3
Hodgkin Lymphoma, Lymphocyte-Rich		icdo:9651/3
Hodgkin Lymphoma, Mixed Cellularity, NOS		icdo:9652/3
Hodgkin Lymphoma, Lymphocytic Deplet., NOS		icdo:9653/3
Hodgkin Lymphoma, Lymphocytic Deplet., Diffuse Fibrosis		icdo:9654/3
Hodgkin Lymphoma, Lymphocytic Deplet., Reticular		icdo:9655/3
Hodgkin Lymphoma, Nodular Lymphocyte Predom.		icdo:9659/3
Hodgkin Granuloma [Obs]		icdo:9661/3
Hodgkin Sarcoma [Obs]		icdo:9662/3
Hodgkin Lymphoma, Nod. Scler., Cellular Phase		icdo:9664/3
Hodgkin Lymphoma, Nod. Scler., Grade 1		icdo:9665/3
Hodgkin Lymphoma, Nod. Scler., Grade 2		icdo:9667/3
ML, Small B Lymphocytic, NOS		icdo:9670/3
ML, Lymphoplasmacytic		icdo:9671/3
Mantle Cell Lymphoma		icdo:9673/3
ML, Mixed Sm. and Lg. Cell, Diffuse		icdo:9675/3
ML, Large B-Cell, Diffuse		icdo:9680/3
ML, Large B-Cell, Diffuse, Immunoblastic, NOS		icdo:9684/3
Burkitt Lymphoma, NOS		icdo:9687/3
T-Cell Histiocyte Rich Large B-Cell Lymphoma		icdo:9688/3
Follicular Lymphoma, NOS		icdo:9690/3
Follicular Lymphoma, Grade 2		icdo:9691/3
Follicular Lymphoma, Grade 1		icdo:9695/3
Follicular Lymphoma, Grade 3		icdo:9698/3
Sezary Syndrome		icdo:9701/3
Mature T-Cell Lymphoma, NOS		icdo:9702/3
Angioimmunoblastic T-Cell Lymphoma		icdo:9705/3
Anaplastic Large Cell Lymphoma, T-Cell and Null Cell Type		icdo:9714/3
Anaplastic Large Cell Lymphoma, ALK Negative		icdo:9715/3
NK/T-Cell Lymphoma, Nasal and Nasal-Type		icdo:9719/3
Systemic EBV Pos. T-Cell Lymphoproliferative Disease of Childhood		icdo:9724/3
Precursor Cell Lymphoblastic Lymphoma, NOS		icdo:9727/3
Precursor B-Cell Lymphoblastic Lymphoma		icdo:9728/3
Precursor T-Cell Lymphoblastic Lymphoma		icdo:9729/3
Plasmacytoma, Extramedullary		icdo:9734/3
Plasmablastic Lymphoma		icdo:9735/3
ALK Positive Large B-Cell Lymphoma		icdo:9737/3
Lrg B-Cell Lymphoma in HHV8-Assoc. Multicentric Castleman DZ		icdo:9738/3
Mast Cell Sarcoma		icdo:9740/3
Malignant Mastocytosis		icdo:9741/3
Erdhiem-Chester Disease		icdo:9749/3
Malignant Histiocytosis		icdo:9750/3
Langerhans Cell Histiocytosis, NOS		icdo:9751/3
Langerhans Cell Histiocytosis, Disseminated		icdo:9754/3
Langerhans Cell Sarcoma		icdo:9756/3
Interdigitating Dendritic Cell Sarcoma		icdo:9757/3
Follicular Dendritic Cell Sarcoma		icdo:9758/3
Fibroblastic Reticular Cell Tumor		icdo:9759/3
Lymphomatoid Granulomatosis, Grade 3		icdo:9766/3
B Lymphoblastic Leukemia/Lymphoma, NOS		icdo:9811/3
Leukemia/Lymphoma with t(9;22)(q34;q11.2);BCR-ABL1		icdo:9812/3
Leukemia/Lymphoma with t(v;11q23);MLL Rearranged		icdo:9813/3
Leukemia/Lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)		icdo:9814/3
B Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy		icdo:9815/3
Leukemia/Lymphoma with Hypodiploidy (Hypodiploid ALL)		icdo:9816/3
B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31;q32);IL3-IGH		icdo:9817/3
Leukemia/Lymphoma with t(1;19)(q23;p13.3);E2A PBX1 (TCF3 PBX1)		icdo:9818/3
B-Lymphocytic Leukemia/Lymphoma, BCR-ABL1-Like		icdo:9819/3
T-Cell Large Granular Lymphocytic Leukemia		icdo:9831/3
T Lymphoblastic Leukemia/Lymphoma		icdo:9837/3
Myeloid and Lymphoid Neoplasms with PDGFRB Rearrangement		icdo:9965/3
Myeloid and Lymphoid Neoplasm with FGFR1 Abnormalities		icdo:9967/3
Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable		icdo:9975/3
Clear Cell Adenocarcinoma, NOS		icdo:8310/3
Acinar Cell Carcinoma		icdo:8550/3
Acinar Cell Cystadenocarcinoma		icdo:8551/3
Fascial Fibrosarcoma		icdo:8813/3
Carcinosarcoma, Nos		icdo:8980/3
Carcinosarcoma, Embryonal Type		icdo:8981/3
Malignant Myoepithelioma		icdo:8982/3
Trabecular Adenocarcinoma		icdo:8190/3
Duct Carcinoma In Situ, Solid Type		icdo:8230/2
Solid Carcinoma, Nos		icdo:8230/3
Carcinoma Simplex		icdo:8231/3
Oxyphilic Adenocarcinoma		icdo:8290/3
Invasive Carcinoma Of No Special Type		icdo:8500/3
Secretory Carcinoma Of No Special Type		icdo:8502/3
Polymorphous Low Grade Adenocarcinoma		icdo:8525/3
Warthin Tumor, Malignant		icdo:8561/3
Sarcoma, Nos		icdo:8800/3
Spindle Cell Sarcoma		icdo:8801/3
Giant Cell Sarcoma		icdo:8802/3
Small Cell Sarcoma		icdo:8803/3
Epithelioid Sarcoma		icdo:8804/3
Undifferentiated Sarcoma		icdo:8805/3
Liposarcoma, Nos		icdo:8850/3
Liposarcoma, Well Differentiated		icdo:8851/3
Round Cell Liposarcoma		icdo:8853/3
Mixed Type Liposarcoma		icdo:8855/3
Fibroblastic Liposarcoma		icdo:8857/3
Epithelioid Leiomyosarcoma		icdo:8891/3
Mesenchymoma, Malignant		icdo:8990/3
Embryonal Sarcoma		icdo:8991/3
Transitional Cell Carcinoma In Situ		icdo:8120/2
Transitional Cell Carcinoma, Nos		icdo:8120/3
Schneiderian Carcinoma		icdo:8121/3
Trans. Cell Carcinoma, Spindle Cell		icdo:8122/3
Basaloid Carcinoma		icdo:8123/3
Cloacogenic Carcinoma		icdo:8124/3
Mal. Melanoma In Giant Pigmented Nevus		icdo:8761/3
Small Cell Carcinoma, Nos		icdo:8041/3
Small Cell Carcinoma, Fusiform Cell		icdo:8043/3
Embryonal Carcinoma, Nos		icdo:9070/3
Yolk Sac Tumor		icdo:9071/3
Polyembryoma		icdo:9072/3
Chordoma, Nos		icdo:9370/3
Chondroid Chordoma		icdo:9371/3
Dedifferentiated Chordoma		icdo:9372/3
Combined Small Cell Carcinoma		icdo:8045/3
Carcinoma, Diffuse Type		icdo:8145/3
Mixed Neuroendocrine Non-Neuroendocrine Neoplasm		icdo:8154/3
Carcinoid Tumor, Malignant		icdo:8240/3
Composite Carcinoid		icdo:8244/3
Neuroendocrine Carcinoma		icdo:8246/3
Neuroendocrine Tumor		icdo:8249/3
Linitis Plastica		icdo:8142/3
Intestinal-Type Adenoma, High Grade		icdo:8144/2
Adenocarcinoma, Intestinal Type		icdo:8144/3
Gastrinoma, Malignant		icdo:8153/3
Somatostatinoma, Malignant		icdo:8156/3
Adenocarcinoma In Situ In Adenomatous Polyp		icdo:8210/2
Adenocarcinoma In Adenomatous Polyp		icdo:8210/3
Tubular Adenocarcinoma		icdo:8211/3
Serrated Dysplasia, High Grade		icdo:8213/2
Parietal Cell Carcinoma		icdo:8214/3
Adenocarcinoma In Situ In Familial Polyp. Coli		icdo:8220/2
Adenocarcinoma In Adenoma. Polyposis Coli		icdo:8220/3
Adenocarc. In Situ In Mult. Adenomatous Polyps		icdo:8221/2
Adenocarcinoma In Mult. Adenomatous Polyps		icdo:8221/3
Enterochromaffin Cell Carcinoid		icdo:8241/3
Enterochromaffin-Like Cell Tumor, Malignant		icdo:8242/3
Goblet Cell Carcinoid		icdo:8243/3
Adenocarcinoid Tumor		icdo:8245/3
Signet Ring Cell Carcinoma		icdo:8490/3
Medullary Carcinoma, Nos		icdo:8510/3
Medullary Carcinoma With Lymphoid Stroma		icdo:8512/3
Hepatoid Adenocarcinoma		icdo:8576/3
Carcinofibroma		icdo:8934/3
Stromal Sarcoma, Nos		icdo:8935/3
Gastrointestinal Stromal Sarcoma		icdo:8936/3
Multiple Myeloma		icdo:9732/3
Glucagonoma, Malignant		icdo:8152/3
Enteroglucagonoma, Malignant		icdo:8157/3
Pancreatobiliary-Type Carcinoma		icdo:8163/3
Extra-Adrenal Paraganglioma, Malignant		icdo:8693/3
Intestinal T-Cell Lymphoma		icdo:9717/3
Immunoproliferative Small Intestinal Disease		icdo:9764/3
Serrated Adenocarcinoma		icdo:8213/3
Micropapillary Carcinoma, Nos		icdo:8265/3
Mucinous Cystadenocarcinoma, Non-Invasive		icdo:8470/2
Mucinous Cystadenocarcinoma, Nos		icdo:8470/3
Papillary Mucinous Cystadenocarcinoma		icdo:8471/3
High Grade Appendiceal Mucinous Neoplasm		icdo:8480/2
Squamous Intraepithelial Neoplasia, Grade Iii		icdo:8077/2
Adenocarcinoma Of Anal Glands		icdo:8215/3
Intraductal Carcinoma, Noninfiltrating, Nos		icdo:8500/2
Noninfiltrating Intraductal Papillary Adenocarcinoma		icdo:8503/2
Intraductal Papillary Adenocarcinoma With Invasion		icdo:8503/3
Noninfiltrating Intracystic Carcinoma		icdo:8504/2
Intracystic Carcinoma, Nos		icdo:8504/3
Paget Disease, Extramammary		icdo:8542/3
Bile Duct Cystadenocarcinoma		icdo:8161/3
Hepatocellular Carcinoma, Nos		icdo:8170/3
Hepatocellular Carcinoma, Fibrolamellar		icdo:8171/3
Hepatocellular Carcinoma, Scirrhous		icdo:8172/3
Hepatocellular Carcinoma, Spindle Cell Variant		icdo:8173/3
Hepatocellular Carcinoma, Clear Cell Type		icdo:8174/3
Hepatocellular Carcinoma, Pleomorphic Type		icdo:8175/3
Comb. Hepatocel. Carcinoma & Cholangiocarcinoma		icdo:8180/3
Comedocarcinoma, Non-Infiltrating		icdo:8501/2
Comedocarcinoma, Nos		icdo:8501/3
Intraductal Micropapillary Carcinoma		icdo:8507/2
Cystic Hypersecretory Carcinoma		icdo:8508/3
Kupffer Cell Sarcoma		icdo:9124/3
Hemangioendothelioma, Malignant		icdo:9130/3
Epithelioid Hemangioendothelioma, Malignant		icdo:9133/3
Hepatosplenic Gamma-Delta Cell Lymphoma		icdo:9716/3
Klatskin Tumor		icdo:8162/3
Glandular Intraepithelial Neoplasia, Grade Iii		icdo:8148/2
Islet Cell Carcinoma		icdo:8150/3
Insulinoma, Malignant		icdo:8151/3
Vipoma		icdo:8155/3
Acth-Producing Tumor		icdo:8158/3
Mixed Cell Adenocarcinoma		icdo:8323/3
Serous Cystadenocarcinoma		icdo:8441/3
Papillary Cystadenocarcinoma, Nos		icdo:8450/3
Solid Pseudopapillary Carcinoma		icdo:8452/3
Intraductal Papillary-Mucinous Carcinoma, Non-Inv.		icdo:8453/2
Intraductal Papillary-Mucinous Carcinoma, Invasive		icdo:8453/3
Intraductal Oncocytic Papillary Neoplasm, Nos		icdo:8455/2
Intraductal Oncocytic Papillary Neoplasms With Associated Invasive		icdo:8455/3
Duct Carcinoma, Desmoplastic Type		icdo:8514/3
Infiltrating Ductular Carcinoma		icdo:8521/3
Mixed Acinar Ductal Carcinoma		icdo:8552/3
Papillary Trans. Cell Carcinoma, Non-Invasive		icdo:8130/2
Papillary Trans. Cell Carcinoma		icdo:8130/3
Transitional Cell Carcinoma, Micropapillary		icdo:8131/3
Alveolar Adenocarcinoma		icdo:8251/3
Granular Cell Carcinoma		icdo:8320/3
Endometrioid Carcinoma		icdo:8380/3
Apocrine Adenocarcinoma		icdo:8401/3
Fibrous Histiocytoma, Malignant		icdo:8830/3
Alveolar Rhabdomyosarcoma		icdo:8920/3
Rhabdomyosarcoma With Ganglionic Differentiation		icdo:8921/3
Mullerian Mixed Tumor		icdo:8950/3
Mesodermal Mixed Tumor		icdo:8951/3
Synovial Sarcoma, Nos		icdo:9040/3
Synovial Sarcoma, Spindle Cell		icdo:9041/3
Synovial Sarcoma, Epithelioid Cell		icdo:9042/3
Synovial Sarcoma, Biphasic		icdo:9043/3
Clear Cell Sarcoma, Nos (Except Of Kidney M-		icdo:9044/3
Germ Cell Tumor, Nonseminomatous		icdo:9065/3
Teratoma, Malignant, Nos		icdo:9080/3
Malignant Teratoma, Undiff.		icdo:9082/3
Malignant Teratoma, Intermediate		icdo:9083/3
Teratoma With Malig. Transformation		icdo:9084/3
Choriocarcinoma Combined W/ Other Germ Cell Elements		icdo:9101/3
Trophoblastic Tumor, Epithelioid		icdo:9105/3
Mesonephroma, Malignant		icdo:9110/3
Hemangiopericytoma, Malignant		icdo:9150/3
Malignant Giant Cell Tumor Of Soft Parts		icdo:9251/3
Malignant Tenosynovial Giant Cell Tumor		icdo:9252/3
Neuroblastoma, Nos		icdo:9500/3
Medulloepithelioma, Nos		icdo:9501/3
Teratoid Medulloepithelioma		icdo:9502/3
Neuroepithelioma, Nos		icdo:9503/3
Ganglioglioma, Anaplastic		icdo:9505/3
Neurilemmoma, Malignant		icdo:9560/3
MpnsT With Rhabdomyoblastic Differentiation		icdo:9561/3
Perineurioma, Malignant		icdo:9571/3
Nut Carcinoma		icdo:8023/3
Biphenotypic Sinonasal Sarcoma		icdo:9045/3
Chondrosarcoma, Nos		icdo:9220/3
Juxtacortical Chondrosarcoma		icdo:9221/3
Olfactory Neurogenic Tumor		icdo:9520/3
Olfactory Neurcytoma		icdo:9521/3
Olfactory Neuroblastoma		icdo:9522/3
Olfactory Neuroepithelioma		icdo:9523/3
Non-Small Cell Carcinoma		icdo:8046/3
Oat Cell Carcinoma		icdo:8042/3
Small Cell Carcinoma, Intermediate Cell		icdo:8044/3
Lepidic Adenocarcinoma		icdo:8250/3
Bronchiolo-Alveolar Carcinoma, Non-Mucinous		icdo:8252/3
Invasive Mucinous Adenocarcinoma		icdo:8253/3
Mixed Invasive Mucinous And Non-Mucinous Adenocarcinoma		icdo:8254/3
Pulmonary Blastoma		icdo:8972/3
Pleuropulmonary Blastoma		icdo:8973/3
Adenocarcinoma In Situ, Non-Mucinous		icdo:8250/2
Adenocarcinoma In Situ, Mucinous		icdo:8253/2
Minimally Invasive Adenocarcinoma, Non-Mucinous		icdo:8256/3
Minimally Invasive Adenocarcinoma, Mucinous		icdo:8257/3
Fetal Adenocarcinoma		icdo:8333/3
Pecoma, Malignant		icdo:8714/3
Pulmonary Myxoid Sarcoma With Ewsr1-Creb1 Translocation		icdo:8842/3
Mesothelioma, In Situ		icdo:9050/2
Mesothelioma, Malignant		icdo:9050/3
Fibrous Mesothelioma, Malignant		icdo:9051/3
Epithel. Mesothelioma, Mal.		icdo:9052/3
Mesothelioma, Biphasic, Malignant		icdo:9053/3
Primary Effusion Lymphoma		icdo:9678/3
Mediastinal Large B-Cell Lymphoma		icdo:9679/3
Thymoma, Malignant, Nos		icdo:8580/3
Thymoma, Type A, Malignant		icdo:8581/3
Thymoma, Type Ab, Malignant		icdo:8582/3
Thymoma, Type B1, Malignant		icdo:8583/3
Thymoma, Type B2, Malignant		icdo:8584/3
Thymoma, Type B3, Malignant		icdo:8585/3
Thymic Carcinoma, Nos		icdo:8586/3
Spindle Epithelial Tumor With Thymus-Like Element		icdo:8588/3
Carcinoma Showing Thymus-Like Element		icdo:8589/3
Germ Cell Tumors With Associated Hematological Malignancy		icdo:9086/3
Splenic Marginal Zone B-Cell Lymphoma		icdo:9689/3
Mycosis Fungoides		icdo:9700/3
Subcutaneous Panniculitis-Like T-Cell Lymphoma		icdo:9708/3
Cutaneous T-Cell Lymphoma, Nos		icdo:9709/3
Primary Cutan. Cd30+ T-Cell Lymphoprolif. Disorder		icdo:9718/3
Paraganglioma, Malignant		icdo:8680/3
Myxoid Pleomorphic Liposarcoma		icdo:8859/3
Seminoma, Nos		icdo:9061/3
Seminoma, Anaplastic		icdo:9062/3
Spermatocytic Seminoma		icdo:9063/3
Peripheral Neuroectodermal Tumor		icdo:9364/3
Askin Tumor		icdo:9365/3
Periosteal Fibrosarcoma		icdo:8812/3
Osteosarcoma, Nos		icdo:9180/3
Telangiectatic Osteosarcoma		icdo:9183/3
Osteosarcoma In Paget Disease		icdo:9184/3
Small Cell Osteosarcoma		icdo:9185/3
Central Osteosarcoma		icdo:9186/3
Instrosseous Well Differentiated Osteosarcoma		icdo:9187/3
High Grade Surface Osteosarcoma		icdo:9194/3
Intracortical Osteosarcoma		icdo:9195/3
Chondroblastoma, Malignant		icdo:9230/3
Myxoid Chondrosarcoma		icdo:9231/3
Clear Cell Chondrosarcoma		icdo:9242/3
Dedifferentiated Chondrosarcoma		icdo:9243/3
Giant Cell Tumor Of Bone, Malignant		icdo:9250/3
Adamantinoma Of Long Bones		icdo:9261/3
Odontogenic Tumor, Malignant		icdo:9270/3
Ameloblastic Odontosarcoma		icdo:9290/3
Ameloblastoma, Malignant		icdo:9310/3
Ameloblastic Fibrosarcoma		icdo:9330/3
Odontogenic Carcinosarcoma		icdo:9342/3
Ghost Cell Odontogenic Carcinoma		icdo:9302/3
Clear Cell Odontogenic Carcinoma		icdo:9341/3
Round Cell Sarcoma With Ewsr1-Non-Ets Fusions		icdo:9366/3
Cic-Rearranged Sarcoma		icdo:9367/3
Sarcoma With Bcor Genetic Alterations		icdo:9368/3
Plasma Cell Leukemia		icdo:9733/3
Mast Cell Leukemia		icdo:9742/3
Immunoproliferative Disease, Nos		icdo:9760/3
Waldenstrom Macroglobulinemia		icdo:9761/3
Heavy Chain Disease, Nos		icdo:9762/3
Leukemia, Nos		icdo:9800/3
Acute Leukemia, Nos		icdo:9801/3
Acute Biphenotypic Leukemia		icdo:9805/3
Mixed Phenotype Acute Leukemia With T(9;22)(Q34;Q11.2);Bcr-Abl1		icdo:9806/3
Mixed Phenotype Acute Leukemia With T(V;11Q23);Mll Rearranged		icdo:9807/3
Mixed Phenotype Acute Leukemia, B/Myeloid, Nos		icdo:9808/3
Mixed Phenotype Acute Leukemia, T/Myeloid, Nos		icdo:9809/3
Lymphoid Leukemia, Nos		icdo:9820/3
Burkitt Cell Leukemia		icdo:9826/3
Adult T-Cell Leukemia/Lymphoma (Htlv-1 Pos.)		icdo:9827/3
Acute Lymphoblastic Leukemia, L2 Type, Nos		icdo:9828/3
Prolymphocytic Leukemia, Nos		icdo:9832/3
Prolymphocytic Leukemia, B-Cell Type		icdo:9833/3
Prolymphocytic Leukemia, T-Cell Type		icdo:9834/3
Precursor Cell Lymphoblastic Leukemia, Nos		icdo:9835/3
Precursor B-Cell Lymphoblastic Leukemia		icdo:9836/3
Acute Myeloid Leukemia, M6 Type		icdo:9840/3
Myeloid Leukemia, Nos		icdo:9860/3
Chronic Myeloid Leukemia, Nos		icdo:9863/3
Acute Myeloid Leukemia With T(6;9)(P23;Q34) Dek-Nup214		icdo:9865/3
Acute Promyelocytic Leuk.,T(15;17)(Q22;Q11-12)		icdo:9866/3
Acute Myelomonocytic Leukemia		icdo:9867/3
Acute Myeloid Leukemia With Inv(3)(Q21Q26.2) Or		icdo:9869/3
Acute Basophilic Leukemia		icdo:9870/3
Ac. Myelomonocytic Leuk. W Abn. Mar. Eosinophils		icdo:9871/3
Acute Myeloid Leukemia, Minimal Differentiation		icdo:9872/3
Acute Myeloid Leukemia Without Maturation		icdo:9873/3
Acute Myeloid Leukemia With Maturation		icdo:9874/3
Chronic Myelogenous Leukemia, Bcr/Abl Positive		icdo:9875/3
Atypical Chronic Myeloid Leuk., Bcr/Abl Negative		icdo:9876/3
Acute Myeloid Leukemia With Mutated Npm1		icdo:9877/3
Acute Myeloid Leukemia With Biallelic Mutations Of Cebpa		icdo:9878/3
Acute Myeloid Leukemia With Mutated Runx1		icdo:9879/3
Acute Monocytic Leukemia		icdo:9891/3
Acute Myeloid Leukemia With Multilineage Dysplasia		icdo:9895/3
Acute Myeloid Leukemia, T(8;21)(Q22;Q22)		icdo:9896/3
Acute Myeloid Leukemia, 11Q23 Abnormalities		icdo:9897/3
Myeloid Leukemia Associated With Down Syndrome		icdo:9898/3
Acute Megakaryoblastic Leukemia		icdo:9910/3
Acute Myeloid Leukemia (Megakaryoblastic) With		icdo:9911/3
Acute Myeloid Leukemia With Bcr-Abl1		icdo:9912/3
Therapy-Related Acute Myeloid Leukemia, Nos		icdo:9920/3
Myeloid Sarcoma		icdo:9930/3
Acute Panmyelosis With Myelofibrosis		icdo:9931/3
Hairy Cell Leukemia		icdo:9940/3
Chronic Myelomonocytic Leukemia, Nos		icdo:9945/3
Juvenile Myelomonocytic Leukemia		icdo:9946/3
Aggressive Nk-Cell Leukemia		icdo:9948/3
Polycythemia Vera		icdo:9950/3
Chronic Myeloproliferative Disease, Nos		icdo:9960/3
Myelosclerosis With Myeloid Metaplasia		icdo:9961/3
Essential Thrombocythemia		icdo:9962/3
Chronic Neutrophilic Leukemia		icdo:9963/3
Hypereosinophilic Syndrome		icdo:9964/3
Refractory Anemia		icdo:9980/3
Refractory Anemia With Sideroblasts		icdo:9982/3
Refractory Anemia With Excess Blasts		icdo:9983/3
Refract. Anemia With Excess Blasts In Transformation		icdo:9984/3
Refractory Cytopenia With Multilineage Dysplasia		icdo:9985/3
Myelodysplastic Syndr. With 5Q Deletion Syndrome		icdo:9986/3
Therapy-Related Myelodysplastic Syndrome, Nos		icdo:9987/3
Myelodysplastic Syndrome, Nos		icdo:9989/3
Refractory Neutropenia		icdo:9991/3
Refractory Thrombocytopenia		icdo:9992/3
Myelodysplastic Syndrome With Ring Sideroblasts And Multilineage		icdo:9993/3
Trichilemmocarcinoma		icdo:8102/3
Pilomatrix Carcinoma		icdo:8110/3
Merkel Cell Carcinoma		icdo:8247/3
Skin Appendage Carcinoma		icdo:8390/3
Sweat Gland Adenocarcinoma		icdo:8400/3
Nodular Hidradenoma, Malignant		icdo:8402/3
Malignant Eccrine Spiradenoma		icdo:8403/3
Sclerosing Sweat Duct Carcinoma		icdo:8407/3
Eccrine Papillary Adenocarcinoma		icdo:8408/3
Eccrine Poroma, Malignant		icdo:8409/3
Sebaceous Adenocarcinoma		icdo:8410/3
Eccrine Adenocarcinoma		icdo:8413/3
Ceruminous Adenocarcinoma		icdo:8420/3
Mal. Melanoma In Junctional Nevus		icdo:8740/3
Precancerous Melanosis, NOS		icdo:8741/2
Mal. Melanoma In Precan. Melanosis		icdo:8741/3
Lentigo Maligna		icdo:8742/2
Lentigo Maligna Melanoma		icdo:8742/3
Superficial Spreading Melanoma, In Situ		icdo:8743/2
Acral Lentiginous Melanoma, Malig.		icdo:8744/3
Blue Nevus, Malignant		icdo:8780/3
Dermatofibrosarcoma, Nos		icdo:8832/3
Pigmented Dermatofibrosarcoma Protuberans		icdo:8833/3
Primary Cutaneous Follicle Centre Lymphoma		icdo:9597/3
Hydroa Vacciniforme-Like Lymphoma		icdo:9725/3
Primary Cutaneous Gamma-Delta T-Cell Lymphoma		icdo:9726/3
Granular Cell Tumor, Malignant		icdo:9580/3
Alveolar Soft Part Sarcoma		icdo:9581/3
Low-Grade Serous Carcinoma		icdo:8460/3
High-Grade Serous Carcinoma		icdo:8461/3
Endometrial Stromal Sarcoma		icdo:8930/3
Endometrial Stromal Sarcoma, Low Grade		icdo:8931/3
Myeloid And Lymphoid Neoplasms With Pdgfrb Re Arrangement		icdo:9966/3
Myeloid/Lymphoid Neoplasm With Pcm1-Jak2		icdo:9968/3
Lipid-Rich Carcinoma		icdo:8314/3
Glycogen-Rich Carcinoma		icdo:8315/3
Invasive Micropapillary Carcinoma		icdo:8507/3
Solid Papillary Carcinoma In Situ		icdo:8509/2
Solid Papillary Carcinoma With Invasion		icdo:8509/3
Atypical Medullary Carcinoma		icdo:8513/3
Pleomorphic Lobular Carcinoma In Situ		icdo:8519/2
Lobular Carcinoma In Situ		icdo:8520/2
Lobular Carcinoma, Nos		icdo:8520/3
Intraductal And Lobular In Situ Carcinoma		icdo:8522/2
Infiltrating Duct And Lobular Carcinoma		icdo:8522/3
Infiltr. Duct Mixed With Other Types Of Carcinoma, In Situ		icdo:8523/2
Infiltr. Duct Mixed With Other Types Of Carcinoma		icdo:8523/3
Infiltrating Lobular Mixed With Other Types Of Carc.		icdo:8524/3
Inflammatory Carcinoma		icdo:8530/3
Paget Disease, Mammary		icdo:8540/3
Paget Dis. & Infil. Duct Carcinoma		icdo:8541/3
Paget Disease And Intraductal Ca.		icdo:8543/3
Adenomyoepithelioma With Carcinoma		icdo:8983/3
Phyllodes Tumor, Malignant		icdo:9020/3
Sq. Cell Carcinoma, Keratinizing, Nos, In Situ		icdo:8071/2
Basal Cell Carcinoma, Nos		icdo:8090/3
Multifocal Superficial Basal Cell Carcinoma		icdo:8091/3
Infiltrating Basal Cell Carcinoma, Nos		icdo:8092/3
Basal Cell Carcinoma, Fibroepithelial		icdo:8093/3
Basosquamous Carcinoma		icdo:8094/3
Metatypical Carcinoma		icdo:8095/3
Basal Cell Carcinoma, Nodular		icdo:8097/3
Adenoid Basal Cell Carcinoma		icdo:8098/3
Mucinous Adenocarcinoma, Endocervical Type		icdo:8482/3
Adenocarcinoma, Hpv-Associated		icdo:8483/3
Phyllodes Tumor, Malignant (9092/3)		icdo:9092/3
Sq. Cell Carcinoma, Lg. Cell, Non-Ker., In Situ		icdo:8072/2
Adenocarcinoma, Endocervical Type		icdo:8384/3
Adenocarcinoma, Hpv-Independent, Nos		icdo:8484/3
Endometrioid Intraepithelial Neoplasia		icdo:8380/2
Endometrioid Adenofibroma, Malignant		icdo:8381/3
Endometrioid Adenocarcinoma, Secretory Variant		icdo:8382/3
Endometrioid Adenocarcinoma, Ciliated Cell Variant		icdo:8383/3
Serous Tubal Intraepithelial Carcinoma		icdo:8441/2
Mesonephric-Like Adenocarcinoma		icdo:9111/3
Clear Cell Adenocarcinofibroma		icdo:8313/3
Serous Cystadenoma, Borderline Malignancy (C56.9)		icdo:8442/1
Papillary Cystadenoma, Borderline Malignancy (C56.9)		icdo:8451/1
Non-Invasive Low Grade Serous Carcinoma		icdo:8460/2
Serous Papillary Cystic Tumor Of Borderline Malignancy (C56.9)		icdo:8462/1
Mucinous Cystic Tumor Of Borderline Malignancy (C56.9)		icdo:8472/1
Papillary Mucinous Cystadenoma, Borderline Malignancy (C56.9)		icdo:8473/1
Seromucinous Carcinoma		icdo:8474/3
Ovarian Stromal Tumor, Mal.		icdo:8590/3
Thecoma, Malignant		icdo:8600/3
Granulosa Cell Tumor, Malignant		icdo:8620/3
Granulosa Cell-Theca Cell Tumor, Mal.		icdo:8621/3
Androblastoma, Malignant		icdo:8630/3
Sertoli-Leydig Cell Tumor, Poorly Differentiated		icdo:8631/3
Gynandroblastoma, Malignant		icdo:8632/3
Sertoli-Leydig Cl Tum., P.D. W Heterologous Elements		icdo:8634/3
Steroid Cell Tumor, Malignant		icdo:8670/3
Brenner Tumor, Malignant		icdo:9000/3
Serous Adenocarcinofibroma		icdo:9014/3
Mucinous Adenocarcinofibroma		icdo:9015/3
Struma Ovarii, Malignant		icdo:9090/3
Malignant Placental Site Trophoblastic Tumor		icdo:9104/3
Warty Carcinoma		icdo:8054/3
Queyrat Erythroplasia		icdo:8080/2
Sertoli Cell Carcinoma		icdo:8640/3
Leydig Cell Tumor, Malignant		icdo:8650/3
Intratubular Malignant Germ Cells		icdo:9064/2
Malignant Teratoma, Trophoblastic		icdo:9102/3
Hereditary Leiomyomatosis And Rcc-Associated Renal Cell Carcinoma		icdo:8311/3
Renal Cell Carcinoma		icdo:8312/3
Cyst-Associated Renal Cell Carcinoma		icdo:8316/3
Renal Cell Carcinoma, Chromophobe Type		icdo:8317/3
Renal Cell Carcinoma, Sarcomatoid		icdo:8318/3
Collecting Duct Carcinoma		icdo:8319/3
Malignant Cystic Nephroma		icdo:8959/3
Nephroblastoma, Nos		icdo:8960/3
Malignant Rhabdoid Tumor		icdo:8963/3
Clear Cell Sarcoma Of Kidney		icdo:8964/3
Spindle Cell Melanoma, Type A		icdo:8773/3
Spindle Cell Melanoma, Type B		icdo:8774/3
Retinoblastoma, Nos		icdo:9510/3
Retinoblastoma, Differentiated		icdo:9511/3
Retinoblastoma, Undifferentiated		icdo:9512/3
Retinoblastoma, Diffuse		icdo:9513/3
Neoplasm, Benign		icdo:8000/0
Neoplasm, Uncertain Whether Benign Or Malignant		icdo:8000/1
Tumor Cells, Benign		icdo:8001/0
Tumor Cells, Uncertain Whether Benign Or Malignant		icdo:8001/1
Diffuse Melanocytosis		icdo:8728/0
Meningeal Melanocytoma		icdo:8728/1
Meningeal Melanomatosis		icdo:8728/3
Soft Tissue Tumor, Benign		icdo:8800/0
Fibroma, Nos		icdo:8810/0
Lipoma, Nos		icdo:8850/0
Angiolipoma, Nos		icdo:8861/0
Teratoma, Benign		icdo:9080/0
Teratoma, NOS		icdo:9080/1
Dermoid Cyst, NOS		icdo:9084/0
Cavernous Hemangioma		icdo:9121/0
Hemangiopericytoma, Benign		icdo:9150/0
Meningiomatosis, NOS		icdo:9530/1
Meningioma, Malignant		icdo:9530/3
Meningothelial Meningioma		icdo:9531/0
Fibrous Meningioma		icdo:9532/0
Psammomatous Meningioma		icdo:9533/0
Angiomatous Meningioma		icdo:9534/0
Transitional Meningioma		icdo:9537/0
Clear Cell Meningioma		icdo:9538/1
Papillary Meningioma		icdo:9538/3
Atypical Meningioma		icdo:9539/1
Meningeal Sarcomatosis		icdo:9539/3
Paraganglioma, Nos		icdo:8680/1
Solitary Fibrous Tumor/Hemangiopericytoma Grade 2		icdo:8815/1
Venous Hemangioma		icdo:9122/0
Capillary Hemangioma		icdo:9131/0
Glioma, Malignant		icdo:9380/3
Gliomatosis Cerebri		icdo:9381/3
Mixed Glioma		icdo:9382/3
Supependymal Giant Cell Astrocytoma		icdo:9384/1
Diffuse Midline Glioma, H3 K27M-Mutant		icdo:9385/3
Sellar Ependymoma		icdo:9391/1
Ependymoma, NOS		icdo:9391/3
Ependymoma, Anaplastic		icdo:9392/3
Papillary Ependymoma		icdo:9393/3
Ependymoma, Rela Fusion-Positive		icdo:9396/3
Astrocytoma, Anaplastic		icdo:9401/3
Protoplasmic Astrocytoma		icdo:9410/3
Gemistocytic Astrocytoma		icdo:9411/3
Desmoplastic Infantile Astrocytoma		icdo:9412/1
Fibrillary Astrocytoma		icdo:9420/3
Polar Spongioblastoma		icdo:9423/3
Glioblastoma, Nos		icdo:9440/3
Giant Cell Glioblastoma		icdo:9441/3
Chordoid Glioma		icdo:9444/1
Glioblastoma, Idh-Mutant		icdo:9445/3
Oligodendroglioma, Nos		icdo:9450/3
Oligodendroglioma, Anaplastic		icdo:9451/3
Medulloblastoma, Wnt-Activated		icdo:9475/3
Medulloblastoma, Shh-Activated And Tp53-Mutant		icdo:9476/3
Medulloblastoma, Non-Wnt/Non-Shh		icdo:9477/3
Embryonal Tumor With Multilayered Rosettes, Nos		icdo:9478/3
Multinodular And Vascolating Neuronal Tumor		icdo:9505/0
Ganglioglioma, Nos		icdo:9505/1
Atypical Teratoid/Rhabdoid Tumor		icdo:9508/3
Neurofibroma, Nos		icdo:9540/0
Neurofibromatosis, Nos		icdo:9540/1
Melanotic Neurofibroma		icdo:9541/0
Plexiform Neurofibroma		icdo:9550/0
Neurilemoma, Nos		icdo:9560/0
Melanotic Schwannoma		icdo:9560/1
Choroid Plexus Papilloma, NOS		icdo:9390/0
Choroid Plexus Papilloma, Malignant		icdo:9390/3
Centrol Neurocytoma		icdo:9506/1
Medulloblastoma, Nos		icdo:9470/3
Desmoplastic Medulloblastoma		icdo:9471/3
Large Cell Medulloblastoma		icdo:9474/3
Cerebellar Sarcoma, NOS		icdo:9480/3
Dysplastic Gangliocytoma Of Cerebellum (Lhermitte-Duclos)		icdo:9493/0
Multinodular And Vacuolating Neuronal Tumor		icdo:9509/0
Atypical Lipoma		icdo:8850/1
Leiomyoma, Nos		icdo:8890/0
Leiomyomatosis, NOS		icdo:8890/1
Smooth Muscle Tumor, NOS		icdo:8897/1
Hemangioendothelioma, Benign		icdo:9130/0
Follicular Adenocarcinoma, NOS		icdo:8330/3
Follicular Adenocarcinoma Well Diff.		icdo:8331/3
Follicular Adenocarcinoma Trabecular		icdo:8332/3
Follicular Carcinoma, Minimally Invasive		icdo:8335/3
Insular Carcinoma		icdo:8337/3
Follicular Thyroid Carcinoma (Ftc), Encapsulated Angioinvasive		icdo:8339/3
Papillary Carcinoma, Follicular Variant		icdo:8340/3
Papillary Microcarcinoma		icdo:8341/3
Papillary Carcinoma, Oxyphilic Cell		icdo:8342/3
Non-Invasive Efvptc		icdo:8343/2
Papillary Carcinoma, Encapsulated		icdo:8343/3
Papillary Carcinoma, Columnar Cell		icdo:8344/3
Medullary Carcinoma With Amyloid Stroma		icdo:8345/3
Mixed Medullary-Follicular Carcinoma		icdo:8346/3
Mixed Medullary-Papillary Carcinoma		icdo:8347/3
Nonencapsulated Sclerosing Carcinoma		icdo:8350/3
Adrenal Cortical Carcinoma		icdo:8370/3
Water-Clear Cell Adenocarcinoma		icdo:8322/3
Clear Cell Tumor, NOS		icdo:8005/0
Epithelial Tumor, Benign		icdo:8010/0
Monomorphic Adenoma		icdo:8146/0
Papillary Adenoma, NOS		icdo:8260/0
Chromophobe Adenoma		icdo:8270/0
Chromophobe Carcinoma		icdo:8270/3
Pituitary Adenoma, NOS		icdo:8272/0
Pituitary Carcinoma, NOS		icdo:8272/3
Pituitary Blastoma		icdo:8273/3
Acidophil Adenoma		icdo:8280/0
Acidophil Carcinoma		icdo:8280/3
Mixed Acidophil-Basophil Adenoma		icdo:8281/0
Mixed Acidophil-Basophil Carcinoma		icdo:8281/3
Oxyphilic Adenoma		icdo:8290/0
Basophil Adenoma		icdo:8300/0
Basophil Carcinoma		icdo:8300/3
Clear Cell Adenoma		icdo:8310/0
Mixed Cell Adenoma		icdo:8323/0
Granular Cell Tumor, NOS		icdo:9580/0
Granular Cell Tumor Of The Sellar Region		icdo:9582/0
Pinealoma, NOS		icdo:9360/1
Pineoblastoma		icdo:9362/3
Papillary Tumor Of Pineal Region		icdo:9395/3
Parasympathetic Paraganglioma		icdo:8682/3
Middle Ear Paraganglioma		icdo:8690/3
Aortic Body Tumor, Malignant		icdo:8691/3
Carotid Body Tumor, Malignant		icdo:8692/3

DiseasePhaseEnum

Permissible Value	Description	Meaning
Initial Diagnosis	(gct) ConsortiumNote: Disease phase could be 'Initial Diagnosis' phase, 'Relapse' phase, etc... (hl) ConsortiumNote: Disease phase could be 'Initial Diagnosis' phase, a 'Relapse' phase, etc...	ncit:C156813
Post-Mortem		ncit:C94193
Predisposed Disease Surveillance
Progression		ncit:C17747
Refractory		ncit:C38014
Refractory/Progression		ncit:C174991
Relapse		ncit:C38155
Relapse/Progression		ncit:C174991
Relapse/Refractory		ncit:C203382
Off Therapy

DiseaseSiteEnum

Permissible Value	Description	Meaning
Abdomen		ncit:C12664
Abdominal Peritoneum		ncit:C159355
Abdominal Skin		ncit:C52758
Abdominal Wall		ncit:C28256
Acetabulum		ncit:C32042
Adjacent Organ		ncit:C180347
Adrenal Gland		ncit:C12666
Adrenal Cortex
Adrenal medulla
Ampulla		ncit:C93230
Anal/Perianal		ncit:C99148
Anastomosis
Ankle		ncit:C32078
Ankle Joint		ncit:C32078
Anterior Skull Base		ncit:C180372
Anus		ncit:C43362
Appendiceal Orifice
Appendix		ncit:C12380
Arm Skin		ncit:C52754
Ascending
Ascitic Fluid		ncit:C159203
Axilla		ncit:C12674
Axilla or Pectoral
Axillary Nodes		ncit:C12904
Basal Ganglia-Thalamus		ncit:C158080
Basin		ncit:C12439
Bile duct
Bladder		ncit:C12414
Bladder/Prostate		ncit:C12410
Bone Face		ncit:C63706
Bone Foot		ncit:C13068
Bone Marrow		ncit:C12431
Bone Shoulder Girdle		ncit:C33547
Bone or Bone Marrow		ncit:C12431
Bone, NOS		ncit:C12366
Brain		ncit:C12439
Brain/Leptomeninges		ncit:C32979
Breast		ncit:C12971
Bronchus		ncit:C12683
Buccal Mucosa		ncit:C12505
Buttock		ncit:C89806
Calcaneum		ncit:C32250
Carpal Bone		ncit:C12688
Carpus
Cauda Equina Spinal Cord		ncit:C12689
Cecum
Celiac Nodes		ncit:C65166
Central Nervous System		ncit:C12438
Cerebellum		ncit:C12445
Cerebrospinal Fluid		ncit:C12692
Cervical Nodes		ncit:C32298
Cervical Spine		ncit:C69313
Cervical Vertebra		ncit:C12415
Cervix		ncit:C12311
Cervix Lymph Node		ncit:C32622
Cervix Uteri
Cheek		ncit:C13070
Chest		ncit:C25389
Chest Wall		ncit:C62484
Choroid
Clavicle		ncit:C24203
Coccyx		ncit:C12696
Colon		ncit:C12382
Corpus Callosum		ncit:C12446
Cranium		ncit:C12697
Cutaneous		ncit:C13316
Dermis		ncit:C12701
Descending
Distal Cholangiocarcinoma		ncit:C7976
Distal Esophagus
Distant Lymph Nodes		ncit:C12745
Dorsal Spine		ncit:C32472
Dorsal Vertebra		ncit:C12693
Duodenal Bulb (D1)
Duodenum		ncit:C12263
Ear Skin		ncit:C49481
Elbow		ncit:C32497
Elbow Joint		ncit:C32497
Endometrium
Epididymis		ncit:C12328
Epitrochlear Nodes		ncit:C98182
Esophagus		ncit:C12389
Esophagus, NOS
Ethmoid Bone		ncit:C12711
Extra CNS
Extrahepatic		ncit:C28358
Eye
Eye, Anterior Chamber		ncit:C12667
Eye, Choroid		ncit:C12344
Eye, Intra-Retinal
Eye, Schlemm's Canal		ncit:C32256
Eye, Stroma of Iris		ncit:C199652
Eye, Trabecular Meshwork		ncit:C12803
Eyelid		ncit:C12713
Face		ncit:C13071
Facial Region		ncit:C13071
Fallopian Tube		ncit:C12403
Female Reproductive System Part		ncit:C13039
Femur		ncit:C12717
Fibula		ncit:C12718
Fibular Head		ncit:C32719
Finger		ncit:C32608
Foot		ncit:C32622
Foot Bone		ncit:C32622
Foot Joint		ncit:C32623
Foot Phalanges		ncit:C52772
Forearm		ncit:C32628
Fourth Portion of Duodenum (D4)
Fourth Ventricle		ncit:C12828
Frontal Bone		ncit:C32635
Frontal Cortex		ncit:C12352
Frontal Lobe		ncit:C12352
GE Junction
Gallbladder		ncit:C12377
Gastric Antrum
Gastric Body
Gastric Cardia
Gastric Fundus
Gastric, NOS
Gastrointestinal Tract		ncit:C34082
Gingiva, Lower, Anterior		ncit:C32677
Gingiva, Lower, Posterior		ncit:C32677
Gingiva, NOS		ncit:C32677
Gingiva, Upper, Anterior		ncit:C32677
Gingiva, Upper, Posterior		ncit:C32677
Glottis		ncit:C12724
Groin		ncit:C12726
Hand		ncit:C32712
Hand Bone		ncit:C52771
Hand Joint		ncit:C32868
Hand Phalanges		ncit:C12418
Hand Skin		ncit:C52753
Head		ncit:C12419
Head and Neck
Heart		ncit:C12727
Hepatic flexure
Hilar Cholangiocarcinoma		ncit:C36077
Hilar Nodes		ncit:C134731
Hilum
Hip		ncit:C64193
Hip/Inguinal Region		ncit:C12726
Humerus		ncit:C12731
Hypodermis		ncit:C92441
Hypopharynx		ncit:C12246
Ileocecal Valve
Ileum
Iliac
Iliac Crest		ncit:C32765
Ilium		ncit:C32765
Inferior Limb		ncit:C12982
Infraclavicular Lymph Node		ncit:C63705
Infraclavicular Nodes		ncit:C63705
Infratemporal Fossa/Pterygopalatine
Infratemporal Fossa/Pterygopalatine and Parapharyngeal Area
Inguinal Nodes		ncit:C32801
Inguinal or Femoral Nodes		ncit:C32801
Intestine		ncit:C12736
Intra-Abdominal		ncit:C12726
Intrahepatic Cholangiocarcinoma		ncit:C35417
Intraperitoneal		ncit:C13352
Intrathoracic		ncit:C105579
Intraspinal		ncit:C96908
Ischium		ncit:C32884
Jaw, NOS		ncit:C26470
Jejunum
Joint, NOS
Kidney		ncit:C12415
Knee		ncit:C32898
Knee Joint		ncit:C32899
Lacrimal Bone		ncit:C32906
Larynx		ncit:C12420
Lateral Ventricle		ncit:C12834
Leg		ncit:C32974
Leg Skin		ncit:C52749
Leptomeningeal		ncit:C32979
Ligament of Treitz
Lip		ncit:C12220
Liver		ncit:C12392
Liver/Biliary Tract		ncit:C12678
Lower Arm
Lower Extremity		ncit:C12742
Lower Leg
Lower Limb, NOS		ncit:C12742
Lower Spine		ncit:C69314
Lumbar Spinal Cord		ncit:C12895
Lumbar Spine		ncit:C69314
Lumbar Vertebra		ncit:C45874
Lung		ncit:C12468
Lung/Pleura		ncit:C12469
Lymph Node		ncit:C12745
Lymphatic Basin		ncit:C94547
Mandible		ncit:C12290
Maxilla		ncit:C26470
Mediastinal Lymph Node		ncit:C32628
Mediastinum		ncit:C6634
Medulla		ncit:C12442
Meninges		ncit:C12348
Mesenteric Nodes		ncit:C77641
Metacarpals		ncit:C12751
Metacarpus		ncit:C12751
Metatarsals		ncit:C12752
Metatarsus		ncit:C12752
Mid Esophagus
Midbrain		ncit:C12510
Middle Ear		ncit:C12274
Muscle
Nasal Bone		ncit:C33157
Nasal Cavity		ncit:C12424
Nasal Cavity and Paranasal Sinuses		ncit:C12763
Nasal Septum		ncit:C33160
Nasopharynx		ncit:C12423
Neck		ncit:C13063
Neck Skin		ncit:C52756
Occipital Bone		ncit:C12757
Occipital Cortex		ncit:C32250
Occipital Lobe		ncit:C12355
Omentum		ncit:C12692
Omentum Lymph Node		ncit:C177766
Omentum/Peritoneum		ncit:C33209
Optic Chiasm		ncit:C90609
Optic Nerve		ncit:C12761
Optic Nerve Head, Intra-Laminar
Optic Nerve Head, Pre-Laminar
Oral Cavity		ncit:C12421
Orbit		ncit:C12347
Oropharynx		ncit:C12762
Other Extremity
Other Face
Other GU Non-Bladder/Prostate
Other Head and Neck
Other Orbit
Other Parameningeal
Ovarian		ncit:C28047
Ovary		ncit:C12404
Palate		ncit:C12229
Pancreas		ncit:C12393
Pancreas Body
Pancreas Head
Pancreas Tail
Paraaortic Lymph Node		ncit:C77643
Paraganglia
Paranasal Sinuses		ncit:C12763
Parapharyngeal Area		ncit:C162818
Paraspinal		ncit:C129461
Paratesticular		ncit:C162491
Parathyroid
Parietal Bone		ncit:C12766
Parietal Cortex		ncit:C12354
Parietal Lobe		ncit:C12354
Parotid		ncit:C12427
Patella		ncit:C33282
Pectoral Nodes		ncit:C120322
Pelvic Lymph Node		ncit:C32712
Pelvis, Ilium		ncit:C32765
Pelvis, Ischium		ncit:C32884
Pelvis, NOS		ncit:C12767
Pelvis, Pubis
Pelvis, Sacrum		ncit:C33508
Penis		ncit:C12409
Perineum		ncit:C33301
Peritoneum	(ews) ConsortiumNote: Included so that peritoneal effusions can be reported.	ncit:C12770
Phalanges
Pharynx		ncit:C12425
Pineal		ncit:C12398
Pituitary gland
Pleura	(ews) ConsortiumNote: Included so that pleural effusions can be reported. (os) ConsortiumNote: Included so that pleural effusions can be reported.	ncit:C12469
Pleural Effusion		ncit:C3331
Pons		ncit:C12511
Popliteal Nodes		ncit:C53146
Pouch
Preauricular Lymph Node		ncit:C103429
Primary Peritoneal		ncit:C40022
Prostate		ncit:C12410
Proximal Esophagus
Pyriform Sinus		ncit:C33439
Radius		ncit:C12777
Radius Bone		ncit:C12777
Rectosigmoid
Rectum		ncit:C12390
Regional Lymph Nodes
Retina
Retroperitoneum		ncit:C12298
Retroperitoneum Lymph Node		ncit:C12418
Rib		ncit:C12782
Sacral Region		ncit:C33508
Sacrococcygeal		ncit:C33506
Salivary Gland		ncit:C12426
Sacrum		ncit:C33508
Scalp		ncit:C89807
Scapula		ncit:C12744
Second Portion of Duodenum (D2)
Shoulder		ncit:C12783
Shoulder Girdle		ncit:C33547
Shoulder Joint		ncit:C33548
Sigmoid
Skin		ncit:C12470
Skin of the Back		ncit:C142318
Skin of the Chest		ncit:C161379
Skin of the Face		ncit:C33561
Skin of the Lip		ncit:C12291
Skin of the Upper Limb and Shoulder		ncit:C12296
Skin, NOS		ncit:C12470
Skull, NOS		ncit:C12789
Small Intestine		ncit:C12386
Soft Tissue		ncit:C12471
Sphenoid Bone		ncit:C12790
Spinal Cord		ncit:C12464
Spine		ncit:C12998
Spleen		ncit:C12432
Splenic Hilar Nodes		ncit:C33600
Splenic flexure
Sternum		ncit:C62484
Stoma
Stomach		ncit:C12391
Stroma of Iris
Submandibular		ncit:C129462
Superior Maxilla		ncit:C33682
Supraclavicular Lymph Node		ncit:C12903
Supraclavicular Nodes		ncit:C12903
Suprasellar Pituitary		ncit:C95445
Suprasellar/Neurohypophyseal		ncit:C42602
Talus		ncit:C52799
Tarsal Bone		ncit:C12796
Tarsals		ncit:C12796
Temporal Bone		ncit:C12797
Temporal Cortex		ncit:C12353
Temporal Lobe		ncit:C12353
Testis		ncit:C12412
Thalamus		ncit:C12459
Thigh		ncit:C33763
Third Portion of Duodenum (D3)
Third Ventricle		ncit:C12827
Thoracic Spinal Cord		ncit:C12894
Thoracic Vertebra		ncit:C12798
Thorax		ncit:C12799
Thymus		ncit:C12433
Thyroid		ncit:C12400
Tibia		ncit:C12800
Toe		ncit:C33788
Tongue		ncit:C12422
Tonsil		ncit:C12802
Trachea		ncit:C12428
Transverse
Transverse Colon		ncit:C12385
Trabecular Meshwork
Trunk		ncit:C33816
Ulna		ncit:C12809
Unknown Primary
Upper Airway		ncit:C33839
Upper Arm		ncit:C32141
Upper Extremity		ncit:C12671
Upper Limb, NOS		ncit:C12671
Ureter		ncit:C12416
Urethra
Urinary bladder
Urogenital		ncit:C25350
Uterus		ncit:C12405
Vagina		ncit:C12407
Vasculo-Nervous		ncit:C74603
Viscera		ncit:C28287
Vulva		ncit:C12408
Waldeyer's Ring		ncit:C73468
Wrist		ncit:C33894
Wrist Joint		ncit:C33895
Zygomatic Bone		ncit:C33897
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

DnaIndexEnum

Permissible Value	Description	Meaning
DNA Index </= 1 (Hypodiploid, Diploid)
DNA Index >1 (Hyperdiploid)
Dna Index </= 1 (Hypodiploid, Diploid)
Dna Index >1 (Hyperdiploid)
Unknown		ncit:C17998
Not Reported		ncit:C43234

DonorRelationshipEnum

Permissible Value	Description	Meaning
Biological Parent		ncit:C166114
Biological Relative		ncit:C71384
Biological Sibling		ncit:C100809
Biologically Unrelated		ncit:C130053
Unknown		ncit:C17998
Not Reported		ncit:C43234

EthnicitySpecifiedEnum

Permissible Value	Description	Meaning
Not Specified
Spanish/Spaniard
Argentinean/Argentine
Bolivian
Central American Indian
Chilean
Colombian
Costa Rican
Cuban
Ecuadorian
Guatemalan
Honduran
Mexican
Mexican American Indian
Nicaraguan
Panamanian
Paraguayan
Peruvian
Puerto Rican
Salvadoran
South American Indian
Uruguayan
Venezuelan
Other

EvaluatorEnum

Permissible Value	Description	Meaning
Clinical Non-Pediatrician (General Practitioner, Optometrist)		ncit:C132424
Ophthalmologist		ncit:C17822
Pediatrician		ncit:C83190
Unknown		ncit:C17998
Not Reported		ncit:C43234

ExtentEnum

Permissible Value	Description	Meaning
Biopsy Only		ncit:C15189
Complete Resection		ncit:C175027
Equivocal		ncit:C178921
Gross Total		ncit:C131672
Gross Total or Near Total Resection
Near Total Resection
Partial Resection		ncit:C131680
Partial or Subtotal Resection
Subtotal Resection		ncit:C131680
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

FertilityConsultOutcomeEnum

Permissible Value	Description	Meaning
Sperm Cryopreservation
Oocyte Or Embryo Cryopreservation
Testicular Tissue Cryopreservation
Ovarian Tissue Cryopreservation
Declined Fertility Preservation Consult
No Fertility Preservation Available
No Fertility Preservation Indicated
Unknown
Not Reported

FertilityProcedureEnum

Permissible Value	Description	Meaning
Cryopreserved Ovarian Tissue Reimplantation
Cryopreserved Testicular Cell Reimplantation
Cryopreserved Testicular Tissue Reimplantation
Embryo Cryopreservation
Epidydimal Sperm Aspiration
Oocyte Cryopreservation
Oocyte Retrieval from Transplanted Ovarian Tissue
Oophoropexy
OTC, Cortical Strip
OTC, Oophorectomy
OTC, Partial Oophorectomy
Semen Collection
Sperm Retrieval from Transplanted Testicular Cells
Sperm Retrieval from Transplanted Testicular Tissue
Testicular Sperm Aspiration
Testicular Sperm Extraction, Micro TESE
Testicular Sperm Extraction, TESE
Testicular Tissue Cryopreservation, Orchiectomy
Testicular Tissue Cryopreservation, Partial Orchiectomy/Biopsy

FindingEnum

Permissible Value	Description	Meaning
Anterior Segment Tumor
Aseptic Orbital Cellulitis
Blunting Atrophy
Buphthalmia
Cataract		ncit:C26713
Decreased Vision
Diverticulosis
Duodenitis
Excavated (III) Polyp
Extranodal Tumor Deposit
Flat (IIb) Polyp
Gastric Atrophy
Gastric Ulcer(s)
Gastritis / Inflammation/ Erythema/ Edema
Gastropathy
Glaucoma		ncit:C26782
Heterochromia
Hyphema		ncit:C50592
Hypopyon		ncit:C50593
Invasion of Ciliary Body
Jejunitis
Leukocoria
Lymphatic Vascular Invasion
Macroscopic Tumor Perforation
None		ncit:C41132
Opaque Media
Orbital Cellulitis		ncit:C99000
Pedunculated (Ip) Polyp
Perineural Invasion
Photoleukocoria
Proptosis		ncit:C87114
Rubeosis
Semi-Pedunculated (Isp) Polyp
Sessile (Is) Polyp
Slightly Depressed (IIc) Polyp
Slightly Elevated (IIa) Polyp
Small Bowel Ulcer(s)
Strabismus		ncit:C35040
Tumor in Anterior Chamber
Uveitis		ncit:C26909
Visual Ampulla
Visualized Mucosa
Vitreous Hemorrhage		ncit:C50469
Unknown		ncit:C17998
Not Reported		ncit:C43234

FounderPopulationEnum

Permissible Value	Description	Meaning
Ammish/Mennonite/Hutterite
Brazilian
Dutch
French Canadian
Gypsy
Indian
Jewish (Ashkenazi)
Mixe
South Asian
South African
Other
Unknown
Not Reported

FrequencyEnum

Permissible Value	Description	Meaning
As needed
Before every meal
Before meals and at bedtime
Every 2 weeks
Every 3 months
Every 4 weeks
Every 6 months
Every 6 weeks
Every 8 weeks
Every night at bedtime
Every other day
Every week
Four times a day
Once
Once per day
Three times a day
Two times a day

FunctionTestEnum

Permissible Value	Description	Meaning
Audiogram, NOS		ncit:C92448
Cochlear, OEAP
Cochlear, PEAP
EKG		ncit:C168186
Echocardiogram		ncit:C16525
Intraocular Pressure
Pulmonary Function Test		ncit:C38081
Vestibular, VHIT
Vestibular, cVEMP
Visual Acuity		ncit:C87149
Visual Evoked Potentials		ncit:C191332

FunctionTestGradeEnum

Permissible Value	Description	Meaning
Chang >> Grade 0
Chang >> Grade 1a
Chang >> Grade 1b
Chang >> Grade 2a
Chang >> Grade 2b
Chang >> Grade 3
Chang >> Grade 4
SIOP Boston >> Grade 0
SIOP Boston >> Grade 1
SIOP Boston >> Grade 2
SIOP Boston >> Grade 3
SIOP Boston >> Grade 4
Unknown		ncit:C17998
Not Reported		ncit:C43234

FunctionalMeasurementTypeEnum

Permissible Value	Description	Meaning
Allen Picture Card
Cardiff Acuity Card
DLCO		ncit:C38083
Ejection Fraction		ncit:C99524
FEF at 25-75%		ncit:C119546
FEV1		ncit:C38084
FVC		ncit:C111361
HOTV Test
Landolt C
Lea Numbers
Lea Symbols
LogMAR Chart
QTc		ncit:C100391
Shortening Fraction		ncit:C38020
Snellen Chart
Teller Acuity Card
Total Lung Capacity		ncit:C111325
Tumbling E
Visual Evoked Potentials (VEP)

GenderIdentityEnum

Permissible Value	Description	Meaning
Asked But Declined
Female-to-male transsexual		SCTID:407377005
Identifies As Female Gender		SCTID:446141000124107
Identifies As Male Gender		SCTID:446151000124109
Identifies As Nonbinary Gender		SCTID:33791000087105
Male-To-Female Transsexual		SCTID:407377005
Male-To-Female Transgender		SCTID: 33791000087105
Female-To-Male Transgender		SCTID: 407377005
Transgender, NOS
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported

GeneticAnalysisMethodEnum

Permissible Value	Description	Meaning
Cytogenetics, FISH		ncit:C17563
Cytogenetics, Karyotyping		ncit:C25215
Cytogenetics, Microarray, SNP Array		ncit:C116151
Cytogenetics, Microarray, aCGH		ncit:C18084
Cytogenetics, NOS		ncit:C16487
DNA Methylation, Array		ncit:C165222
DNA Methylation, NOS		ncit:C16848
Expression Profiling, Nanostring
Genotyping, NOS		ncit:C45447
PCR, MLPA		ncit:C116161
PCR, NOS		ncit:C17003
PCR, RT-PCR		ncit:C18136
Sequencing, NGS, ATAC-seq		ncit:C156056
Sequencing, NGS, Long-Read, Nanopore		ncit:C146818
Sequencing, NGS, Long-Read, SMRT		ncit:C146819
Sequencing, NGS, NOS		ncit:C101293
Sequencing, NGS, RNA-seq		ncit:C124261
Sequencing, NGS, Single Cell RNA-seq		ncit:C171152
Sequencing, NGS, Single Gene (DNA)
Sequencing, NGS, Single Site (Hotspot)
Sequencing, NGS, Targeted DNA Panel		ncit:C158253
Sequencing, NGS, Targeted RNA Panel		ncit:C158252
Sequencing, NGS, Total RNA		ncit:C124261
Sequencing, NGS, Whole Exome		ncit:C101295
Sequencing, NGS, Whole Genome		ncit:C101294
Sequencing, Sanger, Capillary Electrophoresis
Sequencing, Sanger, Gel Electrophoresis
Sequencing, Sanger, NOS
Western Blot		ncit:C16357
Unknown		ncit:C17998
Not Reported		ncit:C43234

GeneticAnalysisSpecimenEnum

Permissible Value	Description	Meaning
Aqueous		ncit:C28273
Blood		ncit:C17610
Bone Marrow		ncit:C12431
Buccal Swab		ncit:C113747
Buffy Coat		ncit:C84507
Cerebrospinal Fluid		ncit:C12692
Chorionic Villus Sampling		ncit:C92755
Cord Blood
Fetal Amniocytes
Hair
Lymph Node		ncit:C12745
Lymphoblastoid Cell Line
Nails
Peripheral Blood Lymphocytes
Potentially Malignant Lesion
Fibroblast		ncit:C12482
Saliva	(pre) ConsortiumNote: Map to Buccal Swab/Saliva	ncit:C174119
Tissue (Non-Neoplastic)
Primary Tumor		ncit:C8509
Metastatic Tumor		ncit:C3261
Unknown		ncit:C17998
Not Reported		ncit:C43234

GroupEnum

Permissible Value	Description	Meaning
ICRB >> Group A	(rb) ConsortiumNote: GROUP_SYSTEM = 'ICRB' or 'IIRC'
ICRB >> Group B	(rb) ConsortiumNote: GROUP_SYSTEM = 'ICRB' or 'IIRC'
ICRB >> Group C	(rb) ConsortiumNote: GROUP_SYSTEM = 'ICRB' or 'IIRC'
ICRB >> Group D	(rb) ConsortiumNote: GROUP_SYSTEM = 'ICRB' or 'IIRC'
ICRB >> Group E	(rb) ConsortiumNote: GROUP_SYSTEM = 'ICRB' or 'IIRC'
IIRC >> Group A	(rb) ConsortiumNote: GROUP_SYSTEM = 'ICRB' or 'IIRC'
IIRC >> Group B	(rb) ConsortiumNote: GROUP_SYSTEM = 'ICRB' or 'IIRC'
IIRC >> Group C	(rb) ConsortiumNote: GROUP_SYSTEM = 'ICRB' or 'IIRC'
IIRC >> Group D	(rb) ConsortiumNote: GROUP_SYSTEM = 'ICRB' or 'IIRC'
IIRC >> Group E	(rb) ConsortiumNote: GROUP_SYSTEM = 'ICRB' or 'IIRC'
IRS >> Group I	(rms) ConsortiumNote: Tied to AGE_AT_STAGING.
IRS >> Group II NOS
IRS >> Group IIA
IRS >> Group IIB
IRS >> Group IIC
IRS >> Group III
IRS >> Group IV
IRS >> Stage 1
IRS >> Stage 2
IRS >> Stage 3
IRS >> Stage 4
Reese-Ellsworth >> Group 1A	(rb) ConsortiumNote: GROUP_SYSTEM = 'Reese Ellsworth'
Reese-Ellsworth >> Group 1B	(rb) ConsortiumNote: GROUP_SYSTEM = 'Reese Ellsworth'
Reese-Ellsworth >> Group 2A	(rb) ConsortiumNote: GROUP_SYSTEM = 'Reese Ellsworth'
Reese-Ellsworth >> Group 2B	(rb) ConsortiumNote: GROUP_SYSTEM = 'Reese Ellsworth'
Reese-Ellsworth >> Group 3A	(rb) ConsortiumNote: GROUP_SYSTEM = 'Reese Ellsworth'
Reese-Ellsworth >> Group 3B	(rb) ConsortiumNote: GROUP_SYSTEM = 'Reese Ellsworth'
Reese-Ellsworth >> Group 4A	(rb) ConsortiumNote: GROUP_SYSTEM = 'Reese Ellsworth'
Reese-Ellsworth >> Group 4B	(rb) ConsortiumNote: GROUP_SYSTEM = 'Reese Ellsworth'
Reese-Ellsworth >> Group 5A	(rb) ConsortiumNote: GROUP_SYSTEM = 'Reese Ellsworth'
Reese-Ellsworth >> Group 5B	(rb) ConsortiumNote: GROUP_SYSTEM = 'Reese Ellsworth'
Unknown		ncit:C17998
Not Reported		ncit:C43234

GroupSystemEnum

Permissible Value	Description	Meaning
ICRB		ncit:C189851
IIRC		ncit:C189851
Intergroup Rhabdomyosarcoma Study Group Clinical Staging and Grouping System		ncit:C148010
Reese-Ellsworth		ncit:C123333
Unknown		ncit:C17998
Not Reported		ncit:C43234

GvhdOrganEnum

Permissible Value	Description	Meaning
Gastrointestinal Tract		ncit:C34082
Liver		ncit:C12392
Lung		ncit:C12468
Muscles and Joints		ncit:C12463
Nails
Oral Mucosa
Scalp and Body Hair
Skin		ncit:C12470
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

HistologicFeaturesEnum

Permissible Value	Description	Meaning
Apoptosis		ncit:C17557
Fleurette
Flexner-Wintersteiner Rosette
Full Thickness Sclera, into the outer third		ncit:C76132
Homer-Wright Rosette
Increased Cell Mitotic Activity		ncit:C163732
Involvement of Adipose Tissue		ncit:C12472
Involvement of Anterior Chamber		ncit:C12667
Involvement of Bone		ncit:C8288
Involvement of Ciliary Body		ncit:C12345
Involvement of Conjunctiva		ncit:C12341
Involvement of Emissary Channels		ncit:C112364
Involvement of Episclera		ncit:C12989
Involvement of Extraocular Muscle		ncit:C33199
Involvement of Iris		ncit:C25548
Involvement of Meningeal Spaces around Optic Nerve		ncit:C33094
Involvement of Optic Nerve Cut End		ncit:C6769
Involvement of Optic Nerve Head, Intra-Laminar		ncit:C12761
Involvement of Optic Nerve Head, Posterior-Laminar		ncit:C12761
Involvement of Optic Nerve Head, Pre-Laminar		ncit:C12761
Involvement of Orbit		ncit:C12347
Involvement of Peripapillary Choroid		ncit:C4562
Involvement of Schlemm's Canal		ncit:C32256
Involvement of Trabecular Meshwork		ncit:C12803
Invovement of Eyelids		ncit:C32679
Massive Choroidal Extension, full thickness into the outer third		ncit:C76132
Massive Choroidal Extension, multiple foci more than 3mm		ncit:C121127
Massive Choroidal Extension, one focus more than 3mm		ncit:C115811
Necrosis		ncit:C112114
Nuclear Moulding		ncit:C13361
Partial Thickness Sclera, within the inner two-thirds		ncit:C201274
Pseudo-Rosettes		ncit:C186534
Teratoid Feature, Melanin-producing
Teratoid Feature, Neuroendocrine
Teratoid Feature, Neuroepithelial
Teratoid Feature, Other e.g., Yolk sac tumor-like
With Lymphoid Infiltration
Without Lymphoid Infiltration
Unknown		ncit:C17998
Not Reported		ncit:C43234

HistologyGradeEnum

Permissible Value	Description	Meaning
FNCLCC >> Grade 1
FNCLCC >> Grade 2
FNCLCC >> Grade 3
FNCLCC >> Grade GX
Gleason >> Grade Group 1
Gleason >> Grade Group 2
Gleason >> Grade Group 3
Gleason >> Grade Group 4
Gleason >> Grade Group 5
INPC >> Differentiating
INPC >> Undifferentiated or Poorly Differentiated
Norris Immature Teratoma Grading System >> Grade 1	(gct) ConsortiumNote: Only associated with Immature Teratoma.	ncit:C28077
Norris Immature Teratoma Grading System >> Grade 2		ncit:C28078
Norris Immature Teratoma Grading System >> Grade 3		ncit:C28079
System NOS >> Grade 1		ncit:C41338
System NOS >> Grade 2		ncit:C41339
System NOS >> Grade 3		ncit:C41340
System NOS >> Well Differentiated		ncit:C28077
System NOS >> Moderately Differentiated		ncit:C28078
System NOS >> Poorly Differentiated		ncit:C28079
WHO CNS >> Grade 1	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Low-Grade Glioma'	ncit:C62394
WHO CNS >> Grade 2	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'Low-Grade Glioma'	ncit:C62395
WHO CNS >> Grade 3	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C62396
WHO CNS >> Grade 4	(cns) ConsortiumNote: DIAGNOSIS_CATEGORY = 'High-Grade Glioma'	ncit:C62397
WHO Glioma >> Grade I
WHO Glioma >> Grade II
WHO Glioma >> Grade III
WHO Glioma >> Grade IV
Unknown		ncit:C17998
Not Reported	(nbl) ConsortiumNote: Use for 'Cannot be determined'	ncit:C43234

HlaAResultEnum

Permissible Value	Description	Meaning
Both Alleles Matched		ncit:C168821
One Allele Mismatched		ncit:C168819
Two Alleles Mismatched		ncit:C168820
Unknown		ncit:C17998
Not Reported		ncit:C43234

HlaBResultEnum

Permissible Value	Description	Meaning
Both Alleles Matched		ncit:C168821
One Allele Mismatched		ncit:C168819
Two Alleles Mismatched		ncit:C168820
Unknown		ncit:C17998
Not Reported		ncit:C43234

HlaCResultEnum

Permissible Value	Description	Meaning
Both Alleles Matched		ncit:C168821
One Allele Mismatched		ncit:C168819
Two Alleles Mismatched		ncit:C168820
Unknown		ncit:C17998
Not Reported		ncit:C43234

HlaDqResultEnum

Permissible Value	Description	Meaning
Both Alleles Matched		ncit:C168821
One Allele Mismatched		ncit:C168819
Two Alleles Mismatched		ncit:C168820
Unknown		ncit:C17998
Not Reported		ncit:C43234

HlaDrb1ResultEnum

Permissible Value	Description	Meaning
Both Alleles Matched		ncit:C168821
One Allele Mismatched		ncit:C168819
Two Alleles Mismatched		ncit:C168820
Unknown		ncit:C17998
Not Reported		ncit:C43234

HospitalizationReasonEnum

Permissible Value	Description	Meaning
Fever		ncit:C3038
Neutropenia		ncit:C80520
Platelets Transfusion		ncit:C15366
Positive Blood Culture		ncit:C122437
Red Blood Cells Transfusion		ncit:C15409
Transfusion		ncit:C15192
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

IndicationEnum

Permissible Value	Description	Meaning
Adjuvant for extrascleral disease
Adjuvant for positive margin
Consolidation of completely responding metastases
Consolidation of inadequately responding metastases
Definitive
Incidental Exposure	(rb) ConsortiumNote: If the patient has existing Brachytherapy observations
Salvage
Unknown		ncit:C17998
Not Reported		ncit:C43234

InfectionClassificationEnum

Permissible Value	Description	Meaning
Clinically Documented		ncit:C178092
Microbiologically Documented Non-Sterile Site		ncit:C178093
Microbiologically Documented Sterile Site		ncit:C178094

InitialTreatmentCategoryEnum

Permissible Value	Description	Meaning
Conventional-dose chemotherapy (2-8 cycles) plus surgery
Intensive multi-modality therapy: no stem cell or bone marrow transplant
Intensive multi-modality therapy: plus stem cell or bone marrow transplant
Intensive multi-modality therapy: plus stem cell or bone marrow transplant and anti-GD2 antibody
Intensive multi-modality therapy: specific type unknown
None (observation)
Surgery alone
Unknown

IntraopAdjuvantEnum

Permissible Value	Description	Meaning
Indocyanine Green (ICG) Fluorescence Angiography
Methylene Blue Dye Marking
Navigation and Robotics
Wire Localization
Other
Not Reported		ncit:C43234

KaryotypeStatusEnum

Permissible Value	Description	Meaning
Abnormal		ncit:C168875
Abnormal Karyotype		ncit:C168875
Complex		ncit:C97138
Normal		ncit:C173277
Normal Karyotype		ncit:C173277
Unknown		ncit:C17998
Not Reported		ncit:C43234

LaboratoryTestEnum

Permissible Value	Description	Meaning
AFP		ncit:C21577
ALC		ncit:C113237
ALP		ncit:C64432
ALT	(fa) ConsortiumNote: Liver Function Test	ncit:C64433
ANA		ncit:C176313
ANC		ncit:C63321
AQP4 Ab
AST	(fa) ConsortiumNote: Liver Function Test	ncit:C64467
Absolute B Lymphocyte Count	(fa) ConsortiumNote: METHOD = 'Flow Cytometry'	ncit:C201188
Absolute Basophil Count	(fa) ConsortiumNote: CBC	ncit:C64470
Absolute Blood Lymphocyte Count	(fa) ConsortiumNote: CBC	ncit:C113237
Absolute Eosinophil Count	(fa) ConsortiumNote: CBC	ncit:C188680
Absolute Monocyte Count	(fa) ConsortiumNote: CBC	ncit:C181278
Absolute Neutrophil Count (ANC)		ncit:C63321
Albumin		ncit:C64431
Alkaline Phophatase	(fa) ConsortiumNote: Liver Function Test	ncit:C64432
Angiotension Converting Enzyme		ncit:C80169
Anti-Mullerian Hormone (AMH)		ncit:C120625
Antral Follicle Count		ncit:C97213
Auer Rods		ncit:C74657
Autoantibodies, NOS		ncit:C181397
Basophils	(fa) ConsortiumNote: CBC	ncit:C64470
Blast Count	(fa) ConsortiumNote: CBC or Bone Marrow	ncit:C74605
Blasts		ncit:C74605
Blood Urea Nitrogen	(fa) ConsortiumNote: Basic Metabolic Panel	ncit:C61019
CD19+ B Cells		ncit:C201193
CD3+ T Cells		ncit:C201180
CD34		ncit:C102260
CD4+ T Cells		ncit:C201182
CD8+ T Cells		ncit:C201184
CRP		ncit:C64548
CSF Luekocyte Count	(fa) ConsortiumNote: CSF Studies	ncit:C168921
CSF RBC Count	(fa) ConsortiumNote: CSF Studies	ncit:C168920
Calcium		ncit:C64488
Cellularity		ncit:C111153
Chloride		ncit:C64495
Chromosome Breakage, DEB
Chromosome Breakage, DEB/MMC
Chromosome Breakage, MMC
Chromosome Breakage, Treated (unknown agent)
Chromosome Breakage, Untreated
Creatinine	(fa) ConsortiumNote: Basic Metabolic Panel	ncit:C64547
Creatinine Clearance		ncit:C25747
Cytology Malignant Cells		ncit:C74660
Direct Bilirubin		ncit:C64481
Dysplasia		ncit:C204680
EBER		ncit:C96602
EBV DNA		ncit:C166035
EBV IgG		ncit:C184675
EBV-PCR
EBV-VCA-IgA-IFT
ESR		ncit:C74611
Estradiol		ncit:C74782
Eosinophils	(fa) ConsortiumNote: CBC	ncit:C64550
Erythroid Precursors Count	(fa) ConsortiumNote: CBC	ncit:C187802
Estrogen Receptor Test
Ferritin
Follicle-Stimulating Hormone (FSH)
Free T3		ncit:C74787
Free T4		ncit:C74786
Free Testosterone		ncit:C74785
GGT		ncit:C64847
Glucose	(fa) ConsortiumNote: Basic Metabolic Panel	ncit:C105585
Granulomas		ncit:C176334
hCG		ncit:C75387
HCT		ncit:C64796
HIV-1 Ab
Hematocrit Measurement	(fa) ConsortiumNote: CBC	ncit:C64796
Hemoglobin	(fa) ConsortiumNote: CBC	ncit:C64848
Hemoglobin A1c Measurement		ncit:C64849
Histiocytes		ncit:C12563
IgA		ncit:C198278
IgD
IgE
IgG		ncit:C198279
IgG1		ncit:C204624
IgG2		ncit:C204625
IgG3		ncit:C204626
IgG4
IgM		ncit:C198280
Immature Granulocytes	(fa) ConsortiumNote: CBC with Differential	ncit:C100445
Infectious Diseases, NOS		ncit:C26726
Inhibin-B		ncit:C2276
JCV		ncit:C199960
Kappa to Lambda Ratio	(fa) ConsortiumNote: METHOD = 'Flow Cytometry'	ncit:C161351
LDH		ncit:C64855
Luteinizing Hormone Test		ncit:C74790
LDL	(fa) ConsortiumNote: Lipid Testing	ncit:C189506
Lactage Dehydrogenase		ncit:C64855
Leukocyte Count	(fa) ConsortiumNote: CBC	ncit:C51948
Lymphocytes		ncit:C12535
Lymphoid Aggregates		ncit:C187947
MCH	(fa) ConsortiumNote: CBC	ncit:C64797
MCHC	(fa) ConsortiumNote: CBC	ncit:C64798
MCV	(fa) ConsortiumNote: CBC	ncit:C64799
Malignant Cells		ncit:C74660
Mast Cell Count	(fa) ConsortiumNote: SPECIMEN = 'Bone Marrow'	ncit:C111246
Megakaryocytes Count	(fa) ConsortiumNote: SPECIMEN = 'Bone Marrow'	ncit:C96688
Microsatellite Instability Test
Monocyte Count	(fa) ConsortiumNote: CBC	ncit:C64823
Monocytes		ncit:C64823
Myeloblast Count	(fa) ConsortiumNote: SPECIMEN = 'Bone Marrow'	ncit:C74632
Myelocyte		ncit:C13115
Myelocyte Count	(fa) ConsortiumNote: SPECIMEN = 'Bone Marrow'	ncit:C74662
Myeloid Cell Count	(fa) ConsortiumNote: SPECIMEN = 'Bone Marrow'	ncit:C184425
Myeloid to Erythroid Ratio Measurement	(fa) ConsortiumNote: SPECIMEN = 'Bone Marrow'	ncit:C92242
Natural Killer Cells to Lymphocytes Ratio Measurement	(fa) ConsortiumNote: METHOD = 'Flow Cytometry'	ncit:C181258
Neutrophil Band Form Count	(fa) ConsortiumNote: CBC	ncit:C64830
Neutrophil Count	(fa) ConsortiumNote: CBC	ncit:C51950
Oligoclonal Bands	(fa) ConsortiumNote: CSF Studies	ncit:C122139
Opening Pressure	(fa) ConsortiumNote: CSF Studies	ncit:C180559
Phosphorus		ncit:C47934
Plasma Cells	(fa) ConsortiumNote: SPECIMEN = 'Bone Marrow'	ncit:C128974
Platelets	(fa) ConsortiumNote: CBC	ncit:C51951
Potassium		ncit:C64853
Progesterone Receptor Test		ncit:C74791
Progesterone		ncit:C74791
Prolactin		ncit:C74870
Promyelocyte Count	(fa) ConsortiumNote: SPECIMEN = 'Bone Marrow'	ncit:C74622
Protein Total		ncit:C64858
RBC	(fa) ConsortiumNote: CBC	ncit:C51946
Reticulocyte Count	(fa) ConsortiumNote: CBC	ncit:C51947
Reticulocyte Mean Corpuscular Volume	(fa) ConsortiumNote: CBC	ncitC114215
Retinal Nerve Fiber Layer Thickness
Ringed Sideroblasts	(fa) ConsortiumNote: SPECIMEN = 'Bone Marrow'	ncit:C100419
Segmented Neutrophils	(fa) ConsortiumNote: CBC	ncit:C81997
Sodium	(fa) ConsortiumNote: Basic Metabolic Panel	ncit:C64809
TSH		ncit:C64813
Total Bilirubin	(fa) ConsortiumNote: Liver Function Test	ncit:C38037
Total Cholesterol	(fa) ConsortiumNote: Lipid Testing	ncit:C61032
Total T4		ncit:C74794
Total Testosterone		ncit:C74793
Triglyceride Measurement	(fa) ConsortiumNote: Lipid Testing	ncit:C64812
Uric Acid		ncit:C62652
Urine Cytology		ncit:C94473
Vitamin D 25
WBC		ncit:C51948
cfDNA		ncit:C128274
miR-367-3p		ncit:C177302
miR-371a-3p		ncit:C158711
miR-372-3p		ncit:C82190
miR-373-3p		ncit:C82191
miR-375-3p		ncit:C101665
beta-hCG		ncit:C64851

LaboratoryTestMethodEnum

Permissible Value	Description	Meaning
Cytology		ncit:C16491
Flow Cytometry		ncit:C16585
MicroRNA Sequencing		ncit:C156057
Morphology Method		ncit:C117624
Morphology/Histology		ncit:C17943
PCR		ncit:C17003
Ploidy		ncit:C18303
ddPCR		ncit:C166064
qPCR		ncit:C51962
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

LaboratoryTestResultUnitEnum

Permissible Value	Description	Meaning
%		ncit:C48570
IU/mL		ncit:C67378
U/L		ncit:C67456
U/mL		ncit:C77607
count/mm3		ncit:C173275
cp/mL
g/dL		ncit:C64783
mg/L		ncit:C64572
mg/dL		ncit:C67015
mIU/mL
mm/h		ncit:C67419
mmHg		ncit:C49670
mmol/L		ncit:C64387
pmol/L		ncit:C67434
ng/mL		ncit:C67306
ng/dL		ncit:C67326
pg/mL		ncit:C67327
pmol/l
ng/L		ncit:C67327
uIU/mL		ncit:C67405
Unknown		ncit:C17998
Not Reported		ncit:C43234

LaboratoryTestSpecimenEnum

Permissible Value	Description	Meaning
Blood		ncit:C17610
Bone Marrow		ncit:C12431
Bone Marrow Aspirate		ncit:C133261
Bone Marrow Core/Trephine Biopsy		ncit:C159488
Buccal Mucosa		ncit:C12505
Cell Free DNA BCT
Cerebrospinal Fluid		ncit:C12692
Cervical Specimen
Chorionic Villus Sampling		ncit:C92755
Cord Blood		ncit:C13300
Fetal Amniocytes		ncit:C12497
K2EDTA
Oral Brush Lesion
Oral Brush Normal Appearing Mucosa
Peritoneal Fluid		ncit:C185197
Plasma		ncit:C185204
Pleural Fluid		ncit:C77613
Primary Fibroblast
Saliva		ncit:C174119
Serum		ncit:C178987
Stool Sample		ncit:C189125
Tumor		ncit:C18009
Tumor Sample		ncit:C18009
Urine		ncit:C13283
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

LateralityEnum

Permissible Value	Description	Meaning
Bilateral		ncit:C13332
Left		ncit:C160200
Midline		ncit:C81170
Right		ncit:C160199
Unilateral		ncit:C28012
Unknown		ncit:C17998
Not Reported		ncit:C43234

LeDetailEnum

Permissible Value	Description	Meaning
Acquired Immunodeficiency		ncit:C2851
Arrhythmia		ncit:C2881
Arthritis		ncit:C2883
Atrophy		ncit:C79748
Autoimmune Reaction		ncit:C16313
Avascular-Necrosis		ncit:C118385
Bladder Disorder		ncit:C2900
Conduction Abnormality		ncit:C78245
Contraction		ncit:C30085
Dryness		ncit:C25489
Esophagitis		ncit:C9224
GI Adhesions		ncit:C185688
Gastritis		ncit:C26780
Gonadal Dysfunction		ncit:C26786
Hepatic Dysfunction		ncit:C50634
Hypertension		ncit:C3117
Musculoskeletal Hypoplasia		ncit:C185696
Neurocognitive Functions		ncit:C94321
Neuropathy		ncit:C4731
Obstructive Lung Disease		ncit:C3199
Osteopenia		ncit:C50910
Osteoporosis		ncit:C3298
Pancreatitis		ncit:C3306
Pericarditis		ncit:C34915
Pigment Changes		ncit:C124224
Reactive Airway Disease		ncit:C113673
Renal Disorder		ncit:C3149
Restrictive Lung Disease		ncit:C91762
Scarring		ncit:C34483
Scoliosis		ncit:C78603
Stroke		ncit:C3390
Telangiectasia		ncit:C28194
Thyroid Disorder		ncit:C26893
Valvular Disease		ncit:C45525
Vascular Disorder		ncit:C35117
Ventricular Dysfunction		ncit:C111655
Other		ncit:C17649

LeEnum

Permissible Value	Description	Meaning
Breast Hypoplasia		ncit:C78222
Cardiovascular Disorder		ncit:C2931
Dermatologic Disorder		ncit:C3371
Endocrine Disorder		ncit:C3009
Fatigue		ncit:C3036
GI Disorder		ncit:C2990
Genitourinary Disorder		ncit:C156660
Immunologic Disorder		ncit:C3507
Musculoskeletal Disorder		ncit:C107377
Neurological Disorder		ncit:C26835
Psychiatric Disorder		ncit:C2893
Pulmonary Disorder		ncit:C3198
Xerostomia		ncit:C26917

LeSeverityGradeEnum

Permissible Value	Description	Meaning
CTCAE >> Grade 1		ncit:C41338
CTCAE >> Grade 2		ncit:C41339
CTCAE >> Grade 3		ncit:C41340
CTCAE >> Grade 4		ncit:C84266
CTCAE >> Grade 5		ncit:C48275

LeSubDetailEnum

Permissible Value	Description	Meaning
AIN		ncit:C176730
AKI		ncit:C26808
Amenorrhea		ncit:C61443
Asthma		ncit:C28397
Cardiomyopathy, NOS		ncit:C34830
Decreased Creatinine Clearance		ncit:C185671
Decreased GFR		ncit:C78326
Dilated Cardiomyopathy		ncit:C84673
Fertility Disorder		ncit:C3836
Germ Cell Failure, Confirmed		ncit:C185685
Germ Cell Failure, Suspected		ncit:C185684
Heart Block		ncit:C50501
Hyperthyroid	(hl) ConsortiumNote: If multiple late effect sub-details, include one observation per late effect sub-detail.	ncit:C3123
Hypothyroid		ncit:C26800
Menstrual Cycle Dysfunction		ncit:C34815
Motor Neuropathy		ncit:C3500
Prolonged QT		ncit:C71034
Pulmonary Fibrosis		ncit:C26869
Restrictive Cardiomyopathy		ncit:C62798
Sensory Neuropathy		ncit:C3501
Supraventricular Tachycardia		ncit:C35061
Testosterone Deficiency		ncit:C143195
Thyroid Nodule		ncit:C3415
Tubular Damage		ncit:C185689
Other		ncit:C17649

LesionMeasurementAxisEnum

Permissible Value	Description	Meaning
Anteroposterior
Base	D4CGNote: Disease-specific, not a universal axis.	ncit:C92955
Cranial-Caudal	D4CGNote: This value is synonymous with 'Height'.	ncit:C182395
Transverse		ncit:C182199
Unknown		ncit:C17998

LocalizationTechniqueEnum

Permissible Value	Description	Meaning
Indocyanine Green (ICG) Fluorescence Angiography		ncit:C175030
Methylene Blue Dye Marking		ncit:C175031
Navigation and Robotics		ncit:C140885
None		ncit:C41132
Wire Localization		ncit:C91832
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

MarginsEnum

Permissible Value	Description	Meaning
Biopsy Only		ncit:C15189
Gross Total Resection, Unknown Margins
Incomplete Resection		ncit:C182305
No Surgical Resection
No Viable Tumor Identified
No lung metastases remain
R0 - Complete Resection, Negative Margins	(lt) ConsortiumNote: sub-procedures have no margins, only the multi-focal procedures	ncit:C139578
R1 - Complete Resection, Positive Margins		ncit:C139579
R2 - Gross Residual Disease		ncit:C139580
Some lung metastases remain
Unresectable
Unknown		ncit:C17998
Not Reported		ncit:C43234

MaritalStatusEnum

Permissible Value	Description	Meaning
Divorced		ncit:C51776
Domestic Partnership		ncit:C53262
Married		ncit:C51773
Never Married		ncit:C51774
Separated		ncit:C156541
Widowed		ncit:C51775
Marital or Civil Status Not Disclosed		ncit:C150742
Unknown		ncit:C17998
Not Reported		ncit:C43234

MarkersEnum

Permissible Value	Description	Meaning
CD20		ncit:C38896
CD30		ncit:C38906
CD45		ncit:C17282
CD99/Cell Surface Antigen O13/Cell Surface Antigen HBA-71		ncit:C102941
Desmin		ncit:C96450
EBER		ncit:C111618
FLI-1		ncit:C18566
GPC3		ncit:C88175
Her2 FISH		ncit:C38906
Her2 Protein		ncit:C38896
LMP1		ncit:C18863
NSE		ncit:C62216
PAS		ncit:C23019
S100		ncit:C29924
Vimentin		ncit:C48797
beta-catenin		ncit:C17478

Measurement1AxisEnum

Permissible Value	Description	Meaning
Anteroposterior
Base	D4CGNote: Disease-specific, not a universal axis.	ncit:C92955
Cranial-Caudal	D4CGNote: This value is synonymous with 'Height'.	ncit:C182395
Transverse		ncit:C182199
Unknown		ncit:C17998

Measurement2AxisEnum

Permissible Value	Description	Meaning
Anteroposterior
Base	D4CGNote: Disease-specific, not a universal axis.	ncit:C92955
Cranial-Caudal	D4CGNote: This value is synonymous with 'Height'.	ncit:C182395
Transverse		ncit:C182199
Unknown		ncit:C17998

Measurement3AxisEnum

Permissible Value	Description	Meaning
Anteroposterior
Base	D4CGNote: Disease-specific, not a universal axis.	ncit:C92955
Cranial-Caudal	D4CGNote: This value is synonymous with 'Height'.	ncit:C182395
Transverse		ncit:C182199
Unknown		ncit:C17998

MediaEnum

Permissible Value	Description	Meaning
ALL Media
CellSave
EDTA
Li Hep
LiHep PST
Nahep
Oragene
PAXGene RNA
PAXgene DNA
PAXgene RNA
PaxGene RNA
RED TOP
Red Top
SST
Smart Tube PROT1
Streck Cyto-Chex
Streck RNA Complete
Streck cfDNA
Streck cfRNA
Tiger Top
Transport Media
edta
Other

MedicalHistoryConditionEnum

Permissible Value	Description	Meaning
13q Syndrome		ncit:C98993
Acoustic Neuroma
ANKRD26-Related Thrombocytopenia and Leukemia Predisposition		ncit:C178387
APC
Acute Lymphoblastic Leukemia Susceptibility - PAX5		ncit:C176907
Acute Lymphoblastic Leukemia		ncit:C3167
Acute Myeloid Leukemia		ncit:C3171
Adenomatous Polyposis Coli		ncit:C17687
Anal Anomaly, NOS
Angiosarcoma
Appendiceal
Astrocytoma
Ataxia Telangiectasia Syndrome		ncit:C2887
Ataxia-Pancytopenia Syndrome		ncit:C176909
Attenuated Familial Adenomatous Polyposis		ncit:C6729
Autism Spectrum Disorder		ncit:C88412
BAP1 Tumor Predisposition Syndrome		ncit:C172639
Basal Cell Carcinoma
Beckwith-Wiedemann Syndrome		ncit:C34415
Beckwith-Wiedemann Syndrome/Isolated Hemihyperplasia		ncit:C34415
Birt-Hogg-Dube Syndrome		ncit:C28244
Bladder Cancer		ncit:C4912
Bloom Syndrome		ncit:C2903
Bohring-Opitz Syndrome		ncit:C131533
Bone Cancer		ncit:C131533
Brain Cancer		ncit:C131533
Breast Cancer		ncit:C4872
Breast and Ovarian Cancer		ncit:C8493
CBL Syndrome		ncit:C176942
CDC73-Related Neoplastic Syndrome		ncit:C178382
CDH1-Associated Breast Carcinoma Syndrome		ncit:C176628
CEBPA-Related Leukemia Predisposition		ncit:C178379
CHEK2-Associated Cancer Predisposition		ncit:C176588
Cancer, NOS
Cardiac Structure Anomaly, NOS
Carney Complex		ncit:C4705
Celiac Disease		ncit:C26714
Central Hypoventilation Syndrome		ncit:C98889
Cherubism		ncit:C84630
Cleft Lip		ncit:C87175
Cleft Palate		ncit:C87069
Clubfoot		ncit:C84641
Congenital Amegakaryocytic Thrombocytopenia		ncit:C115207
Constitutional Mismatch Repair Deficiency		ncit:C130202
Costello
Costello Syndrome		ncit:C84652
Cowden Syndrome		ncit:C3076
Cushing Syndrome		ncit:C2969
DDX41-Related Leukemia Predisposition		ncit:C178380
DICER1
DICER1 Syndrome		ncit:C123317
Denys-Drash Syndrome		ncit:C84668
Diabetes Mellitus (Type I)		ncit:C2986
Diamond-Blackfan Anemia		ncit:C61236
Down Syndrome		ncit:C2993
Dyskeratosis Congenita		ncit:C111802
ETV6-Related Thrombocytopenia and Leukemia Predisposition		ncit:C178386
Esophageal or Duodenal Atresia		ncit:C99105
Ewing Sarcoma
Familial Adenomatous Polyposis		ncit:C3339
Familial Gastrointestinal Stromal Tumor		ncit:C176906
Familial Paraganglioma-Pheochromocytoma Syndrome		ncit:C190373
Familial Platelet Disorder and AML Syndrome		ncit:C162696
Fanconi Anemia		ncit:C62505
GATA2 Deficiency		ncit:C126349
Gardner Syndrome		ncit:C6728
Gastroschisis		ncit:C84725
Genetic Predisposition to Melanoma		ncit:C179472
Genetic Predisposition to Meningioma		ncit:C179471
Genetic Predisposition to Myofibromatosis		ncit:C179470
Genetic Predisposition to Neuroblastoma		ncit:C179469
Genetic Predisposition to Non-Syndromic Wilms Tumor		ncit:C178392
Genetic Predisposition to Papillary Renal Cell Carcinoma		ncit:C179473
Gonadoblastoma		ncit:C3754
Goodpasture's Syndrome		ncit:C34649
Gorlin Syndrome		ncit:C2892
Graves' Disease		ncit:C3071
Hashimoto's Thyroiditis		ncit:C27191
Heart Defect		ncit:C168217
Hemihypertrophy		ncit:C88541
Hepatolenticular Degeneration		ncit:C84756
Hereditary Breast and Ovarian Cancer Syndrome
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome		ncit:C51302
Hereditary Retinoblastoma		ncit:C8495
Hirschprung Disease		ncit:C34700
Hydrocephalus
Inflammatory Bowel Disease		ncit:C3138
Intraocular Melanoma
Juvenile Idiopathic Arthritis		ncit:C114357
Juvenile Polyposis Syndrome		ncit:C7754
Kidney (Renal Cell)
Klinefelter Syndrome		ncit:C34752
LEOPARD Syndrome		ncit:C84820
Legius Syndrome		ncit:C176941
Leukemia
Li-Fraumeni Syndrome		ncit:C3476
Liposarcoma		ncit:C3194
Low Birth Weight		ncit:C34724
Lung Cancer		ncit:C4878
Lymphoproliferative Syndrome 1/ITK Deficiency		ncit:C126344
Lynch Syndrome		ncit:C8494
MIRAGE Syndrome		ncit:C147530
MUTYH-Associated Polyposis		ncit:C96520
Maffucci Syndrome		ncit:C3213
Malignant Peripheral Nerve Sheath Tumor		ncit:C3798
McCune-Albright Syndrome		ncit:C48627
Melanoma		ncit:C3224
Mixed Connective Tissue Disease		ncit:C84892
Mosaic Variegated Aneuploidy Syndrome 1		ncit:C128192
Mulibrey Nanism		ncit:C84906
Multiple Endocrine Neoplasia Type 1		ncit:C3225
Multiple Endocrine Neoplasia Type 2		ncit:C123329
Multiple Endocrine Neoplasia Type 4		ncit:C157449
Multiple Myeloma / Plasma Cell
Multiple Osteochondromas		ncit:C53457
Multiple Sclerosis		ncit:C3243
Myelodysplastic / Myeloproliferative Cancers
NF-1
NF1		ncit:C3273
NF2		ncit:C3274
Nervous System Abnormality
Neuroblastoma
Neurofibromatosis Type 1		ncit:C3273
Neurofibromatosis Type 2		ncit:C3274
Neurofibromatosis Type I		ncit:C143014
Nevoid Basal Cell Carcinoma Syndrome		ncit:C2892
Nijmegen Breakage Syndrome		ncit:C4692
Non-Hodgkin Lymphoma
Noonan Syndrome		ncit:C34854
Noonan Syndrome-Like Disorder with Loose Anagen Hair		ncit:C178129
Oculocutaneous Albinism		ncit:C84941
Ollier Disease		ncit:C3008
Osteosarcoma		ncit:C9145
Other Cancer
Otological Abnormality
Ovarian Cancer
PIK3CA-Related Overgrowth Spectrum		ncit:C178285
Paget Disease		ncit:C7073
Parathyroid Carcinoma / Adenoma
Perlman Syndrome		ncit:C103144
Peutz-Jeghers Syndrome		ncit:C43324
Pineal Gland Tumor		ncit:C6965
Pineoblastoma		icdo:9362/3
Preterm Birth		ncit:92861
Primary Peritoneal
Psoriasis		ncit:C3346
RB1
Radial Aplasia-Thrombocytopenia Syndrome		ncit:C99038
Renal Anomaly, NOS
Retinoblastoma		ncit:C7541
Retinoblastoma Syndrome		ncit:C7541
Rhabdoid Tumor Predisposition Syndrome 1		ncit:C178393
Rhabdoid Tumor Predisposition Syndrome 2		ncit:C178394
Rhabdomyosarcoma		ncit:C3359
Rothmund-Thomson Syndrome		ncit:C3335
Rubinstein-Taybi Syndrome		ncit:C75466
Sarcoma, NOS
Salivary Gland
SAMD9L-Related Myelodysplastic Syndrome Predisposition		ncit:C178390
Schinzel-Giedion Syndrome		ncit:C129308
Schwannomatosis		ncit:C6557
Scleroderma		ncit:C26746
Sebaceous Adenocarcinoma
Secondary Malignancy
Short Stature
Shwachman-Diamond Syndrome		ncit:C61235
Simpson-Golabi-Behmel Syndrome		ncit:C131002
Skin, NOS
Skin Pigmentation
Small Bowel
Small Eyes
Small Head
Soft Tissue Sarcoma		ncit:C9306
Sotos Syndrome		ncit:C75019
Stomach
Systemic Lupus Erythematosus		ncit:C3201
Testicular
Thymoma / Thymic Carcinoma
Thyroid Cancer		ncit:C4815
Trisomy 21		ncit:C43224
Trisomy 21 Mosaicism		ncit:C142099
Tuberous Sclerosis		ncit:C3424
Tyrosinemia Type I		ncit:C98641
Upper Limb Anomaly, NOS
Urethral
Urinary Tract, NOS
Vertebral Anomaly, NOS
Vitiligo		ncit:C26915
Von Hippel-Lindau Syndrome		ncit:C3105
WAGR Syndrome		ncit:C3718
WT1 Syndromes		ncit:C131006
Weaver Syndrome		ncit:C125599
Werner Syndrome		ncit:C3447
X-linked Lymphoproliferative Syndrome		ncit:C61246
Xeroderma Pigmentosum		ncit:C3452
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

MedicationDoseUnitEnum

Permissible Value	Description	Meaning
AUC		ncit:C64774
g
g/m2
IU		ncit:C48579
IU/m2		ncit:C67378
MBq
mcg		ncit:C48152
mg		ncit:C28253
mg/kg		ncit:C105468
mg/m2		ncit:C67402
Units
Unknown		ncit:C17998
Not Reported		ncit:C43234

MedicationEnum

Permissible Value	Description	Meaning
Ixabepilone		rxcui:10485
Iobenguane I-131		rxcui:10485
6 Thioguanine		rxcui:10485
6 Mercaptopurine		rxcui:103
Alemtuzumab		rxcui:117055
Aleve		rxcui:215101
Anastrazole (Arimidex)		rxcui:84857
ALRN 6924		ncit:C118669
Abemaciclib		ncit:C97660
Acetylcysteine		ncit:C200
Adalimumab		ncit:C65216
Akt Inhibitor MK2206		ncit:C90581
Alemtuzumab (Campath)
Alpelisib		ncit:C94214
Amifostine		ncit:C488
Amsacrine		ncit:C240
Anakinra		ncit:C38717
Anastrozole		ncit;C1607
Anti-AFP CART
Anti-GPC3 CART
Anti-thymocyte Globulin		ncit:C278
Antineoplaston A10		ncit:C1004
Antineoplaston AS2-1		ncit:C1613
Arsenic Trioxide		ncit:C1005
Aspirin		ncit:C287
Aspacytarabine		ncit:C1614
Atezolizumab		ncit:C106250
Atorvastatin		ncit:C61527
Axitinib		rxcui:1242999
Azathioprine	(lt) ConsortiumNote: Supportive Care Agent, Liver Transplant	rxcui:1256
BXQ-350 Nanovesicle Formulation		ncit:C131491
Belinostat		ncit:C48812
Bendamustine		ncit:C73261
Bevacizumab		rxcui:253337
Bilnatumomab		ncit:
Bismaleimide sulfoxide (BMSO)
Bleomycin		rxcui:1622
Bortezomib		ncit:C1851
Brentuximab Vedotin		ncit:C66944
Briquilimab
Busulfan		ncit:C321
Cabazitaxel		ncit:C66937
Cabozantinib		ncit:C52200
Camizestrant		ncit:C160603
Capecitabine		rxcui:194000
CapeOx		ncit:C63597
Capivasertib		ncit:C102564
Carbogen		ncit:C1038
Carboplatin		rxcui:40048
Carmustine		ncit:C349
Cediranib		ncit:C80867
Celebrex		rxcui:215927
Celecoxib		ncit:C1728
Cellcept (MMF)	(lt) ConsortiumNote: Supportive Care Agent, Liver Transplant	ncit:C1468
Cetrotide		rxcui:284693
Cetuximab		rxcui:318341
Cilengitide		ncit:C1834
Cisplatin		rxcui:2555
Chlorambucil		rxcui:2346
Cladribine		ncit:C1336
Clofarabine		ncit:C26638
Codrituzumab		ncit:C80043
Combination Estrogen/Progestin Hormonal Contraception		ncit:C91717
Contraceptive Patch		rxcui:220714
Corticorelin Acetate		ncit:C76112
Crenolanib		ncit:C64639
Crizotinib		ncit:C74061
Cyclophosphamide		rxcui:3002
Cyclosporine	(lt) ConsortiumNote: Supportive Care Agent, Liver Transplant	rxcui:3008
Cytarabine		rxcui:3041
DNAJB1-PRKACA Vaccine
DT 2216
DTaP (Diphtheria and tetanus)		ncit:C91718
Dabrafenib		rxcui:1424911
Dacarbazine		rxcui:3098
Dactinomycin		rxcui:3100
Actinomycin		rxcui:3100
Danazol		ncit:C414
Dasatinib		ncit:C38713
Daunorubicin		rxcui:3109
Daunorubicin (Liposomal)		ncit:C2213
Daunorubicin and Cytarabine (Liposomal)		ncit:C67504
Dendritic Cell Therapy		ncit:C28976
Denosumab		ncit:C61313
Depo Provera		rxcui:202886
Deruxtecan		rxcui:2657010
Dexamethasone		ncit:C422
Dexrazoxane	(lt) ConsortiumNote: Supportive Care Agent, Toxicity Prevention	ncit:C1333
Dinutuximab		rxcui:1606274
Docetaxel		rxcui:72962
Dordaviprone		ncit:C113792
Doxil		rxcui:80773
Doxorubicin		rxcui:1799303
Doxycycline Hyclate		ncit:C29007
Durvalumab		ncit:C103194
ENMD 2076
Elacestrant		rxcui:2628483
Eltrombopag		ncit:C71634
Entrectinib		rxcui:2197862
Epirubicin		rxcui:3995
Eribulin		rxcui:1045453
Erlotinib		ncit:C65530
Erythropoeitin		ncit:C20429
Estradiol		rxcui:4083
Etopophos		ncit:C1093
Etoposide		rxcui:4179
Etoposide Phosphate		ncit:C1093
Everolimus		rxcui:141704
Exemestane		ncit:C1097
Faslodex		rxcui:203870
Fenofibrate		ncit:C29047
Filgrastim		ncit:C1474
Firtecan Pegol		ncit:C70651
Fludarabine		ncit:C1094
Fluorouracil (5FU)		rxcui:4492
Fulvestrant		ncit:C1379
Futibatinib		rxcui:2628190
Ganilreix		rxcui:35825
GCSF		ncit:C26078
GMCSF		ncit:C20545
Gabapentin		ncit:C1108
Gadolinium		ncit:C39765
Gefitinib		ncit:C1855
Gemcitabine		rxcui:12574
Gemtuzumab Ozogamicin		ncit:C1806
Gilteritinib		ncit:C116722
Glembatumumab		ncit:C84520
Golimumab
Goserelin		rxcui:50610
HER2 Inhibitor		ncit:C159156
HepA (Hepatitis A)		ncit:C29090
HepB (Hepatitis B)		ncit:C29091
HiB (Haemophilus influenza type B)		ncit:C1126
Human Papilloma Virus Vaccine		ncit:C1951
Human Chorionic Gonadotropin (hCG)		ncit:C528
Human Menopausal Gonadotropin (hMG)		ncit:C2274
Hydrocortisone Sodium Succinate		ncit:C1819
Hydroxyurea		rxcui:5552
IPV (Poliovirus)		ncit:C91715
Ibuprofen		rxcui:5640
Idarubicin		rxcui:5650
Ifosfamide		rxcui:5657
Imatinib Mesylate		ncit:C1687
Imetelstat		ncit:C49084
Immune Checkpoint Inhibitors		ncit:C143250
Indocyanine green	(lt) ConsortiumNote: Supportive Care Agent, Pre-surgical Medication
Indoximod		ncit:C71535
Infliximab
Influenza		ncit:C178427
Inotuzumab Ozogamicin		ncit:C71542
Interferon		ncit:C20493
Intravenous Immunoglobulin Therapy		ncit:C121331
Intron		ncit:C13249
Ipililumab		ncit:C2654
Ipilimumab		ncit:C2654
Irinotecan		ncit:C62040
Isotretinoin		ncit:C603
Itacnosertib		ncit:C156729
Ivosidenib		rxcui:2049873
Labradimil		ncit:C1606
Lapatinib		ncit:C26653
Laromustine		ncit:C2653
Larotrectinib		rxcui:2105628
Leflunomide		rxcui:27169
Lenalidomide		ncit:C2668
Lenvatinib		rxcui:1603296
Letrozole		rxcui:72965
Leucovorin		rxcui:6313
Leuprolide Acetate		rxcui:203217
Liposomal Doxorubicin		ncit:C160080
Lomustine		rxcui:6466
Lonafarnib		ncit:C1829
MCV4 (Meningococcal)		ncit:C96397
MMR (Measles, Mumps, & Rubella)		ncit:C96403
Mebendazole		ncit:C47595
Mechlorethamine		rxcui:6674
Medroxyprogesterone		rxcui:6691
Melphalan		rxcui:6718
Metformin		ncit:C61612
Methotrexate		rxcui:6851
Methylprednisolone	(fa) ConsortiumNote: Also known as IVMP	ncit:C166880
Methylprednisone	(lt) ConsortiumNote: Supportive Care Agent, Liver Transplant
Midostaurin		ncit:C1872
Mifamurtide		ncit:C1394
Mitoxantrone		rxcui:7005
Mizoribine		ncit:C66172
Mobic		rxcui:152699
Monoclonal Antibody		ncit:C20401
Morphine		ncit:C62051
Motexafin Gadolinium		ncit:C1881
Mycophenolate Mofetil
Mycophenolate		rxcui:265323
Nab-Paclitaxel		ncit:C2688
Naproxen		ncit:C680
Nelarabine		rxcui:274771
Neratinib		ncit:C49094
Nimotuzumab		ncit:C2733
Niraparib		rxcui:1918231
Nitrogen Mustard		rxcui:6674
Nivolumab		rxcui:1597876
Non-Corticosteroid Immunosuppressive Agent		ncit:C185652
Nuva Ring		rxcui:1367439
O6-Benzylguanine		ncit:C1306
Olaparib		rxcui:1597582
Oxaliplatin		rxcui:32592
PCV (Pneumococcal)		ncit:C97123
PEG-filgrastim		ncit:C1854
Paclitaxel		ncit:C1411
Palbociclib		ncit:C49176
Panobinostat		ncit:C66948
Pazopanib		rxcui:714438
Pegylated Liposomal Doxorubicin Hydrochloride		ncit:C1555
Pembrolizumab		rxcui:1547545
Pemetrexed		ncit:C61614
Pemigatinib		rxcui:2359268
Perifosine		ncit:C1727
Pertuzumab		ncit:C38692
Pirarubicin		ncit:C1197
Plerixafor		ncit:C1777
Pomalidomide		ncit:C72560
Prednisone	(lt) ConsortiumNote: Supportive Care Agent, Liver Transplant	ncit:C770
Prexasertib		ncit:C91392
Procarbazine		rxcui:8702
Procarbazine Hydrochloride		ncit:C773
Progestin Implant
Progestin-Only Pills
Progestogen		ncit:C2296
Progestational Intrauterine Device		ncit:C184790
Pseudomonas Exotoxin Immunoconjugate		ncit:C78532
Quercetin		ncit:C792
RV (Rotavirus)		ncit:C96394
Ramucirumab		ncit:C70792
Rapamune		rxcui:258355
Rebeccamycin		ncit:C1213
Recombinant Human Hyaluronidase and Pembrolizumab		ncit:C200181
Recombinant FSH		ncit:C1822
Regorafenib		ncit:C78204
Ribociclib		rxcui:1873986
Ridaforolimus		ncit:C49061
Rituximab		rxcui:121191
Romiplostim		ncit:C52183
Rucaparib		rxcui:1862579
Sacituzumab Govitecan		rxcui:2360537
Satraplatin		ncit:C1493
Savolitinib		ncit:C104732
Selpercatinib		rxcui:2370147
Semaxanib		ncit:C11778
Sirolimus		rxcui:35302
Sirpiglenastat		ncit:C174038
Sodium Phenylbutyrate		ncit:C1440
Sodium Thiosulfate	(gct) ConsortiumNote: CATEGORY == 'Supportive Care Agent' (lt) ConsortiumNote: Supportive Care Agent, Toxicity Prevention	ncit:C1230
Sorafenib		ncit:C61948
Sunitinib		rxcui:357977
Systemic Corticosteroid		ncit:C122080
Tacrolimus	(lt) ConsortiumNote: Supportive Care Agent, Liver Transplant	ncit:C1311
Talazoparib		rxcui:2099949
Tamoxifen		rxcui:10324
Tazemetostat		ncit:C107506
Tdap (Tetanus, diphtheria, & acellular pertussis)		ncit:C91717
Tegavivint		ncit:C155885
Temozolomide		rxcui:37776
Temsirolimus		ncit:C1244
Testosterone		rxcui:10379
Tetrathiomolybdate (TM)		ncit:C160684
Thalidomide		ncit:C1844
Therapuetic Growth Hormone		ncit:C164163
Thioguanine		ncit:C876
Thiotepa		rxcui:10473
Thyroid Hormone Replacement		ncit:C888
Thyroxine		ncit:C2302
Tipifarnib		ncit:C1703
Tisotumab Vedotin		ncit:C113164
Tocilizumab		ncit:C84217
Topical Corticosteroid		ncit:C29505
Topotecan		rxcui:57308
Toxin		ncit:C894
Trabectedin		ncit:C1691
Trametinib		ncit:C1413
Trastuzumab		rxcui:224905
Trastuzumab Deruxtecan		ncit:C128799
Trastuzumab Emtansine		ncit:C82492
Tremelimumab		ncit:C49085
Treosulfan		rxcui:38508
Tretinoin		ncit:C900
Triiodothyronine		ncit:C2303
Triptorelin		rxcui:38782
Tucatinib		ncit:C77896
VAR (Varicella)		ncit:C77799
Valproate		ncit:C181410
Valproic Acid		ncit:C29536
Vandetanib		ncit:C2737
Vinblastine		rxcui:11198
Vincristine		rxcui:11202
Vinorelbine		rxcui:39541
Vismodegib		ncit:C933
Voltaren		rxcui:202976
Vorinostat		ncit:C74038
Ziv-Aflibercept		rxcui:1946825
ZOS (Zoster/Shingles)		ncit:C71079
Zoledronic Acid		ncit:C1699
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

MitoticRateEnum

Permissible Value	Description	Meaning
Score 1: 0-9 Mitoses per 10 HPF		ncit:C138983
Score 2: 10-19 Mitoses per 10 HPF		ncit:C138984
Score 3: > 19 Mitoses per 10 HPF		ncit:C138985
Unknown		ncit:C17998

ModificationBasisEnum

Permissible Value	Description	Meaning
Clinical Indication	(hl) ConsortiumNote: Only fill in Disease Phase, Disease Phase Number, Course, and Course Number if 'AGE_' not known Note: Course Number is grouped within subcategory. I.e. number Induction 1, 2, 3, 4, etc..., Prephase 1, 2, 3, 4, etc..., Maintenance 1,2,3,4,5,6 etc...	ncit:C185637
Per Protocol	(pre) ConsortiumNote: If multiple modifications made, include one observation per modification.	ncit:C181023
Unknown	(hl) ConsortiumNote: If multiple modifications made, include one observation per modification.	ncit:C17998
Not Reported		ncit:C43234

ModificationEnum

Permissible Value	Description	Meaning
Delayed		ncit:C25476
Discontinued		ncit:C25484
Dose Reduction		ncit:C49505
New Agent Addition		ncit:C185633
Not Given		ncit:C106487
Substitution		ncit:C54071
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

MolecularMarkersEnum

Permissible Value	Description	Meaning
CEBPA Mutation - Biallelic		ncit:C157569
CEBPA Mutation - Monoallelic		ncit:C168774
CEBPA Variant		ncit:C38372
CKIT Mutation - Ex17		ncit:C116396
CKIT Mutation - Ex8		ncit:C128660
CKIT Mutation - Unspecified		ncit:C39712
FLT3 Internal Tandem Duplication (ITD)		ncit:C67494
FLT3 Tyrosine Kinase Domain (TKD)		ncit:C67495
GATA1 Mutation		ncit:C82340
K-RAS Mutation		ncit:C41361
MLL Other Partner		ncit:C36517
MLL Rearrangement (Translocation)		ncit:C122623
Monosomy 5		ncit:C36523
Monosomy 7		ncit:C36411
N-RAS Mutation		ncit:C41381
NPM1 Mutation		ncit:C82429
Non-KMT2A MLLT10		ncit:C168771
PTPN11 Mutation		ncit:C82612
RUNX1 Mutation		ncit:C38362
RUNX1-RUNX1T1 Fusion		ncit:C99294
Trisomy 8		ncit:C36396
WT1 Mutation		ncit:C146726
del(13q)		ncit:C36497
del(13q)(13q 14 - 21)		ncit:C168770
del(17p)		ncit:C36499
del(5q)(5q31-q32)		ncit:C168769
der.12p		ncit:C173542
inv(16)(p13.3q24.3) / CBFA2T3-GLIS2		ncit:C167195
inv(16)(p13q22)		ncit:C36373
inv(3)(q21;q21.2)		ncit:C36407
t(10;11)(p11.2;q23)		ncit:C168758
t(10;11)(p12;q23) / MLL-MLLT10(AF10)		ncit:C132102
t(11;15)(p15;q35) / NUP98/JARID1A		ncit:C131505
t(11;17)(AF17)		ncit:C168760
t(11;19)(q23;p13) / (MLL-ENL)/(MLL-ELL)		ncit:C168764
t(11;19)(q23;p13.1)(MLL-ELL)		ncit:C36371
t(11;19)(q23;p13.3)(MLL-ENL)		ncit:C36372
t(15;17)(q24;q21)		ncit:C27758
t(16;16)(p13.1;q22)		ncit:C27759
t(16;21)(p11;q22) / FUS/ERG		ncit:C36616
t(16;21)(q24;q22) / RUNX1-CBFA2T3		ncit:C168773
t(1;11)(q21;q23) / MLL-MLLT11(AF1Q)		ncit:C168759
t(1;22)(RBM15-MKL1)		ncit:C36417
t(2;12)		ncit:C173543
t(3;12)(q23;p12.3)(ETV6/EVI1)		ncit:C168766
t(3;3)(q21;q26.2)		ncit:C36406
t(3;5)(q25;q34) / NPM1/MLF1		ncit:C36415
t(3;5)(q25;q34)NPM1/MLF2
t(3;5)(q25;q34)NPM1/MLF3
t(4;11)(q21;q23) / MLL-MLLT2(AF4)		ncit:C36365
t(5;11)(q35;p15) / NSD1/NUP98		ncit:C131503
t(6;11)(q27;q23) / MLL-MLLT4(AF6)		ncit:C36610
t(6;9)(p23;q34) DEK/NUP214		ncit:C36532
t(7;12)(q36;p13) / HLXB9(MNX1)/ETV6(TEL)		ncit:C122689
t(8;16)MOZ/CBP		ncit:C167194
t(8;21)		ncit:C119608
t(9;11)(p22;q23) / MLL-MLLT3(AF9)		ncit:C36370
t(9;22)(q34;q11.2) ABL/BCR		ncit:C13271
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

MrdMethodEnum

Permissible Value	Description	Meaning
Flow Cytometry, Different-From-Normal
Flow Cytometry, Leukemia-Associated Immunophenotypes
Flow Cytometry, NOS
Molecular Real-time Quantitative PCR
Next Generation Sequencing
Other
Unknown
Not Reported

NecrosisEnum

Permissible Value	Description	Meaning
<50% Necrosis
<= 90% Necrosis		ncit:C180353
> 90% Necrosis		ncit:C180348
>=50% Necrosis
Score 0: No Necrosis
Unknown		ncit:C17998
Not Reported		ncit:C43234

OffTypeEnum

Permissible Value	Description	Meaning
Protocol Therapy	(ews) ConsortiumNote: In EE99, we only collected the reason for the end of study treatment (for randomized and non randomized patients).	ncit:C173257
Study		ncit:C29851
Not Reported		ncit:C43234

OriginalAgentEnum

Permissible Value	Description	Meaning
Bendamustine		ncit:C73261
Bleomycin		ncit:C313
Brentuximab Vedotin		ncit:C66944
Busulfan		ncit:C321
Carboplatin		ncit:C1282
Carmustine		ncit:C349
Cisplatin		rxcui:2555
Cyclophosphamide		ncit:C405
Cytarabine		ncit:C408
Dacarbazine		ncit:C411
Dexamethasone		ncit:C422
Doxorubicin		ncit:C456
Etoposide		ncit:C491
Etoposide Phosphate		ncit:C1093
Fludarabine		ncit:C1094
Gemcitabine		ncit:C66876
Ifosfamide		ncit:C564
Iobenguane I-131		rxcui:2053281
Ipilimumab		rxcui:1094833
Ixabepilone		rxcui:337523
Melphalan		ncit:C633
Methotrexate		ncit:C642
Nitrogen Mustard		ncit:C62056
Nivolumab		ncit:C68814
Pembrolizumab		ncit:C106432
Prednisone		ncit:C770
Procarbazine		ncit:C62072
Thiotepa		ncit:C875
Vinblastine		ncit:C930
Vincristine		ncit:C933
Vinorelbine		ncit:C1275
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

OtcSurgicalEnergySourceEnum

Permissible Value	Description	Meaning
Ligasure Bipolar
Harmonic Bipolar
Monopolar
None / Cold Scissor
Cold Scissor Converted to Ligasure Bipolar
Cold Scissor Converted to Harmonic Bipolar
Cold Scissor Converted to Monopolar
Other
Unknown
Not Reported

OutcomeEnum

Permissible Value	Description	Meaning
Adequate for Analysis
Death, Contributory		ncit:C168948
Death, Noncontributory		ncit:C173315
Hemodiluated
Inadequate for Analysis
Indeterminate		ncit:C48658
Non-Viable Tumor
Not Recovered		ncit:C49494
Not Yet Recovered		ncit:C49494
Recovered		ncit:C49498
Recovered with Sequelae		ncit:C49495
Small Amount
Viable Tumor
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

PerformanceScoreEnum

Permissible Value	Description	Meaning
ASA >> 1		ncit:C174992
ASA >> 2
ASA >> 3
ASA >> 4
ASA >> 5
GPOH >> 1		ncit:C174992
GPOH >> 2		ncit:C174993
GPOH >> 3		ncit:C174994
GPOH >> 4		ncit:C174995
GPOH >> 5		ncit:C174996
Karnofsky >> 0		ncit:C105720
Karnofsky >> 10		ncit:C105718
Karnofsky >> 100		ncit:C105707
Karnofsky >> 20		ncit:C105716
Karnofsky >> 30		ncit:C105715
Karnofsky >> 40		ncit:C105714
Karnofsky >> 50		ncit:C105713
Karnofsky >> 60		ncit:C105712
Karnofsky >> 70		ncit:C105711
Karnofsky >> 80		ncit:C105710
Karnofsky >> 90		ncit:C105709
Lansky >> 0		ncit:C70538
Lansky >> 10		ncit:C70539
Lansky >> 100		ncit:C69426
Lansky >> 20		ncit:C70540
Lansky >> 30		ncit:C70541
Lansky >> 40		ncit:C70542
Lansky >> 50		ncit:C69421
Lansky >> 60		ncit:C69422
Lansky >> 70		ncit:C69423
Lansky >> 80		ncit:C69424
Lansky >> 90		ncit:C69425
Unknown		ncit:C17998
Not Reported		ncit:C43234

PhenosEnum

Permissible Value	Description	Meaning
Eye Abnormality	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019]
Genitalia Abnormality	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019]
Microcephaly	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019] (fa) ConsortiumNote: [Mexico Registry].[Congenital_anomalies_detected_at_birth].[6=microcephaly]
Nervous System Abnormality	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019] (fa) ConsortiumNote: [German FA Support Group Questionnaire].[Questions about Fanconi Anemia].[Which or where do you have physical abnormalities?].[Neurological abnormalities]
Otological Abnormality	(fa) ConsortiumNote: [Israel].[Ear Anomaly] (fa) ConsortiumNote: [Fiesco-Roa et al. - 2019] (fa) ConsortiumNote: [German FA Support Group Questionnaire].[Questions about Fanconi Anemia].[Which or where do you have physical abnormalities?].[Ears/Hearing]
Short Stature	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019] (fa) ConsortiumNote: [German FA Support Group Questionnaire].[Questions about Fanconi Anemia].[Which or where do you have physical abnormalities?].[Growth]
Skin Pigmentation	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019] (fa) ConsortiumNote: [German FA Support Group Questionnaire].[Questions about Fanconi Anemia].[Which or where do you have physical abnormalities?].[Skin]

PresentationSymptomsEnum

Permissible Value	Description	Meaning
Amblyopia (Lazy Eye)		ncit:C118764
Conjunctivitis (Pink Eye)		ncit:C34504
Fever		ncit:C3038
Heterochromia (Different Colored Eyes)
Leukocoria (Abnormal Glow)
Night Sweats		ncit:C3279
None		ncit:C41132
Periorbital Edema (Swelling Around The Eye)		ncit:C78530
Strabismus (Crossed Eyes)		ncit:C35040
Weight Loss		ncit:C55339
Unknown		ncit:C17998
Not Reported		ncit:C43234

ProMeasurementTypeEnum

Permissible Value	Description	Meaning
Health Profile		ncit:C62359
Health Utility		ncit:C185674
Symptom Scale		ncit:C124147
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C432234

ProMeasuresEnum

Permissible Value	Description	Meaning
Fact NTX		ncit:C177378
PEDPRO-CTCAE		ncit:C186439
PRO-CTCAE		ncit:C103843
PROMIS Fatigue Short Form		ncit:C129493
PROMIS Global		ncit:C103253
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

ProbandGenerationEnum

Permissible Value	Description	Meaning
Children's Generation (including nieces and nephews)
Grandchildren's Generation
Grandparents' Generation (including great aunts and uncles)
Great Grandparents' Generation
Parents' Generation (including aunts and uncles)
Same Generation (including siblings and cousins)
Unknown		ncit:C17998
Not Reported		ncit:C43234

ProcedureEnum

Permissible Value	Description	Meaning
Abdominoperineal Resection		ncit:C91826
Abdominal Myomectomy
Allograft and Vascularized Autograft	(ews) ConsortiumNote: Reconstruction procedure (os) ConsortiumNote: Reconstruction procedure
Allograft-Prosthetic	(ews) ConsortiumNote: Reconstruction procedure (os) ConsortiumNote: Reconstruction procedure
Amputation, NOS	(ews) ConsortiumNote: Resection procedure (always wide) with no reconstruction. (os) ConsortiumNote: Resection procedure (always wide) with no reconstruction.
Amputation, proximal to involved bone	(ews) ConsortiumNote: Resection procedure (always wide) with no reconstruction. (os) ConsortiumNote: Resection procedure (always wide) with no reconstruction.
Amputation, through involved bone	(ews) ConsortiumNote: Resection procedure (always wide) with no reconstruction. (os) ConsortiumNote: Resection procedure (always wide) with no reconstruction.
Anal Repair
Anastomosis
Appendectomy		ncit:C51687
Axial Skeleton Resection	(ews) ConsortiumNote: Resection procedure. (os) ConsortiumNote: Resection procedure.
Bilateral Salpingo-Oophorectomy		ncit:C51765
Bile Duct		ncit:C12376
Biopsy, NOS		ncit:C15189
Cardiac Repair
Cecectomy
Cervical Decompression
Cholangiocarcinoma		ncit:C4436
Cold Biopsy
Cold Snare
Colectomy		ncit:C15209
Coloproctostomy
Colostomy
Colposcopy/Leep
Conization
Continent Ileostomy
Core Needle Biopsy
Core Needle, Laparscopic Biopsy
Core Needle, Percutaneous Biopsy
Craniofacial Resection	(ews) ConsortiumNote: Resection procedure. (os) ConsortiumNote: Resection procedure.
Creation of Ileal Reservoir (S or J)
Creation of Mucofistula
Cryotherapy
Cystectomy		ncit:C15217
Cystoprostatectomy		ncit:C94464
Debulking (radical dissection)
Destruction of Lesion(s), extensive
Destruction of Lesion(s), simple
Diagnostic Laparoscopy
Disarticulation
Distal Pancreatoduodenectomy (Distal Pancreatectomy)
Endoprosthetic	(ews) ConsortiumNote: Reconstruction procedure (os) ConsortiumNote: Reconstruction procedure.
Endoscopic Mucosal Resection		ncit:C103242
Endoscopic Submucosal Dissection		ncit:C157837
Enterolysis
Enterostomy
Enucleation of Eye
Esophageal Repair
Esophagectomy		ncit:C15357
Esophagogastrectomy
Excision	(ews) ConsortiumNote: Resection procedure. (os) ConsortiumNote: Resection procedure.
Excisional Biopsy
Experimental Procedure
Exploratory Laparotomy
External Hemipelvectomy	(ews) ConsortiumNote: Resection procedure. (os) ConsortiumNote: Resection procedure.
Extra-Articular Resection	(ews) ConsortiumNote: Resection procedure. (os) ConsortiumNote: Resection procedure.
Extracorporeal Photopheresis
Extreme Hepatectomy
Fine Needle Aspiration		ncit:C15361
Gallbladder Surgery		ncit:C157797
Gastrectomy		ncit:C15236
Hartmann Type Procedure
Hemicolectomy		ncit:C86074
Hemiglossectomy
Hemivulvectomy
Hepatectomy, NOS
Hot Biopsy
Hot Snare
Hysterectomy		ncit:C15256
Hysteroscopy
Ileocolonic Anastomosis
Ileocolostomy
Ileorectal Anastamosis
Ileosigmoid Anastomosis
Ileostomy or Ileoproctostomy
Incisional Biopsy
Inguinofemoral Lymphadenectomy
Intercalary Allograft	(ews) ConsortiumNote: Reconstruction procedure (os) ConsortiumNote: Reconstruction procedure.
Intercalary Resection	(ews) ConsortiumNote: Resection procedure. (os) ConsortiumNote: Resection procedure.
Internal Hemipelvectomy	(ews) ConsortiumNote: Resection procedure. (os) ConsortiumNote: Resection procedure.
Intra-Articular Resection	(ews) ConsortiumNote: Resection procedure. (os) ConsortiumNote: Resection procedure.
Intra-Operative Ablation
Laparoscopic Appendectomy
Laparoscopic Assisted Vaginal Hysterectomy
Laparscopic Biopsy, NOS
Laparoscopic Enterectomy
Laparoscopic Enterolysis
Laparoscopy with Aspiration of Cavity or Cyst
Laparscopic, Incisional Biopsy
Laparoscopic Partial Colectomy Anastomosis
Laparoscopic Partial Colectomy, NOS
Laparoscopy, NOS
Laryngopharyngectomy
Leep conization
Level II-V Dissection
Limited Para-aortic Lymphadenectomy
Limb Salvage, NOS	(ews) ConsortiumNote: Both a resection and reconstruction procedure. (os) ConsortiumNote: Both a resection and reconstruction procedure.
Lobectomy	(ews) ConsortiumNote: Resection procedure (for metastatic disease). (os) ConsortiumNote: Resection procedure (for metastatic disease).
Low Anterior Resection		ncit:C113716
Lumbar Decompression
Lumpectomy		ncit:C15755
Lung Resection, NOS
Lymph Node Dissection, NOS
Mastectomy		ncit:C15277
Maxillectomy
Mesohepatectomy
Metastasectomy, NOS
Multi-focal Resection
Neck Dissection
Nephrectomy		ncit:C15284
Nephroureterectomy/Ureterectomy		ncit:C51646
Non-Anatomic Wedge
Non-Vascularized Autograft	(ews) ConsortiumNote: Reconstruction procedure (os) ConsortiumNote: Reconstruction procedure.
Omentectomy
Oophorectomy, NOS		ncit:C15291
Open Biopsy, NOS
Open, Incisional Biopsy
Orchiectomy
Orthotopic Transplant
Orthotopic Transplant, Multivisceral
Osteoarticular Allograft	(ews) ConsortiumNote: Reconstruction procedure (os) ConsortiumNote: Reconstruction procedure.
Paratrachial Node Dissection
Partial Colectomy with Anastomosis
Partial Colectomy, NOS
Partial Gastrectomy
Partial Glossectomy
Partial Hepatectomy / Hemi-hepatectomy
Partial Mandibulectomy
Partial Pharyngectomy
Para-aortic Lymph Node Sampling
Pelvic Lymphadenectomy
Pharingolaryngocervicalesophagectomy
Pharyngectomy
Pharyngotomy
Pneumonectomy	(ews) ConsortiumNote: Resection procedure (for metastatic disease). (os) ConsortiumNote: Resection procedure (for metastatic disease).
Portal lymphadenectomy
Proctectomy		ncit:C15300
Prostatectomy		ncit:C15307
Radical Cystoprostatectomy
Radical Hysterectomy
Radical Neck Dissection
Radical Trachelectomy
Random Gastric Biopsy
Reconstruction, NOS
Removal of Paravaginal Tissue (radical)
Removal of Terminal Ileum
Resection, NOS
Resection, with Colostomy or Ileostomy
Retroperitoneal Sampling
Rotationplasty	(ews) ConsortiumNote: Both a resection and reconstruction procedure. (os) ConsortiumNote: Both a resection and reconstruction procedure.
Roux-En-Y		ncit:C51758
Salpingectomy		ncit:C51605
Segmentectomy / Sectionectomy
Sigmoid Colectomy		ncit:C91838
Skin Level Cecostomy or Colostomy
Sleeve Gastrectomy		ncit:C167213
Small Bowel Resection		ncit:C51510
Sternotomy, Lobectomy
Sternotomy, Other
Sternotomy, Pneumonectomy
Sternotomy, Wedge Resection
Subtotal Glossectomy
Thoracotomy
Thoracotomy, Lobectomy
Thoracotomy, Other
Thoracotomy, Pneumonectomy
Thoracotomy, Wedge Resection
Total Abdominal Hysterectomy		ncit:C51695
Total Abdominal Hysterectomy With A Bilateral Salpingo-Oophorectomy		ncit:C51761
Total Colectomy, NOS
Total Colectomy with End Ileostomy
Total Colectomy with Ileorectal Anastomosis
Total Colectomy with Ileosigmoid Anastomosis
Total Esophagectomy
Total Gastrectomy		ncit:C185240
Total Laparoscopic Hysterectomy
Total Laryngectomy
Total Pancreatectomy		ncit:C51933
Total Proctocolectomy with End Ileostomy
Total Proctocolectomy with Ileal Pouch
Tracheostomy
Tracheo-esophageal Repair
Transverse Hemicolectomy
Trisegmentectomy / Trisectionectomy / Extended Hepatectomy
Ureterolysis
Vaginectomy, Complete
Vaginectomy, Partial
Vascularized Autograft	(ews) ConsortiumNote: Reconstruction procedure (os) ConsortiumNote: Reconstruction procedure.
Vascularized Autograft Endoprosthetic Composite	(ews) ConsortiumNote: Reconstruction procedure (os) ConsortiumNote: Reconstruction procedure.
Ventriculoperitoneal Shunt Placement
Video-Assisted Thoroscopic Surgery, Lobectomy
Video-Assisted Thoroscopic Surgery, Wedge Resection
Vulvectomy, Radical, Partial
Vulvectomy, Radical, Complete
Vulvectomy, Simple, Complete
Vulvectomy, Simple, Partial
Wedge Resection	(ews) ConsortiumNote: Resection procedure (for metastatic disease). (os) ConsortiumNote: Resection procedure (for metastatic disease).
Whipple Pancreaticoduodenectomy		ncit:C15356
Wide Resection	(ews) ConsortiumNote: Resection procedure (modifier). (os) ConsortiumNote: Resection procedure (modifier).
Dialysis
Endometrial Ablation/Resection
Kidney Surgery, NOS
Kidney Transplant
None
Oophorectomy, Complete
Oophorectomy, Partial
Retroperitoneal Lymph Node Dissection
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

ProcedureExtentEnum

Permissible Value	Description	Meaning
Complete Resection		ncit:C175027
Equivocal		ncit:C178921
Gross Total		ncit:C131672
Partial Resection		ncit:C131680
Unknown		ncit:C17998
Not Reported		ncit:C43234

ProcedureSiteEnum

Permissible Value	Description	Meaning
Abdomen		ncit:C12664
Abdominal Skin
Abdominal Wall		ncit:C77608
Acetabulum		ncit:C32042
Adrenal Gland		ncit:C12666
Anal/Perianal		ncit:C99148
Ankle Joint		ncit:C32078
Anterior Skull Base		ncit:C180372
Anus		ncit:C43362
Appendiceal Orifice
Appendix		ncit:C12380
Arm Skin		ncit:C52754
Ascending Colon		ncit:C12265
Axilla		ncit:C12674
Axillary Nodes		ncit:C12904
Basal Ganglia-Thalamus		ncit:C158080
Bladder		ncit:C12414
Bladder/Prostate
Bone / Skeletal		ncit:C12366
Bone Face		ncit:C63706
Bone Foot		ncit:C13068
Bone Marrow		ncit:C12431
Bone Shoulder Girdle		ncit:C33547
Bone or Bone Marrow
Bone, NOS		ncit:C12366
Brain		ncit:C12439
Brain/Leptomeninges		ncit:C32979
Breast		ncit:C12971
Bronchus		ncit:C12683
Buccal Mucosa		ncit:C12505
Buttock		ncit:C89806
Calcaneus		ncit:C32250
Carpal		ncit:C12688
Carpal Bone		ncit:C12688
Cauda Equina Spinal Cord		ncit:C12689
Cecum		ncit:C12381
Celiac Nodes		ncit:C65166
Central Nervous System		ncit:C12438
Cerebellum		ncit:C12445
Cervical Nodes		ncit:C32298
Cervical Spine		ncit:C69313
Cervical Vertebra		ncit:C12693
Cervix		ncit:C12311
Cheek
Chest		ncit:C25389
Chest Wall		ncit:C62484
Clavicle		ncit:C12695
Coccyx		ncit:C12696
Colon		ncit:C12382
Cranium		ncit:C12789
Cutaneous		ncit:C13316
Descending Colon		ncit:C12268
Diaphragm
Distant Lymph Nodes		ncit:C160424
Dorsal Spine		ncit:C32472
Duodenum		ncit:C12263
Ear Skin		ncit:C49481
Elbow		ncit:C32497
Elbow Joint		ncit:C32497
Epididymis		ncit:C12328
Epitrochlear		ncit:C98182
Esophagus		ncit:C12389
Ethmoid		ncit:C12711
Ethmoid Bone		ncit:C12711
Extra CNS
Eye		ncit:C12401
Eyelid
Face		ncit:C13071
Facial Region		ncit:C13071
Fallopian Tube
Female Reproductive System Part		ncit:C13039
Femur		ncit:C12717
Fibula		ncit:C12718
Fibular Head		ncit:C32719
Finger		ncit:C32608
Foot		ncit:C32622
Foot Bone		ncit:C32622
Foot Phalanges		ncit:C52772
Forearm		ncit:C32628
Fourth Ventricle		ncit:C12828
Frontal Bone		ncit:C32635
Frontal Cortex		ncit:C32635
Frontal Lobe		ncit:C12352
Gallbladder		ncit:C12377
Gastrointestinal Tract		ncit:C34082
Gingiva, Lower, Anterior		ncit:C32677
Gingiva, Lower, Posterior		ncit:C32677
Gingiva, NOS		ncit:C32677
Gingiva, Upper, Anterior		ncit:C32677
Gingiva, Upper, Posterior		ncit:C32677
Glottis		ncit:C12724
Great Blood Vessels		ncit:C102955
Groin		ncit:C12726
Hand		ncit:C32712
Hand Bone		ncit:C52771
Hand Phalanges		ncit:C32868
Hand Skin		ncit:C52753
Head
Head and Neck		ncit:C12418
Heart		ncit:C12727
Hepatic Flexure		ncit:C12266
Hilar Nodes		ncit:C102330
Hilum
Hip
Hip/Inguinal Region		ncit:C12726
Humerus		ncit:C12731
Hypopharynx		ncit:C12246
Ileocecal Valve		ncit:C13066
Iliac Crest		ncit:C32765
Inferior Limb		ncit:C12982
Infraclavicular Nodes		ncit:C63705
Infratemporal Fossa/Pterygopalatine
Infratemporal Fossa/Pterygopalatine and Parapharyngeal Area
Inguinal		ncit:C32801
Intestine		ncit:C12736
Intra-Abdominal		ncit:C12726
Intra-Abdominal, Other
Jaw, NOS		ncit:C26470
Intraperitoneal
Intrathoracic
Ischium		ncit:C32884
Kidney		ncit:C12415
Knee		ncit:C32898
Knee Joint		ncit:C32898
Lacrimal Bone		ncit:C32906
Larynx		ncit:C12420
Lateral Ventricle		ncit:C12834
Leg		ncit:C32974
Leg Skin		ncit:C52749
Leptomeningeal		ncit:C32979
Limb		ncit:C12429
Lip		ncit:C12220
Liver		ncit:C12392
Liver, Segment 1 (Caudate)
Liver, Segment 2
Liver, Segment 3
Liver, Segment 4a
Liver, Segment 4b
Liver, Segment 5
Liver, Segment 6
Liver, Segment 7
Liver, Segment 8
Liver/Biliary Tract
Lower Arm
Lower Extremity		ncit:C12742
Lower Leg
Lower Limb, NOS		ncit:C12742
Lumbar Spinal Cord		ncit:C12895
Lumbar Spine		ncit:C69314
Lumbar Vertebra		ncit:C12744
Lung		ncit:C12468
Lymph Node		ncit:C12745
Lymph Node, NOS
Lymph Nodes		ncit:C12745
Lymphatic Basin		ncit:C94547
Mandible		ncit:C12290
Maxilla		ncit:C26470
Mediastinal Node
Mediastinum		ncit:C12748
Medulla		ncit:C12442
Meninges		ncit:C12348
Mesenteric Nodes		ncit:C77641
Metacarpals		ncit:C12751
Metacarpus		ncit:C12751
Metatarsals		ncit:C12752
Metatarsus		ncit:C12752
Midbrain		ncit:C12510
Middle Ear
Nasal Bone		ncit:C33157
Nasal Cavity		ncit:C12424
Nasal Cavity and Paranasal Sinuses
Nasal Septum		ncit:C33160
Nasopharynx		ncit:C12423
Neck		ncit:C13063
Neck Skin		ncit:C52756
Occipital Bone		ncit:C12757
Occipital Cortex		ncit:C12757
Occipital Lobe		ncit:C12355
Optic Chiasm		ncit:C90609
Optic Nerve		ncit:C12761
Oral Cavity		ncit:C12421
Orbit		ncit:C12347
Oropharynx		ncit:C12762
Ovary		ncit:C12404
Palate		ncit:C12229
Pancreas		ncit:C12393
Para-Aortic Nodes		ncit:C77643
Paranasal Sinus		ncit:C12763
Paranasal Sinuses
Parapharyngeal Area
Paraspinal
Paratesticular		ncit:C162491
Paratracheal Nodes
Parietal Bone		ncit:C12766
Parietal Cortex		ncit:C12766
Parietal Lobe		ncit:C12354
Parotid
Patella		ncit:C33282
Pectoral Nodes		ncit:C120322
Pelvis, Ilium		ncit:C32765
Pelvis, Ischium		ncit:C32884
Pelvis, NOS		ncit:C12767
Pelvis, Pubis
Pelvis, Sacrum		ncit:C33508
Penis		ncit:C12409
Pericardium
Perineum
Peritoneum		ncit:C12770
Pharynx		ncit:C12425
Pineal		ncit:C12398
Pleura		ncit:C12469
Pleural Effusion
Pons		ncit:C12511
Popliteal Nodes		ncit:C53146
Preauricular Nodes		ncit:C103429
Primary Peritoneal
Prostate		ncit:C12410
Pyriform Sinus		ncit:C33439
Radius		ncit:C12777
Radius Bone		ncit:C12777
Rectum		ncit:C12390
Retroperitoneal
Retroperitoneum		ncit:C12298
Rib		ncit:C12782
Sacral Region		ncit:C33508
Sacrococcygeal		ncit:C33506
Salivary Gland		ncit:C12426
Scalp		ncit:C89807
Scapula		ncit:C12783
Shoulder		ncit:C25203
Shoulder Girdle		ncit:C33547
Shoulder Joint		ncit:C33548
Sigmoid Colon		ncit:C12384
Sigmoid Flexure		ncit:C33550
Skin		ncit:C12470
Skin of the Back		ncit:C142318
Skin of the Chest		ncit:C161379
Skin of the Face		ncit:C33561
Skin of the Lip		ncit:C12291
Skin of the Upper Limb and Shoulder		ncit:C12296
Skin, NOS		ncit:C12470
Skull, NOS		ncit:C12789
Small Bowel
Small Intestine		ncit:C12386
Soft Tissue
Sphenoid Bone		ncit:C12790
Spinal Cord		ncit:C12464
Spine		ncit:C12998
Spleen		ncit:C7295
Splenic Flexure		ncit:C12267
Splenic Hilar Nodes		ncit:C33600
Sternum		ncit:C12793
Stomach		ncit:C12391
Submandibular		ncit:C129462
Superior Maxilla		ncit:C33682
Supraclavicular Nodes		ncit:C12903
Suprasellar Pituitary		ncit:C95445
Suprasellar/Neurohypophyseal		ncit:C177357
Talus		ncit:C52799
Tarsal Bone		ncit:C12796
Tarsals		ncit:C12796
Temporal Bone		ncit:C12797
Temporal Cortex		ncit:C12797
Temporal Lobe		ncit:C12353
Terminal Ileum		ncit:C33757
Testis		ncit:C12412
Thalamus		ncit:C12459
Thigh		ncit:C33763
Third Ventricle		ncit:C12827
Thoracic Spinal Cord		ncit:C12894
Thoracic Vertebra		ncit:C12798
Thorax		ncit:C12799
Thymus		ncit:C12433
Thyroid		ncit:C12400
Thyroid and Parathyroid
Tibia		ncit:C12800
Toe		ncit:C33788
Tongue		ncit:C12422
Tonsil		ncit:C12802
Trachea		ncit:C12428
Transverse Colon		ncit:C12385
Trunk
Ulna		ncit:C12809
Upper Airway		ncit:C33839
Upper Arm		ncit:C32141
Upper Extremity		ncit:C12671
Upper Limb, NOS		ncit:C12671
Ureter		ncit:C12416
Urogenital
Uterus		ncit:C12405
Vagina		ncit:C12407
Vaginal Mucosa
Viscera		ncit:C28287
Vulva		ncit:C12408
Waldeyer's Ring		ncit:C73468
Wrist Joint		ncit:C33894
Zygomatic Bone		ncit:C33897
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

PurposeEnum

Permissible Value	Description	Meaning
Biopsy of Distant Site for Staging		ncit:C185530
Diagnostic Biopsy for Possible Recurrence		ncit:C185534
Initial Diagnostic Procedure		ncit:C185527
Second Look Surgery to Attempt Total Resection		ncit:C185528
Other		ncit:C17649

RaceEnum

Permissible Value	Description	Meaning
American Indian or Alaska Native		ncit:C41259
Asian		ncit:C41260
Black or African American		ncit:C16352
Multiracial		ncit:C67109
Native Hawaiian or Other Pacific Islander		ncit:C41219
White		ncit:C41261
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

RaceSpecifiedEnum

Permissible Value	Description	Meaning
Asian Indian
Bangladeshi
Baram/Burman
Bengali
Bhutanese
Burmese
Cambodian
Chinese
Filipino
Hmong
Hongkonger
Indonesian
Japanese
Kazakh/Qazaq
Kazakhstani
Korean
Laotian/Lao
Malay
Malaysian
Nepalese/Nepali
Okinawan
Pakistani
Singaporean
Sri Lankan
Tagalog
Taiwanese
Thai
Vietnamese
Agikuyu/Kikuyu
Akan
Amara/Amhara
Australian
Bahamian
Bantu
Barbadian/Bajan
Cameroonian
Congolese
Eritrean
Ethiopian
Fijian
Grenadian
Guamanian or Chamorro
Haitian
Ivoirian/Cote d'Ivoire
Jamaican
Kenyan
Liberian
Libyan
Mende
Native Hawaiian/Hawaiian
Nevis Islander/ Kittitian/Nevisian
New Zealander
Nigerian
Oromo
Polynesian
Samoan
Shona
St Lucia Islander/ Saint Lucian
Tahitian
Tanzanian
Temne/Temme/Themne
Tigrinya/Tigray/Tigraway
Togolese
Tongan
U.S. Virgin Islander
Ugandan
Part Hawaiian
Acadian/Cajun
Afghanistani/Afghan/ Afghani
Albanian
Algerian
Alsatian
Arab/Arabic
Armenian
Assyrian
Austrian
Azerbaijani
Azeri
Belgian
Belorussian/Belarusian
Berber/Amazigh/ Imazighen
Bosniak
British Isles/ British Isles origin
British/Briton
Bulgarian
Canadian
Celtic
Chaldean
Croatian/Croat
Cypriot
Czech
Czechoslovakian
Danish/Dane
Dutch
Dutch West Indian
Egyptian
English
Estonian
Finnish/Finn
Flemish/Fleming
French
French Canadian
Georgian
German
Greek
Herzegovinian
Hungarian
Icelander
Iranian
Iraqi
Irish
Israeli
Italian
Jordanian
Karelian
Kurdish/Kurd
Kuwaiti
Latvian
Lebanese
Lithuanian
Luxemburger
Macedonian
Maltese
Norwegian
Palestinian
Pennsylvania German
Persian
Polish/Pole
Portuguese
Romanian
Russian
Saudi/Saudi Arabian
Scandinavian
Scotch Irish
Scottish
Serbian
Slavic
Slovak
Slovene
Soviet
Swedish/Swede
Swiss
Syriac
Syrian
Turkish/Turk
Ukrainian
United Arab Emirates/ Emirati
Uzbeg/Uzbek
Uzbekistani
Welsh
Yemeni
Yugoslavian
Native American
Alaska Native
First Nation
Inuit
Other
Not Specified

RatersEnum

Permissible Value	Description	Meaning
Subject		ncit:C41189
Parent/Guardian		ncit:C185701
Subject + Parent/GuardianParent/Guardian		ncit:C185702
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C432234

ReasonEnum

Permissible Value	Description	Meaning
Drug Not Available		ncit:C185643
Hematologic Toxicity		ncit:C15474
Non-Hematologic Toxicity		ncit:C185641
Pre-Existing Organ Dysfunction		ncit:C185644
Scheduling Issues		ncit:C1685642
Subject Non-Compliance		ncit:C91752
Surgical Complications		ncit:C164157
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

ReasonOffEnum

Permissible Value	Description	Meaning
Adverse Event		ncit:C41331
Completion of Follow-Up		ncit:C178071
Completion of Planned Therapy		ncit:C168935
Death	(os) ConsortiumNote: If multiple reasons for off 'Protocol Therapy' or off 'Study', include one observation per reason.	ncit:C28554
Development of SMN		ncit:C4968
Disease Progression		ncit:C17747
Failure to Attain Remission		ncit:C178072
Ineligible		ncit:C40412
Left System
Lost to Follow-Up		ncit:C70740
Major Deviation
Physician Decision		ncit:C48250
Relapse		ncit:C38155
Study Discontinuation		ncit:C142444
Subject Non-Compliance		ncit:C91752
Subject/Guardian Refused Further Treatment		ncit:C168934
Toxicity		ncit:C27990
Withdrawal of Consent		ncit:C48271
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

RegimenEnum

Permissible Value	Description	Meaning
CapeOx		ncit:C63597
Carboplatin/Paclitaxel		ncit:C63402
Cisplatin/Gemcitabine
Cisplatin/Gemcitabine + Immune Checkpoint Inhibitor (Durvalumab, Pembrolizumab, etc)
Cisplatin/Gemcitabine/Nab-paclitaxel		ncit:C188462
FLOT		ncit:C160565
FOLFIRI		ncit:C63593
FOLFIRINOX		ncit:C11764
FOLFOX		ncit:C63594
Futibatinib/Pemigatinib

RelationEnum

Permissible Value	Description	Meaning
Aunt
Brother		ncit:C96570
Cousin
Daughter		ncit:C150887
Father		ncit:C96572
First-Degree Relative, NOS		ncit:C21481
Mother		ncit:C96580
Second degree relative, NOS
Sibling		ncit:C96586
Sister		ncit:C96586
Son		ncit:C150888
Uncle
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234
Half-Sibling
Child
Grandmother
Grandfather
Niece or Nephew
Great Grandfather
Great Grandmother
Great Uncle
Great Aunt

ReligionTypeEnum

Permissible Value	Description	Meaning
None		ncit:C41132
Christian		ncit:C176033
Buddhist		ncit:C103284
Hindu		ncit:C103291
Jewish		ncit:C211623
Muslim		ncit:C103285
Sikh		ncit:C176036
Other		ncit:C17649

RemainingColonEnum

Permissible Value	Description	Meaning
Ascending Colon		ncit:C12265
Cecum		ncit:C12381
Descending Colon		ncit:C12268
Hepatic Flexure		ncit:C12266
Rectum		ncit:C12390
Sigmoid Colon		ncit:C33550
Sigmoid Flexure		ncit:C12384
Splenic Flexure		ncit:C12267
Transverse Colon		ncit:C12385

ReportedSignificanceEnum

Permissible Value	Description	Meaning
Benign		ncit:C168802
Likely Benign		ncit:C168801
Likely Pathogenic		ncit:C168800
Pathogenic		ncit:C168799
Uncertain Significance		ncit:C94187
Other		ncit:C17649
Unknown		ncit:C17998

ResponseCategoryEnum

Permissible Value	Description	Meaning
Bone Marrow Response		ncit:C173307
Central Nervous System Response		ncit:C168952
Lymph Node Response		ncit:C159957
Metastatic Response
Myeloid Sarcoma Response		ncit:C168965
Non-Target Lesions		ncit:C94535
Overall Response		ncit:C96613
Primary Site Response		ncit:C200253
Retinal Response
Sub-Retinal Response
Target Lesions		ncit:C94534
Vitreous Response
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

ResponseEnum

Permissible Value	Description	Meaning
CHIC >> Disease Free
Choi >> Complete Response
Choi >> Partial Response
Choi >> Progressive Disease
Choi >> Stable Disease
EXPeRT >> Complete Response
EXPeRT >> Minor Response
EXPeRT >> Partial Response
EXPeRT >> Progressive Disease
EXPeRT >> Stable Disease
EXPeRT >> Very Good Partial Response
INRC, Brodeur 1993 >> Complete Response
INRC, Brodeur 1993 >> Mixed Response
INRC, Brodeur 1993 >> No Response
INRC, Brodeur 1993 >> Partial Response
INRC, Brodeur 1993 >> Progressive Disease
INRC, Brodeur 1993 >> Very Good Partial Response
INRC, Park 2017 >> Minimal Disease
INRC, Park 2017 >> Minor Response
INRC, Park 2017 >> Partial Response
INRC, Park 2017 >> Progressive Disease
INRC, Park 2017 >> Stable Disease
Modified MacDonald >> Partial Response
Modified MacDonald >> Progressive Disease
Modified MacDonald >> Stable Disease
Modified Macdonald >> Complete Response
Not Applicable		ncit:C48660
Not Evaluable		ncit:C62222
PERCIST >> Complete Metabolic Response
PERCIST >> Partial Metabolic Response
PERCIST >> Progressive Metabolic Disease
PERCIST >> Stable Metabolic Disease
RANO >> Complete Response
RANO >> Partial Response
RANO >> Progressive Disease
RANO >> Stable Disease
RAPNO >> Complete Response
RAPNO >> Major Response	(cns_v1.2approved) ConsortiumNote: Only use for RAPNO low-grade gliomas
RAPNO >> Minor Response
RAPNO >> Partial Response
RAPNO >> Stable Disease
RB-RECIST >> Complete Response
RB-RECIST >> Partial Response
RB-RECIST >> Progressive Disease
RB-RECIST >> Stable Disease
RECIST >> Complete Response		ncit:C4870
RECIST >> Partial Response		ncit:C159547
RECIST >> Progressive Disease		ncit:C159716
RECIST >> Stable Disease		ncit:C159546
System NOS >> Complete Response	(hl) ConsortiumNote: For HL, refers to end of chemotherapy or late response.	ncit:C4870
System NOS >> Complete Surgical Remission
System NOS >> Major Response	(cns) ConsortiumNote: Only use for RAPNO low-grade gliomas	ncit:C123590
System NOS >> Minor Response		ncit:C123598
System NOS >> Non-Response		ncit:C173526
System NOS >> Partial Response		ncit:C18058
System NOS >> Progressive Disease		ncit:C35571
System NOS >> Stable Disease		ncit:C18213
System NOS >> Very Good Partial Response		ncit:C123618
WHO >> Complete Response
WHO >> Partial Response
WHO >> Progressive Disease
WHO >> Stable Disease
iRANO >> Complete Response
iRANO >> Minor Response
iRANO >> Partial Response
iRANO >> Progressive Disease
iRANO >> Stable Disease
mRECIST >> Complete Response
mRECIST >> Incomplete Reseponse/Stable Disease	ConsortiumNote: Use for non-target lesions.
mRECIST >> Partial Response
mRECIST >> Progressive Disease
mRECIST >> Stable Disease
Unknown		ncit:C17998
Not Reported		ncit:C43234

ResponseMethodEnum

Permissible Value	Description	Meaning
Biopsy		ncit:C15189
Bone Marrow Biopsy		ncit:C15193
Bone Scan		ncit:C17646
CT		ncit:C17204
CT Scan		ncit:C17204
Cytology		ncit:C16491
EUA		ncit:C40971
Gallium		ncit:C66798
Imaging		ncit:C17220
MRI		ncit:C16809
Not Applicable		ncit:C48660
PET	(hl) ConsortiumNote: If RESPONSE_CATEGORY is 'overall' and not based on a single response method, RESPONSE_METHOD should be 'Not applicable'	ncit:C17007
PET Scan		ncit:C17007
PET-CT		ncit:C103512
PET-MRI		ncit:C103514
Pathology		ncit:C18189
Physical Examination		ncit:C20989
Surgical Resection		ncit:C158758
Tumor Marker		ncit:C17369
Ultrasound		ncit:C64384
X-Ray		ncit:C38101
X-ray		ncit:C38101
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

ResponseSystemEnum

Permissible Value	Description	Meaning
Choi		ncit:C122394
EXPeRT
INRC, Brodeur 1993
INRC, Park 2017
Modified MacDonald		ncit:C198862
PERCIST		ncit:C126039
RANO		ncit:C114879
RAPNO		ncit:C198863
RB-RECIST
RECIST		ncit:C49164
WHO		ncit:C75419
iRANO		ncit:C131131
mRECIST		ncit:C126031
Unknown		ncit:C17998
Not Reported		ncit:C43234

RetinalDetachmentEnum

Permissible Value	Description	Meaning
No		ncit:C49487
Yes, 1 Quadrant
Yes, 2 Quadrants
Yes, 3 Quadrants
Yes, 4 Quadrants
Yes, NOS		ncit:C49488
Unknown		ncit:C17998
Not Reported		ncit:C43234

RouteEnum

Permissible Value	Description	Meaning
Intraarterial		ncit:C38222
Intracameral		ncit:C64984
Intracerebral, Convection-Enhanced Delivery		ncit:C116566
Intramuscular
Intraperitoneal
Intrathecal		ncit:C173292
Intravenously		ncit:C38276
Intravitreal		ncit:C38280
Oral
Parenteral		ncit:C38291
Subcutaneous
Systemic		ncit:C173291
Transscleral		ncit:C199207
Unknown		ncit:C17998
Not Reported		ncit:C43234

RtSiteEnum

Permissible Value	Description	Meaning
Abdomen		ncit:C12664
Abdominal Wall
Adrenal Gland		ncit:C12666
Anal/Perianal
Ankle Joint		ncit:C32078
Anterior Skull Base		ncit:C180372
Anus		ncit:C43362
Appendix		ncit:C12380
Axilla		ncit:C12674
Axilla or Pectoral
Basin		ncit:C94547
Bladder
Bladder/Prostate
Bone Face		ncit:C63706
Bone Foot
Bone Marrow
Bone Shoulder Girdle		ncit:C33547
Bone or Bone Marrow
Bone, NOS
Brain		ncit:C12439
Brain/Leptomeninges
Breast
Bronchus		ncit:C12683
Buttock		ncit:C89806
Carpal		ncit:C33894
Cervical Spine		ncit:C69313
Cervix
Cheek
Chest		ncit:C25389
Chest Wall
Clavicle		ncit:C12695
Coccyx		ncit:C12696
Colon		ncit:C12382
Craniospinal		ncit:C84352
Cranium		ncit:C12789
Cutaneous		ncit:C13316
Distant Lymph Nodes
Distant Nodes
Dorsal Spine		ncit:C32472
Duodenum		ncit:C12263
Elbow		ncit:C32497
Elbow Joint		ncit:C32497
Epididymis		ncit:C12328
Esophagus		ncit:C12389
Ethmoid		ncit:C12711
Exact Volume Unknown
Eye
Eye, Fovea
Eye, Lens
Eye, Macula
Eye, Optic Disk
Eye, Optic Nerve
Eye, Sclera
Eyelid
Fallopian Tube		ncit:C12403
Femur		ncit:C12717
Fibula		ncit:C12718
Finger		ncit:C32608
Focal		ncit:C28224
Foot		ncit:C32622
Foot Bone		ncit:C13068
Foot Phalanges		ncit:C52772
Forearm		ncit:C32628
Frontal Cortex		ncit:C32635
Gallbladder		ncit:C12377
Gastrointestinal Tract		ncit:C34082
Groin		ncit:C12726
Gross Tumor Volume		ncit:C192975
Gynecological Area		ncit:C13039
Hand		ncit:C32712
Hand Bone		ncit:C52771
Hand Phalanges		ncit:C32868
Head
Head and Neck		ncit:C12418
Heart		ncit:C12727
Heart, Pericardium
Hilum
Hip
Humerus		ncit:C12731
Hypopharynx
Iliac
Inferior Limb		ncit:C12982
Infratemporal Fossa/Pterygopalatine
Infratemporal Fossa/Pterygopalatine and Parapharyngeal Area
Intraperitoneal
Intrathoracic
Jaw, NOS		ncit:C26470
Kidney		ncit:C12415
Knee		ncit:C32898
Knee Joint		ncit:C32898
Large Vessels		ncit:C102955
Larynx
Leg		ncit:C12392
Level I Nodes
Level II Nodes
Level III Nodes
Level IV Nodes
Level V Nodes
Liver		ncit:C12392
Liver/Biliary Tract
Lower Arm
Lower Extremity		ncit:C12742
Lower Leg
Lower Limb, NOS		ncit:C12742
Lumbar Spine		ncit:C69314
Lung		ncit:C12468
Lymph Node, NOS
Lymph Nodes		ncit:C12745
Mandible		ncit:C12290
Maxilla		ncit:C26470
Mediastinum		ncit:C12748
Meninges		ncit:C12348
Mesenteric or Hepatis Porta
Metacarpals		ncit:C12751
Metatarsals		ncit:C12752
Middle Ear
Nasal Cavity
Nasal Cavity and Paranasal Sinuses
Nasal Septum		ncit:C33160
Nasopharynx
Neck		ncit:C13063
Occiptial Cortex		ncit:C12757
Oral Cavity
Orbit
Oropharynx
Ovary		ncit:C12404
Pancreas		ncit:C12393
Paraaortic
Paranasal Fossa		ncit:C12763
Paranasal Sinuses
Parapharyngeal Area
Paraspinal
Paratesticular		ncit:C162491
Paratracheal
Parietal Cortex		ncit:C12766
Parotid
Patella		ncit:C33282
Pelvis, Ilium		ncit:C32765
Pelvis, Ischium		ncit:C32884
Pelvis, NOS		ncit:C12767
Pelvis, Pubis
Pelvis, Sacrum		ncit:C33508
Penis		ncit:C12409
Perineum
Peritoneum		ncit:C12770
Pineal		ncit:C12398
Pleura
Pleural Effusion
Posterior Fossa
Prostate
Radius		ncit:C12777
Rectum		ncit:C12390
Regional Lymph Nodes, NOS
Retroperitoneal
Retroperitoneum		ncit:C28256
Retropharyngeal Nodes
Rib		ncit:C12782
Sacrococcygeal		ncit:C33506
Salivary Gland		ncit:C12426
Scalp
Scapula		ncit:C12783
Schlemm's Canal		ncit:C12783
Shoulder
Shoulder Girdle		ncit:C33547
Shoulder Joint		ncit:C33548
Skull and Face Bone		ncit:C12386
Skull, NOS		ncit:C12789
Small Intestine		ncit:C12386
Soft Tissue
Spinal Cord		ncit:C12464
Spine		ncit:C12998
Spleen		ncit:C12432
Splenic Hilar or Spleen
Sternum		ncit:C12793
Stomach		ncit:C12391
Superior Maxilla		ncit:C33682
Suprasellar/Neurohypophyseal		ncit:C177357
Tarsals		ncit:C12796
Temporal Cortex		ncit:C12797
Testes		ncit:C12412
Thalamus		ncit:C12459
Thigh
Thoracoabdominal
Thorax		ncit:C12799
Thyroid		ncit:C12400
Thyroid and Parathyroid
Tibia		ncit:C12800
Toe		ncit:C33788
Tonsil		ncit:C12802
Total Body
Total Lymphoid
Trachea		ncit:C12428
Trunk
Tumor Bed Plus Margin
Ulna		ncit:C12809
Upper Airway		ncit:C33839
Upper Arm
Upper Extremity		ncit:C12671
Upper Limb, NOS		ncit:C12671
Ureter		ncit:C12416
Urogenital
Uterus
Vagina		ncit:C12407
Viscera		ncit:C28287
Vulva		ncit:C12408
Whole Brain
Whole Spinal Cord
Whole Ventricle
Whole Ventricular With Spine
Wrist Joint		ncit:C33894
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

SctTypeEnum

Permissible Value	Description	Meaning
Allogeneic		ncit:C46089
Autologous, NOS		ncit:C201465
Autologous, Single
Autologous, Tandem		ncit:C116466
Unknown		ncit:C17998
Not Reported		ncit:C43234

SedationTypeEnum

Permissible Value	Description	Meaning
Moderate Sedation (Fentanyl, Midazolam, Diphenhydramine, Meperidine)
Monitored Anesthesia Care (Propofol)
No Sedation
Not Reported		ncit:C43234

SexEnum

Permissible Value	Description	Meaning
Female		ncit:C16576
Male		ncit:C20197
Intersex, NOS		ncit:C45908
Undifferentiated		ncit:C41438
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

SexualMaturityIndexEnum

Permissible Value	Description	Meaning
NOS, Stage 1
NOS, Stage 2
NOS, Stage 3
NOS, Stage 4
NOS, Stage 5
Genital, Stage 1
Genital, Stage 2
Genital, Stage 3
Genital, Stage 4
Genital, Stage 5
Pubic Hair, Stage 1, Female
Pubic Hair, Stage 2, Female
Pubic Hair, Stage 3, Female
Pubic Hair, Stage 4, Female
Pubic Hair, Stage 5, Female
Pubic Hair, Stage 1, Male
Pubic Hair, Stage 2, Male
Pubic Hair, Stage 3, Male
Pubic Hair, Stage 4, Male
Pubic Hair, Stage 5, Male

SiteClassificationEnum

Permissible Value	Description	Meaning
Benign		ncit:C14172
Local Extension
Metastatic		ncit:C3261
Not Applicable
Premalignant		ncit:C25624
Primary		ncit:C8509
Regional Nodes	(npc) ConsortiumNote: Includes 'PTV2' and 'PTV3'
Regional	(os) ConsortiumNote: Regional to the local site.
Unknown		ncit:C17998
Not Reported		ncit:C43234

SiteWithinBoneEnum

Permissible Value	Description	Meaning
Diaphysis		ncit:C32529
Distal		ncit:C25237
Epiphysis		ncit:C32460
Metaphysis		ncit:C52723
Proximal		ncit:C25236
Unknown		ncit:C17998
Not Reported		ncit:C43234

SmnSiteEnum

Permissible Value	Description	Meaning
Abdomen
Brain		ncit:C12439
Head and Neck		ncit:C12418
Limbs
Not Applicable		ncit:C48660
Pelvis
Thorax
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

SmnTypeEnum

Permissible Value	Description	Meaning
ALL		ncit:C3167
AML		ncit:C3171
Carcinoma		ncit:C2916
Glioblastoma		ncit:C3058
Leukemia		ncit:C3161
Low Grade Glioma		ncit:C132067
Lymphoma		ncit:C3208
Melanoma		ncit:C3224
Osteosarcoma		ncit:C9145
Sarcoma
Soft Tissue Sarcoma		ncit:C9306
Solid Tumor, NOS		ncit:C9292
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

SomaticMalignancyTypeEnum

Permissible Value	Description	Meaning
Adenocarcinoma		ncit:C2852
Malignant Histiocytosis		ncit:C7202
Rhabdomyosarcoma		ncit:C3359
Sarcoma, NOS		ncit:C9118
Squamous Cell Carcinoma		ncit:C2929
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

SourceLabEnum

Permissible Value	Description	Meaning
Boston Children's
Cincinnati Children's Hospital Medical Center
Dana-Farber Cancer Institute
GeneDX
Invitae
Julius-Maximilians-Universität of Würzburg
Laboratorio de Citogenética, Instituto Nacional de Pediatría, México
Prevention Genetics
Quest Diagnostics
Sloan Kettering
Stanford University
The Rockefeller University
Toronto
University of Chicago
University of Minnesota
Other

StageEnum

Permissible Value	Description	Meaning
AJCC >> Stage 0		ncit:C4523
AJCC >> Stage 1		ncit:C7901
AJCC >> Stage 1A		ncit:C6361
AJCC >> Stage 1B		ncit:C6362
AJCC >> Stage 1s		ncit:C6363
AJCC >> Stage 2		ncit:C9073
AJCC >> Stage 2A		ncit:C6364
AJCC >> Stage 2B		ncit:C6365
AJCC >> Stage 2C		ncit:C6366
AJCC >> Stage 3		ncit:C9074
AJCC >> Stage 3A		ncit:C6369
AJCC >> Stage 3B		ncit:C6368
AJCC >> Stage 3C		ncit:C6367
AJCC, v6 >> Stage 0		C90529
AJCC, v6 >> Stage 1		C90529
AJCC, v6 >> Stage 2		C90529
AJCC, v6 >> Stage 3		C90529
AJCC, v6 >> Stage 4		C90529
AJCC, v7 >> Stage 0		ncit:C90530
AJCC, v7 >> Stage 1		ncit:C90530
AJCC, v7 >> Stage 2		ncit:C90530
AJCC, v7 >> Stage 3		ncit:C90530
AJCC, v7 >> Stage 4		ncit:C90530
AJCC, v8 >> Stage 0		ncit:C132248
AJCC, v8 >> Stage 1		ncit:C132248
AJCC, v8 >> Stage 2		ncit:C132248
AJCC, v8 >> Stage 3		ncit:C132248
AJCC, v8 >> Stage 4		ncit:C132248
Ann Arbor >> Stage 1		ncit:C8071
Ann Arbor >> Stage 2		ncit:C8116
Ann Arbor >> Stage 3		ncit:C8129
Ann Arbor >> Stage 4		ncit:C8142
Children's Oncology Group Liver Tumor Staging System >> Stage 1		ncit:C177630
Children's Oncology Group Liver Tumor Staging System >> Stage 2		ncit:C177630
Children's Oncology Group Liver Tumor Staging System >> Stage 3		ncit:C177630
Children's Oncology Group Liver Tumor Staging System >> Stage 4		ncit:C177630
Children's Oncology Group Neuroblastoma Risk Group Staging System >> Stage L1		ncit:C177631
Children's Oncology Group Neuroblastoma Risk Group Staging System >> Stage L2		ncit:C177632
Children's Oncology Group Neuroblastoma Risk Group Staging System >> Stage M		ncit:C177632
Children's Oncology Group Neuroblastoma Risk Group Staging System >> Stage MS		ncit:C177632
Children's Oncology Group Renal Cancer Staging System >> Stage 1		ncit:C177632
Children's Oncology Group Renal Cancer Staging System >> Stage 2		ncit:C177632
Children's Oncology Group Renal Cancer Staging System >> Stage 3		ncit:C177632
Children's Oncology Group Renal Cancer Staging System >> Stage 4		ncit:C177632
Children's Oncology Group Renal Cancer Staging System >> Stage 5		ncit:C177632
Children's Oncology Group Retinoblastoma Risk Group Staging System >> High Risk		ncit:C102401
Children's Oncology Group Retinoblastoma Risk Group Staging System >> Intermediate Risk		ncit:C102402
Children's Oncology Group Retinoblastoma Risk Group Staging System >> Low Risk		ncit:C102403
Childrens Oncology Group/National Wilms Tumor Study Group Staging System >> Stage 1		ncit:C198025
Childrens Oncology Group/National Wilms Tumor Study Group Staging System >> Stage 2		ncit:C198025
Childrens Oncology Group/National Wilms Tumor Study Group Staging System >> Stage 3		ncit:C198025
Childrens Oncology Group/National Wilms Tumor Study Group Staging System >> Stage 4		ncit:C198025
Childrens Oncology Group/National Wilms Tumor Study Group Staging System >> Stage 5		ncit:C198025
COG >> Stage 1		ncit:C27966
COG >> Stage 2		ncit:C28054
COG >> Stage 3		ncit:C27970
COG >> Stage 4		ncit:C27971
COG >> Stage 4S
Enneking Staging System >> Stage 1a		ncit:C146701
Enneking Staging System >> Stage 1b		ncit:C146702
Enneking Staging System >> Stage 2a		ncit:C146703
Enneking Staging System >> Stage 2b		ncit:C146704
Enneking Staging System >> Stage 3		ncit:C146705
Evans >> Stage 1
Evans >> Stage 2
Evans >> Stage 3
Evans >> Stage 4
Evans >> Stage 4s
Evans Surgical Staging System >> Stage 1
Evans Surgical Staging System >> Stage 2
Evans Surgical Staging System >> Stage 3
Evans Surgical Staging System >> Stage 4
FIGO >> Stage 1		ncit:C96244
FIGO >> Stage 2		ncit:C96252
FIGO >> Stage 3		ncit:C96255
FIGO >> Stage 4		ncit:C96261
INRGSS >> Stage L1
INRGSS >> Stage L2
INRGSS >> Stage M
INRGSS >> Stage Ms
INSS >> Stage 1
INSS >> Stage 2a
INSS >> Stage 2b
INSS >> Stage 3
INSS >> Stage 4
INSS >> Stage 4s
IRS >> Stage 1
IRS >> Stage 2
IRS >> Stage 3
IRS >> Stage 4
IRSS >> Stage 0
IRSS >> Stage 1
IRSS >> Stage 2
IRSS >> Stage 3a
IRSS >> Stage 3b
IRSS >> Stage 4a
IRSS >> Stage 4b
Intergroup Rhabdomyosarcoma Study Group Clinical Staging and Grouping System >> Group 1		C148012
Intergroup Rhabdomyosarcoma Study Group Clinical Staging and Grouping System >> Group 2		C148015
Intergroup Rhabdomyosarcoma Study Group Clinical Staging and Grouping System >> Stage 3		C148019
Intergroup Rhabdomyosarcoma Study Group Clinical Staging and Grouping System >> Stage 4		C148022
International Society of Pediatric Oncology Staging System >> Stage 1
International Society of Pediatric Oncology Staging System >> Stage 2
International Society of Pediatric Oncology Staging System >> Stage 3
International Society of Pediatric Oncology Staging System >> Stage 4
International Society of Pediatric Oncology Staging System >> Stage 5
IRSS >> Group 0
IRSS >> Group 1a
IRSS >> Group 1b
IRSS >> Group 2a
IRSS >> Group 2b
IRSS >> Group 3a
IRSS >> Group 3b
IRSS >> Group 4a
IRSS >> Group 4b
Group 1		ncit:C137992
Group 2		ncit:C137993
Group 3		ncit:C137994
Group 4		ncit:C137995
Group 5		ncit:C137996
Lugano Stage >> Stage 1		ncit:C141180
Lugano Stage >> Stage 1E		ncit:C141181
Lugano Stage >> Stage 2		ncit:C141182
Lugano Stage >> Stage 2E		ncit:C141183
Lugano Stage >> Stage 3		ncit:C141186
Lugano Stage >> Stage 4		ncit:C141187
Modified Chang Staging >> M+
Modified Chang Staging >> M0		ncit:C48699
Modified Chang Staging >> M0 / M1
Modified Chang Staging >> M1		ncit:C48700
Modified Chang Staging >> M2
Modified Chang Staging >> M3
Modified Chang Staging >> M4
PRETEXT, 1992 >> Group I	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 1992 >> Group II	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 1992 >> Group III	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 1992 >> Group IV	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 2005 >> Group I	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 2005 >> Group II	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 2005 >> Group III	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 2005 >> Group IV	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 2005-COG >> Group I	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 2005-COG >> Group II	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 2005-COG >> Group III	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 2005-COG >> Group IV	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 2017 >> Group I	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 2017 >> Group II	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 2017 >> Group III	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, 2017 >> Group IV	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, NOS >> Group I	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, NOS >> Group II	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, NOS >> Group III	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
PRETEXT, NOS >> Group IV	(lt) ConsortiumNote: STAGE_SYSTEM = 'PRETEXT Staging System'
Stage IIa
Stage IIb
Stage IIc
Stage IIIa
Stage IIIb
Stage IIIc
St. Jude Stage >> Stage 1		C141218
St. Jude Stage >> Stage 2		C141219
St. Jude Stage >> Stage 3		C141220
St. Jude Stage >> Stage 4		C141221
System NOS >> Localized
System NOS >> Metastatic
System NOS >> Regionally Advanced
System NOS >> Stage 0
System NOS >> Stage 1
System NOS >> Stage 2
System NOS >> Stage 3
System NOS >> Stage 4
System NOS, L1
System NOS, L2
System NOS, M
System NOS, MS
Unknown		ncit:C17998
Not Reported		ncit:C43234
Not Applicable

StageSystemEnum

Permissible Value	Description	Meaning
AIDS-Related Kaposi Sarcoma Stage		ncit:C134969
AJCC		ncit:C39315
AJCC v6 Stage		ncit:C90529
AJCC v7 Stage		ncit:C90530
AJCC v8 Stage		ncit:C132248
Ann Arbor		ncit:C54179
Children's Oncology Group		ncit:C39353
Children's Oncology Group Liver Tumor Staging System		ncit:C177630
Children's Oncology Group Neuroblastoma Risk Group Staging System		ncit:C177631
Children's Oncology Group Renal Cancer Staging System		ncit:C177632
Children's Oncology Group Retinoblastoma Risk Group Staging System		ncit:C177633
Childrens Oncology Group/National Wilms Tumor Study Group Staging System		ncit:C140271
EVANS		ncit:C85407
Enneking Staging System		ncit:C140258
Evans Surgical Staging System
FIGO		ncit:C125738
Gleason Grading System
INRGSS		ncit:C133427
INSS		ncit:C85416
IRSS
Intergroup Rhabdomyosarcoma Study Group Clinical Staging and Grouping System		ncit:C148010
International Retinoblastoma Staging System
International Society of Pediatric Oncology Staging System		ncit:C140270
Lugano Stage		ncit:C141147
Modified Chang Staging		ncit:C198826
PRETEXT Staging System		ncit:C141133
Pediatric Oncology Group Neuroblastoma Staging System		ncit:C85423
Reese-Ellsworth Staging System
St. Jude Stage		ncit:C141216
Staging System, NOS
TNM Staging System
Toronto Childhood Cancer Stage Guidelines		ncit:C197985
Unknown		ncit:C17998
Not Reported		ncit:C43234

StemCellSourceEnum

Permissible Value	Description	Meaning
Bone Marrow		ncit:C12431
Cord Blood		ncit:C15640
Mixture of Stem Cells		ncit:C168886
Mobilized Peripheral Blood Stem Cells
Peripheral Blood		ncit:C15430
Stem Cell Mixture		ncit:C168886
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

StudyIdEnum

Permissible Value	Description	Meaning
02-294 DFCI
0892
0896
0901
0902
0911
0914
0924
0925
0926
0927
0931
0935
0936
0937
0961
0962
09709
099
10-C-0219
11-C-0161
15-C-0093
321P1
321P2
321P3
321P4
323P
3881
3891
3951
461
4941
4941L
7942
8105
8340
8441
8605
8607
8661
8671
8741
8742
8743
8863
892
896
8970
9000
901
902
9047
9072
9075
9082
911
914
9140
924
9243
9244
9248
925
926
9262
927
9272
9275
9280
9284
9285
931
9340
9341
9342
9343
9346
9347
935
936
9360
9361
937
9372
9375
9376
9382
9464
9466
9470
9571
9572
9579
9581
961
962
9640
9670
9675
9709
99
9900
9907
A0935A
A09713
A3961
A3973
A9952
AADM01P1
AALL0232
AALL0331
AALL03B1
AALL0434
AALL08B1
AALL1731
AAML00P2
AAML03P1		ncit:C168936
AAML0531		ncit:C168937
AAML05P1
AAML07P1
AAML1031		ncit:C168938
AB9804
ABTR01B1
ABTR04B1
ACCL0331
ACCL0423
ACCL0431
ACCL05C1
ACCL0934
ACCL0935
ACCL1031
ACCL1032
ACCL1034
ACCL15N1CD
ACCL1633
ACCL21C2
ACNS0121
ACNS0122
ACNS0126
ACNS0222
ACNS0223
ACNS0224
ACNS0232
ACNS02B3
ACNS0331
ACNS0332
ACNS0333
ACNS0334
ACNS0423
ACNS0621
ACNS0821
ACNS0822
ACNS0831
ACNS0927
ACNS1021
ACNS1022
ACNS1123
ACNS1221
ACNS1422
ACNS1721
ACNS1723
ACNS1821
ACNS1831
ACNS1833
ACNS1931
ACNS2021
ADVL0012
ADVL0016
ADVL0017
ADVL0018
ADVL0122
ADVL0211
ADVL0212
ADVL0214
ADVL0215
ADVL0314
ADVL0316
ADVL0413
ADVL0414
ADVL0416
ADVL0421
ADVL0515
ADVL0516
ADVL0517
ADVL0524
ADVL0525
ADVL0612
ADVL06B1
ADVL0714
ADVL0812
ADVL0813
ADVL0815
ADVL0816
ADVL0819
ADVL0821
ADVL0911
ADVL0912
ADVL0916
ADVL0918
ADVL0921
ADVL1011
ADVL1013
ADVL1014
ADVL1111
ADVL1112
ADVL1115
ADVL1211
ADVL1212
ADVL1213
ADVL1217
ADVL1312
ADVL1314
ADVL1315
ADVL1411
ADVL1412
ADVL1414
ADVL1416
ADVL1513
ADVL1514
ADVL1515
ADVL1522
ADVL1615
ADVL1622
ADVL1711
AEIOPAML2002		ncit:C168942
AEPI07N1
AEWS0031		ncit:C174970
AEWS0331		ncit:C174969
AEWS07B1
AEWS07P1		ncit:C174974
AEWS1031		ncit:C174971
AEWS1221		ncit:C174968
AFLACST1501
AG881-C-004
AGCT0132		ncit:C177343
AGCT01P1		ncit:C177342
AGCT0521		ncit:C177344
AGCT1531
AGCT1532
AHEP0731	D4CGNote: DATA_CONTRIBUTOR = 'COG'
AHEP1531
AHOD0031		ncit:C185311
AHOD03P1		ncit:C185314
AHOD0431		ncit:C185310
AHOD0831		ncit:C185308
AHOD1221		ncit:C185313
AHOD1331		ncit:C185312
AIEOP EP II
AIEOPLAM92		ncit:C173254
ALTE03N1
ALTE05N1
ALTE15N2
ALTE1621
AML-BFM Registry2012		ncit:C173251
AML-BFM Registry2017		ncit:C182031
AML-BFM1998		ncit:C182032
AML-BFM2004		ncit:C168939
AML-BFM2004 Interim
AML-BFM2012		ncit:C173250
AML-BFM2019
AML-BFM2020
AML-BFM83/87
AML-BFM87/93
AML-BFM93
AML-BFM98
AML-BFM98 Interim 2003
ANBL0032
ANBL00B1
ANBL00P1
ANBL00P2
ANBL00P3
ANBL02P1
ANBL0321
ANBL0322
ANBL0421
ANBL0531
ANBL0532
ANBL0621
ANBL0931
ANBL09P1
ANBL1021
ANBL1221
ANBL1232
ANBL12P1
ANBL1531
ANBL17P1
ANBL1821
ANBL19P1
ANHL0131
ANHL01P1
ANUR0631
ANUR1131
AOST0331
AOST0331/EURAMOS1	(os) ConsortiumNote: also known by COG study id AOST0331	ncit:C180361
AOST06B1
AOST0221		ncit:C180360
AOST0121		ncit:C180358
AOST01P1		ncit:C180359
AOST1321		ncit:C180362
AOST1421		ncit:C180363
APEC14B1
APEC1621
APEC1621E
APEC1621F
APEC1621H
APEC1621I
APEC1621SC
APL
ARAR0331
AREN0321
AREN03B2
AREN1921
ARET0231
ARET0321
ARET0331
ARET0332
ARET12P1
ARST0331
ARST0431
ARST0531
ARST08P1
AS942
AS972
AS9801
Ad-RTS-hIL-12
Anogenital Cancer Database	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == The Rockefeller University
Antineoplaston Therapy protocol
B003
B903
B904
B925
B947
B953
B954
B973
BC Oral Cancer Registry	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == BC Cancer
BIOMEDE
BRAINCHILD-01
BRAINCHILD-02
BRAINCHILD-03
BRF116013
BXQ-350 AD
Baby POG-1
C3P Registry
CA209908
CCG-782		C180364
CCG-921
CCG-7942		C180365
CCG-9921
CCG-9942
CCG-99701
CCG-99703
CCG-A5971
CCG-A9952
CCG-A9961
CCG-D9803
CCG-P9970
CCG09712
CCG945
CCG9941
CCG99703
CCLG-EPSSG-NRSTS-2005
CCLG-EPSSG-RMS-2005
CCMC1411
CDRB436G2201
CERN-08-01
CHLA Registry		ncit:C192782
CHMC-6006
CHP455
CHP693
CHP719
CHP735
CLEE011XUS17T
CNS1100
COG A09712
COJEC
CONNECT 1701
CONNECT 1702
CONNECT1701
CONNECT1702
CPT-SIOP-2000
CPT-SIOP-2009
CWS-IV-2002
CWS2002P
CWS91
CWS96
ChildrenHLA
Clinical features and outcome of patients with Fanconi's anemia, CMCL	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == Christian Medical College and Hospital
CMC Vellore FA Registry
D9501
D9602
D9802
D9803
DART Clinical Trial
DBAML01		ncit:C168944
DEPICT Registry		ncit:C192784
DFMO
DIPG-BATS
E04
E15
E18
ECREST study
EE99	(ews) ConsortiumNote: COG not submitting any EE99	ncit:C174972
EICESS92		ncit:C174973
ENSG5
ETMR One
EWS2008	(ews) ConsortiumNote: EE99 data should not include patients from Ewing2008
EWS2012
EZH-102
EZH-202
Egypt57357-AML
Egypt57357-StJudeTotal15
EuRBG Registry		ncit:C192785
Fanconi Anemia Patient Registry	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == Fanconi Cancer Foundation
GALOP Registry		ncit:C192786
GC1		ncit:C177335
GC2		ncit:C177336
GCC1949
GOG0078
GOG0090
GOG0116		ncit:C177339
GPOH-NPC 2016 Registry	(npc) ConsortiumNote: data_contributor_id == 'GPOH'
GemPOx
GenRare	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == CIBER
German Liver Tumor Registry	D4CGNote: DATA_CONTRIBUTOR = 'GPOH'
HB89	D4CGNote: DATA_CONTRIBUTOR = 'GPOH'
HB99	D4CGNote: DATA_CONTRIBUTOR = 'GPOH'
HERBY
HGG-01
HGG-BAT
HIT-GBM-C
HIT-HGG-2013
HIT-SIOP PNET 4
HLHR13
HOD05
HOD08
HOD99
HSPPC-96
HUMC 1612
Head Start 4
Head Start II
Head Start III
I03
ICE
ICG RMS96
INCB7839
INDIGO
INT0098	D4CGNote: DATA_CONTRIBUTOR = 'COG'
INT133
IRS-III
ISG/AIEOP Ew1
ISG/AIEOP Ew2
ISPHO
Indraprastha Apollo Hospital Fanconi Anemia Patient Database	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == Indraprastha Apollo Hospital; Manipal Hospital Dwarka New Delhi
International Fanconi Anemia Registry	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == The Rockefeller University
JACLSAML99		ncit:C168943
JET Protocol
JPLSGAML05		ncit:C168941
JPLT1	D4CGNote: DATA_CONTRIBUTOR = 'JCCG'
JPLT2	D4CGNote: DATA_CONTRIBUTOR = 'JCCG'
JPLT3	D4CGNote: DATA_CONTRIBUTOR = 'JCCG'
LGG 14C03
LINEAGE
LNESG1
LOXO-TRK 15003
MEK116540
MEK162
MEMMAT
METRICS
MIN-001P-1501
MK-3475
ML-DS-2006
MMT95
MRCAML12		ncit:C168945
MRCAML15		ncit:C173252
MSKCC 09-014
MSKCC 11-011
MSKCC-03077
MTS2008
Mazumdar Shaw Medical Centrem Bangalore Fanconi Anemia Patient Database	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == Mazumdar Shaw Medical Centrem Bengalore
Medanta Gurugram Fanconi Anemia Patient Database	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == Medanta Gurugram
N2012-01
N891
NB2004-HR
NB2005
NB2008
NB2012
NB84
NB8814
NB91
NB97
NCI 001109	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == National Cancer Institute
NCI 02-C-0052	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == National Cancer Institute
NCI 02-C-0193
NCI-MATCH
NCT01185964
NCT01222754
NCT01502917
NCT02924038
NCT03696355
NCT04196413
NCT04264143
NF105
NF106
NLG2105
NMTRC V0706
NMTRC009
NOPHOAML1993
NOPHOAML2004		ncit:C168946
NOPHOAML2012		ncit:C173253
GPOH-NPC-2003 Study	(npc) ConsortiumNote: data_contributor_id == 'GPOH'
GPOH-NPC-91 Study	(npc) ConsortiumNote: data_contributor_id == 'GPOH'
ONC028
ONC201
OS2 Trial (2011-2018)
OZM-063
OZM-075
OZM-077
P9462
P9480
P9485
P9641
P9645	D4CGNote: DATA_CONTRIBUTOR = 'COG'
P9749		ncit:C177340
P9761
P9772
P9851
P9963
P9972
PBTC 029
PBTC-029
PBTC-039
PBTC-50
PBTC001
PBTC004
PBTC005
PBTC0056
PBTC006
PBTC007
PBTC014
PBTC016
PBTC017
PBTC018
PBTC020
PBTC021
PBTC022
PBTC023
PBTC024
PBTC025
PBTC026
PBTC027
PBTC030
PBTC031
PBTC033
PBTC042
PBTC043
PBTC045
PBTC047
PBTC048
PBTC049
PBTC050
PBTC051
PBTC053
PBTC055
PBTC056
PEDSCCT6005
PEG-Intron
PEPN2011
PEPN2111
PNET 3
PNOC001
PNOC0013
PNOC0015
PNOC0016
PNOC0018
PNOC002
PNOC0022
PNOC0023
PNOC003
PNOC005
PNOC007
PNOC008
PNOC009
PNOC010
PNOC013
PNOC014
PNOC015
PNOC016
PNOC022
PNOC023
PNOC026
PNOC027
POE08-01
POG 9239
POG 9631
POG 9836
POG 9879
POG-8844
POG-9905
POG-P9934
POG9048
POG9049		ncit:C177341
POG9233
PPLLSGAML98		ncit:C168947
PRO13110086
Pittsburgh Vaccine Trial Cycle
Protocol BT-55
R115777-INT-11
R9702
RAD001
RAFMex	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == Instituto Nacional de Pediatria
REGOBONE
REMATCH
REMIND
RMS 4.99
RMS2005
RTOG-0929
Re-MATCH
Registry of the Deutsche Fanconi-Anämie-Hilfe e.V.	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == Deutsche Fanconi Anämie-Hilfe e.V.
S31
S901
S912
S921
SARC006
SARC011
SARC031
SARC037
SC-9006
SC9005
SCFEELAM02		ncit:C173255
SCH52365
SDT-201
SEL-TH-1601
SIOP CNS GCT II
SIOP LGG 2004
SIOP-CNS-GCT-96
SIOP-EP-II
SIOP-LGG-2004
SIOP-PNET-4
SIOPEL2	D4CGNote: DATA_CONTRIBUTOR = 'SIOPEL'
SIOPEL3	D4CGNote: DATA_CONTRIBUTOR = 'SIOPEL'
SIOPEL4	D4CGNote: DATA_CONTRIBUTOR = 'SIOPEL'
SIOPEL6	D4CGNote: DATA_CONTRIBUTOR = 'SIOPEL'
SIOPEN HR-NBL1
SIOPEN-EUNB
SJATART
SJBG07
SJCRHAML02		ncit:C168940
SJDAWN
SJHG12
SJHG98
SJMB-96
SJMB03
SJMB12
SJPDGF
SJREFU
SJYC07
STRIvE-02
SU5416
SARC038
Sarcome-09/OS2006		ncit:C180367
Sarcome-13/OS2016		ncit:C180370
Schneider Children's Medical Center Fanconi Anemia Registry	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == Schneider Children's Medical Center
Shalby Sanar International Hospital Fanconi Anemia Patient Registry	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == Shalby Sanar International Hospital
Stanford University Fanconi Anemia Patient Registry	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == Stanford University
Study # 2014-0135
Stupp Protocol
TATA
TB-403
TCGM2004
TE04		ncit:C177345
TE05		ncit:C177346
TE08		ncit:C177347
TE09		ncit:C177349
TE13		ncit:C177350
TE20		ncit:C177351
TE22		ncit:C177348
TGM85		ncit:C177332
TGM90		ncit:C177333
TGM95		ncit:C177334
TIP		ncit:C177352
TK216
TOPNOC
TOPNOC-001
TOTEM
TROD1
UK Fanconi Anaemia Registry	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == University of Manchester
Un Corazón por Fanconi Anemia Patient Registry	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == Un Corazón por Fanconi
University of Düsseldorf Fanconi Anemia Patient Registry	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == University of Düsseldorf
VINILO study
VITAC
VOIT
VP-16
Wayne Crismani Australia Fanconi Anemia Research Study	(fa) ConsortiumNote: DATA_CONTRIBUTOR_ID == St. Vincent's Institute for Medical Research
X0942
YMB 1000 013
ZD-1839
cHOD17
rHSC-DIPGVax
Fertility Preservation And Outcomes Of Fertility Treatment Registries
National Fertility Preservation Database
NIH 000106
NIH 000715
De-Identified Clinical Data Of Patients Seen At Indiana University
De-Identified Patients Seen For Oncofertility At Cincinnati Children'S Hospital Medical Center
National Oncofertility Database

SubAgentEnum

Permissible Value	Description	Meaning
Bendamustine		ncit:C73261
Bleomycin		ncit:C313
Brentuximab Vedotin		ncit:C66944
Busulfan		ncit:C321
Carboplatin		ncit:C1282
Carmustine		ncit:C349
Cisplatin		ncit:C376
Cyclophosphamide		ncit:C405
Cytarabine		ncit:C408
Dacarbazine		ncit:C411
Dexamethasone		ncit:C422
Doxorubicin		ncit:C456
Etoposide		ncit:C491
Etoposide Phosphate		ncit:C1093
Fludarabine		ncit:C1094
Gemcitabine		ncit:C66876
Ifosfamide		ncit:C564
Melphalan		ncit:C633
Methotrexate		ncit:C642
Nitrogen Mustard		ncit:C62056
Nivolumab		ncit:C68814
Pembrolizumab		ncit:C106432
Prednisone		ncit:C770
Procarbazine		ncit:C62072
Thiotepa		ncit:C875
Vinblastine		ncit:C930
Vincristine		ncit:C933
Vinorelbine		ncit:C1275
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

SubgroupNameEnum

Permissible Value	Description	Meaning
11-C-0161:Arm 1 (AZD6244)
11-C-0161:Arm 2 (AZD6244)
15-C-0093:Phase I (Turalio)
15-C-0093:Phase II (Turalio)
A3973:Arm I (unpurged PBSC collection) (carboplatin, cisplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, isotretinoin, melphalan, topotecan hydrochloride, vincristine sulfate)
A3973:Arm II (unpurged PBSC collection) (carboplatin, cisplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, isotretinoin, melphalan, topotecan hydrochloride, vincristine sulfate)
AALL0434:Group 0 Induction Therapy (Cytarabine, Daunorubicin Hydrochloride, Methotrexate, Pegaspargase, Prednisone, Vincristine Sulfate)
AALL0434:Group 1 Arm IV (Consolidation chemotherapy) (Cyclophosphamide, Cytarabine, Mercaptopurine, Methotrexate, Nelarabine, Pegaspargase,)
AALL0434:Group I Arm I (Consolidation chemotherapy) (Cyclophosphamide, Cytarabine, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Vincristine Sulfate)
AALL0434:Group I Arm I (Delayed intensification chemotherapy (Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Methotrexate, Pegaspargase, Thioguanine, Vincristine Sulfate)
AALL0434:Group I Arm I (Interim maintenance chemotherapy) (Leucovorin Calcium, Methotrexate, Pegaspargase, Vincristine Sulfate)
AALL0434:Group I Arm I (Maintenance chemotherapy) (Mercaptopurine, Methotrexate, Prednisone, Vincristine Sulfate)
AALL0434:Group I Arm II (Consolidation chemotherapy) (Cyclophosphamide, Cytarabine, Mercaptopurine, Methotrexate, Nelarabine, Pegaspargase, Vincristine Sulfate)
AALL0434:Group I Arm II (Delayed intensification chemotherapy) (Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Nelarabine, Pegaspargase, Thioguanine, Vincristine Sulfate)
AALL0434:Group I Arm II (Interim maintenance chemotherapy) (Asparaginase, Methotrexate, Pegaspargase, Vincristine Sulfate)
AALL0434:Group I Arm II (Maintenance chemotherapy) (Mercaptopurine, Methotrexate, Nelarabine, Prednisone, Vincristine Sulfate)
AALL0434:Group I Arm III (Consolidation chemotherapy) (Cyclophosphamide, Cytarabine, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Vincristine Sulfate)
AALL0434:Group I Arm III (Delayed intensification chemotherapy) (Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Methotrexate, Pegaspargase, Thioguanine, Vincristine Sulfate)
AALL0434:Group I Arm III (Interim maintenance chemotherapy) (Leucovorin Calcium, Mercaptopurine, Methotrexate, Vincristine Sulfate)
AALL0434:Group I Arm III (Maintenance chemotherapy) (Methotrexate, Prednisone, Vincristine Sulfate)
AALL0434:Group I Arm IV (Delayed intensification chemotherapy) (Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Methotrexate, Nelarabine, Pegaspargase, Thioguanine, Vincristine Sulfate)
AALL0434:Group I Arm IV (Interim maintenance chemotherapy) (Leucovorin Calcium, Mercaptopurine, Methotrexate, Vincristine Sulfate)
AALL0434:Group I Arm IV (Maintenance chemotherapy) (Mercaptopurine, Methotrexate, Nelarabine, Prednisone, Vincristine Sulfate)
AALL1731:Arm A (SR-Avg control) (Asparaginase Erwinia chrysanthemi, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Mercaptopurine Oral Suspension, Methotrexate, Pegaspargase, Prednisone, Thioguanine, Vincristine Sulfate)
AALL1731:Arm B (SR-Avg experimental) (Asparaginase Erwinia chrysanthemi, Blinatumomab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Mercaptopurine Oral Suspension, Methotrexate, Pegaspargase, Thioguanine, Vincristine Sulfate)
AALL1731:Arm C (SR-High Control) (Asparaginase Erwinia chrysanthemi, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Mercaptopurine Oral Suspension, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Thioguanine, Vincristine Sulfate)
AALL1731:Arm D (SR-High experimental) (Asparaginase Erwinia chrysanthemi, Blinatumomab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Mercaptopurine Oral Suspension, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Thioguanine, Vincristine Sulfate)
AALL1731:B-LLy (Asparaginase Erwinia chrysanthemi, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Mercaptopurine Oral Suspension, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Thioguanine, Vincristine Sulfate,)
AALL1731:DS B-ALL (Asparaginase Erwinia chrysanthemi, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Mercaptopurine Oral Suspension, Methotrexate, Pegaspargase, Thioguanine, Vincristine Sulfate)
AALL1731:NCI SR or HR DS B-ALL (Asparaginase Erwinia chrysanthemi, Blinatumomab, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Mercaptopurine Oral Suspension, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Vincristine Sulfate)
AAML03P1:N/A (asparaginase, busulfan, cyclophosphamide, cyclosporine, cytarabine, daunorubicin hydrochloride, etoposide, gemtuzumab ozogamicin, methotrexate, mitoxantrone hydrochloride)
AAML0531:Arm A HR
AAML0531:Arm A LR
AAML0531:Arm A: Standard Arm - No GMTZ, AML Patients with Down Syndrome (asparaginase, cytarabine, daunorubicin hydrochloride, etoposide, mitoxantrone hydrochloride)
AAML0531:Arm A: Standard Arm - No GMTZ, AML Pts w/out Down Syndrome (asparaginase, cytarabine, daunorubicin hydrochloride, etoposide, mitoxantrone hydrochloride)
AAML0531:Arm B HR
AAML0531:Arm B LR
AAML0531:Arm B: Experimental - with GMTZ, AML Pts w/out Down Syndrome (asparaginase, cytarabine, daunorubicin hydrochloride, etoposide, gemtuzumab ozogamicin, gemtuzumab ozogamicin)
AAML0531:HR
AAML0531:LR
AAML1031:Arm A HR
AAML1031:Arm A LR
AAML1031:Arm B HR
AAML1031:Arm B LR
AAML1031:Arm C
ACNS0121:GTR (radiation only)
ACNS0121:GTR Supratentorial Differentiated (observation)
ACNS0121:STR (interim chemotherapy/second look surgery) (Vincristine, Carboplatin, Cyclophosphamide, Etoposide)
ACNS0122:Induction and Consolidation (High dose chemotherapy) (carboplatin, etoposide, ifosfamide, Thiotepa)
ACNS0122:Induction only (No high-dose therapy) (carboplatin, etoposide, ifosfamide)
ACNS0232:Regimen A (Radiotherapy Alone)
ACNS0232:Regimen B (Cycles 1 and 2 only) (Carboplatin, Etoposide)
ACNS0232:Regimen B (MRD/PR/SD = 4 cycles) (Carboplatin, Etoposide, Cisplatin, Cyclophosphamide)
ACNS0331:Arm I (3-7 years of age, LDCSI, IFRT)
ACNS0331:Arm I (3-7 years of age, LDCSI, IFRT) (Cisplatin, Lomustine, Vincristine, Cyclophosphamide)
ACNS0331:Arm II (3-7 years of age, LDCSI, PFRT)
ACNS0331:Arm II (3-7 years of age, LDCSI, PFRT) (Cisplatin, Lomustine, Vincristine, Cyclophosphamide)
ACNS0331:Arm III (3-7 years of age, SDCSI, IFRT)
ACNS0331:Arm III (3-7 years of age, SDCSI, IFRT) (Cisplatin, Lomustine, Vincristine, Cyclophosphamide)
ACNS0331:Arm IV (3-7 years of age, SDCSI, PFRT)
ACNS0331:Arm IV (3-7 years of age, SDCSI, PFRT) (Cisplatin, Lomustine, Vincristine, Cyclophosphamide)
ACNS0331:Arm V (8-21 years of age, SDCSI, IFRT)
ACNS0331:Arm V (8-21 years of age, SDCSI, IFRT) (Cisplatin, Lomustine, Vincristine, Cyclophosphamide)
ACNS0331:Arm VI (8-21 years of age, SDCSI, PFRT
ACNS0331:Arm VI (8-21 years of age, SDCSI, PFRT) (Cisplatin, Lomustine, Vincristine, Cyclophosphamide)
ACNS0332:Arm A
ACNS0332:Arm B (Carboplatin)
ACNS0332:Arm C (Isotretinoin)
ACNS0332:Arm D (Carboplatin and Isotretinoin)
ACNS0332:Regimen A (no carboplatin, no isotretinoin) (Cisplatin, Cyclophosphamide, Vincristine)
ACNS0332:Regimen B (carboplatin, no isotretinoin) (Carboplatin, Cisplatin, Cyclophosphamide, Vincristine)
ACNS0332:Regimen C (no carboplatin, isotretinoin) (Cisplatin, Cyclophosphamide, Vincristine, Isotretinoin)
ACNS0332:Regimen D (carboplatin, isotretinoin) (Carboplatin, Cisplatin, Cyclophosphamide, Vincristine, Isotretinoin)
ACNS0333:Arm I (Chemotherapy, Autologous PBSC, 3D-CRT)
ACNS0333:Arm I (chemotherapy, autologous PBSC, 3D-CRT) (Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Filgrastim, Leucovorin Calcium, Methotrexate, Thiotepa, Vincristine Sulfate)
ACNS0333:Arm II (Chemotherapy, 3D-CRT, Autologous PBSC)
ACNS0333:Arm II (chemotherapy, 3D-CRT, autologous PBSC) (Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Filgrastim, Leucovorin Calcium, Methotrexate, Thiotepa, Vincristine Sulfate)
ACNS0334:Arm A (Induction+Consolidation Chemotherapy, Autologous PBSC)
ACNS0334:Arm B (Induction+Consolidation Chemotherapy, Autologous PBSC)
ACNS0334:Regimen A (Cisplatin, Cyclophosphamide, Vincristine, Etoposide, Carboplatin, Thiotepa, ASCR)
ACNS0334:Regimen B (Methotrexate, Cisplatin, Cyclophosphamide, Vincristine, Etoposide, Carboplatin, Thiotepa, ASCR)
ACNS0821:TEMO+IRIN (Temozolomide, Irinotecan)
ACNS0821:TEMO+IRIN+BEVA (Temozolomide, Irinotecan, Bevacizumab)
ACNS0822:Arm I (Vorinostat) (Vorinostat, Bevacizumab, Temozolomide)
ACNS0822:Arm II (Temozolomide) (Bevacizumab, Temozolomide)
ACNS0822:Arm III (Bevacizumab) (Bevacizumab, Temozolomide)
ACNS0822:Arm IV (temozolomide) (Bevacizumab, Temozolomide)
ACNS0822:Arm V (vorinostat/bevacizumab (Vorinostat, Bevacizumab, Temozolomide)
ACNS0822:Feasibility (vorinostat) (Vorinostat, Bevacizumab, Temozolomide)
ACNS0831:Arm I (radiotherapy, chemotherapy) (Vincristine, Carboplatin, Cyclophosphamide, Etoposide)
ACNS0831:Arm II (radiotherapy, chemotherapy) (Vincristine, Cyclophosphamide, Etoposide, Cisplatin)
ACNS0831:Arm III (radiotherapy, observation)
ACNS0831:GTR (Randomized to Maintenance Chemotherapy) (Vincristine, Cisplatin, Cyclophosphamide, Etoposide)
ACNS0831:GTR (Randomized to No Chemotherapy)
ACNS0831:STR (Induction only) (Vincristine, Carboplatin, Cyclophosphamide, Etoposide)
ACNS0831:STR Differentiated (observation)
ACNS1022:Arm I (low-dose lenalidomide) (Lenalidomide)
ACNS1022:Arm II (high-dose lenalidomide) (Lenalidomide)
ACNS1123:Stratum 1 (NGGCT) (carboplatin, etoposide, ifosfamide)
ACNS1123:Stratum 2 (Germinoma) (carboplatin, etoposide)
ACNS1831:Arm 1 (Carboplatin, Vincristine)
ACNS1831:Arm 2 (Selumetinib)
ACNS1833:Arm 1 (Carboplatin, Vincristine)
ACNS1833:Arm 2 (Selumetinib)
ACNS1931:Active Comparator: Efficacy Phase Arm II (selumetinib) (Selumetinib Sulfate)
ACNS1931:Experimental: Feasibility & Efficacy Phase Arm I (selumetinib, vinblastine) (Selumetinib, Vinblastine)
ACNS2021:Plan A (WVSCI - whole ventricular and spinal canal radiation) (Carboplatin, Etoposide, Ifosfamide, Mesna)
ACNS2021:Plan B (HDCSCR- high dose chemotherapy with stem cell rescue) (Carboplatin, Etoposide, Ifosfamide, Mesna, Thiotepa)
ADVL0416:ARM I (vorinostat)
ADVL0416:ARM II (vorinostat)
ADVL0416:ARM III (vorinostat, isotretinoin)
ADVL0612:PART A (sunitinib malate)
ADVL0612:PART B (sunitinib malate)
ADVL0921:Arm I (neuroblastoma- measurable) (Alisertib)
ADVL0921:Arm II (Neuroblastoma- MIBG evaluable) (Alisertib)
ADVL0921:Arm III (rhabdomyosarcoma) (Alisertib)
ADVL0921:Arm IV (osteosarcoma) (Alisertib)
ADVL0921:Arm IX (Wilms tumor) (Alisertib)
ADVL0921:Arm V (Ewing sarcoma/peripheral PNET) (Alisertib)
ADVL0921:Arm VI (non-RMS soft tissue sarcoma) (Alisertib)
ADVL0921:Arm VII (hepatoblastoma) (Alisertib)
ADVL0921:Arm VIII (malignant germ cell tumor) (Alisertib)
ADVL0921:Arm X (acute lymphoblastic leukemia) (Alisertib)
ADVL0921:Arm XI (acute myelogenous leukemia) (Alisertib)
ADVL0921:Arm XII (rhabdoid malignancy) (Alisertib)
ADVL1411:Phase 1 (talazoparib, temozolomide)
ADVL1411:Phase 2 (talazoparib, temozolomide)
AEIOP LAM 2002:ICE-ICE-AVE-HAM- HD-AraC/SR
AEIOP LAM 2002:ICE-ICE-AVE-HAM-SCT/HR
AEWS0031:2W-VDC-MESNA+IFO-GCSF		ncit:C174976
AEWS0031:3W-VDC-MESNA+IFO-GCSF		ncit:C174975
AEWS0031:Regimen A (cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, vincristine sulfate)
AEWS0031:Regimen B (cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, vincristine sulfate)
AEWS0331:VIDE-Surgery-R1-VAI-VAC/VAI
AEWS0331:VIDE-Surgery-R2-VAI-VAI/BuMel
AEWS0331:VIDE-Surgery-R3-VAI-MEME/TreoMel/BuMel/P2
AEWS07P1:EVAIA-EVAIA
AEWS07P1:VAIA-VACA
AEWS07P1:VAIA-VAIA
AEWS1031:Arm A (combination chemotherapy) (Cyclophosphamide, Dexrazoxane, Doxorubicin Hydrochloride, Etoposide, Ifosfamide, Vincristine Sulfate)
AEWS1031:Arm B (combination chemotherapy, topotecan hydrochloride) (Cyclophosphamide, Dexrazoxane, Doxorubicin Hydrochloride, Etoposide, Ifosfamide, Topotecan Hydrochloride, Vincristine Sulfate)
AEWS1031:VIDEC		ncit:C174982
AEWS1031:VIDEC+Topotecan		ncit:C174983
AEWS1221:VDC-IE		ncit:C174977
AEWS1221:VDC-IE+Ganitumab		ncit:C174978
AG881-C-004:Experimental: Vorasidenib (Vorasidenib)
AG881-C-004:Placebo Comparator: Matching Placebo (Matching Placebo)
AGCT0132:Arm 2
AGCT0132:Arm I (cisplatin, etoposide)
AGCT1531:Arm I (bleomycin, carboplatin, etoposide) (Carboplatin, Etoposide)
AGCT1531:Arm II (bleomycin, etoposide, cisplatin) (Cisplatin, Etoposide)
AGCT1531:Arm III (bleomycin, etoposide, carboplatin) (Carboplatin, Etoposide)
AGCT1531:Arm IV (bleomycin, etoposide, cisplatin) (Cisplatin, Etoposide)
AGCT1531:Low-Risk (observation)
AGCT1532:Arm A: TIP (paclitaxel, ifosfamide, cisplatin, pegylated G-CSF, G-CSF)
AGCT1532:Arm B: TI-CE (paclitaxel, ifosfamide, pegylated G-CSF, G-CSF, carboplatin, etoposide phosphate,)
AIEOP LAM 92:ICE(3+5+10) + ICE(2+3+7) + AUTO/ALLO SCT
AIEOP LAM 92:ICE(3+5+10) + ICE(2+3+7) + Consolidation
AIEOP LAM 92:ICE(3+5+10) + ICE(2+3+7) + Consolidation + AUTO/ALLO SCT
AIEOP LAM 92:ICE(3+5+10) + ICE(3+5+10) + AUTO/ALLO SCT
AIEOP LAM 92:ICE(3+5+10) + ICE(3+5+10) + Consolidation
AIEOP LAM 92:ICE(3+5+10) + ICE(3+5+10) + Consolidation + AUTO/ALLO SCT
AML BFM 2012:ADxE - AI-haM, AI- HAE - Standard Maintenance (Standard Risk Arm)
AML BFM 2012:ADxE - AI-haM, AI- HAE -Short Maintenance (Standard Risk Arm)
AML BFM 2012:ADxE - HAM- AI- haM-HAE -Short Maintenance (Standard Risk Arm)
AML BFM 2012:ADxE - HAM- AI- haM-HAE -Standard Maintenance (Standard Risk Arm)
AML BFM 2012:ADxE- HAM Sorafenib, AI Sorafenib, haM Sorafenib, Stem Cell Transplantation (High Risk Arm)
AML BFM 2012:ADxE- HAM, AI, haM, Stem Cell Transplantation (High Risk Arm)
AML BFM 2012:ADxE- HAM- AI-haM- HAE-Short Maintenance (Intermediate Risk Arm)
AML BFM 2012:ADxE- HAM- AI-haM- HAE-Standard Maintenance (Intermediate Risk Arm)
AML BFM 2012:CDxA- AI-haM, AI- HAE - Standard Maintenance (Standard Risk Arm)
AML BFM 2012:CDxA- AI-haM, AI- HAE -Short Maintenance (Standard Risk Arm)
AML BFM 2012:CDxA- HAM Sorafenib, AI Sorafenib, haM Sorafenib, Short Maintenance (Intermediate Risk Arm)
AML BFM 2012:CDxA- HAM Sorafenib, AI Sorafenib, haM Sorafenib, Standard Maintenance (Intermediate Risk Arm)
AML BFM 2012:CDxA- HAM Sorafenib, AI Sorafenib, haM Sorafenib, Stem Cell Transplantation (High Risk Arm)
AML BFM 2012:CDxA- HAM- AI- haM-HAE -Short Maintenance (Standard Risk Arm)
AML BFM 2012:CDxA- HAM- AI- haM-HAE -Standard Maintenance (Standard Risk Arm)
AML BFM 2012:CDxA-HAM, AI, haM, Stem Cell Transplantation(High Risk Arm)
AML BFM 2012:CDxA-HAM- AI-haM- HAE -Standard Maintenance (Intermediate Risk Arm)
AML BFM 2012:CDxA-HAM- AI-haM- HAE-Short Maintenance (Intermediate Risk Arm)
AML BFM Registry 2012:ADxE- AI-haM-HAE- Standard Maintenance (Standard Risk Arm)
AML BFM Registry 2012:ADxE-HAM- AI-haM, HAE- Standard Maintenance (Intermediate Risk Arm)
AML BFM Registry 2012:ADxE-HAM- AI-haM, SCT (High Risk Arm)
AML-BFM 2004:ADxE- AI-haM-HAE- Standard maintenance, 12 Gy (Standard Risk arm)
AML-BFM 2004:ADxE- AI-haM-HAE- Standard maintenance, 18 Gy (Standard Risk arm)
AML-BFM 2004:ADxE-HAM- AI-haM, HAE- Standard maintenance, 12 Gy (High Risk arm)
AML-BFM 2004:ADxE-HAM- AI-haM, HAE- Standard maintenance, 18 Gy (High Risk arm)
AML-BFM 2004:ADxE-HAM- AI-haM, SCT
AML-BFM 2004:ADxE-HAM- AI/2CDA-haM, HAE- Standard maintenance, 12 Gy (High Risk arm)
AML-BFM 2004:ADxE-HAM- AI/2CDA-haM, HAE- Standard maintenance, 18 Gy (High Risk arm)
AML-BFM 2004:ADxE-HAM- AI/2CDA-haM, SCT
AML-BFM 2004:AIE- AI-haM-HAE- Standard maintenance, 12 Gy (Standard Risk arm)
AML-BFM 2004:AIE- AI-haM-HAE- Standard maintenance, 18 Gy(Standard Risk arm)
AML-BFM 2004:AIE-HAM- AI-haM, HAE- Standard maintenance, 12 Gy (High Risk arm)
AML-BFM 2004:AIE-HAM- AI-haM, HAE- Standard maintenance, 18 Gy (High Risk arm)
AML-BFM 2004:AIE-HAM- AI-haM, SCT
AML-BFM 2004:AIE-HAM- AI/2CDA-haM, HAE- Standard maintenance, 12 Gy (High Risk arm)
AML-BFM 2004:AIE-HAM- AI/2CDA-haM, HAE- Standard maintenance, 18 Gy (High Risk arm)
AML-BFM 2004:AIE-HAM- AI/2CDA-haM, SCT
ANBL0531:Group 2 (chemotherapy, surgery) (carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, topotecan hydrochloride, Filgrastim)
ANBL0531:Group 3 (chemotherapy, surgery) (carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, topotecan hydrochloride, Filgrastim)
ANBL0531:Group 4 (chemotherapy, surgery, antineoplastic therapy) (Isotretinoin, carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, topotecan hydrochloride, Filgrastim)
ANBL0531:Non-intermediate risk enrolled on intermediate risk trial
ANBL0532:Consolidation Arm A: single myeloablative consolidation (Carboplatin, Cisplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Filgrastim, Isotretinoin, Melphalan, Topotecan Hydrochloride, Vincristine Sulfate Liposome)
ANBL0532:Consolidation Arm B: tandem myeloablative consolidation (Carboplatin, Cisplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Filgrastim, Isotretinoin, Melphalan, Thiotepa, Topotecan Hydrochloride, Vincristine Sulfate Liposome)
ANBL1531:Arm A (chemotherapy, HSCT, EBRT) (Carboplatin, Cisplatin, Cyclophosphamide, Dexrazoxane Hydrochloride, Dinutuximab, Doxorubicin Hydrochloride, Etoposide Phosphate, Isotretinoin, Sargramostim, Thiotepa, Topotecan Hydrochloride, Vincristine Sulfate)
ANBL1531:Arm B (Iobenguane I-131, chemotherapy, HSCT, EBRT) (Carboplatin, Cisplatin, Cyclophosphamide, Dexrazoxane Hydrochloride, Dinutuximab, Doxorubicin Hydrochloride, Etoposide Phosphate, Isotretinoin, Sargramostim, Thiotepa, Topotecan Hydrochloride, Vincristine Sulfate)
ANBL1531:Arm C (Iobenguane I-131, chemotherapy, BuMel, HSCT, EBRT) (Busulfan, Cisplatin, Cyclophosphamide, Dexrazoxane Hydrochloride, Dinutuximab, Doxorubicin Hydrochloride, Etoposide Phosphate, Isotretinoin, Melphalan Hydrochloride, Sargramostim, Thiotepa, Topotecan Hydrochloride, Vincristine Sulfate)
ANBL1531:Arm D (chemotherapy, HSCT, EBRT) (Carboplatin, Cisplatin, Cyclophosphamide, Dexrazoxane Hydrochloride, Dinutuximab, Doxorubicin Hydrochloride, Etoposide Phosphate, Isotretinoin, Sargramostim, Thiotepa, Topotecan Hydrochloride, Vincristine Sulfate,)
ANBL1531:Arm E (crizotinib, chemotherapy, HSCT, EBRT) (Crizotinib, Carboplatin, Cisplatin, Cyclophosphamide, Dexrazoxane Hydrochloride, Dinutuximab, Doxorubicin Hydrochloride, Etoposide Phosphate, Isotretinoin, Sargramostim, Thiotepa, Topotecan Hydrochloride)
ANHL0131:Experimental: Consolidation with Vinblastine (doxorubicin hydrochloride, mercaptopurine, methotrexate, prednisone, vincristine sulfate)
ANHL0131:Standard APO with Vincristine (Arm I) (doxorubicin hydrochloride, mercaptopurine, methotrexate, prednisone, vincristine sulfate)
ANHL01P1:Group B (chemotherapy, protective therapy, monoclonal antib.) (doxorubicin hydrochloride, cyclophosphamide, methotrexate, rasburicase, leucovorin calcium, prednisone, methylprednisolone, cytarabine, vincristine sulfate, hydrocortisone sodium succinate)
ANHL01P1:Group C (Chemotherapy, monoclonal antibody therapy) (doxorubicin hydrochloride, cyclophosphamide, methotrexate, leucovorin calcium, prednisone, methylprednisolone, cytarabine, etoposide, vincristine sulfate, hydrocortisone sodium succinate)
AOST0331:Maintenance therapy group 1 arm I (Cisplatin, Doxorubicin Hydrochloride, Methotrexate)
AOST0331:Maintenance therapy group 1 arm II (Cisplatin, Doxorubicin Hydrochloride, Methotrexate)
AOST0331:Maintenance therapy group 2 arm I (Cisplatin, Doxorubicin Hydrochloride, Methotrexate)
AOST0331:Maintenance therapy group 2 arm II (Cisplatin, Doxorubicin Hydrochloride, Etoposide, Ifosfamide, Methotrexate)
APEC1621:Subprotcol M (HRAS gene alterations) (Tipifarnib)
APEC1621:Subprotocol A (NTRK1, NTRK2, or NTRK3 gene fusion) (Larotrectinib Sulfate)
APEC1621:Subprotocol B (FGFR1, FGFR2, FGFR3, or FGFR4 gene mutation) (Erdafitinib)
APEC1621:Subprotocol C (EZH2, SMARCB1, or SMARCA4 gene mutation) (Tazemetostat)
APEC1621:Subprotocol D (TSC1, TSC2, or PI3K/mTOR gene mutation) (Samotolisib)
APEC1621:Subprotocol E (activating MAPK pathway gene mutation) (Selumetinib Sulfate)
APEC1621:Subprotocol F (ALK or ROS1 gene alteration) (Ensartinib)
APEC1621:Subprotocol G (BRAF V600 gene mutation) (Vemurafenib)
APEC1621:Subprotocol H (ATM, BRCA1, BRCA2, RAD51C, RAD51D mutations) (Olaparib)
APEC1621:Subprotocol I (Rb positive, alterations in cell cycle genes) (Palbociclib)
APEC1621:Subprotocol J (MAPK pathway mutations) (Ulixertinib)
APEC1621:Subprotocol N (activating RET mutations) (Selpercatinib)
AREN1921:Arm I (Regimen UH-3) (Carboplatin, Cyclophosphamide, Doxorubicin, Etoposide, Irinotecan, Vincristine)
AREN1921:Arm II (Regimen ICE/Cyclo/Topo) (Carboplatin, Cyclophosphamide, Etoposide, Ifosfamide, Topotecan)
ARET0321:Treatment (chemotherapy, radiotherapy, autologous SCI) (Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Thiotepa, Vincristine Sulfate)
ARST0331:Regimen I
ARST0331:Regimen II
ARST0431:High Risk Rhabdomyosarcoma
ARST0531:Arm I (Chemotherapy, Radiotherapy)
ARST0531:Arm I (chemotherapy, radiotherapy) (Cyclophosphamide, Vincristine Sulfate)
ARST0531:Arm II (Chemotherapy, Radiotherapy)
ARST0531:Arm II (chemotherapy, radiotherapy) (Cyclophosphamide, Irinotecan Hydrochloride, Vincristine Sulfate)
ARST08P1:Group 1 (Chemotherapy, Radiation Therapy, Cixutumumab)
Arm A
Arm B
Arm C
Arm D
Arm E
Assigned to Regimen B
BRAINCHILD-01:Arm A (tumor cavity delivery) (HER2-specific chimeric antigen receptor (CAR) T cell)
BRAINCHILD-01:Arm B (intraventricular delivery) (HER2-specific chimeric antigen receptor (CAR) T cell)
BRAINCHILD-02:Arm A (tumor cavity delivery) (EGFR806-specific chimeric antigen receptor (CAR) T cell)
BRAINCHILD-02:Arm B (intraventricular delivery) (EGFR806-specific chimeric antigen receptor (CAR) T cell)
BRAINCHILD-03:Arm A (tumor cavity delivery) (CAR-T cell targeting B7H3)
BRAINCHILD-03:Arm B (intraventricular delivery) (CAR-T cell targeting B7H3)
BRAINCHILD-03:Arm C (DIPG, intraventricular delivery) (CAR-T cell targeting B7H3)
BRF116013: (Dabrafenib)
Baseline Treatment with 2 cycles
Baseline Treatment with 4 cycles
Baseline Treatment with 8 cycles
Bleomycin + Doxurubicin + Cisplatin (BAC)
CCG-921:Regimen A (VCR, lomustine, prednisone)
CCG-921:Regimen B (VCR, methylprednisone, lomustine, hydroxyurea, procarbazine, cisplatin, cyclophosphamide, cytarabine)
CCG-9921:Regimen A (vincristine, cisplatin, cyclophosphamide, etoposide)
CCG-9921:Regimen B (vincristine, carboplatin, ifosfamide, etoposide)
CCG-99701:Regimen A (carboplatin, vincristine, cyclophosphamide)
CCG-99701:Regimen B (carboplatin, vincristine, cyclophosphamide, cisplatin)
CCG-A5971:A0 (localized disease Stg I/II) Modified CCG BFM (asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, mercaptopurine, methotrexate, prednisone, thioguanine, vincristine sulfate)
CCG-A5971:A1 (Disseminated, No CNS - CCG mod BFM w/out intens (asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, mercaptopurine, methotrexate, prednisone, thioguanine, vincristine sulfate)
CCG-A5971:A2 (Disseminated, No CNS - CCG mod BFM w/ intens (asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, mercaptopurine, methotrexate, prednisone, thioguanine, vincristine sulfate)
CCG-A5971:B1 (Disseminated CNS- <Amend 7B) NHL/BFM-95 w/out intens (asparaginase, cyclophosphamide, cyt mercaptopurine, methotrexate, prednisone, thioguanine, vincristine sulfatearabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, leucovorin calcium,)
CCG-A5971:B1 (Disseminated CNS-) NHL/BFM-95 w/out intens (asparaginase, cyclophosphamide, cyt mercaptopurine, methotrexate, prednisone, thioguanine, vincristine sulfatearabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, leucovorin calcium)
CCG-A5971:B2 (CNS+) NHL/BFM-95 w/intens delayed radiation therapy (asparaginase, cyclophosphamide, cyt mercaptopurine, methotrexate, prednisone, thioguanine, vincristine sulfatearabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, leucovorin calcium,)
CCG-A5971:B2 (Disseminated,CNS- (< Amend 7B)) NHL/BFM-95 w/intens (asparaginase, cyclophosphamide, cyt mercaptopurine, methotrexate, prednisone, thioguanine, vincristine sulfatearabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, leucovorin calcium)
CCG-A9952:Regimen A (CV Chemotherapy) (carboplatin, vincristine sulfate)
CCG-A9952:Regimen B (TPCV Chemotherapy) (lomustine, procarbazine hydrochloride, thioguanine, vincristine sulfate)
CCG-A9961:Regimen A (cisplatin, lomustine, vincristine)
CCG-A9961:Regimen B (cisplatin, cyclophosphamide, vincristine)
CCG-D9803:Arm I (dactinomycin, vincristine sulfate, cyclophosphamide,)
CCG-D9803:Arm II (vincristine sulfate, cyclophosphamide, topotecan hydrochloride)
CCLG-EPSSG-NRSTS-2005:Group 1
CCLG-EPSSG-NRSTS-2005:Group 2 (ifosfamide , IFO-DOX)
CCLG-EPSSG-NRSTS-2005:Group 3 (IFO-DOX)
CCLG-EPSSG-NRSTS-2005:Group 4 (IFO-DOX, ifosfamide)
CCLG-EPSSG-NRSTS-2005:Group 5 (IFO-DOX)
CCLG-EPSSG-RMS-2005: ()
CCMC1411:High-grade Glioma/Pontine Glioma (Mebendazole, Bevacizumab, Irinotecan)
CCMC1411:Low-grade Glioma (Mebendazole, Vincristine, Carboplatin, Temozolomide)
CDRB436G2201:HGG cohort: Dabrafenib and trametinib (dabrafenib, Trametinib)
CDRB436G2201:LGG cohort: Carboplatin with vincristine (Carboplatin, Vincristine)
CDRB436G2201:LGG cohort: Dabrafenib and trametinib (dabrafenib, Trametinib)
CHEMO
CHEMO-ZOL		ncit:C186777
CHP735:Consolidation (Thiotepa, Etoposide, Carboplatin)
CHP735:Induction (Methrotrexate, Vincristine, Etoposide, Cyclophosphamide, Cisplatin)
CNS1100:Experimental (Busulfan)
CPT-SIOP-2000:Carboplatin + Etoposide + Vincristine (Carboplatin, Etoposide, Vincristine)
CPT-SIOP-2000:Cyclophosphamide + Etoposide + Vincristine (Cyclophosphamide, Etoposide, Vincristine)
CPT-SIOP-2009:Doxorubicin/cisplatin arm (2) (Carboplatin, Cisplatin, Cyclophosphamide, Dactinomycin, Doxorubicin, Etoposide, Vincristine)
CPT-SIOP-2009:Methotrexate Arm (3) (Carboplatin, cyclophosphamide, etoposide, Leucovorin, Methotrexate, Vincristine)
CPT-SIOP-2009:Standard Arm (1) (Carboplatin, Cyclophosphamide, etoposide, Vincristine)
CPT-SIOP-2009:Temozolomide Irinotecan arm (4) (Carboplatin, Cyclophosphamide, Etoposide, Irinotecan, Temozolomide, Vincristine)
CWS-IV-2002
CWS2002P:HR
CWS2002P:LR
CWS2002P:SR
CWS2002P:VHR
CWS91
CWS96:High Dose Therapy (HDT)
CWS96:Oral Maintenance Therapy (OMT)
ChildrenHLA:Phase 1 (MEK162)
ChildrenHLA:Phase 2 (MEK162)
ChildrenHLA:Target Validation (MEK162)
Cisplatin + Docetaxel
Cisplatin + Gemcitabine
Cisplatine + 5FU
D9602:Subgroup A
D9602:Subgroup B
D9802
D9803
DB - AML01:AIET-Immediate AM-Off Protocol
DB - AML01:AIET-Immediate FLA/Dnx-HA2E+HA3+HA2E
DB - AML01:AIET-Immediate FLA/Dnx-Off Protocol
DB - AML01:AIET-Immediate AM-HA2E+HA3+HA2E
DB - AML01:AIET-Post Recovery AM-HA2E+HA3+HA2E
DB - AML01:AIET-Post Recovery AM-Off Protocol
DB - AML01:AIET-Post Recovery FLA/Dnx-HA2E+HA3+HA2E
DB - AML01:AIET-Post Recovery FLA/Dnx-Off Protocol
DIPG-BATS:radiation + bevacizumab (Bevacizumab)
DIPG-BATS:radiation + bevacizumab + erlotinib (Bevacizumab, Erlotinib)
DIPG-BATS:radiation + bevacizumab + erlotinib + temozolomide (Bevacizumab, erlotinib, temozolomide)
DIPG-BATS:radiation + bevacizumab + temozolomide (Bevacizumab, Temozolomide,)
DOX		C1326
DOX-IFOS		C63686
Docetaxel + Cisplatin + 5FU
EE99:Not Randomized
EE99:R1-VAC
EE99:R1-VAI
EE99:R2Loc-BuMel
EE99:R2Loc-VAI
EE99:R2Pulm-BuMel
EE99:R2Pulm-VAI + lung RT
EICESS92:HR-EVAIA		ncit:C174987
EICESS92:HR-VAIA		ncit:C174986
EICESS92:SR-VACA		ncit:C174985
EICESS92:SR-VAIA		ncit:C174984
EZH-102:Open-label Tazemetostat (Tazemetostat)
EZH-202:Open-label Tazemetostat (Tazemetostat)
GCC1949:Core Regimen, sub-cohort A (indoximod with oral temozolomide) (Indoximod, Temozolomide)
GCC1949:Core Regimen, sub-cohort B (low-dose radiation or not all disease sites included, indoximod with oral temozolomide) (Indoximod, Temozolomide)
GCC1949:Core Regimen, sub-cohort C (palliative full-dose radiation, (indoximod with oral temozolomide)) (Indoximod, Temozolomide)
GCC1949:Salvage Regimen 1 (Cross-over to indoximod with oral metronomic cyclophosphamide and etoposide) (Indoximod, Cyclophosphamide, Etoposide)
GCC1949:Salvage Regimen 2 (Cross-over to indoximod with oral lomustine and temozolomide) (Indoximod, Temozolomide, Lomustine)
HGG-01:Active Comparator: Main Cohort: Chemoradiation + TMZ (Temozolomide (TMZ))
HGG-01:Experimental: Bevacizumab + TMZ Young Patient Cohort (YPC) (Bevacizumab, Temozolomide (TMZ))
HGG-01:Experimental: Main Cohort: Chemoradiation + Bevacizumab + TMZ (Bevacizumab, Temozolomide (TMZ))
HIT-SIOP PNET 4: Hyperfractionated radiotherapy
HIT-SIOP PNET 4: Standard Fractionation Regimen
HOD05: Experimental
HSPPC-96:Newly Diagnosed High Grade Glioma (HGG)
HSPPC-96:Recurrent HGG and Ependymoma
Head Start 4:Induction (vincristine, cisplatin, cyclophosphamide, etoposide, high-dose methotrexate)
Head Start 4:Single Cycle Intensive Chemotherapy (Carboplatin, thiotepa, etoposide)
Head Start 4:Tandem 3 Cycle Intensive Chemotherapy (Carboplatin, thiotepa)
Head Start II:Submyeloablative/consolidation chemotherapy (Carboplatin, thiotepa, etoposide)
Head Start II:induction (vincristine, cisplatin, cyclophosphamide, etoposide)
Head Start III:induction (vincristine, cisplatin, cyclophosphamide, etoposide, and high dose methotrexate)
Head Start III:myeloablative chemotherapy (thiotepa, carboplatin and etoposide)
ICG RMS96
INDIGO:Experimental: Vorasidenib (Vorasidenib)
INDIGO:Placebo Comparator: Matching Placebo (Matching Placebo)
IRS-III:Group 1 (vincristine (V), dactinomycin (A), cyclophosphamide (C) or standard VA)
IRS-III:Group 2 (intensive VA or repetitive-pulse VAC)
IRS-III:Group 3 (repetitive-pulse VAC or repetitivepulse VAdrC-VAC (Adr, Adriamycin [doxorubicin]))
JACLS AML99:HR
JACLS AML99:IR
JACLS AML99:LR
JPLSG AML05:JACLS
LOXO-TRK 15003:Phase 1 dose escalation: Dose expansion (Larotrectinib)
LOXO-TRK 15003:Phase 1 dose escalation: Dose level 1_Cohort 1 (Larotrectinib)
LOXO-TRK 15003:Phase 1 dose escalation: Dose level 2_Cohort 2 (Larotrectinib)
LOXO-TRK 15003:Phase 1 dose escalation: Dose level 3_Cohort 3 (Larotrectinib)
LOXO-TRK 15003:Phase 2 expansion: Other extra-cranial solid tumors_Cohort 2 (Larotrectinib)
LOXO-TRK 15003:Phase 2 expansion: Patients with tumors bearing NTRK fusions (IFS)_Cohort 1 (Larotrectinib)
LOXO-TRK 15003:Phase 2 expansion: Primary CNS tumors_Cohort 3 (Larotrectinib)
LOXO-TRK 15003:Phase 2 expansion: bone health assessment_sub-cohort (Larotrectinib)
MAP		ncit:C67339
MAP-GR		ncit:C186769
MAP-IE-PR		ncit:C186772
MAP-IFN-GR		ncit:C186770
MAP-NR		ncit:C186773
MAP-PR		ncit:C186771
MEK116540:Part A - TMT 0.0125 mg/kg/day (Trametinib)
MEK116540:Part A - TMT 0.025 mg/kg/day (Trametinib)
MEK116540:Part A - TMT 0.032 mg/kg/day (Trametinib)
MEK116540:Part A - TMT 0.04 mg/kg/day (Trametinib)
MEK116540:Part B - BRAF V600 mutant solid tumor (Trametinib)
MEK116540:Part B - LGG fusion (Trametinib)
MEK116540:Part B - NF-1 with PN (Trametinib)
MEK116540:Part B - Neuroblastoma (Trametinib)
MEK116540:Part C - TMT 0.025 mg/kg/day + 100% DRB RP2D (Trametinib, Dabrafenib)
MEK116540:Part C - TMT 0.025 mg/kg/day + 50% DRB RP2D (Trametinib, Dabrafenib)
MEK116540:Part C - TMT 0.032 mg/kg/day + 100% DRB RP2D (Trametinib, Dabrafenib)
MEK116540:Part D - LCH (Trametinib, Dabrafenib)
MEK116540:Part D - LGG (Trametinib, Dabrafenib)
MK-3475:MEL: Pembrolizumab 10 mg/kg Q2W (Part B) (Pembrolizumab)
MK-3475:MEL: Pembrolizumab 10 mg/kg Q3W (Parts B+D) (Pembrolizumab)
MK-3475:MEL: Pembrolizumab 2 mg/kg Q3W (Parts B+D) (Pembrolizumab)
MK-3475:NSCLC: Pembrolizumab 10 mg/kg Q2W (Part F) (Pembrolizumab)
MK-3475:NSCLC: Pembrolizumab 10 mg/kg Q3W (Part E-Not Enrolled) (Pembrolizumab)
MK-3475:NSCLC: Pembrolizumab 10 mg/kg Q3W (Parts C+F) (Pembrolizumab)
MK-3475:NSCLC: Pembrolizumab 2 mg/kg Q3W (Part E-Not Enrolled) (Pembrolizumab)
MK-3475:NSCLC: Pembrolizumab 2 mg/kg Q3W (Part F) (Pembrolizumab)
MK-3475:NSCLC: Pembrolizumab 5 mg/kg Q3W (Part E-Not Enrolled) (Pembrolizumab)
MK-3475:Solid Tumors: Pembrolizumab 1 mg/kg Q2W (Part A) (Pembrolizumab)
MK-3475:Solid Tumors: Pembrolizumab 10 mg/kg Q2W (Parts A+A1) (Pembrolizumab)
MK-3475:Solid Tumors: Pembrolizumab 3 mg/kg Q2W (Part A) (Pembrolizumab)
MK-3475:Solid Tumors: Pembrolizumab Titration Cohort 1 Q3W (Part A2) (Pembrolizumab)
MK-3475:Solid Tumors: Pembrolizumab Titration Cohort 2 Q3W (Part A2) (Pembrolizumab)
MK-3475:Solid Tumors: Pembrolizumab Titration Cohort 3 Q3W (Part A2) (Pembrolizumab)
MMT95
MRC AML12:ADE-ADE-MACE-CLASP-MidAC
MRC AML12:ADE-ADE-MACE-CLASP-SCT
MRC AML12:ADE-ADE-MACE-MidAC
MRC AML12:ADE-ADE-MACE-SCT
MRC AML12:ADE-ADE-off trial
MRC AML12:MAE-MAE-MACE-CLASP-MidAC
MRC AML12:MAE-MAE-MACE-CLASP-SCT
MRC AML12:MAE-MAE-MACE-MidAC
MRC AML12:MAE-MAE-MACE-SCT
MRC AML12:MAE-MAE-Off Trial
MRC AML15:ADE-ADE-AraC3g-AraC3g-AraC
MRC AML15:ADE-ADE-AraC3g-AraC3g-No Further Therapy
MRC AML15:ADE-ADE-AraC3g/Mytolarg-AraC3g-AraC
MRC AML15:ADE-ADE-AraC3g/Mytolarg-AraC3g-No Further Therapy
MRC AML15:ADE-ADE-MACE-MidAC-AraC
MRC AML15:ADE-ADE-MACE-MidAC-No Further Therapy
MRC AML15:ADE-ADE-MACE/Mytolarg-MidAC-AraC
MRC AML15:ADE-ADE-MACE/Mytolarg-MidAC-No Further Therapy
MRC AML15:ADE/Mytolarg-ADE-AraC3g-AraC3g-AraC
MRC AML15:ADE/Mytolarg-ADE-AraC3g-AraC3g-No Further Therapy
MRC AML15:ADE/Mytolarg-ADE-AraC3g/Mytolarg-AraC3g-AraC
MRC AML15:ADE/Mytolarg-ADE-AraC3g/Mytolarg-AraC3g-No Further Therapy
MRC AML15:ADE/Mytolarg-ADE-MACE-MidAC-AraC
MRC AML15:ADE/Mytolarg-ADE-MACE-MidAC-No Further Therapy
MRC AML15:ADE/Mytolarg-ADE-MACE/Mytolarg-MidAC-AraC
MRC AML15:ADE/Mytolarg-ADE-MACE/Mytolarg-MidAC-No Further Therapy
MRC AML15:FLAGIda-FLAGIda-AraC3g-AraC3g-AraC
MRC AML15:FLAGIda-FLAGIda-AraC3g-AraC3g-No Further Therapy
MRC AML15:FLAGIda-FLAGIda-AraC3g/Mytolarg-AraC3g-AraC
MRC AML15:FLAGIda-FLAGIda-AraC3g/Mytolarg-AraC3g-No Further Therapy
MRC AML15:FLAGIda-FLAGIda-MACE-MidAC-AraC
MRC AML15:FLAGIda-FLAGIda-MACE-MidAC-No Further Therapy
MRC AML15:FLAGIda-FLAGIda-MACE/Mytolarg-MidAC-AraC
MRC AML15:FLAGIda-FLAGIda-MACE/Mytolarg-MidAC-No Further Therapy
MRC AML15:FLAGIda/Mytolarg-FLAGIda-AraC3g-AraC3g-AraC
MRC AML15:FLAGIda/Mytolarg-FLAGIda-AraC3g-AraC3g-No Further Therapy
MRC AML15:FLAGIda/Mytolarg-FLAGIda-AraC3g/Mytolarg-AraC3g-AraC
MRC AML15:FLAGIda/Mytolarg-FLAGIda-AraC3g/Mytolarg-AraC3g-No Further Therapy
MRC AML15:FLAGIda/Mytolarg-FLAGIda-MACE-MidAC-AraC
MRC AML15:FLAGIda/Mytolarg-FLAGIda-MACE-MidAC-No Further Therapy
MRC AML15:FLAGIda/Mytolarg-FLAGIda-MACE/Mytolarg-MidAC-AraC
MRC AML15:FLAGIda/Mytolarg-FLAGIda-MACE/Mytolarg-MidAC-No Further Therapy
MSKCC-03077:patients have no evidence of disease (anti-GD2 murine IgG3 monoclonal antibody 3F8)
MSKCC-03077:patients have refractory bone marrow disease (anti-GD2 murine IgG3 monoclonal antibody 3F8)
MTS2008
NCI-MATCH:Subprotocol A (EGFR activating mutation) (Afatinib, Afatinib Dimaleate,)
NCI-MATCH:Subprotocol B (HER2 activating mutation) (Afatinib, Afatinib Dimaleate,)
NCI-MATCH:Subprotocol C1 (MET amplification) (Crizotinib)
NCI-MATCH:Subprotocol C2 (MET exon 14 deletion/mutation) (Crizotinib)
NCI-MATCH:Subprotocol E (EGFR T790M or rare activating mutation) (Osimertinib)
NCI-MATCH:Subprotocol F (ALK translocation) (Crizotinib)
NCI-MATCH:Subprotocol G (ROS1 translocation or inversion) (Crizotinib)
NCI-MATCH:Subprotocol H (BRAF V600E/R/K/D mutation) (Dabrafenib, Dabrafenib Mesylate, Trametinib)
NCI-MATCH:Subprotocol I (PIK3CA mutation) (Taselisib)
NCI-MATCH:Subprotocol J (HER2 amplification >= 7 copy numbers
NCI-MATCH:Subprotocol K1 (FGFR amplification) (Erdafitinib)
NCI-MATCH:Subprotocol K2 (FGFR mutation or fusion) (Erdafitinib)
NCI-MATCH:Subprotocol L (mTOR mutation) (Sapanisertib)
NCI-MATCH:Subprotocol M (TSC1 or TSC2 mutation) (Sapanisertib)
NCI-MATCH:Subprotocol N (PTEN mutation or deletion and PTEN expression) (PI3K-beta Inhibitor GSK2636771)
NCI-MATCH:Subprotocol P (PTEN loss) (PI3K-beta Inhibitor GSK2636771)
NCI-MATCH:Subprotocol Q (HER2 amplification) (Trastuzumab)
NCI-MATCH:Subprotocol R (BRAF fusion or BRAF non-V600 mutation) (Trametinib)
NCI-MATCH:Subprotocol S1 (NF1 mutation) (Trametinib)
NCI-MATCH:Subprotocol S2 (GNAQ or GNA11 mutation) (Trametinib)
NCI-MATCH:Subprotocol T (SMO or PTCH1 mutation) (Vismodegib)
NCI-MATCH:Subprotocol U (NF2 inactivating mutation) (Defactinib, Defactinib,)
NCI-MATCH:Subprotocol V (cKIT exon 9, 11, 13, or 14 mutation) (Sunitinib Malate)
NCI-MATCH:Subprotocol W (FGFR pathway aberrations) (FGFR Inhibitor AZD4547)
NCI-MATCH:Subprotocol X (DDR2 S768R, I638F, or L239R mutation) (Dasatinib)
NCI-MATCH:Subprotocol Y (Akt mutation) (Capivasertib)
NCI-MATCH:Subprotocol Z1A (NRAS mutation in codon 12, 13, or 61) (Binimetinib)
NCI-MATCH:Subprotocol Z1B (CCND1, 2, or 3 amplification with Rb by IHC) (Palbociclib)
NCI-MATCH:Subprotocol Z1C (CDK4 or CDK6 amplification and Rb protein) (Palbociclib)
NCI-MATCH:Subprotocol Z1D (Loss of MLH1 or MSH2 by IHC) (Nivolumab)
NCI-MATCH:Subprotocol Z1E (NTRK1, NTRK2 or NTRK3 gene fusion) (Larotrectinib, Larotrectinib Sulfate)
NCI-MATCH:Subprotocol Z1F (PIK3CA mutation) (Copanlisib, Copanlisib Hydrochloride)
NCI-MATCH:Subprotocol Z1G (PTEN loss) (Copanlisib, Copanlisib Hydrochloride)
NCI-MATCH:Subprotocol Z1H (PTEN mutation) (Copanlisib, Copanlisib Hydrochloride)
NCI-MATCH:Subprotocol Z1I (BRCA1 or BRCA2 gene mutation) (Adavosertib, Irinotecan Hydrochloride)
NCI-MATCH:Subprotocol Z1K (AKT mutation) (Ipatasertib)
NCI-MATCH:Subprotocol Z1L (BRAF fusion, aberration or non-V600 mutation) (Ulixertinib)
NCI-MATCH:Subprotocol Z1M (LAG-3 expression >= 1%) (Nivolumab, Relatlimab)
NCT01185964:Phase 1b: Olaratumab + doxorubicin (Doxorubicin)
NCT01185964:Phase 2: Doxorubicin: Optional Olaratumab After Progression (Doxorubicin)
NCT01185964:Phase 2: Olaratumab and doxorubicin (Doxorubicin)
NCT02924038:IMA950/poly-ICLC subQ only
NCT02924038:IMA950/poly-ICLC subcutaneous (subQ) + Varlilumab IV
NCT03696355:Stratum A1 (GDC0084)
NCT03696355:Stratum A2 (GDC0084)
NLG2105:Group 1 (Indoximod, Temozolomide)
NLG2105:Group 2 (Indoximod, Temozolomide)
NLG2105:Group 3 (Indoximod, Temozolomide)
NLG2105:Group 3b (Indoximod, Temozolomide)
NLG2105:Group 4 (Indoximod, Cyclophosphamide)
NOPHO AML 2004:AIET-AM-HA1M-HA2E-HA3-HA2E + Gemtuzumab Ozagamicin
NOPHO AML 2004:AIET-AM-HA1M-HA2E-HA3-HA2E + No Further Therapy
NOPHO AML 2012:DEC -ADE-HA3E-FLA (Low Risk)
NOPHO AML 2012:DEC -ADE-HAM + SCT (High Risk 1)
NOPHO AML 2012:DEC -ADE-HAM-HA3E+ SCT (High Risk 2)
NOPHO AML 2012:DEC -ADE-HAM-HA3E-FLA + SCT (High Risk 3)
NOPHO AML 2012:DEC -ADE-Off Protocol
NOPHO AML 2012:DEC -FLAD-HA3E-FLA (Low Risk)
NOPHO AML 2012:DEC -FLAD-HAM + SCT (High Risk 1)
NOPHO AML 2012:DEC -FLAD-HAM-HA3E+ SCT (High Risk 2)
NOPHO AML 2012:DEC -FLAD-HAM-HA3E-FLA
NOPHO AML 2012:DEC -FLAD-HAM-HA3E-FLA + SCT (High Risk 3)
NOPHO AML 2012:DEC -FLAD-Off Protocol
NOPHO AML 2012:DEC-ADE-HAM-HA3E-FLA
NOPHO AML 2012:MEC-ADE-HA3E-FLA (Low Risk)
NOPHO AML 2012:MEC-ADE-HAM + SCT (High Risk 1)
NOPHO AML 2012:MEC-ADE-HAM-HA3E + SCT (High Risk 2)
NOPHO AML 2012:MEC-ADE-HAM-HA3E-FLA
NOPHO AML 2012:MEC-ADE-HAM-HA3E-FLA + SCT (High Risk 3)
NOPHO AML 2012:MEC-ADE-Off Protocol
NOPHO AML 2012:MEC-FLAD- Off Protocol
NOPHO AML 2012:MEC-FLAD-HA3E-FLA (Low Risk)
NOPHO AML 2012:MEC-FLAD-HAM + SCT (High Risk 1)
NOPHO AML 2012:MEC-FLAD-HAM-HA3E+ SCT (High Risk 2)
NOPHO AML 2012:MEC-FLAD-HAM-HA3E-FLA
NOPHO AML 2012:MEC-FLAD-HAM-HA3E-FLA + SCT (High Risk 3)
No cisRA
Non-randomized conventional chemotherapy
Non-randomly assigned Single HSCT
Not Randomized
ONC201:Arm A (ONC201)
ONC201:Arm B (ONC201)
ONC201:Arm C (ONC201)
ONC201:Arm D (ONC201)
ONC201:Arm E (ONC201)
ONC201:Arm F (ONC201)
ONC201:Arm G (ONC201)
OZM-063:ARM A (Vinblastine)
OZM-063:ARM B (Vinblastine, Bevacizumab)
OZM-077:Phase I Dose-escalation (5 Azacytidine)
OZM-077:Posterior Fossa Ependymoma Expansion Arm (5 Azacytidine)
OZM-077:Recurrent Brain and Solid Tumour Expansion Arm (5 Azacytidine)
PBTC-029:Treatment (selumetinib) (Selumetinib)
PBTC-039:Treatment (peginterferon alfa-2b) ()
PBTC005:Stratum 1a: patients previously not treated with RT or only focal RT (Temozolomide, O-benzylguanine)
PBTC005:Stratum 1b: patients previously not treated with RT or only focal RT (Temozolomide, O-benzylguanine, G-CSF)
PBTC005:Stratum 2a: patients with prior craniospinal irradiation or myeloblative therapy. (Temozolomide, O-benzylguanine)
PBTC005:Stratum 2b: patients with prior craniospinal irradiation or myeloblative therapy. (Temozolomide, O-benzylguanine, G-CSF)
PBTC006:Stratum 1: newly diagnosed localized brainstem tumors (imatinib)
PBTC006:Stratum 2A: recurrent intracranial malignant gliomas - not using EIACD (imatinib)
PBTC006:Stratum 2B: recurrent intracranial malignant gliomas - using EIACD (imatinib)
PBTC007:Stratum 1: Newly diagnosed intrinsic brain stem glioma or incompletely resected supratentorial malignant gliomas not receiving enzyme-inducing anti-convulsant drugs (ZD1839 (Iressa™))
PBTC007:Stratum 2: Incompletely resected supratentorial malignant gliomas receiving enzyme-inducing anticonvulsant drugs (ZD1839 (Iressa™))
PBTC016:Stratum 1: those who are not receiving steroids (Lapatinib)
PBTC016:Stratum 2: those who are receiving steroids (Lapatinib)
PBTC022:Stratum A: Recurrent, progressive or refractory high-grade gliomas (Bevacizumab, Irinotecan)
PBTC022:Stratum B: Recurrent, progressive or refractory Intrinsic brain stem tumors (Bevacizumab, Irinotecan)
PBTC022:Stratum C: Recurrent or progressive Medulloblastomas (Bevacizumab, Irinotecan)
PBTC022:Stratum D: Recurrent or progressive Ependymomas (Bevacizumab, Irinotecan)
PBTC022:Stratum E: Recurrent low grade gliomas (Bevacizumab, Irinotecan)
PBTC043:Treatment (pomalidomide) (Pomalidomide)
PBTC047:Stratum 1 (Panobinostat)
PBTC047:Stratum 2 (Panobinostat)
PBTC048:Newly Diagnosed (Concurrent Optune/focal radiation therapy followed by Optune-only therapy) ()
PBTC048:Recurrent, Progressive or Refractory (Optune System) ()
PBTC055:Stratum 1: BRAF V600E LGG or HGG (Dabrafenib, Trametinib, Hydroxychloroquine)
PBTC055:Stratum 2: BRAF fusion/duplication or NF1- associated LGG (Trametinib, Hydroxychloroquine)
PBTC055:Stratum 3: LGGs with V600E (Dabrafenib, Trametinib, Hydroxychloroquine)
PBTC055:Stratum 4: HGGs with V600E (Dabrafenib, Trametinib, Hydroxychloroquine)
PBTC055:Stratum 5 LGG with BRAF duplication or fusion with any partner (Trametinib, Hydroxychloroquine)
PBTC055:Stratum 6 LGG with neurofibromatosis type 1 (Trametinib, Hydroxychloroquine)
PNOC005:Stratum A (Locally recurrent ATRT/medullo (delivery into tumor bed))
PNOC005:Stratum B (disseminated ATRT/medullo (delivery via LP x 1 dose))
PNOC005:Stratum C (disseminated medullo (delivery via LP x 2 doses))
PNOC007:Stratum A- DIPG treated with vaccine (K27M peptide vaccine, combined with Tetanus Toxoid peptide, emulsified in montanide. Poly-ICLC will be given concurrently)
PNOC007:Stratum B-non-DIPG DMG treated with vaccine; (K27M peptide vaccine, combined with Tetanus Toxoid peptide, emulsified in montanide. Poly-ICLC will be given concurrently)
PNOC007:Stratum C- DIPG/DMG treated with vaccine and nivolumab (Nivolumab)
PNOC008:Stratum A-Hemispheric HGG; (A combination of up to four FDA approved drugs based)
PNOC008:Stratum B-non-DIPG DMG (A combination of up to four FDA approved drugs based)
PNOC022:Arm 1 (ONC201, Panobinostat)
PNOC022:Arm 2 (ONC201, Paxalisib)
PNOC022:Arm 3 (ONC201, Panobinostat)
PNOC022:Arm 4 (ONC201, Paxalisib)
PNOC022:Arm 5 (ONC201, Panobinostat)
PNOC022:Arm 6 (ONC201, Paxalisib)
PNOC023:Arm A: ONC206 for participants with diffuse midline gliomas + prior therapy (ONC206)
PNOC023:Arm B: ONC206 + radiation therapy for newly diagnosed participants (ONC206)
PNOC023:Arm C: ONC206 + radiation therapy, DMGs with evidence of first progression but previously untreated (ONC206)
PNOC023:Arm D: ONC206 Therapy, Primary malignant CNS tumors with progression (ONC206)
PNOC026:Arm 1 - LGG (DAY101)
PNOC026:Arm 2 - LGG extension (DAY101)
PNOC026:Arm 3 - Solid tumor (DAY101)
PNOC027:Individualized Treatment Recommendation ()
POG-9905:Arm I (dexamethasone, leucovorin calcium, mercaptopurine, methotrexate, vincristine sulfate)
POG-9905:Arm II (dexamethasone, leucovorin calcium, mercaptopurine, methotrexate, vincristine sulfate)
POG-9905:Arm III (cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, leucovorin calcium, mercaptopurine, methotrexate, pegaspargase, thioguanine, vincristine sulfate)
POG-9905:Arm IV (cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, leucovorin calcium, mercaptopurine, methotrexate, pegaspargase, thioguanine, vincristine sulfate)
POG9233:Chemotherapy, surgery, radiation therapy (cisplatin, cyclophosphamide, vincristine sulfate, etoposide)
POG9233:Regimen A: Cycle A (cyclophosphamide, vincristine)
POG9233:Regimen A: Cycle A' (vincristine, cyclophosphamide)
POG9233:Regimen A: Cycle B (cisplatin, etoposide)
POG9233:Regimen B: Cycle X (cyclophosphamide, vincristine,)
POG9233:Regimen B: Cycle Y (cisplatin, etoposide)
POSTOP-CHEMO		ncit:C186775
POSTOP-CHEMO-MIF		ncit:C1867763
PPLLSG AML-98:HR
PPLLSG AML-98:SR
Purged
R0
R1
R115777-INT-11:1 (Gemcitabine with R115777)
R115777-INT-11:2 (Gemcitabine with Placebo)
R2
R3
RA only
RA+anti-GD2
REG-ACTIVE		C186778
REG-PLACEBO		C186779
REMATCH:Left ventricular assist device (Left ventricular assist device)
REMATCH:Optimal medical therapy (Optimal medical therapy)
RMS 4.99
RMS2005
RTOG-0929:Phase I: Dose Level 1 (temozolomide, ABT-888)
RTOG-0929:Phase I: Dose Level 2a (temozolomide, ABT-888)
RTOG-0929:Phase I: Dose Level 2b (temozolomide, ABT-888)
RTOG-0929:Phase I: Dose Level 3 (temozolomide, ABT-888)
RTOG-0929:Phase II: Arm 1/BEV-FAILURE (temozolomide, ABT-888)
RTOG-0929:Phase II: Arm 1/BEV-NAIVE (temozolomide, ABT-888)
RTOG-0929:Phase II: Arm 2/BEV-FAILURE (temozolomide, ABT-888)
RTOG-0929:Phase II: Arm 2/BEV-NAIVE (temozolomide, ABT-888)
Randomized ablative chemotherapy with BMT
Randomized conventional chemotherapy
Randomized to Regimen B
Randomized to Single HSCT
Randomized to Tandem HSCT
Re-MATCH:Group A ()
Re-MATCH:Group B ()
Regimen A
Regimen B
SARC006:Chemotherapy and local control by radiotherapy and surgery (doxorubicin hydrochloride, etoposide, ifosfamide)
SARC006:Chemotherapy and local control by surgery (doxorubicin hydrochloride, etoposide, ifosfamide)
SARC011:Cohort 1: Ewings Sarcoma Primary Cohort (RG1507)
SARC011:Cohort 2: Ewings Sarcoma Secondary Cohort (RG1507)
SARC011:Cohort 3: Ewings Sarcoma Expanded Cohort (RG1507)
SARC011:Cohort 4: Osteosarcoma (RG1507)
SARC011:Cohort 5: Synovial Sarcoma (RG1507)
SARC011:Cohort 6: Rhabdomyosarcoma (RG1507)
SARC011:Cohort 7a: Alveolar Soft Part Sarcoma (RG1507)
SARC011:Cohort 7b: Desmoplastic Small Round Cell Tumors. (RG1507)
SARC011:Cohort 7c: Extraskeletal Myxoid Chondrosarcoma (RG1507)
SARC011:Cohort 7d: Clear Cell Sarcoma (RG1507)
SARC011:Cohort 7e: Myxoid Liposarcoma (RG1507)
SARC011:Cohort 8: Diagnosis Not Specified (RG1507)
SARC038: Experimental: Regorafenib and Nivolumab
SC-9006:Regimen A (Temozolomide, Etoposide, Sorafenib)
SC-9006:Regimen B (Temozolomide, Etoposide, Everolimus)
SC-9006:Regimen C (Temozolomide, Etoposide, Erlotinib)
SC-9006:Regimen D (Temozolomide, Etoposide, Dasatinib)
SCFE ELAM02:Induction + Consolidation 1 + Allo HSCT
SCFE ELAM02:Induction + Consolidation 1 + Consolidation 2 + Consolidation 3
SCFE ELAM02:Induction + Consolidation 1 + Consolidation 2 + Consolidation 3 + IL2 Maintenance
SEL-TH-1601:Stratum 1 - NF2 related vestibular schwannomas (Selumetinib)
SEL-TH-1601:Stratum 2: other NF2 related tumors (meningiomas and ependymoma) (Selumetinib)
SIOP CNS GCT II:Germinoma metastatic (none)
SIOP CNS GCT II:Germinoma non-metastatic (Carboplatin, Etoposide, Ifosfamide)
SIOP CNS GCT II:No Intervention: Teratoma ()
SIOP CNS GCT II:Non-Germinoma metastatic high risk (Cisplatin, Etoposide, Ifosfamide (high dose))
SIOP CNS GCT II:Non-Germinoma metastatic standard risk (Cisplatin, etoposide, Ifosfamide (standard))
SIOP CNS GCT II:Non-germinoma non-metastatic high risk (Cisplatin, Etoposide, Ifosfamide (high dose))
SIOP CNS GCT II:Non-germinoma non-metastatic standard risk (Cisplatin, etoposide, Ifosfamide (standard))
SIOP-CNS-GCT-96:Stratum I: Option 1 (see notes) (carboplatin, cisplatin, etoposide phosphate, ifosfamide)
SIOP-CNS-GCT-96:Stratum I: Option 2 (see notes) (carboplatin, cisplatin, etoposide phosphate, ifosfamide)
SIOP-CNS-GCT-96:Stratum II: (secreting tumors and embryonal carcinoma) (cisplatin, etoposide phosphate, ifosfamide)
SIOP-EP-II:Stratum 1 arm A (Vincristine, Etoposide, Cyclophosphamide, Cisplatin)
SIOP-EP-II:Stratum 1 arm B
SIOP-EP-II:Stratum 2 arm A (Vincristine, Etoposide, Cyclophosphamide, Methotrexate)
SIOP-EP-II:Stratum 2 arm B (Vincristine, Etoposide, Cyclophosphamide)
SIOP-EP-II:Stratum 3 arm A (Vincristine, Carboplatin, Methotrexate, Cyclophosphamide, Cisplatin, Valproate)
SIOP-EP-II:Stratum 3 arm B (Vincristine, Carboplatin, Methotrexate Cyclophosphamide, Cisplatin)
SIOP-LGG-2004:Control group
SIOP-LGG-2004:intensified induction chemotherapy group (vincristine, carboplatin, etoposide)
SIOP-LGG-2004:radiation therapy group
SIOP-LGG-2004:standard chemotherapy group (vincristine, carboplatin)
SIOP-PNET-4:Hyperfractionated radiotherapy
SIOP-PNET-4:Standard Fractionation Regimen
SJATART:Intervenion B2 (alisertib, methotrexate, cisplatin, carboplatin, cyclophosphamide, etoposide, topotecan, vincristine)
SJATART:Intervention B1 (alisertib, methotrexate, cisplatin, carboplatin, cyclophosphamide, etoposide, topotecan, vincristine)
SJATART:Stratum A (alisertib)
SJATART:Stratum B (alisertib, methotrexate, cisplatin, carboplatin, cyclophosphamide, etoposide, topotecan, vincristine)
SJATART:Stratum C (alisertib, cisplatin, cyclophosphamide, vincristine)
SJCRH AML02:HDAC-ADE+GO-C1-C2-C3
SJCRH AML02:HDAC-ADE+GO-SCT
SJCRH AML02:HDAC-ADE-C1-C2-C3
SJCRH AML02:HDAC-ADE-SCT
SJCRH AML02:LDAC-ADE+GO-C1-C2-C3
SJCRH AML02:LDAC-ADE+GO-SCT
SJCRH AML02:LDAC-ADE-C1-C2-C3
SJCRH AML02:LDAC-ADE-SCT
SJDAWN:A: ribociclib + gemcitabine (ribociclib, gemcitabine)
SJDAWN:B: ribociclib + trametinib (ribociclib, trametinib)
SJDAWN:C: ribociclib + sonidegib (ribociclib, sonidegib)
SJMB-96:Average-risk (filgrastim, amifostine trihydrate, cisplatin, cyclophosphamide, vincristine sulfate)
SJMB-96:High-risk (filgrastim, amifostine trihydrate, cisplatin, cyclophosphamide, vincristine sulfate)
SJMB03:Stratum 1 (high-risk group) (Vincristine, Cisplatin, Cyclophosphamide)
SJMB03:Stratum 2 (average-risk group) (Vincristine, Cisplatin, Cyclophosphamide)
SJMB12:Stratum N1: Standard Risk (Cyclophosphamide, Cisplatin, Vincristine,)
SJMB12:Stratum N2: Intermediate Risk (Cyclophosphamide, Cisplatin, Vincristine, Pemetrexed, Gemcitabine)
SJMB12:Stratum N3: High Risk (Cyclophosphamide, Cisplatin, Vincristine, Pemetrexed, Gemcitabine)
SJMB12:Stratum S1: Standard Risk (Cyclophosphamide, Cisplatin, Vincristine, Vismodegib)
SJMB12:Stratum S2: High Risk (Cyclophosphamide, Cisplatin, Vincristine, Vismodegib)
SJMB12:Stratum W1: Low Risk (Cyclophosphamide, Cisplatin, Vincristine,)
SJMB12:Stratum W2: Atypical (Cyclophosphamide, Cisplatin, Vincristine,)
SJMB12:Stratum W3: High Risk (Cyclophosphamide, Cisplatin, Vincristine,)
SJYC07:High-Risk Patients (MTX (methotrexate), Oncovin(R) (vincristine), Platinol-AQ(R) (cisplatin), Cytoxan(R) (cyclophosphamide), Velban(R) (vinblastine), Hycamptin(R) (topotecan), Tarceva(TM) (erlotinib), Vepesid(R), VP-16 (etoposide))
SJYC07:Intermediate-Risk Therapy (MTX (methotrexate), Oncovin(R) (vincristine), Platinol-AQ(R) (cisplatin), Cytoxan(R) (cyclophosphamide), Velban(R) (vinblastine), Hycamptin(R) (topotecan), Tarceva(TM) (erlotinib), Vepesid(R), VP-16 (etoposide))
SJYC07:Low-Risk Patients (MTX (methotrexate), Oncovin(R) (vincristine), Platinol-AQ(R) (cisplatin), Cytoxan(R) (cyclophosphamide), Paraplatin(R) (carboplatin), Vepesid(R), VP-16 (etoposide), Hycamptin(R) (topotecan), Tarceva(TM) (erlotinib))
STRIvE-02:SCRI-CARB7H3(s) ()
STRIvE-02:SCRI-CARB7H3(s)x19 ()
STRIvE-02:SCRI-CARB7H3(s)x19 plus pembrolizumab ()
Stupp Protocol:Radiotherapy with concomitant
Stupp Protocol:adjuvant chemotherapy with temozolomide (temozolomide)
TB-403:TB-403 100mg/kg (TB-403)
TB-403:TB-403 175mg/kg (TB-403)
TB-403:TB-403 20mg/kg (TB-403)
TB-403:TB-403 50mg/kg (TB-403)
TE09:BEP (Cisplatin)
TE09:CEP (Carboplatin)
TE13:BEP
TE13:BEP + GCSF
TE13:BOP/VIP
TE13:BOP/VIP + GCSF
TE20:BEP 3 Cycle/3 Day
TE20:BEP 3 Cycle/5 Day
TE20:BEP 3 Cycle/Selected 3 Day
TE20:BEP 4 Cycle/3 Day
TE20:BEP 4 Cycle/5 Day
TE20:BEP 4 Cycle/Selected 3 Day
TOTEM:Intensive follow up
TOTEM:Minimalist follow up
Unpurged
cisRA
rHSC-DIPGVax:"Lead In": rHSC-DIPGVax Monotherapy
rHSC-DIPGVax:Part A: rHSC-DIPGVax in Combination with BALSTILIMAB (Anti-PD1) (Balstilimab)
rHSC-DIPGVax:Part B: Dose Escalation of ZALIFRELIMAB (Anti-CTLA4) (Balstilimab, Zalifrelimab)
rHSC-DIPGVax:Part C: Dose Expansion (Balstilimab, Zalifrelimab)
Not Reported

SupportiveCareDetailEnum

Permissible Value	Description	Meaning
Prevention of Adverse Event		ncit:C185654
Stem Cell Mobilization		ncit:C62604
Treatment for Adverse Event		ncit:C88082
Other		ncit:C17649

SurgicalComplicationsEnum

Permissible Value	Description	Meaning
Bleed
Intra-operative Tumor Rupture
Not Applicable		ncit:C48660
Urgent Surgery for ICP
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

SuspectedReferringDiagnosisEnum

Permissible Value	Description	Meaning
Cataract		ncit:C26713
Coat's Disease
Endophthalmitis		ncit:C34586
Enucleated Eye
Normal		ncit:C162623
Not Applicable		ncit:C48660
Persistent Hyperplastic Primary Viterous (PHPV)
Red Eye
Retinoblastoma		ncit:C7541
Retinopathy of Prematurity
Uveitis		ncit:C26909

TechniqueEnum

Permissible Value	Description	Meaning
Brachytherapy		ncit:C15195
EBRT, 3D Conformal		ncit:C16035
EBRT, Double Scattering	(npc) ConsortiumNote: ENERGY_TYPE = Proton
EBRT, Intensity-Modulated
EBRT, NOS
EBRT, Passive Scattering
EBRT, Pencil Beam Scanning	(npc) ConsortiumNote: ENERGY_TYPE = Proton	ncit:C165502
EBRT, Stereotactic Body	(npc) ConsortiumNote: Stereotactic ablative body radiotherapy	ncit:C118286
EBRT, Stereotactic Radiosurgery		ncit:C15358
EBRT, Tomotherapy	(npc) ConsortiumNote: Helical IMRT	ncit:C62731
EBRT, Volume Modulated Arc Therapy		ncit:C104933
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

TimePointEnum

Permissible Value	Description	Meaning
Baseline		ncit:C25213
On Treatment		ncit:C142170
End of Treatment		ncit:C168935
Follow-Up Assessment		ncit:C168935
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C432234

TissueTypeEnum

Permissible Value	Description	Meaning
Bone		ncit:C12366
Soft Tissue		ncit:C12471
Oocyte		ncit:C12598
Embryo
Ovarian Cortical Tissue
Testicular Tissue		ncit:C33758
Sperm
Epididymal Sperm
Unknown		ncit:C17998
Not Reported		ncit:C43234

TissueTypeUtilizedEnum

Permissible Value	Description	Meaning
Cryopreserved Ovarian Tissue
Cryopreserved Embryo
Cryopreserved Oocyte
Cryopreserved Ovarian Tissue Oocyte
Cryopreserved Ejaculated Sperm
Cryopreserved Testicular Tissue Sperm
Cryopreserved TESE/TESA Sperm
Cryopreserved Testicular Tissue

TmpProductEnum

Permissible Value	Description	Meaning
Plasma		ncit:C13356
Platelets		ncit:C133278
RBC		ncit:C133280
WBC		ncit:C133281
Whole Blood		ncit:C41067
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

TmpTypeEnum

Permissible Value	Description	Meaning
Exchange Transfusion		ncit:C173284
Plasmapheresis		ncit:C15304
Simple Transfusion		ncit:C173285
Therapeutic Apheresis		ncit:C173286
Other		ncit:C17649
Not Reported		ncit:C43234

TnmFindingEnum

Permissible Value	Description	Meaning
Favorable Site, M0	(rms) ConsortiumNote: Tied to AGE_AT_STAGING.
Metastases, ML
Other site, any T, a, N0, M0
Other site, any T, a, N1, M0, any T, b, N0/N1, M0
Unknown
Not Reported

TnmTumorTEnum

Permissible Value	Description	Meaning
T0		ncit:C48719
T1		ncit:C48720
T1a		ncit:C48721
T1b		ncit:C48722
T1c		ncit:C48723
T2		ncit:C48724
T2a		ncit:C48725
T2b		ncit:C48726
T3
T3a		ncit:C48729
T3b		ncit:C48730
T3c		ncit:C48731
T3d		ncit:C148412
T3e
T4		ncit:C48732
T4a		ncit:C48733
T4b		ncit:C48734
T4c		ncit:C48735
T4d		ncit:C48736
TX		ncit:C48737
Tis		ncit:C48738

ToxicityDetailEnum

Permissible Value	Description	Meaning
Allergic Reaction		ncit:C114476
Cardiac Toxicity		ncit:C27994
Endocrine Toxicity		ncit:C138163
GI Toxicity		ncit:C185646
Hepatic Toxicity		ncit:C185645
Infection		ncit:C128320
Mucositis		ncit:C115965
Musculoskeletal Toxicity		ncit:C185647
Neuropathy		ncit:C4731
Neutropenia		ncit:C80520
Psychiatric Toxicity		ncit:C185648
Pulmonary Toxicity		ncit:C177374
Rashes		ncit:C39594
Renal Toxicity		ncit:C115459
Thrombocytopenia		ncit:C3408
Other		ncit:C17649

TransportMediaEnum

Permissible Value	Description	Meaning
Cooper Surgical (OFC Transport Media)
Lactated Ringers		ncit:C65149
Modified Human Tubal Fluid, NOS		ncit:C65149
Irvine Modified Human Tubal Fluid		ncit:C65149
Irvine Modified Human Tubal FluidOrigio Handling Media
Custodiol
Other

TreatmentVolumeEnum

Permissible Value	Description	Meaning
PTV High Risk	(npc) ConsortiumNote: Use for PTV1
PTV Intermediate Risk	(npc) ConsortiumNote: Use for PTV2
PTV Low Risk	(npc) ConsortiumNote: Use for PTV3

TrmTypeEnum

Permissible Value	Description	Meaning
Chemotherapy		ncit:C15632
Immunotherapy		ncit:C15262
Radiation Therapy
Stem Cell Transplant		ncit:C15431
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

VacterlhEnum

Permissible Value	Description	Meaning
Anal Anomaly	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019] (fa) ConsortiumNote: [Mexico Registry].[Congenital_anomalies_detected_at_birth].[1=anal]
Cardiac Structure Anomaly	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019] (fa) ConsortiumNote: [German FA Support Group Questionnaire].[Questions about Fanconi Anemia].[Which or where do you have physical abnormalities?].[Heart] (fa) ConsortiumNote: [Mexico Registry].[Congenital_anomalies_detected_at_birth].[2=cardiac]
Esophageal Duodenal Atresia	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019]
Hydrocephalus	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019] (fa) ConsortiumNote: [Mexico].[Congenital_anomalies_detected_at_birth].[5=hydrocephalus]
Renal Anomaly	(fa) ConsortiumNote: [Israel].[Renal Anomaly] (fa) ConsortiumNote: [Fiesco-Roa et al. - 2019] (fa) ConsortiumNote: [German FA Support Group Questionnaire].[Questions about Fanconi Anemia].[Which or where do you have physical abnormalities?].[Kidneys]
Tracheo-esophageal Fistula	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019] (fa) ConsortiumNote: [Mexico Registry].[Congenital_anomalies_detected_at_birth].[3= tracheoesophageal]
Upper Limb Anomaly	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019] (fa) ConsortiumNote: [German FA Support Group Questionnaire].[Questions about Fanconi Anemia].[Which or where do you have physical abnormalities?].[Thumb/Radius] (fa) ConsortiumNote: [Mexico Registry].[Congenital_anomalies_detected_at_birth].[4= radial ray]
Vertebral Anomaly	(fa) ConsortiumNote: [Fiesco-Roa et al. - 2019]

VitalMeasurementTypeEnum

Permissible Value	Description	Meaning
Diastolic Blood Pressure		ncit:C25299
Pulse		ncit:C25749
Respiratory Rate		ncit:C49678
Systolic Blood Pressure		ncit:C25298
Temperature		ncit:C25206

Permissible Value	Description	Meaning
Confirmed		ncit:C25458
Suspected		ncit:C71458
Unknown		ncit:C17998
Not Reported		ncit:C43234

Permissible Value	Description	Meaning
Alternative Medications
Chemotherapy
Immunotherapy
Radiation Therapy
Stem Cell Transplant
Unknown
Not Reported

Permissible Value	Description	Meaning
Last Menstrual Period
Day of Implantation
Ultrasound Dating
Unspecified Method
Unknown		ncit:C17998

Permissible Value	Description	Meaning
Compound Heterozygous		ncit:C198518
Hemizygous		ncit:C64346
Heterozygous		ncit:C45825
Homozygous		ncit:C45826
Mosaic		ncit:C88144

Permissible Value	Description	Meaning
3' UTR		ncit:C13373
5' UTR		ncit:C13371
Intronic		ncit:C45387
Promoter		ncit:C13297
Splice Site		ncit:C45574

Permissible Value	Description	Meaning
Ann Arbor A Symptoms Indicator		ncit:C185483
Ann Arbor B Symptoms Indicator		ncit:C177585
Unknown		ncit:C17998
Not Reported		ncit:C43234

Permissible Value	Description	Meaning
cm		ncit:C49668
kg		ncit:C28252
kg/m2		ncit:C49671
m2		ncit:C42569
lb
inch
Unknown
Not Reported

Permissible Value	Description	Meaning
Surveillance Assessment
Symptomatic Assessment
Unknown		ncit:C17998
Not Reported		ncit:C43234

Permissible Value	Description	Meaning
High Grade Dysplasia		ncit:C156083
Indeterminate for Dysplasia
Low Grade Dysplasia		ncit:C156084
No Dysplasia

Permissible Value	Description	Meaning
Flow Cytometry		ncit:C16585
Morphology		ncit:C35867
Other		ncit:C17649
Unknown		ncit:C17998
Not Reported		ncit:C43234

Permissible Value	Description	Meaning
M1 (Less Than 5% blasts)		ncit:C137698
M2 (5-25% Blasts)		ncit:C146709
M3 (Greater Than 25% Blasts)		ncit:C140330

Permissible Value	Description	Meaning
None
Sequential
Simultaneous Integrated		ncit:C121139
Unknown		ncit:C17998
Not Reported		ncit:C43234

Permissible Value	Description	Meaning
Adequate
Excellent		ncit:C82488
Fair		ncit:C82489
Good		ncit:C64975
Inadequate
Not Documented
Poor		ncit:C77959

Permissible Value	Description	Meaning
% of CD34 Cells
% of T Cells
% of Granulocytes
% of White Blood Cells

Permissible Value	Description	Meaning
Bag
Block
Card
Cassette
Collection Tube
CoverSlip
Foil
Jar
Slide
Swab
Vial
slide
Unknown
Not Reported

Permissible Value	Description	Meaning
Cooper Surgical (SAGE OFC Cryomedia)
Modified human tubal fluid 5% DMSO 5% SSS
Other

Permissible Value	Description	Meaning
Endoscopic Third Ventriculostomy
No		ncit:C49487
Shunt, NOS		ncit:C50174
Ventriculoatrial Shunt
Ventriculoperitoneal Shunt		ncit:C168483

Permissible Value	Description	Meaning
Score 1		ncit:C99728
Score 2		ncit:C99747
Score 3		ncit:C99748
Score 4		ncit:C99749
Score 5		ncit:C99750

Permissible Value	Description	Meaning
Clinical Testing		ncit:C15791
Research/Retrospective
Retrospective Research		ncit:C53312

Permissible Value	Description	Meaning
Death Certificate
Medical Record Note
Pathology Report
Self-Report

PCDC Data Model 2.0

Subject

ExternalReference

StudyMetadata

StudySubgroupAssignment

ClinicalEpisode

Consult

OffProtocolTherapyOrStudy

SurvivalCharacteristics

FamilyMedicalHistory

MedicalHistory

SocialAndBehavioralDeterminantsOfHealth

VitalsAndAnthropometrics

LaboratoryTest

GeneticAnalysis

Biospecimen

FunctionTest

Immunohistochemistry

Diagnosis

Staging

DiseaseSiteAssessment

DiseaseCharacteristics

SurgicalProcedures

Medication

LocoregionalTherapy

ProtocolTreatmentModifications

RadiationTherapy

StemCellTransplant

TransfusionMedicineProcedure

CellularImmunotherapy

FertilityProcedures

SubjectResponse

MinimalResidualDisease

AdverseEvents

SubsequentMalignantNeoplasm

LateEffects

PatientReportedOutcomesMetadata

ReproductiveOutcomes

ActiveResolvedEnum

AdministrationSiteEnum

AdministrationStatusEnum

AdverseEventEnum

AeAttributionEnum

AeCodeSystemEnum

AeDetectionMethodEnum

AeExpectedEnum

AeGradeEnum

AeGradeSystemEnum

AeInterventionEnum

AeOutcomeEnum

AePathogenConfirmationEnum

AePathogenEnum

AePathogenStatusEnum

AeSiteEnum

AeSystemEnum

AeTreatmentEnum

AgeAtPregnancyMethodEnum

AgePrecisionEnum

AllelicStateEnum

AltStatusEnum

AlterationEffectEnum

AlterationEnum

AlterationRegionEnum

AlterationTypeEnum

AnaplasiaTypeEnum

AnnArborModAbEnum

AnteriorSegmentExamEnum

AnthropometricMeasurementResultUnitEnum

AnthropometricMeasurementTypeEnum

AssessmentReasonEnum

AssistedConceptionEnum

AssociatedConditionEnum

AttributionEnum

AvnJointEnum

BarrettsEsophagusEnum

BbpsScoreEnum

BiologicalAnalyteEnum

BirthWeightUnitEnum

BmAnalysisMethodAtResponseEnum

BmMorphologyEnum

PCDC Data Model `2.0`

Permissible Value	Description	Meaning
Localized
Metastatic
Indeterminant
Unknown		ncit:C17998
Not Reported		ncit:C43234

Permissible Value	Description	Meaning
Mild		ncit:C8362
Moderate		ncit:C8363
Severe		ncit:C8364
Unknown		ncit:C17998
Not Reported		ncit:C43234

Permissible Value	Description	Meaning
Subject has had one or more events
Subject is censored (i.e. has had no events(s))
Unknown
Not Reported

Permissible Value	Description	Meaning
Zygote
Cleavage
Blastocyst
Both Cleavage and Blastocyst
Unknown
Not Reported

Permissible Value	Description	Meaning
Electron		ncit:C40428
Photon		ncit:C88112
Proton		ncit:C66897
Other
Unknown		ncit:C17998
Not Reported		ncit:C43234

Permissible Value	Description	Meaning
Hispanic or Latino		ncit:C17459
Not Hispanic or Latino		ncit:C41222
Unknown		ncit:C17998
Not Reported		ncit:C43234

Permissible Value	Description	Meaning
Diagnostic Evaluation, Clinic and/or EUA
Subsequent, Clinic
Subsequent, EUA

Permissible Value	Description	Meaning
Alcohol		ncit:C168296
Drug Use
E-Cigarettes
Marijuana
Second-Hand Smoke
Tobacco		ncit:C18059
Not Reported
Unknown

Permissible Value	Description	Meaning
Current
Ever		ncit:C159710
Never		ncit:C70543
Past
Unknown		ncit:C17998
Not Reported		ncit:C43234

Permissible Value	Description	Meaning
Tumor, Focal		ncit:C157425
Tumor, NOS		ncit:C3262
Unknown		ncit:C17998
Not Reported		ncit:C43234